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Background.  Depression and anxiety are common and debilitating disorders, 
and at least one third of patients do not respond to available interventions.  
Morita Therapy, a Japanese psychological therapy which contrasts with 
established Western approaches, is currently untested in the UK and may 
represent a potentially effective alternative approach. 
Aim.  To optimise and investigate the feasibility and acceptability of Morita 
Therapy as a treatment for depression and anxiety in the UK. 
Design.  Three studies were undertaken in line with the MRC framework (2008) 
for complex interventions.  Study One: scoping and systematic review to 
describe the extent, range and nature of Morita Therapy research activity 
reported in English.  Study Two: intervention optimisation study, integrating 
literature synthesis with qualitative research, to develop the UK Morita Therapy 
outpatient protocol.  Study Three: mixed methods feasibility study 
encompassing a pilot randomised controlled trial (RCT) and embedded 
qualitative interviews to prepare for a fully-powered RCT of Morita Therapy 
versus treatment as usual (TAU). 
Results.  Study One: 66 papers meeting the inclusion criteria highlighted 
heterogeneity in the implementation of Morita Therapy, and an absence of both 
UK-based research and relevant unbiased RCTs.  Study Two: a potentially 
deliverable and acceptable therapy protocol and tailored therapist training 
programme were developed for a UK population.  Study Three: 68 participants 
were recruited and 94% retained at four month follow-up; 70.6% of Morita 
Therapy participants adhered to the minimum treatment dose, and 66.7% 
achieved remission in depressive symptoms (compared to 30.0% in TAU).  
Qualitative and mixed methods findings indicated that Morita Therapy was 
broadly acceptable to therapists and participants, and highlighted potential 
moderators of acceptability, treatment adherence and outcomes. 
Conclusions.  Patients in the UK can accept the premise of Morita Therapy 
and find the approach beneficial.  It is feasible to conduct a large-scale UK-
based trial of Morita Therapy with minor modifications to the pilot trial protocols. 
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Notes on Thesis Structure 
Volume One of this thesis contains Chapters One to Eight inclusive; Volume 
Two contains Appendices and References. 
The intervention optimisation study and protocol for the feasibility study, 
reported in Chapters Five and Six respectively, are based on published articles: 
the intervention optimisation study has been published in Pilot and Feasibility 
Studies (Sugg, Richards and Frost, 2017); the protocol for the feasibility study 
has been published in Trials (Sugg, Richards and Frost, 2016).  Both articles 
are open access and subject to a Creative Commons Attribution 4.0 
International Public License (CC BY 4.0).  Additional information has been 
provided and formatting adjustments have been made to the articles in order to 
integrate them into the thesis as a whole.  The original articles are provided in 
Appendix III (intervention optimisation study) and Appendix VII (feasibility study 
protocol). 
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CHAPTER ONE.  INTRODUCTION 
This thesis reports the optimisation and investigation of the feasibility and 
acceptability of Morita Therapy as a treatment for depression and anxiety in 
adults in the UK, to prepare for a fully-powered randomised controlled trial 
(RCT) of Morita Therapy plus treatment as usual (TAU) versus TAU alone.  As 
a Japanese psychotherapy for common mental health disorders, Morita 
Therapy aims to re-orientate patients in the natural world through facilitating 
their acceptance and allowance of unpleasant thoughts and emotions as natural 
phenomenon.  As such, Morita Therapy contrasts with the focus of established 
Western approaches on symptom reduction and control (Krech, 2014).  At 
present, the acceptability and effectiveness of Morita Therapy for a UK 
population is unknown.  Thus, such investigations begin within this thesis. 
The purpose of this chapter is to outline the requirement for this programme of 
research in terms of the burden of depression and anxiety, the effectiveness of 
current treatment options and the importance of providing patients with 
alternative choices.  In this context, Morita Therapy is introduced as an 
approach with the potential to provide patients with a meaningfully distinct 
alternative to current treatments; Chapter Two presents a fuller discussion of 
and rationale for investigating this particular approach.  This chapter concludes 
with an overview of this thesis and a summary of each chapter. 
1.1 Background 
1.1.1 The burden of depression and anxiety 
Depression and generalised anxiety disorder (GAD) are the two most common 
mental health disorders, with one in six people in the UK experiencing such a 
disorder each year (McManus, Bebbington, Jenkins et al., 2016).  Overall, the 
cost of depression and anxiety in the UK is significant at an annual rate of 
£17bn in lost output and direct health care costs, and a £9bn impact on the 
Exchequer through benefit payments and lost tax receipts (Layard, 2006).  
Between 2011 and 2030, the effect of depression alone on aggregate economic 
output is predicted to be US$5·36 trillion globally (Bloom, Cafiero, Jané-Llopis 
et al., 2011). 
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Both disorders can be diagnosed using the DSM-V (American Psychiatric 
Association, 2013), with the diagnosis of depression also made using the ICD-
10 (World Health Organization, 1992) (currently under revision (World Health 
Organization, 2017)).  In both systems, a diagnosis of depression is primarily 
based on low mood and/or a loss of interest or pleasure; other symptoms 
include changes in appetite, insomnia or hypersomnia, psychomotor agitation or 
retardation, fatigue, difficulties concentrating and thoughts of worthlessness 
and/or suicide (American Psychiatric Association, 2013).  A diagnosis of GAD is 
primarily based on excessive anxiety and worry about everyday events and 
problems; other symptoms include restlessness, becoming easily fatigued, 
difficulty concentrating, irritability, muscle tension and sleep disturbance 
(American Psychiatric Association, 2013).   
In terms of days lost to disability, depression is the leading cause of disability 
worldwide, affecting 350 million people across the globe (Marcus, Yasamy, Van 
Ommeren et al., 2012).  Epidemiological studies illustrate the high prevalence 
rates for depression.  In the USA, lifetime prevalence has been estimated at 
16.2%; twelve month prevalence rates are 6.6% (Kessler, Berglund, Demler et 
al., 2003).  In the UK, the Adult Psychiatric Morbidity Survey estimated a point 
prevalence of 3.3% (Stansfeld, Clark, Bebbington et al., 2014). 
For individuals, depression is often chronic and recurrent (Keller, 2001; Kessler 
et al., 2003).  At least half of people who recover from an episode will 
experience at least one more; each episode increases the risk of future relapse 
(Eaton, Shao, Nestadt et al., 2008; Kupfer, 1991; Moffitt, Caspi, Taylor et al., 
2010).  Rates of both psychiatric and physical comorbidity, and risk for suicide, 
are also high (Andrews, Henderson and Hall, 2001; Harwood, Hawton, Hope et 
al., 2001; Kasper, Schindler and Neumeister, 1996; Kessler, Berglund, Demler 
et al., 2005a; O'Brien, Singleton, Bumpstead et al., 2001; Rosenthal, 2003). 
GAD is the second most frequently identified common mental health disorder in 
the UK, and accounts for up to 30% of the mental health problems presented to 
General Practitioners (McManus et al., 2016; Stansfeld et al., 2014).  The 
lifetime prevalence of GAD has been estimated at 5.7%; the point prevalence at 
5.9%, which is shown to be rising from previous years (Kessler et al., 2005a; 
Stansfeld et al., 2014).  GAD is typically chronic and disabling, and rates of 
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comorbidity are high (Holaway, Rodebaugh and Heimberg, 2006; Wittchen, 
2002). 
Furthermore, the comorbidity between anxiety and depression makes a strong 
contribution to the total disability attributed to mental disorders, with mixed 
anxiety and depression estimated to cause one fifth of lost working days in 
Britain (Andrews, Sanderson, Slade et al., 2000; Das-Munshi, Goldberg, 
Bebbington et al., 2008; Wittchen, 2002).  The National Psychiatric Comorbidity 
Survey estimates a point prevalence of mixed anxiety and depression at 7.8% 
in the UK: the most frequently identified diagnosis (Stansfeld et al., 2014).  Such 
comorbidity is associated with increased severity, chronicity, disability and use 
of health services (Alonso, Angermeyer, Bernert et al., 2004; Andrews, Slade 
and Issakidis, 2002; Kessler, Chiu, Demler et al., 2005b). 
1.1.2 Current treatment options 
Several interventions are considered efficacious in treating depression and 
GAD.  Medication and Cognitive Behavioural Therapy (CBT) have the strongest 
evidence-base, with evidence also for Interpersonal Therapy (IPT), Behavioural 
Activation (BA), and applied relaxation for GAD: thus, medication, CBT, IPT and 
BA are currently recommended by the National Institute for Health and Clinical 
Excellence (NICE) for the treatment of depression; medication, CBT and 
applied relaxation for GAD (National Collaborating Centre for Mental Health, 
2011; NICE, 2009). 
The forthcoming update to the NICE guidelines for depression (In Consultation) 
will expand these recommendations.  Thus, for the first-line treatment of less 
severe depression, group-based CBT, individual self-help, short-term 
psychodynamic therapy and physical activity are recommended alongside 
individual CBT, BA, IPT and medication.  For more severe depression, the 
recommended options are group or individual CBT, BA, short-term 
psychodynamic therapy and medication.  Collaborative care, incorporating a 
multi-professional approach to patient care, is also recommended for such 
patients.  In addition, stepped care, in which low-intensity treatment is provided 
followed by high-intensity treatment if necessary, is recommended as a means 
of organising the delivery of psychotherapy. 
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For patients who do not respond to first-line treatments (‘treatment-resistant 
depression’), few alternative treatments exist: NICE recommends combining 
psychotherapy with medication, augmenting medication or trying another 
psychotherapy of the aforementioned options.  Similarly, for those with chronic 
depression, CBT in combination with medication is recommended.  Whilst 
acceptance-based models of psychotherapy, such as Acceptance and 
Commitment Therapy (ACT) and Mindfulness-based Cognitive Therapy 
(MBCT), are also available, these are not recommended by NICE except in the 
case of MBCT as a possible relapse-prevention intervention for patients who 
are not currently depressed. 
1.1.3 The effectiveness of current treatments 
Research providing evidence for the effectiveness of the aforementioned NICE 
recommended treatments also suggests that they are approximately equally 
effective (e.g. Amick, Gartlehner, Gaynes et al., 2015; Cuijpers, Andersson, 
Donker et al., 2011; Cuijpers, Sijbrandij, Koole et al., 2013; Dugas, Brillon, 
Savard et al., 2010; Hunot, Churchill, Silva de Lima et al., 2007; Luborsky, 
Rosenthal, Diguer et al., 2002; Luty, Carter, McKenzie et al., 2007; Mitte, 2005; 
Richards, Ekers, McMillan et al., 2016; Spielmans, Berman and Usitalo, 2011; 
Wampold, Minami, Baskin et al., 2002).  However, research also demonstrates 
that they are not effective for all patients: many people are refractory to such 
interventions (Rush, Fava, Wisniewski et al., 2004).  Indeed, current treatments 
appear to have had little impact on the prevalence of common mental disorders 
in the UK, and both depression and anxiety remain chronic disorders despite 
the available interventions (Andrews et al., 2000; Stansfeld et al., 2014).   
The results of multiple RCTs were examined by NICE to inform the updated 
guidelines for depression (In Consultation).  For trials of recommended 
psychotherapies which report the number of patients reaching remission of 
depressive symptoms (n=32), the average remission rate was 44.3% (range 3.4 
- 92.7%).  Similarly, for trials of anti-depressant medication (ADM) which 
reported this data (n=32), the average remission rate was 41.8% (range 16.6 – 
62.9%).  Thus, on average, over 50% of patients remain depressed following 
treatment by ADM or recommended psychotherapies. 
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Similarly, data suggests that between one third and half of depressed patients 
treated with psychotherapy or ADM do not respond to treatment (typically 
defined as a 50% reduction in symptom severity from baseline) (Amick et al., 
2015; Depression Guideline Panel, 1993; DeRubeis, Hollon, Amsterdam et al., 
2005; Jarrett and Rush, 1994; Luty et al., 2007; Richards et al., 2016; Westen 
and Morrison, 2001).  Indeed, a large portion of the disease burden of 
depression is attributable to treatment-resistant depression (Greden, 2001; 
Malhi, Parker, Crawford et al., 2005).  For such patients, whilst CBT is one key 
recommendation made by NICE, the effectiveness of CBT is comparable to that 
found in other trials: one recent large-scale trial showed only 55% of non-
responders to ADM alone responded to CBT as an adjunct to ADM, with only 
40% achieving remission (Wiles, Thomas, Abel et al., 2013). 
Research suggests a similar pattern in the treatment of GAD: meta-analyses 
indicate only 46% of patients who receive psychotherapy based on CBT 
principles respond to treatment (Hunot et al., 2007) and only 44% of patients 
who complete any form of empirically supported psychotherapy can be deemed 
to be ‘improved’ (Westen and Morrison, 2001).  More recent trials of 
psychotherapy for GAD demonstrate an average response rate of 66% (range 
40 – 92%) (Dugas et al., 2010; Newman, Castonguay, Borkovec et al., 2011; 
Stanley, Wilson, Novy et al., 2009; Westra, Arkowitz and Dozois, 2009).  Thus, 
similarly to depression, between one third and half of patients remain anxious 
following recommended treatments for GAD. 
The ‘Improving Access to Psychological Therapies’ (IAPT) programme, a large-
scale UK initiative to provide NICE recommended psychotherapies for 
depression and anxiety within the stepped-care model (Clark, Layard, Smithies 
et al., 2009; NHS England, undated), provides further comparable data.  
According to the report of the first million patients receiving treatment, remission 
or ‘recovery’ is reached by fewer than 50% of patients who complete treatment, 
and only 64.6% show a reliable improvement in symptoms (Community & 
Mental Health team, 2016; IAPT, 2012). 
Thus, even when only those patients who complete treatment are taken into 
account, between one third and half of patients remain depressed and/or 
anxious following NICE recommended interventions.  Such failure to respond to 
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treatment increases patients’ risk of future relapse and the maintenance of 
recurring and chronic problems (Hollon, Muñoz, Barlow et al., 2002).  Thus, 
there is scope to develop and test new potentially effective treatments for 
depression and anxiety.  The rationale for such research is twofold: firstly, on a 
population level, alternative treatments may prove more effective than current 
options; secondly, on an individual level, it is important to provide patients with 
choice in treatment options. 
1.1.4 Supporting patient choice 
The importance of providing patient choice and considering patient preferences 
for treatment is enshrined in the forthcoming NICE guidelines for depression (In 
Consultation).  In order to provide such choice, treatments which are 
qualitatively distinct from the current options and thus have potential to offer 
patients a meaningful alternative warrant particular investigation. 
By establishing an opportunity for patients to choose between truly distinct 
treatments, work on matching patients to treatments may be facilitated.  This 
individualisation of depression treatment stems from the evidence that current 
treatments are approximately equally effective (commonly referred to as the 
‘dodo bird verdict’ (Rosenzweig, 1936)) and the reasons posited for this.  Whilst 
some argue that common therapeutic factors, such as empathy and other 
therapist effects, account for the effects exerted by all psychotherapies 
(Luborsky et al., 2002; Messer and Wampold, 2002; Rosenzweig, 1936), such 
assertions have not been proven in trials comparing ‘effective’ with ‘less 
effective’ therapists.  Others suggest that psychotherapies have different but 
equally effective mechanisms of change and/or that treatment effectiveness 
does vary at the level of the individual: that matching patient characteristics to 
treatment type can produce significant differences in the effectiveness of 
different treatments for different patients (Beutler, Engle, Mohr et al., 1991; Blatt 
and Felsen, 1993; Cuijpers and Christensen, 2017; Luborsky et al., 2002; 
Reynolds, Taylor and Shapiro, 1993). 
Whilst this argument is not new (Kiesler, 1966; Paul, 1967; Stiles, Shapiro and 
Elliott, 1986), little progress has been made in our understanding of which 
patients might benefit from which treatments, and little evidence currently exists 
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to guide treatment choice (Cuijpers, 2014; Cuijpers and Christensen, 2017; 
NICE, 2009).  However, work continues in an attempt to identify moderators of 
treatment effect and key factors in predicting the most optimal treatment option 
for individuals (e.g. DeRubeis, Cohen, Forand et al., 2014; Fournier, DeRubeis, 
Shelton et al., 2009; Kessler, Van Loo, Wardenaar et al., 2017; Kraemer, 2013).  
In the context of different treatments potentially proving effective for and 
acceptable to different patients, the provision of radically different approaches 
should aid this matching of patients to treatments. 
1.1.5 Morita Therapy: an alternative approach 
Morita Therapy is a Japanese psychotherapy developed by Dr Masatake 
(Shōma) Morita (1874-1938) in 1919 (Morita, Kondo and LeVine, 1998).  
Originally developed as an inpatient treatment for psychological problems 
similar to GAD, Morita Therapy is now applied to a wider range of conditions, 
including depression (Ogawa, 2013).  The approach is practiced in Japan and 
applied to a limited degree in countries including Australia, China, North 
America, Russia and Rwanda (Ogawa, 2013). 
Morita Therapy is a holistic approach aiming to improve everyday functioning 
rather than targeting specific symptoms (Ogawa, 2013).  Through 
conceptualising unpleasant emotions as part of the natural ecology of human 
experience, Morita Therapy seeks to re-orientate patients in the natural world 
and potentiate their natural healing capacity.  Morita therapists thus help 
patients to move away from symptom preoccupation and combat, which are 
considered to exacerbate symptoms and interfere with this natural recovery 
process (Nakamura, Kitanishi, Maruyama et al., 2010). 
By helping patients to accept unpleasant thoughts and emotions as natural 
phenomena which ebb and flow as a matter of course, Morita Therapy is in 
sharp contrast to the focus of established Western approaches on symptom 
reduction and control (Krech, 2014).  In Morita Therapy, patients are taught to 
live with, rather than be without, their symptoms.  Thus, Morita Therapy has 
potential to provide patients in the UK with a distinct alternative to current 
treatment options.  In Chapter Two, the distinctive philosophical and cultural 
basis of Morita Therapy, grounded in an Eastern rather than Western 
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worldview, and the related differences between Morita Therapy and current 
treatment options are fully explored.  In this context, Chapter Two culminates in 
a discussion of the potential value of Morita Therapy as a UK treatment 
alternative which offers a fundamentally different approach to mental health 
(section 2.5.2). 
1.1.6 The need for this thesis 
As with the development of many other treatments to date (Hollon et al., 2002), 
initial evidence for the effectiveness of Morita Therapy is largely based on case 
studies, predominantly conducted in Japan.  An existing literature review of 
forty-nine such case studies and four quasi-experimental studies indicates that 
Morita Therapy has been reported as effective for a diverse range of issues, but 
that further work is required to both standardise its delivery and investigate its 
efficacy in controlled trials (Minami, 2011a).  In relation to this, in the context of 
evidence-based medicine and the need for experimental research, the full 
rationale for each study within this thesis is presented in Chapter Three; a 
summary is presented below. 
From contacts within the Japanese Society for Morita Therapy coupled with 
data within the existing review, upon commencing this thesis it was considered 
highly unlikely that research into Morita Therapy had been undertaken in the 
UK.  In the context of cultural differences (see Chapter Two), the effectiveness 
and appropriateness of Morita Therapy within Japan cannot be assumed to 
translate to a UK context.  Thus, it was anticipated that existing research cannot 
provide definitive evidence of how appropriate or effective Morita Therapy is for 
a UK population, nor demonstrate the views of UK patients and therapists about 
Morita Therapy.  However, in the absence of a systematic and up to date review 
of the literature, it cannot be established with confidence whether an RCT, or 
indeed any research, on Morita Therapy has been undertaken in the UK.  Thus, 
a scoping and systematic review enables confirmation of this gap in research 
whilst also providing opportunities to examine and summarise the extent, range 
and nature of Morita Therapy research activity available in English, and to 
appraise any RCTs of Morita Therapy identified. 
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Assuming the results of such a review reveal that the effectiveness of Morita 
Therapy has not been established for UK-based depressed patients, a fully-
powered UK-based RCT of Morita Therapy is required.  However, to maximise 
the chances of success in such a trial, it is necessary to first address several 
uncertainties (Thabane, Ma, Chu et al., 2010).  Firstly, given the lack of UK-
based research in the context of potential cultural differences, alongside the 
availability of a variety of Morita Therapy methods and lack of thorough 
treatment manuals (see Chapter Two), developmental work is required to 
develop a UK Morita Therapy outpatient protocol.  Secondly, a feasibility study 
is required to prepare for the design and conduct of a large-scale trial by 
addressing the clinical, procedural and methodological uncertainties associated 
with such a trial (discussed fully in Chapter Three). 
1.2 Thesis overview 
In response to the need for UK-based Morita Therapy research, the overall aim 
of this programme of work is to optimise and investigate the feasibility and 
acceptability of Morita Therapy as a treatment for depression and anxiety in the 
UK.  Thus, three studies were conducted in line with the Medical Research 
Council Framework (2008) for the development and evaluation of complex 
interventions: (1) a scoping and systematic review, primarily designed to 
describe the extent, range and nature of research activity reported in English in 
the field of Morita Therapy; (2) an intervention optimisation study designed to 
develop a deliverable and acceptable Morita Therapy outpatient protocol for a 
UK clinical population; (3) a mixed methods feasibility study designed to 
prepare for a fully-powered RCT of Morita Therapy plus treatment as usual 
(TAU) versus TAU alone. 
1.2.1 Thesis structure and content 
Chapter One has provided an outline of the prevalence and importance of the 
problem and illustrated the requirement for this thesis in terms of the 
effectiveness of current treatments and the importance of providing patients 
with alternative choices.  Morita Therapy has been introduced as an approach 
with potential to provide patients with a meaningfully distinct alternative to 
current treatments. 
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Chapter Two outlines the origin, definition and international development of 
Morita Therapy in the context of the philosophical and cultural underpinnings of 
the approach, and in contrast to established Western models of mental health 
and treatment.  The implications of this discussion for this thesis are presented, 
highlighting the potential for Morita Therapy to provide patients in the UK with a 
fundamentally different approach to mental health. 
Chapter Three outlines the methodology underpinning this thesis and methods 
adopted throughout.  Part one (methodological framework) situates this thesis in 
the context of evidence-based medicine, the development and evaluation of 
complex interventions and the value of mixed methods in health services 
research.  Part two (methodological approach) provides the overarching design 
of this thesis, including the rationale for each of the studies undertaken and a 
justification of the methods employed. 
Chapter Four presents the scoping and systematic review describing the extent, 
range and nature of research activity reported in English in the field of Morita 
Therapy, and assessing existing evidence on the effectiveness of Morita 
Therapy.  The implications of the review for this thesis, in terms of the current 
status of Morita Therapy research in the UK and beyond, are discussed. 
Chapter Five presents the intervention optimisation study undertaken to develop 
a deliverable and acceptable Morita Therapy outpatient protocol for a UK 
clinical population.  Thus, this process was used to develop a therapy protocol 
and tailored therapist training programme which were fit for purpose in 
proceeding to a UK-based Morita Therapy feasibility study. 
Chapters Six and Seven present the methods and results of the mixed methods 
feasibility study, incorporating a pilot RCT and embedded qualitative interviews, 
undertaken to prepare for a fully-powered RCT of Morita Therapy plus TAU 
versus TAU alone.  Key clinical, methodological and procedural uncertainties 
associated with a large-scale trial are addressed. 
Chapter Eight concludes this thesis with: (1) a summary of key findings; (2) a 
discussion of the substantive, methodological and theoretical contributions 
made within this thesis; (3) a discussion of the strengths and limitations of each 
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study and this thesis overall, and of alternative methodological approaches 
which could have been adopted; (4) recommendations for future research; (5) a 
discussion of the clinical implications of this thesis; (6) a discussion of the 
personal learning obtained through the completion of this thesis; (7) a summary 
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CHAPTER TWO.  SUBJECT OVERVIEW 
This chapter describes Morita Therapy in depth.  Firstly, the core features are 
presented, including the emphasis on nature, conceptualisation of 
psychopathology, process and objectives.  Secondly, the philosophical and 
cultural background of Morita Therapy is discussed.  Thirdly, a comparison 
between Morita Therapy and Western psychotherapies is presented.  Fourthly, 
the development and diversity of Morita Therapy over different formats, patient 
conditions and countries is described.  Finally, the implications of these 
considerations are discussed, highlighting the potential for Morita Therapy to 
provide UK patients with a fundamentally different approach to mental health. 
2.1 What is Morita Therapy? 
In Japan during the 1910s-1920s, Dr Shōma Morita developed a theory of 
psychopathology and related mode of treatment, Morita Therapy, based on his 
clinical observations and own experiences of neurotic symptoms (Kitanishi, 
2005; Morita et al., 1998).  Rather than targeting specific symptoms, Morita 
Therapy is a holistic approach which aims to re-orientate patients in nature, 
ultimately enabling them to live more fulfilling lives (Ogawa, 2013).  The focus is 
on learning to accept and live with suffering as it is, with unpleasant thoughts 
and emotions considered natural phenomena rather than something to control 
or eliminate (Nishizono, 2005).  Morita’s concepts, outlined below, are 
embedded in his philosophy of human nature concerning how the mind interacts 
with the body, and one’s health interacts with their relationship to the natural 
world (Fujita, 1986; Kondo, 1998). 
2.1.1 Nature 
According to Fujita (1986), internal and external human conflicts arise from 
circumstances in which modern humans are estranged from nature: people 
often seek to challenge, conquer and control the environment, essentially living 
in opposition to it (Reynolds, 1995a; Sato, 2011).  Nature here does not refer 
only to an isolated notion of the natural world as distinct from humans, but  
more broadly to the reality or truth of all phenomena, encompassing both 
human nature and the environment (Fujita, 1986; Morita et al., 1998).  Morita 
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Therapy seeks to redress this ultimately self-defeating imbalance by moving 
patients from an unnatural, inauthentic state to a natural, authentic state in 
which they observe, accept and live in harmony with the natural world, including 
their human nature (Fujita, 1986; Kitanishi, 2005; Morita et al., 1998; Sato, 
2011).  This is considered to be achieved by accepting the body and mind’s 
natural reactions to life, as opposed to resisting the inevitable cycles and 
fluctuations of (human) nature (Morita et al., 1998). 
Human nature 
According to Morita, all phenomena, including those of the mind and body, are 
in a constant state of flux: as humans are part of nature, always interacting with 
their environments, their thoughts and emotions shift accordingly (Fujita, 1986; 
Morita et al., 1998; Ogawa, 2007).  Thus, all emotions are natural, integral, 
legitimate and unavoidable features of human experience, induced by the 
circumstances of life (Morita et al., 1998).  As such, Morita Therapy 
conceptualises them only as pleasant or unpleasant (desired or undesired) but 
not as positive or negative (Minami, 2013; Reynolds, 1976).  Indeed, these 
responses are considered functional: the mind and emotions are capable of 
such shifts for the purpose of adapting to situations; ultimately, anxiety and pain 
are necessary for survival, driving the perseverance and improvement of life 
(Fujita, 1986; Kora, 1995; Morita et al., 1998).  As such, they allow life to flow in 
a balanced way, as long as they are not intellectually judged as either ‘positive’ 
or ‘negative’ (Kondo, 1975). 
As per the nature of the world, these responses cannot be controlled or 
manipulated by will: “our emotions evade our rule as the weather evades our 
command” (Ogawa, 2007) (p.92).  Accordingly, the aim of Morita Therapy is not 
to change thoughts or emotions.  Instead, Morita noted that all emotions will 
naturally dissipate, if left to do so (‘the law of emotion’) (Kora, 1995; Morita et 
al., 1998).  As emotions cannot be controlled, people are not considered 
responsible for them; in contrast, behaviour is considered controllable: the 
action one takes need not be dictated by one’s emotions or preferences, and 
people are considered responsible for taking the action which needs to be 
taken, regardless of accompanying emotions (Morita et al., 1998; Ogawa, 
2007). 
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Desire for life 
Morita’s concept of ‘desire for life’, or desire to live, may be defined as the 
natural motivational appetite for self-improvement, self-actualisation and self-
fulfilment; an instinctive force fundamental to human nature (Fujita, 1986; 
Kondo, 1975; Kora, 1995; Morita et al., 1998).  This concept may be considered 
akin to the humanistic notion of a life-propelling inner force: an innate and 
purposive drive to strive and preserve life (Carleton, 2002).  This inherent 
energy and intelligence strives for the optimal health which results when the 
body, mind and emotions are allowed to flow naturally, unimpeded by self-
imposed obstacles (section 2.1.2) (Ogawa, 2007).  Thus, Morita therapists do 
not teach patients how to live meaningful lives, but rather help them to remove 
the obstacles to their intuitive desire to do so. 
According to Morita, with desire for life comes an inevitable fear of death: desire 
and fear are two sides of the same coin (Minami, 2013; Morita et al., 1998).  
Therefore, the stronger one’s desire towards self-fulfilment, the more likely one 
is to experience self-concern and disappointment (Fujita, 1986; Ogawa, 2013).  
Thus, desire both propels one to live, and causes suffering, due to the 
discrepancy between the ideal (desired state) and the realities of life (Kitanishi, 
2005; Morita et al., 1998; Ogawa, 2007).  Accordingly, “those who suffer the 
most can be the most accomplished and successful because of their drive for 
advancement” (Ogawa, 2007) (p.43). Thus, suffering does not indicate a deficit, 
but an excess: a key concept in counteracting feelings of inadequacy and 
worthlessness (Kitanishi, 2005; Morita et al., 1998; Reynolds, 1976). 
Arugamama 
Arugamama (literally, ‘as it is’) means to accept things as they are: to concede 
to phenomenological reality and obey nature (Fujita, 1986; Morita et al., 1998; 
Ogawa, 2007; Reynolds, 1976).  This is conceptualised as a state of insight into 
human nature in which the authentic experience of the self, including the fluidity 
of thoughts and emotions, is accepted as such without judgement or resistance 
(Ishiyama, 2011; Kora, 1995).  This does not refer to an intellectual, wilful 
acceptance but rather an embodied, empirical, intuitive acceptance in which 
one is immersed in action, has no awareness of the self as set apart from 
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nature, and thus no self-consciousness and resulting difficulties (Nakai, 1947: 
cited in Fujita, 1986; Kitanishi, 2005; LeVine, 1998), living “in a state of nature, 
[in the] here and now” (Fujita, 1986) (p.8). 
According to Morita, with arugamama people leave symptoms as they are and 
lead life as it is (Fujita, 1986; Kora, 1995).  This acceptance of and response to 
reality, with its impermanence and transition, is considered to free people to 
change: people can adapt to life circumstances with spontaneity and flexibility 
(Kora, 1995; Ogawa, 2013).  Thus, arugamama denotes not resignation but 
empowerment through the knowledge of what is and is not controllable: one can 
identify what is happening in the moment and act accordingly, taking action to 
change situations in line with their desire for life, whilst allowing the mind and 
body’s natural transformations (Kora, 1995; Ogawa, 2007). 
2.1.2 Psychopathology in Morita Therapy 
With suffering considered a natural phenomenon originating secondarily to the 
desire for life, according to Morita problems do not stem from suffering itself but 
from the meaning attached to suffering: from a resistance to suffering and a 
fixation on the discrepancy between the ideal and real (Fujita, 1986; Morita et 
al., 1998; Ogawa, 2013).  Thus, it is the lack of naturalness, the distortion of the 
arugamama attitude, which is believed to cause difficulties (Fujita, 1986).  This 
is conceptualised as a misdirection of desire for life, with this intuitive energy 
squandered through futile efforts to eliminate unpleasant thoughts and emotions 
(Fujita, 1986; Kora, 1995; Ogawa, 2007). 
The vicious cycle of symptom aggravation 
Two self-defeating components, Toraware (mental preoccupation with 
symptoms) and Hakarai (attempts to control, fight or avoid symptoms), are 
conceptualised as producing a vicious cycle which maintains and exacerbates 
suffering (henceforth referred to as ‘the vicious cycle’) (Morita et al., 1998; 
Reynolds, 1982).  Toraware is characterised by: 
 Attentional fixation on symptoms (Morita et al., 1998).  This results in 
rumination and sensitivity to symptoms, perpetuating a cycle of increased 
CHAPTER TWO: SUBJECT OVERVIEW 
34 
 
distress and fixation (Morita et al., 1998; Ogawa, 2013).  In this way, people 
are ‘self-centred’: fixated on internal states (Kora, 1995; Morita et al., 1998). 
 Contradiction between ideal and real (Morita et al., 1998).  People with this 
trait exhibit a perfectionist, unrealistic, judgemental and dogmatic worldview 
and/or self-image; a discrepancy between how things should be and how 
they are, leading to a conditional acceptance of experiences, the self and 
the world (Kora, 1995; Minami, 2013).  This represents an attachment to 
ideas (the ideal), considered an illusionary product of the ever-changing 
mind, rather than an acceptance of reality, and leads to labelling of thoughts 
and emotions as positive/ acceptable or negative/ unacceptable, rather than 
experiencing them only as they are (Morita et al., 1998). 
Hakarai encapsulates futile attempts to control or remove these otherwise 
natural experiences, which maintain attention on them and aggravate them 
through the secondary distress of being unable to eliminate them (Minami, 
2013; Morita et al., 1998).  These efforts may be made cognitively, such as 
wilful attempts to suppress emotion, or behaviourally, such as activities 
undertaken to escape emotion (Nakamura et al., 2010).  Hakarai is understood 
to interfere in the law of emotion, impeding the mind and body’s capacity to 
dissipate emotions in line with their natural course (Minami, 2013). 
2.1.3 Key features in the process of Morita Therapy 
Overall, the role of the Morita therapist is to help patients to re-establish contact 
with nature, ultimately cultivating an allowance of authentic human nature with 
its natural ebb and flow of emotion.  More specifically, Morita therapists facilitate 
patients’ understanding of the vicious cycle, their capacity to be with symptoms, 
and their engagement in purposeful action (Minami, 2013). 
Fumon 
In an effort to shift patients’ attention away from their symptoms and towards 
purposeful behaviour, the traditional Morita therapist’s stance towards a 
patient’s expression of complaints is Fumon (selective non-response, or 
strategic inattention) (Nakamura et al., 2010).  As such, Morita therapists do not 
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dwell on patients’ symptoms or past, and do not attempt to elucidate reasons for 
suffering beyond the vicious cycle (Nakamura et al., 2010; Ogawa, 2013). 
Rest 
Traditionally, Morita Therapy begins with absolute bed rest, taking a restorative 
approach to potentiate a patient’s natural healing capacity (Kitanishi, 2005; 
Minami, 2013; Morita et al., 1998).  Through this elimination of external stimuli 
and the need to confront suffering, the vicious cycle is thought to be broken: 
thoughts and emotions run their natural course, allowing patients to experience 
how they naturally ebb and flow (Fujita, 1986; Kora, 1995; LeVine, In press; 
Morita et al., 1998; Reynolds, 1982). 
Paradoxically, rest is understood to begin the process of diminishing self-
centredness with increased self-focus (Reynolds, 1976).  Patients, “having 
saturated themselves with self-focus” (Ogawa, 2013) (p.165), reach a state of 
ennui and begin to redirect their attention from introversion (self-preoccupation 
and fixation on symptoms) to extroversion (ecological awareness and 
purposeful behaviour), returning to all of their senses with increased peripheral 
consciousness (Fujita, 1986; LeVine, 1993b; LeVine, In press; Morita et al., 
1998; Ogawa, 2013).  Accordingly, the patient’s spontaneous desire to do is 
heightened, motivated by a revitalised desire for life rather than pursued as a 
means to feel better (Fujita, 1986; Kora, 1995; Morita et al., 1998; Ogawa, 
2013).  This desire is then cultivated through action-taking. 
Action-taking 
A key feature of Morita Therapy is taking, and being absorbed in, purposeful 
action: activity undertaken for the sake of activity itself, not for overcoming 
suffering (Fujita, 1986).  Such action is not pursued with an overinvestment in 
outcomes; rather, patients are instructed “to ‘jump into doing’ what is immediate 
and necessary” (Ogawa, 2013) (p.64).  This action-taking is intended to be both 
a cause and consequence of the patient’s spontaneity and natural appetite for 
activity, constructively channelling the resurfacing desire for life, and inducing 
the confidence to undertake activity in an unconscious manner (Fujita, 1986; 
Minami, 2013; Morita et al., 1998). 
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Through an immersion in acting upon what is significant in their environments 
and continuing action in the presence of emotions, patients cultivate persistence 
and continue to experience how thoughts and emotions naturally ebb and flow if 
left alone (Fujita, 1986; LeVine, 1993a; Morita et al., 1998).  Indeed, it is 
understood that patients’ attentional fixation on their symptoms is dissipated 
(Morita et al., 1998) and they move beyond conscious and evaluative 
processing of the self: they “forget anxious thoughts and feelings and become 
one with action” (Ishiyama, 1986c) (p.379), a fluid mental state in which 
attention moves freely from one event to another with full contact between the 
self and the environment (Ishiyama, 1986c; Morita et al., 1998; Ogawa, 2007). 
Experiential learning 
The overarching method of Morita Therapy is experiential learning.  Given views 
on the dichotomous nature of the intellect (section 2.2) and tendency for this to 
perpetuate the vicious cycle through misinterpretation and over-analysis, 
experiential learning is considered to bring a deeper level of insight (Kondo, 
1975; Morita et al., 1998; Ogawa, 2013).  Through direct emotional 
experiences, contact with nature and personal discovery, patients are thought to 
develop intuitive, empirically-based and embodied understandings of natural 
rhythms and, consequently, a more realistic and spontaneous attitude with 
restored authenticity and desire for life (Fujita, 1986; Morita et al., 1998; Ogawa, 
2013).  Thus, arugamama is not an intellectually induced state willed or born out 
of cognitive re-appraisal, but a continually evolving state both cultivated and 
expressed through living purposefully in the here and now (Ogawa, 2013). 
2.1.4 Key objectives of Morita Therapy 
The overarching objective of Morita Therapy is to cultivate arugamama: an 
acceptance of reality, including suffering, as it is (Reynolds, 1976).  Thus, the 
aim is to remove the distortion of this attitude and disruption of natural cycles 
caused by the vicious cycle (Fujita, 1986; Morita et al., 1998; Nakamura et al., 
2010).  Through what is akin to a process of (experiential) re-education, patients 
are understood to learn the futility of resisting nature, “the quality of non-
resistance” (Krech, 2014) (p.39).  The purpose, therefore, is not to overcome 
suffering or eliminate symptoms: given Morita’s mechanisms of 
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psychopathology, such attempts are considered counter-productive (Minami, 
2013). 
The process of therapy is intended to restore and foreground attention on desire 
for life: through building tolerance for and acceptance of suffering, patients shift 
from being dominated and directed by this to being dominated and directed by 
the desires underlying it, re-channelling their energy into purposeful action 
which fulfils the expectations of such desires (Fujita, 1986; Reynolds, 1976).  
Thus, conduct becomes dictated by external reality rather than internal states; 
patients move from being self-oriented to being reality-oriented (Kora, 1995; 
Krech, 2014).  When patients reduce engagement in the vicious cycle and shift 
their attention to everyday living in this way, their symptoms naturally reduce as 
a by-product of living more meaningful, constructive and adaptable lives (Kora, 
1995; Nakamura et al., 2010; Ogawa, 2013). 
2.2 Philosophical and cultural background 
As philosophical concepts and cultural values are considered to have a 
significant impact upon definitions of mental illness and related 
psychotherapeutic approaches, a full understanding of Morita Therapy 
necessitates an understanding of the distinctive philosophical and sociocultural 
milieu in which it was developed (Busfield, 2001b; Fujita, 1986; Tanaka-
Matsumi, 2011; Tseng, Chang and Nishizono, 2005). 
2.2.1 Traditional Eastern and Western worldviews 
With East Asian cultures generally forming in isolation from Europe, it is 
understood that differences in thought patterns and philosophy emerged 
between them (Watts, 2012).  The core distinction between these worldviews 
may be described in terms of the extent to which the world is categorised and 
dichotomised, the associated way in which the relationship between humans 
and nature (as well as self/others, mind/body and reason/emotion) is 
conceptualised, and the related way in which people within these cultures 
understand and respond to phenomenological reality. 
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Eastern and Western modes of thought 
The dominant epistemology of the West, considered both a cause and 
consequence of the rise of science in Europe, can be traced in particular to the 
philosophies of Plato, Aristotle, Descartes and Kant (Fujita, 1986; Murase and 
Johnson, 1974; Williams, 2001).  These systems emphasise the rational 
application of the intellect in line with the divisions arising from self-conscious 
reflection between reason/ emotion, mind/ body, subject/ object, and internal 
experience/ external world (Fujita, 1986; Murase and Johnson, 1974; Williams, 
2001).  This dichotomisation is characteristic of Western thought which is 
analytical, discriminatory and conceptual: ideas are kept consistent by 
delineating categories as a means to intellectually understand the complexities 
of the world (DeVos, 1980; Reynolds, 1982; Suzuki, Fromm and De Martino, 
1960; Watts, 2012). 
This dualistic thinking led to a conceptual distinction between humans and 
nature: nature is objectified, reduced to systems of abstraction, and studied 
through scientific techniques which approach it as external to and separate from 
humans; humans have been understood in terms of the detached ego, as 
autonomous individuals who observe and control the environment (Davidson, 
2001; Fujita, 1986; Kjolhede, 2000; Pederson, 1977; Watts, 1961; Watts, 2012).  
Accordingly, dominant Western philosophy emphasises the importance of the 
individual and advocates bringing objective reality, including the external world, 
in line with one’s will through the manipulation of thought (DeVos, 1980; 
Reynolds, 1976; Tseng et al., 2005).  Arguably, this has resulted in a conflict 
between humans and nature: the Western mind is predisposed to seek to 
challenge, conquer and control nature (Fujita, 1986; Reynolds, 1995a; Sato, 
2011; Tseng, 2005). 
In contrast, Eastern thought is considered totalising, integrative and non-
discriminatory (Suzuki et al., 1960).  In these terms, the world is not divided and 
the notion of an independent ego is a socially conditioned fiction; instead, all 
phenomena are mutually interdependent and understandable only in relation to 
each other and the context: man cannot be set apart from nature (Brazier, 2012; 
Watts, 1961; Watts, 2012).  Accordingly, Eastern philosophy is naturalistic; 
humans are part of and subordinate to nature; harmony, rather than 
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individualism and conflict, is therefore stressed: humans adapt themselves to 
nature rather than attempting to adapt nature to themselves (Morton and Olenik, 
2004; Reynolds, 1976; Reynolds, 1995a; Tseng et al., 2005; Watts, 2012). 
In sum, Eastern thought emphasises holism, harmony, acceptance and 
intuition; Western thought emphasises dualism, individualism, control and 
rationality (Blocker and Starling, 2010; Chang and Rhee, 2005; Knoblauch, 
1985; Suzuki, 2010; Tseng, 2005).  In Western culture, man is in the world and 
‘nature’ is the verbal reconstruction of the environment; in Eastern culture, man 
is of the world and ‘nature’ is experienced and felt without the application of 
thoughts and words (Davidson, 2001; Watts, 2012).  These tendencies may be 
viewed as reflected and reinforced in dominant religious traditions: Western 
traditions suggest nature conforms to a pattern assigned by an omnipotent God 
(“the ego of the Universe” (Watts, 2012) (p.88)), and that man has a dominion 
over nature afforded to him by God; Eastern traditions suggest nature is a 
pattern, a spontaneous and self-governing embodiment of the absolute 
(Kitanishi, 2005; Morton and Olenik, 2004; Norbury, 2011; Watts, 2012). 
Taoism, Buddhism and Confucianism 
Eastern worldviews are entrenched in philosophical systems including Taoism, 
(Zen) Buddhism and (neo) Confucianism (Chang and Rhee, 2005) which, 
without clear differentiations between self, others and nature, all emphasise 
harmonious living (Tseng, 2005). 
Taoism, a Chinese philosophy, has shaped much thought across East Asia (Hu 
and Allen, 2005).  ‘Tao’ means the way, course or flow of nature; it is 
understood as the organic operating principle of the universe which regulates 
itself spontaneously, always in flux yet balanced by opposing forces (Creel, 
1956; Hu and Allen, 2005; Watts, 2012; Young, Tseng and Zhou, 2005).  
Taoism emphasises monism and eternal cycles: all phenomena exist as 
inseparable parts of the universal whole; all actions and experiences are 
movements within the Tao, from which it is impossible to deviate (Creel, 1956; 
Watts, 2012; Young et al., 2005).  Taoism thus stresses the virtue of ‘not-
contending’, of yielding to rather than interfering in the way of nature (Watts, 
1961; Young et al., 2005).   
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Buddhism, particularly the Mahayana school, has been disseminated to much of 
East Asia from India (Morton and Olenik, 2004).  The underlying premise is that 
pain and conflict are unavoidable, arising from ‘egocentric’ attachments to 
phenomena which are in fact transient and illusionary, such as emotions and 
indeed the ‘self’ (Chang and Rhee, 2005; Kapleau, 2000; Kitanishi, 2005).  
Thus, suffering is caused by not being able to control things according to one’s 
will: in believing our minds, bodies and other phenomena belong to and thus 
can be controlled by us, a vicious cycle of trying to wrest pleasure from pain and 
self from not-self ensues (Brazier, 2012; Kitanishi, 2005; Tseng et al., 2005; 
Watts, 1961).  Buddhism rejects these dualisms, holistically identifying all things 
with intrinsic Buddha-nature and understanding them as empty of anything but 
Buddha-nature (Kapleau, 2000; Watts, 1961). 
It is argued that an illusion of permanent and independent phenomena is a 
product of the discriminative and limiting nature of thought and language: 
people talk about two or more things as separate entities when in fact there is 
only one ‘reality’ (Blocker and Starling, 2010; Kapleau, 2000; Watts, 1961).  
Thus, Buddhism emphasises that reality exists beyond words, in experience 
(Chang and Rhee, 2005).  Buddhism is considered to teach people to reach a 
selfless state (enlightenment) in which the ego and intellect are transcended, all 
phenomena (including human life) are understood as relational and 
impermanent, and one’s Buddha-nature can be realised (Blocker and Starling, 
2010; Chang and Rhee, 2005; Kapleau, 2000; Morton and Olenik, 2004). 
Taoism and Buddhism epitomise the Eastern worldview in emphasising humans 
as part of the universe: the need for humans to accommodate and harmonise 
with nature (Brazier, 2012; Tseng, 2005).  For both, the governing principles of 
nature encompass a self-determining spontaneity that cannot be comprehended 
intellectually, but only in a state of ‘egolessness’ (Kitanishi, 2005; Watts, 2012; 
Young et al., 2005).  They both consider self-centred desire to be the root of 
suffering and have at their basis a philosophy of acceptance and nullification: 
non-interference in the way of nature; consciousness undisturbed by the 
grasping ego (Blocker and Starling, 2010; Kitanishi, 2005; Watts, 2012). 
Confucianism, an ideological system considered at the core of much Asian 
thought, emphasises the cultivation of the ideal moral character through 
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practical learning, pursued for no reward other than they joy of doing good and 
following the ‘Way’ (akin to the ‘Tao’) (Fujita, 1986; Lau, 1979; Yan, 2005).  Key 
teachings, in line with other Eastern philosophies, include minimising self-
centredness and living in harmony with others (Chen, 2001).  Neo-
Confucianism combines this system with elements of Taoism and Buddhism, 
emphasising the consistent principle that the inner nature of all things is the 
same: Buddha-nature in Buddhist terms; human nature as embedded in the Tao 
in Taoist terms; human heartedness in Confucian terms (Blocker and Starling, 
2010; Chen, 2001; Fujita, 1986; Kapleau, 2000; Watts, 1961).  What follows is a 
belief that human nature is basically benevolent and self-sufficient: every 
person has the potential to live with satisfaction, and can be trusted to act with 
authenticity and spontaneity (Tseng, 2005; Yan, 2005). 
Zen Buddhism, which emphasises the everyday world in the present moment, 
developed through an interaction between Mahayana Buddhism, Taoism and 
Confucianism (Kjolhede, 2000; Smith, 2000).  Zen challenges the notion that 
there exists an ‘ego’ or fixed ‘self’, as per all Buddhist thought, and epitomises 
the Buddhist distrust of logic and language with a distinctively practical focus on 
holistic and direct experience through meditation and koans (paradoxical 
questions) (Kapleau, 2000; Smith, 2000; Suzuki, 1961; Watts, 1961).  With 
koans designed so that the intellect or ‘ego’ cannot answer them, it is believed 
that people realise there is no ego which is acting, there is only action (Watts, 
1961); with meditation intended to wholly focus the mind, people are considered 
to enter “a full rapport with life” (Kapleau, 2000) (p.12).  This way, sudden and 
direct enlightenment is considered possible: a state of awareness in which the 
boundaries between mind/ body and self/ nature are transcended (Blocker and 
Starling, 2010; Kapleau, 2000; Suzuki, 1961). 
Relationship to suffering and healing 
The epistemological and philosophical traditions discussed influence how 
suffering and healing are understood (Busfield, 2001b; Tseng et al., 2005).  
Firstly, from a Western rational viewpoint, a dualism exists between reason and 
emotion: emotions are considered unreasonable, chaotic and often 
pathologised; to be rational (ideal) is to be in control of oneself, including one’s 
emotions (Williams, 2001).  Eastern thought, alternatively, understands reason 
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and emotion as embodied and mutually constituted, and unpleasant emotions 
as authentic and natural rather than pathological and to be controlled (Craib, 
2002; Williams, 2001). 
Secondly, considered key to Western culture and embedded in dichotomous 
thought are prevailing ideologies of happiness: in ‘the pursuit of happiness’, 
people seek to experience the pleasant and eliminate suffering, focusing on the 
future, to when this may be attained (Craib, 2002; Flora, 2009; Tseng, 2005; 
Williams, 2001).  As such, Western patients are likely to operate in the realm of 
the ego, focus on the ways things ought to be, and seek manipulation of their 
phenomenological world through symptom control or elimination, as if 
symptoms were detachable entities for which a ‘cure’ can be sought (Craib, 
2002; Reynolds, 1976; Smith, 2000; Watts, 2012). 
In contrast, Eastern thought understands apparently opposite emotions as 
mutually interdependent: one cannot experience happiness without sadness 
(Watts, 2012).  As such, the focus is shifted from future goals and what ought to 
be, to the present, to what is: emotions, the self, and reality are accepted 
without resistance, allowing them to run their natural course in line with the Tao, 
in which moments of happiness spontaneously come and go, and to pursue 
them is to miss the experience itself (Kitanishi, 2005; Reynolds, 1976; Smith, 
2000; Watts, 2012).  The spontaneity of Eastern naturalness specifically 
denotes a path of non-pursuit and non-interference: it is an inner resistance to 
symptoms, rather than symptoms themselves, which must be cured (Blocker 
and Starling, 2010; Reynolds, 1976; Watts, 1961; Watts, 2012). 
2.2.2 Japanese philosophy 
In line with Eastern thought, Japanese culture understands humans as an 
integral part of nature (Ogawa, 2013).  Traditionally, the Japanese people have 
appreciated the beauty of their environment and lived according to seasonal 
rhythms, cultivating and celebrating a symbiotic relationship with nature 
(Blocker and Starling, 2010; Fujita, 1986; Morton and Olenik, 2004).  The 
centrality of love of and reverence for nature is perhaps not surprising given the 
environment and climate of Japan (Suzuki, 2010).  Whilst the richness of the 
environment may have impressed upon those first arriving “a pervading 
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sentiment of gratitude” which has been “stored up in the[ir] racial 
consciousness” (Sansom, 1978) (p.46), that humans are at the mercy of the 
natural world also cannot be far from the Japanese consciousness: Japan is 
located upon one of the world’s most dangerous tectonic plates and in one of its 
most hazardous climatic zones, making it liable to earthquakes, tsunamis and 
severe weather changes (Blocker and Starling, 2010; Morton and Olenik, 2004; 
Norbury, 2011; Ogawa, 2007). 
Although much Japanese thought derives from China, Japan has retained its 
own distinctive perspective by adapting incoming systems to compliment 
indigenous values, which are considered to be even more sensual, aesthetic, 
holistic and naturalistic (and suspicious of that which is intellectual, rational and 
abstract) than those of the Chinese (Blocker and Starling, 2010; Morton and 
Olenik, 2004).  These values are epitomised by Shintoism, the indigenous 
Japanese religion (Inoue, Jun, Mizue et al., 2003).  Characterised by the 
worship of natural phenomena which are considered to possess an inherent life 
force, Shintoism focuses on celebrating life in the here and now and expressing 
gratitude and appeasement towards nature (Blocker and Starling, 2010; 
Ellwood and Pilgrim, 2016; Morton and Olenik, 2004).  As per Eastern 
worldviews, practice and action are prioritised over abstract thought and words 
(Japanese Literature, undated).  Shintoism has permeated Japanese society 
and, as such, the involvement of humans with nature and an emphasis on the 
here and now is at the centre of Japanese culture (Blocker and Starling, 2010; 
LeVine, 1998; Norbury, 2011). 
Shintoism contains no absolutes, allowing it to be syncretised with Taoism, 
Buddhism and Confucianism when introduced into Japan in the 6th century 
(Nishizono, 2005; Norbury, 2011).  Indeed, Zen Buddhism resulted from 
combining and interpreting these philosophies through the lens of the 
indigenous Shinto perspective (Morton and Olenik, 2004).  As such, the 
Japanese reduced “any transcendental, metaphysical aspects of Buddhism to 
ordinary phenomenal reality”; for example, taking the notion of sudden 
enlightenment literally and the notion that all things are Buddha-nature further in 
inferring that Buddha is nothing but such things: there is nothing beyond this 
concrete world (Blocker and Starling, 2010) (p.32).  Hence, Zen becomes the 
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celebration of everyday phenomena in the here and now, by looking at them 
from a completely different perspective (Blocker and Starling, 2010). 
Shintoism and Buddhism remain the dominant religions in Japan today, and the 
ways in which both Zen and a sensitivity to nature infuse Japanese culture can 
continue to be seen in Japanese art, poetry, drama, literature, swordsmanship 
and practices such as the tea ceremony (chadō) (Blocker and Starling, 2010; 
Chiba, 2010; Kapleau, 2000; Morton and Olenik, 2004; Suzuki, 2010).  In 
particular, in the composition of Japanese landscape art humans are 
subordinate to nature, and Japanese aesthetics show an acceptance and 
indeed appreciation of the impermanence and imperfection of all things, 
including the human condition (Blocker and Starling, 2010; Morton and Olenik, 
2004). 
2.2.3 The sociohistorical context of Morita Therapy 
Following the national isolation of the Tokugawa regime, the Meiji Restoration of 
1868 effected significant sociological change in Japan as communication with 
and the impact of the West increased (Hiraki, 2011; Morton and Olenik, 2004; 
Nishizono, 2005).  The corresponding modernisation or “Westernisation” of 
Japan created a deep sense of cultural dissonance, as attempts were made to 
combine Japanese traditions and Eastern worldviews with Western systems 
and science (Blocker and Starling, 2010; Fujita, 1986; Nishizono, 2005). 
Accordingly, the traditional holistic spirit of harmonious integration with nature 
was brought into conflict with dichotomous and rationalistic Western ideologies 
which approach nature as an isolated object to be studied and controlled (Fujita, 
1986; Kitanishi, 2005).  Furthermore, the competitive nature of industry and 
ideological emphasis on individualism contrasted with the traditional Japanese 
family consciousness and attitude of self-inhibiting sensitivity to others (Blocker 
and Starling, 2010; Fujita, 1986; Kondo, 1975; Nishizono, 2005).  It was in the 
context of these conflicts between traditional and modern values, and the 
neuroses they were understood to produce, that Morita developed his therapy 
(Fujita, 1986; Nishizono, 2005; Ogawa, 2013). 
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2.2.4 Eastern philosophy reflected in Morita Therapy 
Although Morita clarified that his therapy was not derived from Buddhism, the 
convergence between Morita Therapy and Zen principles, as well as those of 
other Eastern philosophies, has been noted by many authors (Brazier, 2003; 
Hashi, 2013; Kitanishi, 2005; LeVine, 1998; Matesz, 1990; Mercer, 2015; 
Ogawa, 2007; Reynolds, 1982; Rhyner, 1987; Rush, 2000).  Certainly, Morita 
borrowed many terms from Buddhism, Taoism and Japanese literature, and 
Morita Therapy is considered grounded in both the naturalistic worldview and 
Japan’s distinctive culture (Fujita, 1986; Kitanishi, 2005; Kondo, 1998; 
Nakamoto, 2010; Ogawa, 2013; Reynolds, 1976). 
Morita Therapy clearly incorporates Eastern naturalism in aiming to correct self-
centredness by de-centralising the self (or de-emphasising the ego) through a 
unity of mind, body and nature, expressed and experienced through action, 
whereby one harmonises with nature by adapting to phenomenological reality 
(Fujita, 1986; Kitanishi, 2005; Morita et al., 1998; Young et al., 2005).  
Accordingly, Morita’s approach is monistic and holistic, focusing on the whole 
person rather than their symptoms (Morita et al., 1998; Nakamoto, 2010).  
Furthermore, both Zen and Morita affirm and accept desires and conflicts 
(Kitanishi, 1992).  As in Eastern thought, Morita Therapy stresses the necessity 
of opposites and that suffering is an integral part of life: a consequence of 
desire which cannot be transcended, and which is unproblematic unless 
resisted (Kitanishi, 2005; Reynolds, 1982; Tseng, 2005; Young et al., 2005).   
As epitomised in Zen meditation, Morita Therapy emphasises non-interference 
in the natural flow of thoughts and emotions through self-consciousness and 
ego mechanisms such as obsession, rationalisation, resistance and attachment 
(in essence, Morita’s vicious cycle) (Kapleau, 2000; Reynolds, 1976; Watts, 
1961).  Both Zen and Morita Therapy stress that thoughts and emotions need 
not cause difficulties unless they are intellectually evaluated as good or bad, 
inciting attempts to cling to or banish them (Kapleau, 2000; Kondo, 1975).  
Thus, conflicts are considered to be caused by the ego: the way in which the 
ego grasps for things which are transient and illusionary (the ideal) and, in its 
false conception of a fixed and autonomous ‘self’, resists anything which 
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threatens its position, opposing the natural (the real) and trying to gain control 
over it through thought (the vicious cycle) (Kitanishi, 2005) (p.175). 
As Zen Buddhism emphasises, that there even exists a distinct ‘self’ is 
considered a misconception (Kapleau, 2000; Reynolds, 1976).  This ideology of 
egolessness is key to the Morita Therapy process: shifting focus from the self to 
the environment; moving beyond conscious self-evaluation towards a state in 
which attention moves freely from one external event to another (Ishiyama, 
1986c; Kitanishi, 2005; LeVine, 1998).  In accordance with Zen meditation and 
the paradoxical nature of intense self-enquiry within koan practice, the Morita 
Therapy rest phase diminishes egocentric thinking through facilitating a 
widening of awareness (Kapleau, 2000; Kondo, 1992; LeVine, 1998). 
It is understood that once disruptive ego mechanisms are broken down, natural 
energies are liberated, and adaptability and spontaneity of behaviour becomes 
possible: key to both arugamama and Zen enlightenment (DeVos, 1980; 
Kitanishi, 1992; Reynolds, 1976; Suzuki, 1961).  Such spontaneity is, in Morita 
Therapy, characterised by free-flowing desire for life, unimpeded by self-
consciousness: a concept akin to Buddha-nature, human nature within the Tao, 
and Confucian human-heartedness, all suggesting an authenticity which 
provides the means and drive to live a meaningful life (Blocker and Starling, 
2010; Brazier, 2012; Chen, 2001; Fujita, 1986; Ogawa, 2007; Watts, 1961). 
Both Zen and Morita Therapy stress putting principles into everyday practice, 
mindfully focusing on tasks, and losing the self in productive effort (Kapleau, 
2000; Kitanishi, 1992; Kumasaka, 1965; Reynolds, 1976).  Morita’s action-
based method may also be traced to neo-Confucianism, which holds that 
“knowledge becomes genuine knowledge by means of action” (Fujita, 1986) 
(p.39).  Morita’s holistic focus on experience and embodiment, and associated 
distrust of the divisive rather than relational nature of language and cognition, 
also conforms to Eastern viewpoints, epitomising Zen (Kapleau, 2000; Kitanishi, 
1992; Murase and Johnson, 1974; Watts, 1961; Watts, 2012).  Through directly 
experiencing the activities of the body in relation to the environment, the 
(illusionary) dualism between self (observer) and the world (observed) is 
considered to fall away (Davidson, 2001; LeVine, 1998; Morita et al., 1998; 
Nakamoto, 2010; Reynolds, 1976; Watts, 1961).  Thus, both Zen and Morita 
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target not the intellect but the phenomenology of existence: what it feels like to 
be alive, epitomising the Japanese focus on the phenomenological reality of the 
everyday world in the here and now (Davidson, 2001; Watts, 1961). 
2.3 Distinguishing Morita Therapy and Western psychotherapies 
All psychotherapies may be considered to have cultural bases: just as Morita 
Therapy is infused with an Eastern worldview, the generally empirical and 
rational ways in which the West approaches mental health are grounded in 
Western worldviews (Fujita, 1986; Murase and Johnson, 1974; Reynolds, 1976; 
Tanaka-Matsumi, 2011).  As such, given the conceptualisation of the detached 
‘ego’, it is argued that “Western psychology has directed itself to the study of the 
psyche or mind as a clinical entity” (Watts, 1961) (p.16). 
For example, psychoanalysis, born out of positivism, is based on a view of the 
mind as an isolated object, emphasising the autonomy of the individual and the 
resolution of suffering (Carleton, 2002; DeVos, 1980; Fujita, 1986; Tseng, 
2005).  Accordingly, Morita, a contemporary of Freud, strongly criticised 
psychoanalytic theory, challenging its dualistic and static nature which restricted 
consciousness to the mind and posited an ‘unconscious’ existing as if it were a 
concrete, permanent structure (Davis and Ikeno, 2002; Gibson, 1974; Kitanishi, 
2005; Kondo, 1998).  Indeed, Morita’s method is the antithesis of Freud’s focus 
on historical events and intellectual analysis, with such explorations considered 
to increase counter-productive thoughts of the ‘self’ (Kjolhede, 2000; Murase 
and Johnson, 1974). 
Morita Therapy is therefore in stark contrast to Western models of mental health 
and associated treatments (Krech, 2014).  Although certain parallels may be 
drawn between Morita Therapy and other contemporary approaches (Hofmann, 
2008; Nakamoto, 2010; Reynolds, 1976; Spates, Tateno, Nakamura et al., 
2011), philosophically and epistemologically, Morita Therapy has a 
phenomenological focus which rejects the entire premise of Western 
treatments, grounded in the dualisms of mind/body, self/others and spirit/nature 
(Hall, 2011a; Kitanishi, 2005; LeVine, 2016a; Morita et al., 1998).  Morita 
Therapy is monistic, holistic, experiential and intuitive: it emphasises the reality 
of the present and proposes that the ‘truths’ of (human) nature can be directly 
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experienced through bodily engagement with everyday living; Western 
therapies tend to be mechanistic, verbal and logical: they emphasise specific 
techniques, internal processes and rational understanding in an effort to relieve 
suffering (Burston, 2003; Carleton, 2002; LeVine, 1998; Murase and Johnson, 
1974; Reynolds, 1976; Reynolds, 1982; Tseng, 2005).  Whereas such 
approaches may be seen to intellectualise emotions, Morita Therapy may be 
seen to de-intellectualise emotions (and, indeed, living in general). 
With its aim of accepting and living in harmony with nature, Morita Therapy is 
thus qualitatively different to Western approaches in both method and objective 
(Tseng, 2005).  In contrast to Cognitive Behavioural Therapy (CBT) (Beck, 
2011) and Behavioural Activation (BA) (Lewinsohn, Biglan and Zeiss, 1976), 
Morita Therapy does not seek to reduce symptoms through the modification of 
thought and/or behavioural patterns, which would be considered counter-
productive (Reynolds, 1976).  Although approaches such as Mindfulness-Based 
Cognitive Therapy (MBCT) (Segal, Williams and Teasdale, 2002) and 
Acceptance and Commitment Therapy (ACT) (Hayes, Strosahl and Wilson, 
1999) also cultivate acceptance, in Morita Therapy acceptance has a uniquely 
active, spontaneous and paradoxical quality: it cannot be brought about through 
deliberate cognitive reappraisal, only through everyday behavioural experience 
(Ogawa, 2013; Tateno, 2014; Watts, 1961).  Indeed, in Morita Therapy it is 
understood that there is no ‘I’, or ego, which may choose to accept symptoms 
before proceeding with life; one must proceed with life in the here and now, with 
or without symptoms (Ogawa, 2013; Watts, 1961). 
Further differences are also noteworthy.  Whilst BA and ACT are directive in 
activity scheduling and/or prior goal discrimination, Morita Therapy allows 
action-taking to come about naturally and spontaneously through the inherent 
purposefulness of the resurfacing desire for life (Ogawa, 2007; Ogawa, 2013).  
In addition, whilst approaches such as MBCT may be seen to magnify the 
subjective self, increasing self-awareness in order to shift subjective 
experiences, Morita Therapy minimises it, shifting attention outwardly to induce 
a ‘mindless’ state in which one is fully absorbed in the present moment and thus 
unaware of internal states (Morita et al., 1998; Ogawa, 2013). 
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In sum, the key distinctions between Morita Therapy and Western therapies are: 
(1) underlying philosophy and epistemology; (2) goals: acceptance and 
allowance versus symptom reduction; (3) methods: experiential embodiment 
versus cognitive reappraisal, external versus internal attentional focus; (4) 
impetus for action: spontaneity of desire for life versus planned action-taking.  
Overall, whilst Morita Therapy emphasises readjustment in social terms through 
accommodating environmental forces, with resulting individual improvement, 
Western therapies typically emphasise personal recovery through individualised 
mechanisms for resolving internal conflicts, with resulting improvements in 
social terms (Murase and Johnson, 1974).  In Morita Therapy, symptoms are 
not isolated and treated as if they were independent entities or illnesses to be 
cured, rather they’re approached as part of oneself: indeed, they are oneself, in 
so much as one is one’s phenomenological experience (Reynolds, 1976).  
Thus, Morita Therapy moves beyond symptom relief, emphasising personal 
growth and addressing a patient’s overall outlook and way of life (Kitanishi, 
2005; Tateno, 2014). 
2.4 The development and diversity of Morita Therapy 
In an effort to modernise and universalise Morita Therapy, the scope of the 
approach (where, with whom, and how it is practiced) has been broadening for 
some time (Kitanishi and Mori, 1995; Reynolds, 1976). 
2.4.1 Morita Therapy formats 
Inpatient treatment 
Morita Therapy was developed as a structured inpatient treatment in Morita’s 
own home: a safe and ecologically-based environment which was understood to 
facilitate patients’ natural healing capacities (LeVine, 1998; Morita et al., 1998; 
Ogawa, 2013).  This involved four successive stages of: (1) isolated rest; (2) 
light monotonous work; (3) intensive outdoor work; (4) preparation for daily 
living (Morita et al., 1998).  Both the environment and stages were designed to 
expand patients’ peripheral attention from internal states to the external 
environment; to enable them to experience how the mind may be either fixated 
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on symptoms or tasks at hand, and how emotions naturally ebb and flow when 
left unattended (LeVine, 1998; Morita et al., 1998; Ogawa, 2013). 
The rest phase is, arguably, crucial to Morita’s experiential therapy: the starting 
point for patients becoming engaged in their external environment as, 
paradoxically, their initially consuming self-focus begins to dissipate (LeVine, 
1998).  Stages two and three are of an occupational therapeutic nature in which 
purposeful tasks typically involving hands (stage two) and whole body 
movements (stage three) are used to absorb patients’ attention and channel 
their resurfacing desire for life; gradually, patients’ spontaneity and engagement 
with others, objects and nature are increased (LeVine, 1998; Minami, 2013; 
Morita et al., 1998).  Stage four involves reintegrating patients back into their 
real lives in society (Morita et al., 1998).  Stages two onwards include daily diary 
writings by patients which receive comments by the therapist consistent with 
Morita’s principles (Kora, 1995; LeVine, 1998). 
A number of inpatient clinics still operate in Japan as well as China (Jiangbo, 
2000; Ogawa, 2013; Reynolds, 1976), whilst the only inpatient clinic in the 
English-speaking world operates in Australia (LeVine, 2016b).  There is a great 
deal of variation in the practices of contemporary clinics, particularly in terms of 
how broadly Morita’s theory is interpreted and applied to different patient 
conditions; the degree to which they implement Fumon or allow discussion of 
patient symptoms; the extent to which they emphasise nature, insight, rest, 
work and/or recreational activity, and the relationship between Morita Therapy 
and Zen Buddhism (Ohara and Reynolds, 1968; Reynolds, 1976). 
Outpatient treatment 
Outpatient (or neo-) Morita Therapy is applied throughout Japan and in other 
countries to a limited degree, and practiced in a diverse range of settings 
including via correspondence (Kitanishi, 2005; Minami, 2013; Reynolds, 1976).  
Accordingly, the Japanese Society for Morita Therapy developed outpatient 
guidelines which include the use of diary guidance and summarise the 
therapeutic components as “increasing client awareness and acceptance of 
emotions”; “recognising and mobilising the client’s desire for life”; “clarifying the 
vicious cycle”; “giving instructions for constructive action”; “facilitating client’s re-
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evaluation of their behavioural patterns and lifestyle” (Nakamura et al., 2010) 
(p.8-19).  Rather than adhering to a strict Fumon stance, the outpatient therapist 
does enquire into unpleasant emotion as necessary to portray empathy and 
elucidate the vicious cycle (Hashimoto, 2016; Ishiyama, 1988b). 
There is variation in the application of the outpatient guidelines, perhaps due to 
the absence of a systematic Morita Therapy education system or widely 
accepted Morita Therapy manual (Ogawa, 2013).  Indeed, many practitioners 
refer to implementing ‘outpatient Morita Therapy’ with little further delineation of 
what their process entails (Richards, 2016): thorough protocols detailing the 
precise nature of these approaches are rarely developed and/or published 
(Kitanishi, 2016).  The breadth and scope of outpatient application was 
highlighted in the 9th International Congress of Morita Therapy (Richards, 2016).  
Current methods range from progressively staged approaches adapted for 
outpatient settings (Crowder, 2016; LeVine, 1993b) to individual counselling 
methods with no such structure (Ishida, 2016) such as the active counselling 
method (Ishiyama, 2011) and modal model (Minami, 2013).  Approaches further 
extend (Ogawa, 2013) to include group-based (Ashizawa, Anazawa and 
Honma, 2000; Murray and Ishiyama, 2016), psychosocial (Minami, 2016) and 
psychoeducational (Kobayashi, 2016; Semenova, 2016) interventions.  
Approaches often entail an arguably loose application of Morita Therapy 
principles and/or methods: they may be based on Morita’s perspective, make 
use of Morita’s strategies, and/or use Morita Therapy as a framework 
(Huckvale, 2016; Kobayashi, 2016; Minami, 2016; Semenova, 2016), and at 
times do so in combination with other approaches such as mindfulness 
(Yamada, 2016) and art therapy (Huckvale, 2016). 
2.4.2 Conditions treated with Morita Therapy 
Morita Therapy was originally developed to treat ‘Shinkeishitsu’: a psychiatric 
diagnostic term developed by Morita to describe an arguably ‘culture-bound’ 
syndrome (Kitanishi, Nakamura, Miyake et al., 2002; Russell, 1989).  This term 
denotes a form of ‘neurasthenia’, or neurosis: a category still applied in Japan, 
where DSM (Diagnostic and Statistical Manual) and ICD (International 
Classification of Diseases) classifications have not been widely used until 
recently (Someya and Takahashi, 2001).  Nonetheless, Shinkeishitsu is 
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considered to correspond to DSM-V anxiety disorders, alongside elements of 
mood and personality disorders (Fujita, 1986; Kitanishi et al., 2002; Morita et al., 
1998; Ogawa, 2013; Reynolds, 1995a).  Shinkeishitsu is characterised by 
strong desires for success and social approval and related manifestations of 
fear: such people tend to be introspective, perfectionist, self-conscious and self-
critical (Fujita, 1986; Ogawa, 2013).  Thus, Shinkeishitsu refers to a condition in 
which neurotic symptoms are formed through the mechanisms of Morita’s 
vicious cycle (Kitanishi et al., 2002). 
Whilst Shinkeishitsu is a condition to which the Japanese are considered 
particularly inclined, Shinkeishitsu processes are also considered present to 
some degree in everyone (Morita et al., 1998).  After all, Morita Therapy is 
based on Morita’s perception of universal human nature: all possess desire for 
life to which Morita’s mechanisms of psychopathology are related (Koschmann, 
1976: cited in Reynolds, 1989; Fujita, 1986).  Thus, Morita Therapy is 
considered relevant wherever patients resist suffering and, with it, their 
authentic and natural selves: a principle widely applicable to human difficulties 
(Fujita, 1986; Kitanishi, 2005).  Accordingly, Morita Therapy is now applied to a 
diverse range of conditions and, in contemporary Japan, often to Shinkeishitsu 
tendencies mixed with depression or other symptom combinations (Kitanishi, 
2005; Kitanishi and Mori, 1995; Nishizono, 2005; Reynolds, 1995a). 
The array of conditions now treated with Morita Therapy internationally was, 
again, well demonstrated during the 9th International Congress (Richards, 
2016).  Patient groups include ‘at risk’ children (Crowder, 2016), victims of 
sexual assault (Ogawa, 1988) and civil war victims and perpetrators (Minami, 
2016); conditions include depression (Kobayashi, 2016; Niimura, Kitanishi and 
Masafumi, 2016), bipolar II disorder (Kitanishi and Nakamura, 1989: cited in 
Kitanishi, 2005), schizophrenia (Chen, 2000; Semenova, 2016; Toki, 2016), 
panic disorder (Tatematsu, 2000), obsessive compulsive disorder (Hinoguchi, 
2016; Qiyi and Xiongwei, 2000; Tateno, 2014), social phobia (Shioji, Nakamura 
and Ushijima, 2000), trauma (LeVine, 2016b), eating disorders (LeVine, 1993a), 
insomnia (Itoh, Yamadera, Sasaki et al., 2000), chronic pain (Ashizawa et al., 
2000; Murray and Ishiyama, 2016), occlusal discomfort syndrome (Ishida, 2016) 
and atopic dermatitis (Hosoya, 2016). 
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2.4.3 International developments 
Morita Therapy is now practiced in Australia, China, North America, Russia and 
Rwanda, predominantly by a limited number of Japanese practitioners who 
have transported the treatment to different cultures (Ishiyama, 1987; Kitanishi 
and Mori, 1995; Minami, 2016; Ogawa, 2013).  With regards to English-
speaking countries, both inpatient and outpatient treatment are provided in 
Australia by an Australian practitioner who trained in Japan (LeVine, 1998), and 
outpatient counselling-based methods are used in North America by Japanese 
practitioners (Ishiyama, 1986c; Ogawa, 1988).   
Morita Therapy principles have also influenced other Western approaches: in 
North America, ideas from Morita Therapy and another Japanese approach 
consisting of intensive reflection on past experiences (Naikan Therapy) have 
been modified and combined to form ‘Constructive Living’ (Reynolds, 1995b); in 
England, the My Time mental-health provider for refugees and asylum seekers 
(http://www.richmondfellowship.org.uk/my-time) incorporates elements of Morita 
Therapy such as Fumon; progressive activity; unity of mind, body and 
environment; and horticultural therapy (Ogawa, 2013). 
2.5 Implications for this thesis: Translating Morita Therapy to the UK 
In the context of cross-cultural differences (section 2.2), there were several 
issues to consider in translating Morita Therapy to a UK context. 
2.5.1 Applying and adapting Morita Therapy across cultures 
That Morita Therapy has both been applied internationally and survived the 
rapidly changing environment of Japan, with its growing emphasis on Western 
values and changes in patient profiles, is considered testament to its 
adaptability and transcultural potential (Nishizono, 2005; Kitanishi, 2010: cited in 
Ogawa, 2013; Reynolds, 1989).  It is suggested that this transcultural 
application is made possible by Morita’s holistic approach to well-being, theory 
of universal human nature, widely applicable mechanisms of psychopathology 
and focus on everyday living (Fujita, 1986; Ishiyama, 1987; Kondo, 1992; Morita 
et al., 1998; Nishizono, 2005; Ogawa, 2013). 
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However, it follows from the differences in worldviews discussed that receptivity 
to and expectations for psychotherapy would differ across Eastern and Western 
cultures (Tanaka-Matsumi, 2011).  Given the grounding of Morita Therapy in 
both Eastern naturalism and Japan’s distinctive culture, it is therefore argued 
that considerable modifications are necessary to achieve cultural 
accommodation in the West (Ishiyama, 1994; Ogawa, 2013; Ohara, 1990; 
Reynolds, 1989; Reynolds, 1995a; Tanaka-Matsumi, 2011; Tseng, 1999).  
Particular concerns relate to rest, Fumon, the translation of Zen terms into 
English, and Westerners’ receptivity to the notion of accepting rather than 
controlling symptoms (Kitanishi and Mori, 1995; Kondo, 1998; LeVine, 1998; 
Ogawa, 2013; Koschmann, 1976: cited in Reynolds, 1989; Reynolds, 1995a).  
Indeed, Reynolds, considering Morita Therapy to be confined to the needs of 
early 20th century Japanese patients, modified the approach for a North 
American context by extracting and assimilating elements of Morita Therapy 
into what was considered a more Western-appropriate mode of treatment 
(‘Constructive Living’) (Reynolds, 1989). 
However, the difficulty is the extent to which Morita Therapy can be modified 
and still called ‘Morita Therapy’: there are concerns that the treatment’s 
essential, defining elements are being displaced (LeVine, 1998; Ogawa, 2013; 
Ohara, 1990).  Accordingly, authors challenge the degree to which Reynolds 
truly adopts Morita’s principles within Constructive Living, and note concerns 
around the potential misuse of Morita Therapy across cultures, particularly 
through an over-reliance on the verbal approaches and abstract knowledge 
which Morita precisely warned against (Kondo, 1998; LeVine, 1998; Ogawa, 
2013).  Such authors urge those adapting Morita Therapy to pay due attention 
to the centrality of Morita’s four stages, including rest, to the defining 
progressive and experiential nature of the approach (Kondo, 1998; LeVine, 
1998), and to ensure modification is undertaken without “corrupting its theory, 
offsetting its goals, or tempering its principles” (Ogawa, 2013) (p.48).   
This thesis sought to circumvent such concerns by maintaining a purist stance 
towards Morita Therapy, as far as possible in an outpatient context.  Thus, in 
optimising Morita Therapy for a UK population (see Chapter Five) it was 
considered critical to retain its distinctive philosophical and experiential basis 
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rather than diluting this through assimilation into established Western treatment 
modes, as typically seen in the application of Eastern approaches to the 
treatment of depression in the West (e.g. the integration of Eastern mindfulness 
practices and Western Cognitive Therapy within MBCT (Segal et al., 2002)).  
Indeed, that the distinctive philosophical, cultural and experiential basis of 
Morita Therapy needs to be diluted to make it suitable for the West is thus far 
largely an assumption (LeVine, 1998). 
2.5.2 A fundamentally different approach to mental health 
That Morita Therapy challenges some fundamental assumptions and paradigms 
of Western culture by offering an alternative philosophical basis for 
understanding and approaching mental health, and with it the potential for re-
defining culturally constituted notions of (ab)normality and (un)naturalness 
(Busfield, 2001a), may be exactly what gives Morita Therapy value for Western 
patients.  Indeed, it is argued that healing approaches associated with the 
universal principles of Buddhism, such as Morita Therapy, are applicable across 
cultures and, for the West, may reawaken its “dormant healing potentials, which 
have been eclipsed by its characteristic patterns of thinking” (Chang and Rhee, 
2005) (p.165). 
In the context of suggestions that some patients and practitioners in the West 
are experiencing increasing discontent with Western approach towards 
psychiatry and medicine (Robertson and Walter, 2013), Morita Therapy may 
provide a welcome shift away from this model.  Perhaps indicative of this 
discontent is the growing interest in Eastern-aligned approaches seen in the 
West: the increasing number of Westerners using Eastern, complementary and 
alternative therapies; the current proliferation of mindfulness practices; the shift 
towards acceptance-based models in mental health treatment; the interest in 
‘holistic health’ and healing (as opposed to ‘curing’) as a subjective and holistic 
experience (Berliner and Salmon, 1980; Cassell, 2004; Coulter and Willis, 2004; 
Egnew, 2005; Fisher and Ward, 1994; Hall, 2011b; Hiraki, 2011; Miles, 2009b; 
Roemer and Orsillo, 2002; Scott, Warber, Dieppe et al., 2017; Walsh, 1989). 
Particular difficulties with Western approaches are highlighted in relation to the 
‘disease-based’, biomedical, reductionist approach to health care, in which 
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arguably natural human responses are unhelpfully pathologised, and diagnostic 
labels prioritised over individuals’ unique and holistic experiences of illness 
(Bakx, 1991; Green, Carrillo and Betancourt, 2002; Miles, 2009b).  With regards 
to CBT, which may be considered heavily aligned with Western values of 
autonomy, control and rationality (Hays and Iwamasa, 2006), critics similarly 
argue that the approach is overly mechanistic, and insufficiently holistic and 
experiential (Gaudiano, 2008; Roemer and Orsillo, 2002).  Thus, the holistic 
focus of Morita Therapy on acceptance, experience and the naturalness of 
emotions may provide UK patients and practitioners with a welcome alternative. 
In essence, one cannot know whether a therapy must be supported by 
prevailing cultural trends in order to be effective, or whether a therapy which 
runs counter to cultural trends may be effective for that very reason, until that 
therapy is implemented within the culture in question (LeVine, 1998; Reynolds, 
1989; Young et al., 2005).  Whilst, it is argued, “the effectiveness of Morita 
Therapy depends on whether or not patients can share the human 
understanding of East Asian philosophy” (Kitanishi, 2005) (p.171), whether or 
not UK patients are able to do so is yet to be established.  Thus, this thesis 
begins empirical investigations into the acceptability and feasibility of this 
fundamentally different way of perceiving and approaching mental health and 
illness in the UK. 
2.6 Chapter summary 
This chapter has described and discussed Morita Therapy in terms of the key 
principles, processes and objectives of the approach; its philosophical and 
cultural basis in light of the distinctions between traditional Eastern and Western 
epistemologies; a comparison to Western psychotherapies; and its development 
and diversity over different formats, countries and patient conditions.  The 
discussion of the impact of these considerations on this thesis has highlighted 
the potential for the distinctive worldview underpinning Morita Therapy to 
provide UK-based patients with a fundamentally different approach towards 
mental health.  Chapter Three outlines the methodological framework 
underpinning this thesis and the methodological approaches adopted 
throughout.
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CHAPTER THREE.  METHODOLOGICAL OVERVIEW 
This chapter outlines the methodology underpinning this thesis and methods 
adopted throughout.  Part one (methodological framework) discusses evidence-
based medicine, the need for experimental research, and how bias may be 
minimised within randomised controlled trials (RCTs).  Subsequently, the 
Medical Research Council framework for complex interventions is outlined and 
mixed methods research for complex interventions is discussed.  Part two 
(methodological approach) provides the overarching design of this thesis, 
including a description and justification of the methods employed within each 
study, followed by a discussion of reflexivity (for which the first-person voice is 
adopted). 
CHAPTER THREE.  PART ONE. 
Methodological Framework 
3.1 Evidence-based medicine 
Evidence-based medicine (EBM) and practice (EBP) are long-standing fields 
which continue to evolve (Sackett, Rosenberg, Gray et al., 1996; Skelly and 
Chapman, 2011).  In the UK and North America, the EBM movement has been 
taking hold since medical successes began to generate the potential to 
distinguish between beneficial and less beneficial treatments in the early 20th 
century (Spring, 2007).  The McMaster group, credited with a pivotal role in 
developing EBP, was established in the 1980s, and EBP has since gained 
increasing traction in clinical psychology, social work, and allied disciplines 
(Lilienfeld, Ritschel, Lynn et al., 2013; Spring, 2007). 
3.1.1 What is evidence-based medicine? 
With a view to improving quality in health care services, EBM seeks to move 
from clinical decision-making based on clinical experience and intuition to one 
informed by the scientific evaluation of evidence and systematic application of 
knowledge (Guyatt, Rennie, Meade et al., 2002; Lilienfeld et al., 2013; Montori 
and Guyatt, 2008; Spring, 2007).  Sackett et al. (1996) define EBM as “the 
conscientious, explicit, and judicious use of current best evidence in making 
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decisions about the care of individual patients” (p.71).  In practice, this is a 
bottom-up process in which clinical expertise and clinical evidence are 
integrated (Sackett et al., 1996).  Here, clinical expertise refers to “the 
proficiency and judgement that individual clinicians acquire through clinical 
experience and clinical practice” (Sackett et al., 1996) (p.71); clinical evidence 
refers to clinically relevant research evidence bearing on whether and why a 
treatment works (Lilienfeld et al., 2013; Sackett et al., 1996).   
Although the role of patients was not explicitly demarcated in Sackett et al.’s 
(1996) definition, its importance was acknowledged: clinical expertise is 
indicated in part by “the more thoughtful identification and compassionate use of 
individual patients’ predicaments, rights, and preferences in making clinical 
decisions” (p.73), and “patient centred clinical research” is prioritised within the 
definition of clinical evidence (p.72).  Subsequent definitions explicitly integrate 
patient preferences and characteristics with research evidence and clinical 
expertise, creating a three-legged definition of EBM (Spring, 2007).   
The role of patients and the public in evidence-based medicine 
The consideration of patient preferences within EBM represents the movement 
away from the paternalistic care model, in which healthcare professionals 
remain ultimately responsible for clinical decision-making, towards a more 
shared care model in which patients are more fully involved in decision-making 
(Spring, 2007).  Such involvement is advocated on ethical grounds, considered 
to improve both patient satisfaction and outcomes, and, ultimately, directed 
towards engaging patients more fully in health self-management (Edwards, 
Elwyn, Wood et al., 2005; Gravel, Légaré and Graham, 2006; Spring, 2007). 
Alongside this move towards shared clinical decision-making, patients and the 
public are increasingly involved in research itself.  A call for greater patient and 
public involvement (PPI) (Tallon, Chard and Dieppe, 2000) and 
acknowledgement of its importance have been met with the development of 
infrastructure and guidance to support it.  The James Lind Alliance 
(http://www.lindalliance.org) brings patients, carers and clinicians together on 
equal footing to work on health conditions (Partridge and Scadding, 2004); 
INVOLVE provide guidance on good practice in PPI (http://www.invo.org.uk); 
CHAPTER THREE: METHODOLOGICAL OVERVIEW. PART ONE: METHODOLOGICAL FRAMEWORK 
59 
 
PPI has been introduced as policy in the UK: the National Institute for Health 
Research will not grant funds in the absence of PPI within the research 
programme (http://www.nihr.ac.uk/funding-and-support/funding-for-research-
studies/how-to-apply/support-for-study-teams/involving-the-public/).  Through 
these mechanisms, patients and the public can be involved at all levels of 
research from design through to write up, as active and equal partners in the 
research endeavour (Richards, 2015b). 
Despite acknowledgement of the vital role of PPI in producing appropriate and 
high quality research, and the moral imperative to involve people in research 
which is intended to benefit them, improvements in this area are still required 
(Madden and Speed, 2017; Staley, 2009; Staniszewska, Brett, Mockford et al., 
2011).  In particular, a more critical and contextualised approach towards PPI is 
considered necessary to ensure meaningful and significant involvement; higher 
quality reporting of PPI is required to facilitate a deeper understanding of the 
role, mechanisms and impact of involvement, thus enabling its future 
optimisation (Madden and Speed, 2017; Staley, 2009; Staniszewska et al., 
2011). 
3.1.2 Generating evidence 
As noted, EBM emphasises utilising the best research evidence in clinical 
decision-making.  It is argued that such evidence is required in order to protect 
patients from risks such as medical incompetence and overestimation of 
treatment effects (Kelly, Morgan, Ellis et al., 2010).  Evidence is now key to 
policy determinations; for example, the National Institute for Health and Clinical 
Excellence (NICE) commissions systematic reviews of the evidence-base for an 
intervention before determining if it should be provided by the National Health 
Service (NICE, 2012).  Thus, for an intervention to become the standard of care 
in the UK, evidence is essential. 
Approaches to generating evidence include experimental approaches (in which 
factors are deliberately controlled and manipulated) and non-experimental 
approaches.  Non-experimental approaches include case studies and series 
(descriptive clinical evaluations of single patients or patient groups who have 
received an intervention) and cohort studies (observations of any changes in 
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data routinely collected from a group of people).  Single-subject designs, such 
as pre-post studies, provide a quasi-experimental approach to investigating 
relationships between variables through the administration of repeated 
measures of targeted symptoms (Backman and Harris, 1999).  What constitutes 
the most suitable design for generating ‘the best evidence’ depends upon the 
uncertainty or question being addressed (Sackett and Wennberg, 1997).  For 
questions regarding intervention effectiveness, the best evidence may be 
defined as that which is “the least likely to be biased”, and thus most trustworthy 
(Kelly et al., 2010) (p.1057). 
3.1.3 The importance of experimental research 
Bias, or compromised internal validity, refers to the production of results which 
differ systematically from the ‘truth’ (Eccles, Grimshaw, Campbell and Ramsay, 
2003).  Where studies are subject to such bias, secure inferences of cause and 
effect between the intervention and outcomes cannot be established: a key 
limitation of non-experimental approaches (Field and Hole, 2003).  As noted by 
Burns, Rohrich and Chung (2011), case studies and expert opinion are “often 
biased by the author’s experience or opinions and there is no control of 
confounding factors” (factors, other than the intervention, which influence 
outcomes) (p.2).  Accordingly, the major concern with such approaches is their 
potential to distort, and likely overestimate, treatment effects (Barton, 2000; 
Cook, Guyatt, Laupacis et al., 1992; Mulrow and Oxman, 1997; Sackett et al., 
1996).  For such reasons, evidence generated through non-experimental 
approaches and clinical experience runs the risk of promoting treatments which 
are useless or harmful (Cook et al., 1992; Evans, Thornton, Chalmers et al., 
2011).  This potential for harm is well demonstrated by the case of thalidomide, 
which resulted in birth defects in thousands of babies (Vandenbroucke, 2013). 
In comparison, experimental research is considered to minimise bias through 
controlling confounding variables, thus enabling causality to be established with 
greater certainty (Eccles, Grimshaw, Campbell et al., 2003).  These factors 
have supported a hierarchy of evidence for establishing treatment effects 
(Figure 1, overleaf), in which study designs are ranked according to the 
probability of bias: randomised controlled trials (RCTs) and systematic reviews 
of these are placed highest, and case studies and expert opinions lowest 
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(Barton, 2000; Burns et al., 2011; Kelly et al., 2010).  RCTs allow the 
comparison of the effects of alternative approaches through the random 
allocation of participants to one of two (or more) groups (randomisation).  For 
assessing intervention effectiveness, the RCT is considered the method which 
is least prone to bias and thus the ‘gold standard’ for establishing causality 
(Barton, 2000; Collins and MacMahon, 2001; Eccles et al., 2003; Kelly et al., 
2010; Sackett et al., 1996; Spring, 2007). 
Figure 1. The hierarchy of evidence (Reprinted from Clarity Informatics (2014)) 
 
3.1.4 Addressing bias in randomised controlled trials 
Sources of potential bias are commonly classified in terms of selection, 
performance, attrition and detection (Higgins, Altman, Gøtzsche et al., 2011), 
alongside issues of spontaneous remission and regression to the mean (Field 
and Hole, 2003).  The internal validity of an investigation into intervention 
effectiveness depends on the extent to which such sources of potential bias 
have been avoided, through randomisation and other procedural measures, as 
outlined below (Higgins and Altman, 2008). 




Selection bias occurs whenever those who receive an intervention differ 
systematically from those who do not, in ways likely to affect outcomes (Cullum 
and Dumville, 2015).  These confounding variables may be known or unknown.  
Variables which are believed to impact upon the relevant outcomes may be 
managed through stratification in randomisation: the equal division of 
participants into groups based on these variables (Silcocks and Gheorghe, 
2014).  However, given that which patient characteristics might predict 
treatment response remains largely unknown, other unknown confounding 
variables may remain (Cuijpers, Reynolds, Donker et al., 2012).  Through 
randomisation with appropriate sequence generation (pre-specified rules for 
allocating participants) and allocation concealment (prevention of researchers’ 
knowledge of forthcoming allocations) (Higgins and Altman, 2008), all known 
and unknown confounding variables are made as unsystematic as possible: 
(hopefully) distributed randomly across groups, thus preventing selection bias 
(Field and Hole, 2003).  Randomisation is also the best method available for 
addressing spontaneous remission and regression to the mean (Torgerson and 
Torgerson, 2008). 
Spontaneous remission 
Many patients will recover from illnesses such as depression without any 
intervention: natural healing processes, social support, and positive experiences 
may generate such improvement; indeed, illnesses may be ‘self-limiting’ and 
improve by themselves (Evans et al., 2011; Lilienfeld et al., 2013).  A meta-
regression of 19 studies indicated that 23% of untreated cases of depression 
remit with 3 months, 32% within 6 months and 53% within 12 months 
(Whiteford, Harris, McKeon et al., 2013).  Thus, researchers must include 
techniques to disentangle the impact of these temporal changes from the 
impact of the intervention itself (Field and Hole, 2003). 
Regression to the mean 
Regression to the mean is a statistical phenomenon due to measurement error.  
Due to high levels of error in the measurement of extreme scores, where 
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patients score either very high or very low scores on a first assessment, they 
are by chance likely to produce scores closer to the mean (or their ‘true state’) 
at subsequent assessments, regardless of any intervention (Field and Hole, 
2003).  Thus, researchers must take care when attributing any decreases from 
very high scores or increases from very low scores to the intervention itself.  A 
large enough RCT utilising concealed random allocation reduces the risk of 
serious imbalances across groups in characteristics likely to affect outcomes 
and factors including the impact of spontaneous remission and regression to the 
mean, allowing the comparison of groups which should differ only with respect 
to the intervention received (Lamb and Altman, 2015; Nichol, Bailey and 
Cooper, 2010; Schulz, Chalmers, Hayes et al., 1995). 
Performance bias 
Performance bias refers to systematic differences between groups in the way in 
which care is delivered, aside from the intervention in question (Higgins and 
Altman, 2008).  Thus, all factors other than the intervention must be applied 
equally to all groups.  Blinding of participants may reduce such bias; otherwise, 
part of any benefit apparently effected by the intervention may in fact be due to 
the participant’s knowledge that they have received an intervention (Evans et 
al., 2011).  However, such blinding may not be possible (for example, where 
participants take an active role such as engaging with a psychological therapy) 
(Higgins and Altman, 2008; Lamb and Altman, 2015). 
Attrition bias 
Differential attrition (whereby the rate of participant withdrawal and thus missing 
data is higher in one group) threatens internal validity as some characteristics of 
the groups may be influencing retention, or differences may be present between 
those who do and do not withdraw, with the bias originally avoided through 
randomisation then re-emerging (Moran and Whitman, 2014; Robinson, 
Dennison, Wayman et al., 2007).  Thus, strategies (such as maintaining 
frequent contact) must be employed to optimise retention, especially if a study 
includes a control group, in which enthusiasm for participation may be lower 
(Higgins and Altman, 2008; Hunt and White, 1998; Moran and Whitman, 2014). 




Detection bias refers to systematic differences between groups in how 
outcomes are measured (Higgins and Altman, 2008).  Alongside ensuring the 
same outcome measures and procedures for collecting outcome data are in 
place for all participants, and undertaken by independent researchers, one way 
to minimise such bias is to blind the researchers who collect data, so that their 
knowledge of which intervention has been received cannot have an impact on 
outcomes (Evans et al., 2011; Higgins and Altman, 2008). 
3.1.5 Randomised controlled trials: other considerations 
The above considerations relate to internal validity and stress the need for 
RCTs which incorporate procedural measures to reduce bias.  Other issues to 
be considered in designing and interpreting an RCT include external validity 
(the extent to which the results may be generalised to the wider population) and 
precision (the extent to which the results are free from random error) (Higgins et 
al., 2011).  For example, while differential attrition may threaten internal validity, 
the overall ability to recruit and retain participants (and resulting sample) 
determines how well the target population is represented, and thus external 
validity (Coday, Boutin-Foster, Sher et al., 2005; Moran and Whitman, 2014).  
The trial’s exclusion and inclusion criteria may also affect the extent to which 
the results may be extrapolated to the wider population (Rawlins, 2008). 
Furthermore, a sufficient sample size is essential to generating the statistical 
power required to assess intervention effectiveness: as sample sizes increase, 
confidence intervals become narrower and thus results become more precise, 
although with diminishing returns past a certain point (Taub, Douiri and Walker, 
2014).  Thus, “a small trial with a low risk of bias may provide very imprecise 
results”, because of wide confidence intervals (Higgins et al., 2011) (p.3).  Poor 
recruitment and/or retention, resulting in an under-powered study, can in 
particular result in a failure to identify clinically relevant effects, increasing the 
chance that an effective intervention may be unduly abandoned (Burns et al., 
2011; Moran and Whitman, 2014).  Even RCTs with the power to detect 
treatment effects may lack the power to detect differences in adverse effects, or 
the length of follow-up required to ascertain long-term benefits and harms; thus, 
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RCTs are not free from limitations, and there are circumstances in which cohort 
or case studies may be considered for augmenting understanding (Bothwell, 
Greene, Podolsky et al., 2016; Rawlins, 2008; Skelly and Chapman, 2011). 
3.1.6 Contextualising evidence-based medicine 
EBM is not value-free paradigm: it is informed by a Western scientific 
epistemology and aligned with the biomedical theory of disease (Barry, 2006; 
Jagtenberg, Evans, Grant et al., 2006; Kelly et al., 2010; McKenzie, 2012; 
Miles, 2009b; Tonelli and Callahan, 2001).  As such, EBM prioritises a particular 
form of knowledge (that derived from RCTs: scientific, technical and rational) 
over another (that derived from clinical judgement: contingent, tacit, practical 
and experiential) (Buetow, Upshur, Miles et al., 2006; Gabbay and le May, 
2004; Pope, 2003; Tonelli and Callahan, 2001; Williams and Garner, 2002).  
Thus, EBM is viewed as a social movement as well as a scientific enterprise, 
representing a shift from the arguably ‘eminence-based’ ‘art’ of medicine 
towards the ‘evidence-based’ application of science (Britten, 2010; Isaacs and 
Fitzgerald, 1999; Leggett, 1997; Miles, 2009b; Pope, 2003).  As such, EBM has 
been met with some resistance, with evidence indicating that many clinicians 
perceive EBM as a threat to their clinical expertise and continue not to use 
evidence in everyday decision-making (Adams, 2000; Gabbay and le May, 
2004; Hay, Weisner, Subramanian et al., 2008; Miles, 2009b; Pope, 2003). 
Critics of EBM contend that it oversimplifies the nature of clinical work and 
advocate for the role of clinical judgement (Miles, 2009b; Pope, 2003; Williams 
and Garner, 2002).  Critics argue that EBM does not pay due attention to 
individuality and patient variation, noting difficulties inherent in translating the 
aggregate results of an RCT to clinical practice: population efficacy does not 
necessarily translate to effectiveness for individuals (Pope, 2003; Williams and 
Garner, 2002).  Furthermore, through a reliance on measuring phenomena 
which are accepted within a biomedical theory of disease, critics argue that 
psychological and social factors important in the causation and treatment of 
disease in individuals are being neglected (Leggett, 1997; McKenzie, 2012; 
Tonelli and Callahan, 2001; Williams and Garner, 2002). 
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Similarly, this reductionism is seen to advance health care which is insufficiently 
humanistic, personal, holistic and responsive to individual patients’ experiential 
perspectives: the ‘disease’ has been prioritised over the person who suffers 
from it (Leggett, 1997; Miles, 2009a; Miles, 2009b; Williams and Garner, 2002).  
Thus, many criticisms directed at EBM mirror those directed at Western 
approaches towards mental health treatment (see Chapter Two), concerning a 
lack of holism and individualisation in the biomedical approach. 
3.1.7 Evidence-based medicine in Japan 
Whilst EBM marks a shift away from the traditional approach to health care 
which prioritises clinical judgement (Bhandari, Zlowodzki and Cole, 2004), this 
approach remains in some places the dominant healthcare model.  The 
‘apprenticeship system’ found in Japan, whereby methods and expertise are 
passed from older to younger generations (Bartholomew, 1989), is akin to this 
form of ‘eminence-based’ practice, with which EBM may be considered to 
conflict (Isaacs and Fitzgerald, 1999; Yokota, Kojima, Yamauchi et al., 2005).   
Reasons posited for the lack of acceptance of EBM within Japan reflect the 
criticisms noted above: concerns that EBM disregards the value of clinicians’ 
experience and skill, and takes insufficient account of individual differences 
(Yokota et al., 2005).  Accordingly, experimental approaches and meta-
analyses are rarely utilised within Japanese clinical psychology, and Japan is 
considered to lag behind other ‘developed countries’ in conducting high quality 
clinical research (Fukui and Rahman, 2002; Shimoyama, 2011).  Thus, 
evidence of intervention effectiveness in Japan continues to rely largely on case 
studies and clinical impressions. 
3.2 Developing and evaluating complex interventions 
As the principles, and therefore methods, of EBM were established with a 
biomedical focus (Kelly et al., 2010), attention now turns to how such carefully 
controlled methods can be applied to circumstances which draw on multiple 
disciplines and in which patients, interventions and contexts are complex and 
variable. 
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3.2.1 What is a complex intervention? 
Complex interventions are typically non-pharmacological interventions which 
aim to change behaviour at an individual or organisational level (Clark, 2013), 
and are “widely used in the health service, in public health practice and in areas 
of social policy” (Craig, Dieppe, Macintyre et al., 2008) (p.6).  Traditionally 
defined as “interventions with several interacting components”, the focus is on 
the characteristics of the intervention itself: the number and difficulty of 
behaviours required by those delivering or receiving the intervention; number of 
groups or organisational levels targeted; number and variability of outcomes; 
and degree of flexibility or tailoring permitted (Craig et al., 2008) (p.6).  
Subsequent definitions pay increased attention to context and implementation, 
with complex interventions now considered much more than the sum of their 
component parts (Anderson, Petticrew, Chandler et al., 2013; Datta and 
Petticrew, 2013; Richards, 2015a). 
3.2.2 The Medical Research Council Framework 
In 2000, the UK Medical Research Council (MRC) developed a methodological 
framework for developing and evaluating complex interventions, updated in 
2008 (Craig et al., 2008; Medical Research Council, 2000).  The aim was to 
provide a phased and structured approach to complex intervention design, 
development, evaluation and implementation, in order to improve the quality 
and generalisability of complex interventions in health care (Campbell, 
Fitzpatrick, Haines et al., 2000). 
3.2.3 Why was the MRC Framework developed? 
As noted by Craig et al. (2008), the MRC framework sought to guide 
researchers and funders in recognising and adopting appropriate methods for 
tackling the additional challenges presented by complex interventions, 
alongside the practical and methodological difficulties of any evaluation, such as 
intervention standardisation (Hawe, Shiell, Riley et al., 2004; Rifkin, 2007); 
contextual, organisational and logistical issues (Ogilvie, Mitchell, Mutrie et al., 
2006; Petticrew, Cummins, Ferrell et al., 2005; Rychetnik, Frommer, Hawe et 
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al., 2002; Wolff, 2001); and the length and complexity of the relationships 
between interventions and outcomes (Victora, Habicht and Bryce, 2004). 
The updated framework sought to rectify a number of initial limitations, 
specifically an over-emphasis on clinical trials and evaluation, and the linearity 
implied by the model (Craig et al., 2008).  As such, the 2000 framework may be 
said to have too closely represented the biomedical approach (for example, 
adopting a model based on that typically used in pharmacological evaluations) 
on which EBM was founded (Kelly et al., 2010).  Thus, the broader and more 
flexible 2008 framework provides a range of methods, recognising the value of 
qualitative and descriptive research; and a more iterative, programmatic 
approach in which feedback loops may be incorporated and due consideration 
is given to intervention development, piloting and implementation (Craig et al., 
2008; Craig and Petticrew, 2013; Richards, 2015a). 
3.2.4 An overview of the MRC Framework 
The MRC framework encompasses four stages of develop-test-evaluate-
implement (Figure 2).  At all stages, researchers aim to address key 
uncertainties before proceeding (Richards, 2015a).  In practice, researchers 
often move iteratively between stages rather than following a linear or cyclical 
sequence (Craig et al., 2008; Hallberg, 2015). 
Figure 2. Revised MRC framework (Reprinted from Craig et al., 2008, p.8) 
 




The aim of this stage is to develop an intervention to the point where it can 
reasonably be expected to have a worthwhile effect (Craig et al., 2008).  This 
involves identifying the intervention’s existing evidence base, ideally by 
systematic review; gaining a theoretical understanding of the changes to be 
effected by the intervention and how they should be achieved; and modelling 
the intervention to address who will deliver it, how long delivery will take and 
what each partner will do as part of it (Abraham, Denford, Smith et al., 2015; 
Buhse and Muhlhauser, 2015; Craig et al., 2008; Cullum and Dumville, 2015; 
Denford, Abraham, Smith et al., 2015; Faes, Reelick, Esselink et al., 2010; 
Lovell, Bower, Richards et al., 2008; Sermeus, 2015).  Also crucial to consider 
here is implementation: whether it would be possible to use this intervention, by 
whom and in what setting (Craig et al., 2008; Denford et al., 2015). 
Test 
Following development, uncertainties may remain with the potential to threaten 
the success of an evaluation of intervention effectiveness (Hallberg, 2015; 
Thabane et al., 2010).  This feasibility and piloting stage seeks to address these 
issues by testing the feasibility and acceptability of the research design, 
procedures and intervention; estimating likely rates of recruitment and retention; 
and providing data needed to calculate the required sample size for an 
evaluation to be powered to detect between-group differences (Feeley, 
Cossette, Côté et al., 2009; Jeray and Tanner, 2012; Lancaster, Dodd and 
Williamson, 2004; Robb, 2013; Taub et al., 2014).  To gauge when to proceed, 
each uncertainty should be judged against criteria to be met in order to deem 
the proposed evaluation ‘feasible’ (Thabane et al., 2010). 
Evaluate 
The main aim of this stage is to establish whether a causal relationship exists 
between the intervention and any effect, and the magnitude of any effect 
(Richards, 2015a).  Whilst randomisation should always be considered as the 
most robust method of preventing selection bias, circumstances in which this 
may not be appropriate deem an awareness of the range of possible 
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approaches key to making the most suitable methodological choices at this 
stage (Craig et al., 2008; Lamb and Altman, 2015; Seers, 2007).  Two other 
forms of investigation should also take place here: process evaluations to 
understand the mechanisms by which the intervention exerts its effect, and 
economic evaluations to estimate the cost of an intervention’s benefit compared 
to alternatives (Craig et al., 2008; Moore, Audrey, Barker et al., 2015b; Oakley, 
Strange, Bonell et al., 2006; Payne and Thompson, 2015).  
Implement 
This stage, which should be considered throughout the develop-test-evaluate 
cycle, involves translating evidence into practice or policy (Craig et al., 2008; 
Grol, Wensing, Eccles et al., 2013).  With the development of ‘implementation 
research’, how to successfully embed an intervention within practice has 
received increasing attention over the past decade (Damschroder, Aron, Keith 
et al., 2009; Eccles and Mittman, 2006; van Achterberg, 2015).  This involves 
systematic approaches to examining factors which may facilitate or hinder 
routine adoption of the intervention (Dogherty and Estabrooks, 2015; Grol and 
Grimshaw, 2003; Skolarus and Sales, 2015).  Key factors here include PPI, 
active dissemination of results, formative assessment of the effectiveness of 
implementation efforts, and monitoring long-term outcomes to identify actual 
effects and any unanticipated consequences (Craig et al., 2008; Richards, 
2015a; Stetler, Legro, Wallace et al., 2006; van Achterberg, 2015). 
3.3 Mixed methods research for complex interventions 
The MRC framework stresses the importance of qualitative research in 
answering fundamental questions about complex interventions.  Whereas 
quantitative research, dealing with numbers, seeks to enumerate; qualitative 
research, dealing with words, seeks to explain and interpret phenomenon in 
terms of the meanings people bring to them (Pope and Mays, 2006a). 
3.3.1 Qualitative methods in health services research 
Traditionally employed in the social sciences, qualitative research was originally 
perceived as an unscientific and anecdotal approach with no place within EBM 
(Britten, 2010).  However, as EBM is arguably a social movement as well as a 
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scientific enterprise, it requires the investigation of subjective and social 
processes best suited to qualitative research, and qualitative methods have 
been promoted in response to some of the criticisms directed towards EBM 
(Britten, 2010; Williams and Garner, 2002).  Researchers have increasingly 
acknowledged the value of qualitative methods to health services research and, 
in order to understand service user perspectives, qualitative research is 
increasingly common in the field and alongside RCTs (Bradley, Curry and 
Devers, 2007; Glogowska, 2015; Lewin, Glenton and Oxman, 2009; Pope and 
Mays, 2006a). 
Using qualitative research in conjunction with trials allows one to address the 
diversity of enquiries relating to acceptability, feasibility, evaluation and 
implementation, facilitating the simultaneous investigation of both exploratory 
and explanatory questions (Boeije, Drabble and O’Cathain, 2015).  Quantitative 
and qualitative approaches are now seen as complementary, expanding the 
scope of enquiry by allowing access to a wider range of data (O'Cathain and 
Thomas, 2006; Pope and Mays, 2006a).  Accordingly, a ‘third methodological 
movement’ in which mixed methods research integrates quantitative and 
qualitative methods is now emerging as a dominant paradigm in health research 
(Bradley et al., 2007; Creswell and Plano Clark, 2007; Doyle, Brady and Byrne, 
2009; O'Cathain, Murphy and Nicholl, 2007b; Teddlie and Tashakkori, 2009). 
3.3.2 Qualitative and quantitative paradigms 
One’s methodological choices are related to theoretical perspectives, and 
beliefs about how the social world can be studied (ontology) and how to assess 
the validity of social knowledge obtained (epistemology) (Pope and Mays, 
2006a).  Typically, quantitative approaches are associated with positivism and a 
belief in an external, objective social reality; qualitative approaches with 
interpretivism, and a belief that social reality is constructed through subjective 
meanings (O'Cathain and Thomas, 2006). 
Arguably, methods associated with different theoretical perspectives, ontologies 
and epistemologies in this manner cannot and should not be mixed (Johnson 
and Onwuegbuzie, 2004; O'Cathain and Thomas, 2006).  In the ‘paradigm wars’ 
debating the worth and position of quantitative and qualitative research, the 
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incompatibility of these worldviews has been consistently stressed (Glogowska, 
2015).  However, as a third paradigm arguably capable of bridging the gap 
between positivist and non-positivist positions, mixed methods may provide an 
opportunity to overcome this ‘false dichotomy’, with the philosophy of 
pragmatism offering an epistemological justification and logic for mixing 
quantitative and qualitative methods (Borglin, 2015; Doyle et al., 2009; 
Onwuegbuzie, Johnson and Collins, 2009).   
The pragmatic perspective 
Both pragmatism and mixed methods designs are characterised by the 
importance given to the research question(s), which inform the methods chosen 
(Borglin, 2015; Johnson and Onwuegbuzie, 2004).  Research objectives are 
approached from a pluralistic perspective, rejecting the need to choose between 
positivist and constructivist paradigms (Borglin, 2015).  Thus, pragmatism is 
signified by being pragmatic: regardless of philosophy, the method leading to 
the best evidence with regards to the research objectives should be used 
(Johnson and Onwuegbuzie, 2004). 
The pragmatic approach also emphasises abduction, intersubjectivity and 
transferability (Morgan, 2007).  Abduction allows for moving between induction 
and deduction, enabling both theory generation and verification (Borglin, 2015; 
Johnson and Onwuegbuzie, 2004; Morgan, 2007).  Intersubjectivity 
acknowledges that researchers move between various frames of reference and 
allows for both a single ‘reality’ and individual interpretations of that reality, 
transcending the subjective-objective dichotomy (Morgan, 2007).  
Transferability focuses on investigating factors which affect whether knowledge 
obtained in one setting can be transferred to others, rejecting the need to define 
knowledge as either context-dependent or universal (Morgan, 2007). 
3.3.3 Defining mixed methods 
As a relatively new and evolving area, confusion persists as to what mixed 
methods research entails (Doyle et al., 2009).  Certainly, mixed methods 
studies include qualitative and quantitative dimensions, but difficulties arise in 
terms of how these dimensions relate (Doyle et al., 2009; Tashakkori and 
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Creswell, 2007).  Over time, definitions have shifted from studies including at 
least one quantitative and one qualitative method, to a methodological 
orientation mixing the approaches in all phases of the research process 
including philosophical position, inferences and interpretation of results 
(Creswell and Plano Clark, 2007). 
Accordingly, Creswell and Plano Clark (2007) define mixed methods as “a 
research design with philosophical assumptions as well as methods of inquiry.  
As a methodology, it involves philosophical assumptions that guide the direction 
of the collection and analysis and the mixture of qualitative and quantitative 
approaches in many phases of the research process.  As a method, it focuses 
on collecting, analysing, and mixing both quantitative and qualitative data in a 
single study or series of studies.” (p.5).  Thus, mixed methods research 
incorporates both an overarching framework to guide the integration of 
quantitative and qualitative data throughout a project, and the specific 
techniques and procedures required to do so. 
3.3.4 Mixed methods research designs 
Mixed methods are employed in a range of forms and varied design 
classifications have been developed (Borglin, 2015).  Creswell and Plano 
Clark’s (2007) approach offers six prototypes which differ according to key 
issues in the combination of quantitative and qualitative strands: the priority, in 
addressing the research questions, given to either or both equally; the order in 
which they are conducted; the extent to and process by which they interact, with 
integration at the design level or during data collection, interpretation or 
analysis.  Two of these prototypes are ‘embedded’ and ‘multiphase’ designs 
(Creswell and Plano Clark, 2007).  
An embedded design involves a single study in which one strand is prioritised 
and the other added in a supportive role.  The strands are mixed purposefully at 
the design level so that the supplemental strand enhances the overall design; it 
may be undertaken before, during or after the dominant strand, informing what 
the dominant strand involves or aiding the explanation of results obtained from it 
(Creswell and Plano Clark, 2007).  The premise is that one method is 
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insufficient: different research questions require different types of data (Creswell 
and Plano Clark, 2007). 
The multiphase design includes an iteration of quantitative and qualitative 
studies within a programme of research (Creswell and Plano Clark, 2007).  The 
strands, undertaken either sequentially or concurrently but with equal priority, 
are mixed at the design level to address an overall objective (Creswell and 
Plano Clark, 2007).  As each new approach builds on previous learning, this 
design is particularly suitable for addressing incremental research questions 
within the MRC framework, and typically employed in large studies with 
numerous research questions designed to advance one overarching objective 
(Borglin, 2015; Creswell and Plano Clark, 2007). 
One further consideration in the relationship between quantitative and 
qualitative strands is sampling.  Mixed methods sampling strategies may be 
identical: the same participants included in both strands; nested: a subgroup 
from one strand is included in another; parallel: participants, selected from a 
homogenous group, are in either one or the other strand; or multilevel: 
participants, drawn from a heterogeneous sample, are different in different parts 
of the study (Onwuegbuzie and Collins, 2007). 
3.3.5 The value of mixed methods for complex interventions  
Embedded and multiphase designs highlight the suitability of mixed methods for 
researching complex interventions. 
Complexity 
The problems encountered in health services are multifaceted and, to be of 
value in the reality of health care, research must embrace this complexity with 
practical and methodological tools equipped to manage it (Borglin, 2015; 
Griffiths and Norman, 2012; Ong, 1993).  There is growing recognition of the 
appropriateness of mixed methods for this purpose: with single methods 
insufficient to tackle complex research questions, the integration of a wide 
spectrum of methodologies is necessary for a comprehensive and in-depth 
understanding and evaluation of health services phenomenon (Borglin, 2015; 
O'Cathain et al., 2007b; Wisdom, Cavaleri, Onwuegbuzie et al., 2012).   
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Advantages of gathering quantitative and qualitative information  
Both quantitative and qualitative methods have limitations: quantitatively 
examining many individuals may diminish the understanding of any one, 
whereas one cannot generalise from a qualitative study of a few individuals 
(Creswell and Plano Clark, 2007).  Using both methods together may address 
the limitations of each whilst retaining their strengths (Borglin, 2015; Creswell 
and Plano Clark, 2007; Johnson and Onwuegbuzie, 2004). 
Mixed methods also offer the potential to answer specific research questions 
involving integration.  Alongside separate research questions for each strand, 
Creswell and Plano Clark (2007) advocate for a mixed methods research 
question framing the integration of both to be included in the research design.  
Thus, one may address questions whereby qualitative methods help explain 
quantitative results, or quantitative methods help generalise qualitative 
explorations (Creswell and Plano Clark, 2007).  As such, mixed methods 
potentially offer a deeper understanding of phenomena than possible from one 
method alone.   
Furthermore, mixed methods may enhance the accuracy, relevance, credibility 
and transferability of results (Borglin, 2015; Glogowska, 2015; O'Cathain, 
Murphy and Nicholl, 2007a).  Through triangulation, more than one type of data 
may be used in illuminating a concept, with one form used to check the validity 
of another (Barbour, 1999; Pope and Mays, 2006a).  Where quantitative and 
qualitative results concur, data may be considered more reliable; where they 
conflict, important questions, which would otherwise have been missed, may be 
raised for further investigation. 
Iterative knowledge development 
In describing a phased, iterative approach to researching complex interventions 
which highlights the value of both quantitative and qualitative methods, the 
MRC framework supports mixed methods research.  The multiphase design is 
particularly suited to the MRC framework’s programmatic approach: with 
methodological strands informing each other, feedback loops and the 
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simultaneous investigation of exploratory and explanatory questions may be 
readily incorporated (Borglin, 2015). 
By providing such opportunities, mixed methods may also help reduce levels of 
avoidable research waste in studies which fail to provide useful, credible or 
appropriate information (Chalmers and Glasziou, 2009).  For example, in a 
multiphase design, systematic review results may suggest qualitative research 
necessary to develop an intervention before proceeding to testing; in an 
embedded design, qualitative interviews within a pilot trial may provide 
important insights regarding intervention acceptability and, potentially, the need 
for further intervention development before proceeding to evaluation.  Indeed, 






Part Two overleaf 
CHAPTER THREE: METHODOLOGICAL OVERVIEW. PART TWO: METHODOLOGICAL APPROACH 
77 
 
CHAPTER THREE.  PART TWO. 
Methodological Approach 
3.4 Methodological design and philosophical stance 
To optimise and investigate the feasibility and acceptability of Morita Therapy 
for a UK population, a scoping and systematic review, optimisation study and 
mixed methods feasibility study were undertaken.  These studies can be 
considered to comprise two stages (development and testing) of a multiphase 
mixed methods design organised in line with the MRC framework.  Figure 3 
(overleaf) provides an overview of this programme of research.  The feasibility 
study, incorporating a pilot RCT and qualitative interviews, employed an 
embedded mixed methods design.  A combination of multilevel and nested 
sampling strategies was used: participants in the optimisation and feasibility 
studies were recruited at different times from different populations using 
different criteria; participants in the qualitative strand of the feasibility study 
comprised a sub-group of those in the pilot RCT. 
3.4.1 Pragmatism 
The pragmatic perspective, commonly associated with mixed methods research 
(section 3.3.2), underpins this thesis.  Thus, within this multiphase design, the 
research objectives and methods which were considered to facilitate the best 
evidence with regards to them were prioritised.  For example, the feasibility 
study included quantitative and qualitative strands to best address the variety of 
uncertainties associated with running a large-scale trial of Morita Therapy.  
Consistent with pragmatism, deductive and inductive modes of reasoning were 
combined, the research objectives were approached from a pluralistic 
perspective, and a singular view and multiple views of reality were allowed for in 
how the findings were understood and interpreted. 
Thus, this research encompasses multiple philosophical paradigms.  In 
conducting a pilot RCT, a positivist worldview and associated ‘cause and effect’ 
reasoning has been upheld: for example, the effect of Morita Therapy on 
depressive symptoms was measured.  In exploring participants’ views through 
qualitative interviews, an interpretivist worldview and belief that reality is socially 
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constructed has been upheld: data were interpreted so as to allow for multiple 
participant meanings which are shaped by social interaction with others, 
including myself as the researcher. 
Figure 3. Programme of research to develop and test Morita Therapy 
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3.5 Scoping and Systematic Review 
The scoping and systematic review sits within the MRC framework’s 
development phase.  The primary aim was to describe the extent, range and 
nature of research activity reported in English in the field of Morita Therapy. 
3.5.1 What are scoping and systematic reviews? 
Through identifying, evaluating and summarising all relevant empirical evidence 
on an intervention using systematic and transparent methods, systematic 
reviews are undertaken with the aim of providing a reliable estimate of an 
intervention’s effectiveness (Centre for Reviews and Dissemination (CRD), 
2009).  On the other hand, a scoping review is a technique to comprehensively 
map all relevant literature in a field  (Arksey and O'Malley, 2005).  Although 
scoping reviews may be considered one form of systematic review (Meyer and 
Kopke, 2015), there are key differences.  Systematic reviews tend to address 
well-defined questions with appropriate study designs identified a priori whereas 
scoping reviews address broader topics where various study designs may be 
applicable; systematic reviews aim to provide answers from a relatively narrow 
range of quality assessed studies whereas scoping reviews are less likely to 
address specific research questions or assess study quality (Arksey and 
O'Malley, 2005).   
Common objectives of a scoping review include examining the extent, range 
and nature of research activity in a field; summarising and disseminating 
research findings; and identifying gaps in the existing literature (Arksey and 
O'Malley, 2005).  Accordingly, a scoping review was chosen to address the 
primary aim of this review, with systematic review methods incorporated to 
address research questions specified in relation to any identified RCTs (CRD, 
2009; Higgins and Green, 2011). 
3.5.2 The use of a scoping and systematic review in this thesis 
A systematic review of all Morita Therapy literature would have been required to 
establish the effectiveness of Morita Therapy (Cullum and Dumville, 2015).  
However, this approach was not chosen for the following reasons: 
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 The resources required to translate the Japanese literature into English were 
beyond the scope of this PhD. 
 This thesis investigates Morita Therapy specifically for a UK population.  
Considering cultural differences (see Chapter Two), the effectiveness of 
Morita Therapy within Japan and elsewhere outside the UK cannot be 
assumed to translate to a UK context. 
From contacts within the Japanese Society for Morita Therapy and data within 
an existing literature review (Minami, 2011a), it was considered highly unlikely 
that research into Morita Therapy had been undertaken in the UK.  A scoping 
and systematic review of the Morita Therapy research activity reported in 
English was chosen to enable confirmation of this gap in research.  Such a 
review also provided opportunities to examine and summarise the extent, range 
and nature of Morita Therapy research activity available in English; and to 
appraise any RCTs identified in English, in terms of both risk of bias and 
evidence relating to effectiveness. 
Thus, a two-stage scoping and systematic review was conducted.  Firstly, 
Arksey and O'Malley (2005)’s framework, as informed by systematic review 
methods (CRD, 2001), was followed in order to conduct a scoping review in a 
rigorous and transparent manner.  Accordingly, guided by the objective to 
identify all relevant literature regardless of study design, this process included: 
1. Identifying the research question, using the PICOS method (CRD, 2009) to 
define the patient population(s) (P), intervention(s) (I), comparator(s) (C), 
outcome(s) (O) and study design(s) (S) of interest. 
2. Comprehensively searching a variety of sources to identify relevant studies. 
3. Selecting studies based on PICOS criteria, with the addition of language 
(Cullum and Dumville, 2015). 
4. Charting, or extracting, key items of information from included studies in an 
approach akin to a narrative review (Pawson, 2002). 
5. Collating, summarising and reporting the results to provide a descriptive 
account. 
Secondly, for any RCTs identified, further steps were undertaken in line with 
guidance for undertaking systematic reviews (CRD, 2009; Higgins and Green, 
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2011) in order to address the following research questions: (1) what is the 
quality of any RCTs identified?; (2) what can they tell us about the effectiveness 
of Morita Therapy for mental health difficulties?  These steps were: 
1. Assessing risk of bias using criteria as suggested by the Cochrane 
Handbook for systematic reviews (Higgins and Green, 2011).  Such 
assessments are required, given the potential for bias within RCTs (section 
3.1.4), to determine the internal validity of studies and thus the likely 
robustness of their results (CRD, 2009). 
2. Reporting the results (means and standard deviations) of all standard 
outcome measures at baseline and follow-up, and using these statistics to 
calculate follow-up between-group differences and the 95% confidence 
intervals around these figures. 
3. Considering the use of further statistical synthesis techniques, such as 
meta-analysis, which, if appropriate, would provide a more precise and 
reliable estimate of the effectiveness of Morita Therapy than possible from 
individual studies alone (Oxman and Guyatt, 1993).  Both the quality and 
clinical diversity of the RCTs were taken into account in assessing the 
appropriateness and usefulness of such methods (Higgins and Green, 
2011). 
The details of the scoping and systematic review are presented in Chapter 
Four. 
3.6 Intervention Optimisation Study 
The intervention optimisation study sits within the MRC framework’s 
development phase.  The lack of UK-based Morita Therapy research in the 
context of potential cultural differences, availability of a variety of Morita 
Therapy methods and lack of thorough treatment manuals (see Chapter Two) 
highlighted the requirement for this preparatory work.  The aim was to develop a 
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3.6.1 A person-based approach to intervention development 
The person-based approach is a method for optimising intervention 
acceptability and feasibility prior to a feasibility study, to increase the likelihood 
of a successful outcome in that study (Yardley, Ainsworth, Arden-Close et al., 
2015a).  The approach promotes iterative qualitative studies to ground 
interventions in an in-depth understanding of how potential users may view and 
engage with them (Yardley et al., 2015a).  The method includes intervention 
planning, whereby user perspectives of the proposed or similar interventions 
are qualitatively explored; design, whereby themes from the planning stage 
inform the development of ‘guiding principles’ comprising the intervention’s key 
objectives and features; and development, whereby user reactions to every 
intervention element are obtained and the intervention modified accordingly 
(Yardley et al., 2015a). 
3.6.2 The use of the person-based approach in this thesis 
As the core features of Morita Therapy (see Chapter Two) may be considered 
akin to the ‘guiding principles’ developed during the earlier phases of the 
person-based approach, the final development phase was utilised to optimise 
the acceptability and feasibility of Morita Therapy over four iterative stages: 
1. Interviews explored potential patients’ and therapists’ views and 
understandings of Morita Therapy.  
2. Resulting qualitative themes were developed into recommendations for 
optimising Morita Therapy and a draft therapy protocol was developed by 
synthesising the Morita Therapy literature in line with these. 
3. Repeat interviews investigated how therapists related to the intervention 
content and protocol format.  
4. Resulting qualitative themes were addressed through protocol modification 
and tailoring the proposed therapist training programme. 
By integrating literature synthesis and qualitative research in the cross-cultural 
adaptation of Morita Therapy for the UK, this approach prioritised the 
perspectives of those who will deliver and receive the intervention, whilst 
ensuring adherence to its core features.  This was essential to proceeding to 
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the feasibility study with a treatment which is both true to the essence of Morita 
Therapy and potentially appropriate, accessible and deliverable for the target 
population, particularly in the context of the aforementioned contrast between 
Morita Therapy and established Western approaches (see Chapter Two). 
3.6.3 Qualitative research methods 
To explore participants’ views and understandings of Morita Therapy, multiple 
data collection and analytical techniques were available.  Justifications for the 
methods chosen are outlined below. 
Data collection techniques 
Semi-structured individual interviews, using a combination of qualitative and 
cognitive (Willis, 1999) interviewing techniques, were chosen.  Individual 
interviews were preferred over focus groups, whereby a group discussion is 
held (Kitzinger, 1994), given mental health is a sensitive topic less suited to this 
approach (Fitzpatrick and Boulton, 1996).  Furthermore, probing responses may 
be more difficult in this setting (Fitzpatrick and Boulton, 1996) and, in the 
context of this study, capturing interviewees’ immediate responses to the 
intervention would have been difficult to achieve. 
Semi-structured qualitative interviewing techniques enabled individual 
perspectives of Morita Therapy to be fully appreciated through open-ended 
questions and exploration of interviewees’ responses (Britten, 1995).  The 
inclusion of a list of topics to cover (a topic, or interview, guide) (Turner III, 
2010) also ensured discussion of each intervention element and consistency of 
questions across interviews.  Cognitive interviewing techniques, widely used 
when seeking an understanding of the cognitive processes involved in task 
completion, were then integrated to capture interviewees’ immediate responses 
to Morita Therapy (Ericsson and Simon, 1998; Pressley and Afflerbach, 1995; 
Willis, 1999; Zhelev, Garside and Hyde, 2013). 
Cognitive interviews include ‘think aloud interviewing’ and ‘verbal probing’ 
(Willis, 1999).  The person-based approach promotes think aloud interviewing 
for capturing participants’ immediate reactions to an intervention such as a web-
based one, whereby participants may reveal how they interpret the information 
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by explaining their thought processes as they engage with it (Yardley et al., 
2015a; Yardley, Morrison, Bradbury et al., 2015b).  In the absence of directly 
observing interviewees deliver or receive Morita Therapy, vignettes of therapy 
delivery (stage one) and the draft therapy protocol (stage three) were used to 
elicit views and understandings of the approach.  Accordingly, a variation of 
think aloud interviewing was utilised to allow participants to voice their thoughts 
about Morita Therapy as they occurred to them. 
Analytical techniques 
The framework approach (Ritchie, Lewis, Nicholls et al., 2013), chosen for this 
study, is a development of the matrix-based analysis methods described by 
Miles, Huberman and Saldana (2014) (Pope and Mays, 2006b).  The approach 
is increasingly used in health care research and particularly suited to applied 
research where objectives are typically set in advance (Pope and Mays, 2006b).  
Whereas grounded theory involves the inductive process of generating theory 
from data, an advantage of framework lies in enabling both inductive and 
deductive approaches: beginning from the study aims yet based in participants’ 
original accounts (Pope and Mays, 2006b; Ritchie et al., 2013).  Additionally, 
the approach is systematic and transparent, using a more explicit process than 
the thematic analysis approach (Pope and Mays, 2006b).  Overall, framework is 
considered suitable for both health services research (Green and Thorogood, 
2014) and data collected via cognitive interviewing (Collins, 2014). 
The details of the intervention optimisation study are presented in Chapter Five. 
3.7 Mixed Methods Feasibility Study 
A fully-powered RCT would be required to establish the effectiveness of Morita 
Therapy versus treatment as usual (TAU) for treating depression and anxiety in 
the UK.  In line with the MRC framework’s testing phase, the aim of this study 
was to prepare the ground for the design and conduct of such a trial, or to 
conclude that such a trial would not be appropriate and/or feasible. 
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3.7.1 What are feasibility and pilot studies? 
Whilst some make clear distinctions between feasibility and pilot studies, others 
regard the terms as interchangeable (Richards, 2015a).  Suggested definitions 
describe pilot studies as smaller replicas of proposed trials, undertaken to test 
how well the study protocol elements work together; feasibility studies as ‘pre-
study’ research, undertaken to gather information related to discrete aspects of 
the proposed trial (Arain, Campbell, Cooper et al., 2010; Giangregorio and 
Thabane, 2015).  Their shared aim therefore is “to inform the development and 
conduct of a planned research project” (Giangregorio and Thabane, 2015) 
(p.129). 
Areas in which these studies may inform trials can be clinical, procedural and/or 
methodological (Giangregorio and Thabane, 2015).  Each element being 
assessed should include ‘criteria for success’, clearly defined a priori, to be met 
in order to deem the proposed trial feasible (Thabane et al., 2010).  The 
potential outcomes of these criteria for the proposed trial are that it is feasible 
as proposed, feasible with protocol modification or careful monitoring, or not 
feasible (Giangregorio and Thabane, 2015). 
3.7.2 Why conduct a feasibility or pilot study? 
A major driving force behind the MRC framework was the recognition that, in 
the absence of preparatory work, many trials fail to achieve their goals or deliver 
clear results (Richards, 2015c; Vickers, 2014).  Poor design choices and issues 
of intervention delivery, acceptability, adherence, recruitment, retention and 
smaller than anticipated effect sizes may undermine trials, ultimately 
contributing to research waste (Craig et al., 2008; Dodd, White and Williamson, 
2012; McDonald, Knight, Campbell et al., 2006; Nichol et al., 2010; Richards, 
2015c; Treweek, Mitchell, Pitkethly et al., 2010; Wood, White and Thompson, 
2004).  Many such issues may be eliminated or minimised through feasibility 
and pilot studies (Richards, 2015c; Thabane et al., 2010).  Thus, they 
encourage methodological rigour and enhance the likelihood of making valid 
inferences from large-scale, resource-intensive trials (Feeley et al., 2009; 
Giangregorio and Thabane, 2015; Lancaster et al., 2004). 
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3.7.3 The use of a feasibility study in this thesis 
A number of uncertainties were present which prevented moving directly to a 
fully-powered evaluation of Morita Therapy, and were appropriate to address 
within a feasibility study (Thabane et al., 2010): 
 Clinical uncertainties.  The operationalisability and acceptability of the UK 
Morita Therapy outpatient protocol was unknown.  Gathering data on this 
was essential to ensure that the treatment administered in any large-scale 
trial is deliverable and acceptable to those involved. 
 Procedural uncertainties.  Information was required on likely rates of 
recruitment to and retention in a trial of Morita Therapy, and of treatment 
adherence, to assess the feasibility of a trial and inform the required sample 
size. 
 Methodological uncertainties.  Estimates of the variance in participant 
outcomes and information on how these correlate with baseline scores were 
also required to inform future sample size calculations.   
To collect such data, a mixed methods embedded design incorporating 
exploratory and explanatory components was employed (Creswell and Plano 
Clark, 2007).  Thus, qualitative interviews were embedded within a pilot RCT of 
Morita Therapy plus TAU versus TAU alone for depression and anxiety.  The 
quantitative and qualitative strands were prioritised equally and mixed 
interactively at the design level to address the study purpose (Creswell and 
Plano Clark, 2007).  The data for these strands were collected concurrently, 
analysed sequentially (with quantitative data guiding the qualitative interview 
sampling), and integrated to help explain variability in participants’ treatment 
adherence and ultimately develop a richer understanding of the feasibility and 
acceptability of Morita Therapy. 
3.7.4 Embedded qualitative interviews 
The qualitative interviews included a nested sample from the pilot RCT: all 
those randomised to Morita Therapy were invited, with a sub-group selected for 
analysis on the basis of treatment adherence and quantitative outcomes.  
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Individual semi-structured interviews and framework analysis were utilised, 
given the advantages of these techniques (section 3.6.3). 
3.7.5 Mixed methods analysis 
Multiple analytic strategies are available for integrative mixed methods analysis, 
classified by Creswell and Plano Clark (2007) as side-by-side comparisons, 
joint displays and data transformation.  Within this study, three forms of the joint 
display strategy were utilised: 
1. A typologies/ statistics display, with participants classified according to 
qualitatively derived characteristics, to explore how treatment adherence 
varies for participants whose views on the acceptability of Morita Therapy 
were organised into different typologies. 
2. A categories/ themes display, with participants classified according to 
quantitatively derived characteristics, to explore views of Morita Therapy 
across participants with various degrees of treatment adherence. 
3. A case-oriented merged analysis display, with each participant’s data 
organised along a quantitative scale of treatment adherence, to integrate 
views of Morita Therapy and the number of treatment sessions attended for 
each participant at an individual level. 
The choice and development of these techniques was guided by the nature of 
and inferences obtained from the quantitative and qualitative data separately, 
and by examples from prior mixed methods research (e.g. Li, Marquart and 
Zercher, 2000; McEntarffer, 2003; Mendlinger and Cwikel, 2008; Wittink, Barg 
and Gallo, 2006, cited by Creswell and Plano Clark, 2007); (e.g. Hill, Kuyken 
and Richards, 2014).  These techniques enabled the integration of quantitative 
and qualitative data, and thus the comparison of results generated, in different 
ways: participant data was both categorised and examined at an individual 
level; analysis was both quantitatively and qualitatively driven. 
The details of the feasibility study are presented in Chapters Six and Seven. 
 
 




I acknowledge that, just as approaches towards mental health and research are 
culturally situated and not value-free (as discussed), nor am I a “disembodied 
researcher” (Giltrow, Gooding, Burgoyne et al., 2005) (p.209): I have an active 
role in the research process in which my own identity, experiences and 
preconceptions, and the related methodological choices that I make, shape the 
research.  Thus, within this section I seek to make this subjectivity explicit. 
I have had both personal and professional encounters with depression, and 
worked within a clinical and research setting involving both theoretical and 
hands-on experience with depression treatments for six years.  These 
experiences directed my interest towards this topic and potentially influenced 
data collection and analysis: I likely identified with participants as an ‘insider’ 
with some empathy towards them (Hellawell, 2006).  As a white, British, tertiary-
educated female in my late-twenties during data collection, I am also an ‘insider’ 
and ‘outsider’ to the extent that I interviewed participants with similar and 
differing characteristics respectively: I identified with some participants, and 
they with me, more than others (Hellawell, 2006).  I acknowledge the tensions 
arising from these different social positions (Finlay, 2002): if, for example, an 
older male had been interviewed by another older male, different meanings may 
have been (co-)constructed. 
I also acknowledge that my cultural situation and research experience 
(consisting of qualitative and quantitative research, including trials) aligned me 
with the research paradigm of this PhD: I have assumptions consistent with a 
traditional Western epistemological position which directed my methodological 
approach (Crotty, 2003; Cruz, 2015).  This positioning was also relevant to my 
communications with Japanese Morita therapists (e.g. during the 9th 
International Congress), whereby I experienced at times a profound sense of 
“outsiderness” (Hellawell, 2006), reticence and concern about developing and 
testing (within a Western research paradigm) a treatment established within the 
Japanese culture: whether or not it is my place to do so, and whether the trial 
results would be seen to reflect the potential of Morita Therapy in the UK and/or 
the competency of UK researchers to work with Morita Therapy. 
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My cultural situation and personal and professional experiences are also 
relevant to my preconceptions about mental health treatment, presenting a lens 
through which I came to understand Morita Therapy.  Upon commencing this 
PhD, I simultaneously, and perhaps somewhat contradictorily, held positive 
views of Cognitive Behavioural Therapy and the notion of controlling one’s 
thoughts and emotions, and a belief in the potential value of challenging cultural 
assumptions about mental health and exploring alternative approaches.  As 
such, I approached the study of Morita Therapy with degrees of both scepticism 
and intrigue.  As my understanding of the approach grew, so too did my sense 
of excitement and optimism.  As someone who found the principles personally 
beneficial, I embarked on this project with the hope that Morita Therapy would 
help others too.  Indeed, as an applied Health Services Researcher, it makes 
sense that I would hope to make a difference in this way, and without some 
degree of hopefulness about the approach it is unlikely that my primary 
supervisor would have conceived of this project at the outset. 
This degree of investment in Morita Therapy was potentially compounded by my 
perception of my primary supervisors’ own interest in and optimism about the 
approach, as well as my role in the development of the UK Morita Therapy 
outpatient protocol.  As someone with this involvement in both clinical protocol 
development and therapist training, I also had a significant degree of (clinical) 
understanding of the treatment (including therapists’ views, reservations and 
enthusiasm about the approach) which may have influenced the ways in which I 
interacted with participants and undertook qualitative analysis.  However, this 
understanding may have also given me helpful insights into the potential risks 
and benefits of Morita Therapy, and the ways in which a UK population might 
relate to the approach. 
My degree of investment in and knowledge about Morita Therapy, which 
participants may have perceived in me, may have limited their willingness to talk 
openly about their views and experiences of the approach.  Additionally, as I 
undertook the majority of interviews in the same setting as participants received 
Morita Therapy, the line between their Morita therapist and myself as a 
researcher may have been blurred; indeed, several participants asked if I could 
offer them Morita Therapy as a therapist.  The extent to which participants 
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perceived me as a (health) professional may have contributed to the degree of 
power imbalance between us (Etherington, 2007), influencing how they spoke 
about Morita Therapy.  I attempted to limit the impact of such concerns by 
stressing the importance of sharing with me both negative and positive views of 
Morita Therapy, and by being aware of how my views might influence my own 
responses.  However, my knowledge of Morita Therapy and understanding of 
depression may have also allowed me to understand and probe into 
participants’ responses in greater depth, to build rapport and facilitate 
participants’ disclosure. 
My degree of investment in the pilot trial itself, with a ‘successful’ trial potentially 
presenting more future opportunities for me as a researcher, was particularly 
reflected in the difficulties I encountered managing a professional training year 
student: my reluctance to hand over responsibility for aspects of the trial to 
someone who was less invested in it.  However, these factors also contributed 
to meticulous trial management on my part.  Thus, my own identity, experiences 
and values have played multiple roles in the research process, and may present 
both strengths and weaknesses for this research. 
3.9 Chapter summary 
This chapter has provided a methodological framework for this thesis by 
describing evidence-based medicine, the MRC framework and mixed methods 
research for complex interventions; and an overview of the methodological 
design and approaches used within each study.  In Chapter Four, the scoping 
and systematic review describing the extent, range and nature of research 
activity reported in English in the field of Morita Therapy is presented.
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CHAPTER FOUR.  SCOPING AND SYSTEMATIC REVIEW 
Following guidance on reporting scoping reviews and the PRISMA statement for 
systematic reviews (Arksey and O'Malley, 2005; Liberati, Altman, Tetzlaff et al., 
2009), this chapter presents the objectives, methods and results of a scoping 
and systematic review undertaken to, primarily, describe the extent, range and 
nature of research activity reported in English in the field of Morita Therapy.  
The review was conducted by HVRS (PhD candidate) with assistance from 
DAR (primary supervisor) and a professional training year student on a 
placement with the team (VT); the contributions of DAR and VT are detailed 
within the methods section (4.2).  This chapter concludes with a discussion of 
the key findings and their implications for this thesis.  Further reflections on this 
review, including a discussion of its strengths and limitations, are presented in 
Chapter Eight. 
 4.1 Aim and objectives 
The primary aim of this review was to describe the extent, range and nature of 
research activity reported in English in the field of Morita Therapy.  The overall 
objective was to identify all literature relevant to this aim, regardless of study 
design.  The specific objectives were to map the fields of study, summarise the 
range of research and findings, and identify gaps in the existing literature.  Two 
research questions were also specified in the event that any randomised 
controlled trials (RCTs) of Morita Therapy were identified:  
1. What is the quality of any RCTs identified? 
2. What can they tell us about the effectiveness of Morita Therapy for mental 
health difficulties? 
4.2 Method 
A two-stage process was undertaken.  Firstly, Arksey and O'Malley (2005)’s 
framework for scoping reviews, as informed by systematic review methods 
(Centre for Reviews and Dissemination (CRD), 2001), was followed.  Secondly, 
for any RCTs identified, further steps were undertaken in line with guidance for 
undertaking systematic reviews (CRD, 2009; Higgins and Green, 2011). 
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4.2.1 Identification of the research question 
To formulate a search strategy for this review, the PICOS (CRD, 2009) method 
was employed:  
 P (Population): any patient population or presentation. 
 I (Intervention): any intervention which the author(s) defined as Morita 
Therapy, or Morita-based Therapy, including all in/outpatient formats. 
 C (Comparator): any or no comparators. 
 O (Outcomes): any papers describing the application of Morita Therapy 
using patient-focused data, with no restrictions placed on how effectiveness, 
outcomes, patient experiences or views were measured.  Thus, data were 
referred to in the broadest sense, including all patient-focused empirical 
and/or clinical data (e.g. clinical opinions and observations; questionnaires; 
surveys; narrative descriptions; qualitative data). 
 S (Study design): all designs with no methodological restrictions. 
Additional inclusion criteria 
 Any publication status. 
 Written in English.  Given the resource limitations of a PhD, translation of 
papers was not possible. 
Exclusion criteria 
 Purely theoretical, conceptual, socio-historical or discussion papers. 
 Conference proceedings. 
 Abstracts for which full texts were unavailable. 
4.2.2 Identifying relevant papers: search strategy 
To ensure a comprehensive search of the literature, the following databases 
were searched: Cochrane Library, Embase, PsycINFO, PubMed, Scopus, Web 
of Science.  Upon advice from the University of Exeter Medical School Institute 
for Health Research Evidence Synthesis and Modelling for Health Improvement 
(ESMI) team (http://medicine.exeter.ac.uk/esmi/), these databases were 
considered to provide a spread of purpose and content, thus allowing a broad 
CHAPTER FOUR: SCOPING AND SYSTEMATIC REVIEW 
93 
 
approach to identifying potential literature.  The databases were searched from 
date of inception until present day (March 2016) to ensure the historical context 
of the literature, as well as all up to date papers, was obtained.  The search 
term “morita OR moritian” was used in title, abstract and key word fields. 
Where possible in the databases, results were restricted to those written in 
English only.  Within the databases which allowed differentiation by specific 
author (PsycINFO, Scopus and Web of Science), searches were also 
conducted for key authors in the field, as identified from prior knowledge and 
the results of the first search (Ishiyama, Fumihiko; Kitanishi, Kenji; Kondo, 
Akihisa; Kora, Takehisa; LeVine, Peg; Nakamura, Kei; Ogawa, Brian). 
Grey literature 
Following the initial database searches and upon guidance from the ESMI team, 
grey literature searching took place using British Library EThOS, Dogpile, 
Google Advanced Search and OpenGrey to help ensure literature was not 
omitted.  These databases were searched by looking for “morita” or “moritian” in 
the title and specific authors as detailed above. 
Hand-searching and existing networks 
Lists of publications from known authors were checked for any publications not 
already identified, and known author publications not already identified were 
hand-searched for any empirical or clinical data.  The volumes of the ‘Journal of 
Morita Therapy’ (from 2012 to present), unavailable electronically, were hand-
searched for eligible papers.  An unsuccessful request to provide any additional 
English-language papers contained in the volumes from inception to 2012 was 
also made to the Journal Editor. 
Forwards and backwards citation checking 
Backwards citation checking was undertaken by searching the reference lists of 
all included papers; forwards citation checking using the Scopus database. 
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 4.2.3 Study selection 
Citations were imported into EndNote X7.7 (DISC bv, 2016), where duplicate 
citations were removed.  The first stage of screening, of titles and abstracts 
(Pham, Rajic, Greig et al., 2014), was completed independently by two 
reviewers (HVRS and VT).  In cases of disagreement, the study was discussed 
with a third reviewer (DAR) until consensus was achieved.  Where available, full 
text copies were retrieved for all potentially eligible citations and reviewed by 
HVRS in discussion with DAR, allowing consensus to be reached about the 
papers to be included in the review.  Following retrieval of these papers, hand 
searching and citation checking was undertaken, as described above, to ensure 
comprehensiveness.  Where full papers were not available electronically, the 
first authors were contacted to request these where possible (i.e. an email 
address or online profile could be identified for the author). 
4.2.4 Data charting 
Data were collected from all papers as suggested by Arksey and O'Malley 
(2005).  In Excel v.14 (Office, undated), a data-charting form was iteratively 
developed as batches of data were extracted by HVRS in discussion with DAR 
(Levac, Colquhoun and O'Brien, 2010).  The following information, where 
present, was extracted in an approach akin to a narrative review (Pawson, 
2002): publication year; publication status/ document type; type of report 
(primary or secondary); country; patients’ diagnosis/ symptom profile and age 
range; total number of patients; intervention format (in- or outpatient); summary 
and duration of intervention; outcome measures, if any; study design, if any; 
comparators, if any; a summary of the study’s aims, methods, results and 
conclusions. 
4.2.5 Randomised controlled trials: risk of bias assessment 
For RCTs, risk of bias was assessed (CRD, 2009).  Thus, in addition to the 
above data charting, an assessment of internal validity was conducted using 
criteria as suggested by the Cochrane Handbook for systematic reviews 
(Higgins and Green, 2011): adequate sequence generation; concealment of 
allocation; blinding of participants and outcome assessors; handling of 
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incomplete outcome data; selective outcome reporting; other potential threats to 
internal validity.  Summary assessments were made for each study by counting 
the number of domains in which the study was considered at low risk of bias. 
4.2.6 Collating, summarising and reporting results 
The overall aim of this step was to focus on the landscape of the literature as a 
whole, to aid identification of any gaps in the current evidence-base.  Therefore, 
a descriptive account of the data was developed (Arksey and O'Malley, 2005).  
Firstly, basic numerical analysis of the extent, nature and distribution of included 
papers was conducted.  Thus, papers were mapped according to geographical 
distribution; patient population; study design; type of Morita Therapy 
intervention; outcome measures used and/or type of data presented. 
‘Papers’ included primary studies and reviews/ secondary reports (defined as 
brief and ad hoc reports of data collected within other studies, with no attempt to 
systematically identify nor synthesise studies as per the identified reviews) 
which were included in order to access data not originally reported in English.  
Although some studies reported within these papers may have been originally 
reported in English and thus included as primary papers, no double counting 
took place as the data describes the nature of each included paper (whether 
primary study or review/ secondary report), not each included study (of which 
each review/ secondary report contained multiple).  Thus, each review/ 
secondary report is counted and reported as a single paper; the studies 
contained therein have not been counted or reported individually.  For example, 
for geographical distribution, two reviews including data from studies conducted 
in a mixture of locations are counted and reported as two papers of mixed 
locations. 
Secondly, the literature was organised according to study design (or type of 
paper, for secondary reports) to produce a narrative account.  To ensure clarity 
and consistency in reporting, a template was developed and applied to each 
study design category (Arksey and O'Malley, 2005).  This template included 
commentary on all papers included in that category under the following 
headings: interventions; sample sizes; participants; outcomes; research 
methods; evidence relating to effectiveness.   
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Randomised controlled trials: statistical analysis 
For RCTs, the results (means and standard deviations) of all standard outcome 
measures at baseline and follow-up, as reported in the published papers, were 
also presented.  These statistics were used to calculate between-group 
differences at follow-up, with 95% confidence intervals, in STATA v.14 
(StataCorp, 2015).  The appropriateness of further statistical synthesis 
techniques, such as meta-analysis, was considered in light of the quality and 
clinical diversity of the RCTs (Higgins and Green, 2011). 
4.3 Results 
4.3.1 Inclusion of papers 
A total of 3846 unique records were identified (Figure 4).  After screening, 197 
full text papers were reviewed; 131 did not fulfil study inclusion criteria and were 
excluded; 66 papers were included. 
Figure 4. Scoping and systematic review PRISMA diagram 
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4.3.2 Characteristics of included papers: numerical analysis 
This section describes the extent, nature and distribution of included papers.   
Geographical distribution 
Figure 5 describes papers according to the country in which Morita Therapy 
was implemented.  The largest proportion described interventions implemented 
in Japan (n=29; 43.9%); smaller proportions in China (n=12; 18.2%, including 
two reviews), Canada (n=12; 18.2%), the USA (n=7; 10.6%) and Australia (n=2; 
3.0%).  Two reviews (3.0%) included studies from a mixture of locations 
(Australia, China, Japan and the USA). 
Figure 5. Distribution of Morita Therapy papers by country (n=66) 
 
*Includes two reviews 
**Includes two reviews.  Australia; China; Japan; USA 
Notes: percentages may not always total 100 due to rounding. 
 
Patient population 
Figure 6 (overleaf) describes papers according to patient diagnosis or condition.  
Half of the papers, including one review, reported studies of anxiety disorders 
(n=33; 50.0%), the most frequent form being Japanese Shinkeishitsu (n=11; 
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such as shyness, communication apprehension or feelings of inferiority.  Other 
patient profiles included personality disorder (n=3; 4.5%); schizophrenia (n=3; 
4.5%, including one review); depression (n=2; 3.0%), including post-
schizophrenic depression (n=1; 1.5%); physical conditions (n=2; 3.0%); victims 
of sexual abuse or assault (n=2; 3.0%); eating disorder (n=1; 1.5%); insomnia 
(n=1; 1.5%); somatoform disorder (n=1; 1.5%).  Five papers (7.6%), including 
two reviews, presented data on a mixture of conditions. 
Figure 6. Number and proportion of papers according to patient population 
(n=66) 
*Includes one review. 
**Includes two reviews.  Gastric atony, dementia, low-grade fevers, proteinuria, empyema, hypertrophic 
rhinitis, insomnia, paroxysmal neurosis, depression, obsessive compulsive disorder, shinkeishitsu, neurotic 
disorder, social phobia, anxiety, social withdrawal, panic disorder, somatoform disorder, schizophrenia, 
dysthymia, phobia, post-traumatic stress disorder, mood disorder, eating disorder, adjustment disorder, 
pain disorder, sleep disorder, substance abuse disorder, personality disorder, bipolar II, psychosomatic 
illness, other subclinical issues 
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Mapping geographical distribution by patient population 
The largest proportion of papers focusing on anxiety disorders derived from 
Japan (n=19; 28.6% of all papers) (Table 1), with papers focusing on such 
disorders accounting for the majority of papers based in Japan.  Papers from 
China, Canada, the USA and Australia cover a range of conditions.  Papers 
focusing on depression derived from China (n=1; 1.5%) (post-schizophrenic 
depression) and the USA (n=1; 1.5%) (dysthymia or depression).  Additional 
papers (one review and one secondary report) presenting data on multiple 
conditions, including depression, included data collected in Japan (n=1; 1.5%) 
and Japan, China, Canada and the USA (n=1; 1.5%). 
Table 1. Geographical distribution of papers according to patient population 
(n=66) 
  Japan China Canada USA Australia Mixed Not provided 
  n % n % n % n % n % n % n % 
Anxiety (shinkeishitsu) 9 13.6 - - 1 1.5 - - - - - - 1 1.5 
Anxiety (social anxiety) 2 3.0 - - 3 4.5 1 1.5 - - - - - - 
Anxiety (neurosis) - - 3 4.5 - - - - - - - - - - 
Anxiety (OCD) 1 1.5 1 1.5 - - - - - - - - - - 
Anxiety (panic disorder) 2 3.0 - - - - - - - - - - - - 
Anxiety (mixed) 3 4.5 1* 1.5 - - - - - - - - 1 1.5 
Anxiety (other) 2 3.0 1 1.5 1 1.5 - - - - - - - - 
Personality disorder 1 1.5 - - 2 3.0 - - - - - - - - 
Schizophrenia - - 3* 4.5 - - - - - - - - - - 
Depression - - 1 1.5 - - 1 1.5 - - - - - - 
Physical condition 1 1.5 - - - - 1 1.5 - - - - - - 
Sexual abuse/assault - - - - 1 1.5 1 1.5 - - - - - - 
Eating disorder - - - - - - - - 1 1.5 - - - - 
Insomnia 1 1.5 - - - - - - - - - - - - 
Somatoform disorder - - 1 1.5 - - - - - - - - - - 
Subclinical issue 3 4.5 - - 4 6.1 2 3.0 1 1.5 - - - - 
Mixed 3** 4.5 - - - - - - - - 2*** 3.0 - - 
Undefined 1 1.5 1 1.5 - - 1 1.5 - - - - - - 
Total 29 43.9 12 18.2 12 18.2 7 10.6 2 3.0 2 3.0 2 3.0 
*Includes one review 
**Gastric atony, dementia, low-grade fevers, proteinuria, empyema, hypertrophic rhinitis, insomnia, 
paroxysmal neurosis, obsessive disorders (n=1); social phobia and/or avoidant personality disorder (n=1); 
shinkeishitsu, delusional-type neurosis, obsessive-compulsive neurosis, chronic unipolar depression 
(including bipolar II), dysthymia, schizophrenia, borderline personality, psychosomatic illness (n=1) 
***Includes two reviews.  Japan & China: anxiety disorder, schizophrenia, mood disorder, somatoform 
disorder, eating disorder, adjustment disorder, pain disorder, sleep disorder, substance abuse disorder, 
personality disorder, other subclinical issues (n=1); Japan, China, Australia & USA: depression, obsessive 
compulsive disorder, shinkeishitsu, neurotic disorder, social phobia, anxiety, social withdrawal, bulimia 
nervosa, panic disorder, somatoform disorder, schizophrenia, dysthymia, borderline personality disorder, 
phobia, post-traumatic stress disorder (n=1) 
Notes: percentages may not always total 100 due to rounding; OCD=obsessive compulsive disorder 
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Study designs adopted 
The largest proportion of papers were narrative case studies (n=26; 39.4%) 
(Figure 7).  The second largest category (n=11; 16.7%) was defined as clinical 
impressions: reports of clinical/ empirical data in the form of clinicians’ general 
reflections on or brief examples of patient(s) they have treated, in order to 
illustrate their approach to or the principles of Morita Therapy, without utilising 
any study design nor providing in-depth information on individual patients in the 
form of a case study. 
Only 10.6% (n=7) of papers presented comparative studies comparing Morita 
Therapy against alternative approaches: five (7.6%) were RCTs and two (3.0%) 
were non-randomised comparative studies.  Other designs included measures 
repeated before and after therapy (n=6; 9.1%) and cross-sectional 
observational studies in which follow-up surveys were sent to former patients 
(n= 5; 7.6%).  Reviews accounted for 6.1% of papers (n=4); seven papers 
(10.6%) were counted separately as ‘secondary reports’ summarising data from 
studies originally published in Japanese or Chinese. 
Figure 7. Number and proportion of papers according to study design (n=66) 
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Mapping geographical distribution by study design 
The largest proportions of papers utilising case studies derived from Japan 
(n=13; 19.7% of all papers) and Canada (n=9; 13.6%) (Table 2).  The case 
study design accounted for almost half of papers based in Japan and the 
majority of those conducted in Canada, as well as both studies (3.0%) 
conducted in Australia and both studies (3.0%) in which the location was not 
provided.  RCTs and non-randomised comparative studies were based in China 
(n=3; 4.5% and n=1; 1.5% respectively) and the USA (n=2; 3.0% and n=1; 1.5% 
respectively).   
Before-and-after studies were conducted in Japan (n=1; 1.5%), China (n=3; 
4.5%) and Canada (n=2; 3.0%); cross-sectional observational studies (follow-up 
surveys) in Japan (n=4; 6.1%) and China (n=1; 1.5%).  Both systematic reviews 
(3.0%) included studies based in China and both narrative reviews (3.0%) 
included studies based in various locations.  Secondary reports included data 
collected in Japan (n=6; 9.1%) and China (n=1; 1.5%). 
Table 2. Geographical distribution of papers according to study design (n=66) 
  Japan China Canada USA Australia Mixed 
Not 
provided 
  n % n % n % n % n % n % n % 
Case study 13 19.7 - - 9 13.6 - - 2 3.0 - - 2 3.0 
Before-and-after 
study 1 1.5 3 4.5 2 3.0 - - - - - - - - 
Cross-sectional 
observational study 4 6.1 1 1.5 - - - - - - - - - - 
Randomised 
controlled trial - - 3 4.5 - - 2 3.0 - - - - - - 
Non-randomised 
comparative study - - 1 1.5 - - 1 1.5 - - - - - - 
Systematic/ 
narrative review - - 2 3.0 - - - - - - 2* 3.0 - - 
None (clinical 
impression) 5 7.6 1 1.5 1 1.5 4 6.1 - - - - - - 
Secondary report 6 9.1 1 1.5 - - - - - - - - - - 
Total 29 43.9 12 18.2 12 18.2 7 10.6 2 3.0 2 3.0 2 3.0 
*Japan & China (n=1); Japan, China, Australia & USA (n=1) 
Notes: percentages may not always total 100 due to rounding. 
 
CHAPTER FOUR: SCOPING AND SYSTEMATIC REVIEW 
102 
 
Mapping study design by patient population 
Table 3 (overleaf) describes papers by study design for each patient diagnosis/ 
condition treated.  The largest proportion of case studies treated anxiety 
disorders (n=15; 22.7% of all papers) alongside subclinical issues (n=6; 9.1%).  
Other study designs covered a range of patient populations.  RCTs were utilised 
for various anxiety disorders (n=3; 4.5%), schizophrenia (n=1; 1.5%) and 
subclinical issues (communication apprehension) (n=1; 1.5%); non-randomised 
comparative studies for schizophrenia (n=1; 1.5%), depression and dysthymia 
(n=1; 1.5%).  The systematic reviews were undertaken for unspecified anxiety 
disorders (n=1; 1.5%) and schizophrenia/ schizophrenia-like symptoms (n=1; 
1.5%).  Both narrative reviews (n=2; 3.0%) included a mixture of conditions.  
Secondary reports included data on anxiety disorders (n=5; 7.6%), post-
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Table 3. Distribution of study design according to patient population (n=66) 





















  n % n % n % n % n % n % n % n % 
Anxiety (shinkeishitsu) 4 6.1 - - 3 4.5 - - - - - - 1 1.5 3 4.5 
Anxiety (social anxiety disorder) 4 6.1 1 1.5 - - 1 1.5 - - - - - - - - 
Anxiety (neurosis) - - 2 3.0 - - 1 1.5 - - - - - - - - 
Anxiety (OCD) 1 1.5 - - - - 1 1.5 - - - - - - - - 
Anxiety (panic disorder) 1 1.5 - - - - - - - - - - 1 1.5 - - 
Anxiety (mixed) 2 3.0 - - 1 1.5 - - - - - - - - 2 3.0 
Anxiety (other) 3 4.5 - - - - - - - - 1 1.5 - - - - 
Personality disorder 2 3.0 - - - - - - - - - - 1 1.5 - - 
Schizophrenia - - - - - - 1 1.5 1 1.5 1 1.5 - - - - 
Depression - - - - - - - - 1 1.5 - - - - 1 1.5 
Physical condition - - - - 1 1.5 - - - - - - 1 1.5 - - 
Sexual abuse/assault 1 1.5 - - - - - - - - - - 1 1.5 - - 
Eating disorder 1 1.5 - - - - - - - - - - - - - - 
Insomnia 1 1.5 - - - - - - - - - - - - - - 
Somatoform disorder - - 1 1.5 - - - - - - - - - - - - 
Subclinical issue 6 9.1 1 1.5 - - 1 1.5 - - - - 2 3.0 - - 
Mixed - - 1* 1.5 - - - - - - 2** 3.0 1*** 1.5 1**** 1.5 
Undefined - - - - - - - - - - - - 3 4.5 - - 
Total 26 39.4 6 9.1 5 7.6 5 7.6 2 3.0 4 6.0 11 16.7 7 10.6 
*Social phobia and/or avoidant personality disorder 
See overleaf for further notes
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**Anxiety disorder, schizophrenia, mood disorder, somatoform disorder, eating disorder, adjustment 
disorder, pain disorder, sleep disorder, substance abuse disorder, personality disorder, other subclinical 
issues (n=1); depression, obsessive compulsive disorder, shinkeishitsu, neurotic disorder, social phobia, 
anxiety, social withdrawal, bulimia nervosa, panic disorder, somatoform disorder, schizophrenia, 
dysthymia, borderline personality disorder, phobia, post-traumatic stress disorder (n=1) 
***Gastric atony, dementia, low-grade fevers, proteinuria, empyema, hypertrophic rhinitis, insomnia, 
paroxysmal neurosis, obsessive disorders 
****Shinkeishitsu, delusional-type neurosis, obsessive-compulsive neurosis, chronic unipolar depression 
(including bipolar II), dysthymia, schizophrenia, borderline personality, psychosomatic illness 
Notes: percentages may not always total 100 due to rounding; OCD=obsessive compulsive disorder 
Type of Morita Therapy intervention 
There is little standardisation and transparency in the implementation of Morita 
Therapy (see Chapter Two) and the papers identified reflect this.  No authors 
refer to the use of published treatment manuals.  Particularly in the context of 
outpatient Morita Therapy, less constrained by the four-staged inpatient 
structure of Morita’s original method (Morita et al., 1998), authors/ clinicians 
typically appear to have developed their own approach to Morita Therapy based 
on its traditional principles and/or techniques, and it is difficult to assess the 
extent to which these interventions are comparable across authors/ clinicians.  
Some authors refer to the use of a particular model (such as the Ishiyama 
(2011) counselling model), for which sufficient details to enable replication 
appear to be held by and passed down to individuals rather than accessible 
through publication.  Overall, descriptions of the intervention tended to be 
subsumed within descriptions of the principles of Morita Therapy, with either 
little information provided as to how these principles were operationalised, or 
highly individualised accounts of operationalisation provided in the form of 
narrative case studies (such as excerpts of clinician/ patient conversation, 
included to demonstrate the application of a principle). 
The information provided on interventions was used to categorise them 
according to whether they took place in an inpatient or outpatient setting, and 
whether outpatient Morita Therapy involved face-to-face individual therapy 
(‘outpatient counselling’) or another format (Figure 8, overleaf).  The largest 
proportion of papers (n=23; 34.8%) involved outpatient counselling; a similar 
figure (n=21; 31.8%, including one review) involved inpatient Morita Therapy; 
7.6% (n=5) involved a Morita-based group intervention; 3.0% (n=2) involved the 
Morita-based Seikatsu-no Hakkenka self-help group; 3.0% (n=2) involved tutors 
or school counsellors applying Morita Therapy techniques with students.  Other 
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papers included idiosyncratic and highly modified versions of the therapy (n=3; 
4.5%), a mixture of therapy types (n=8; 12.1%, including three reviews) or the 
intervention was undefined (n=2; 3.0%). 
Figure 8. Number and proportion of papers according to type of Morita Therapy 
intervention (n=66) 
 
*Includes one review 
**Letter therapy; Walking Training therapy; home care with Morita trained family members 
***Includes three reviews.  Inpatient; outpatient; group intervention; self-help group; patients treated at 
school or welfare counselling centres; patients treated by non-mental health professionals such as dentists 
employing Morita Therapy techniques 
Notes: percentages may not always total 100 due to rounding. 
Outcome measures used/ type of data presented 
The majority of papers (n=41; 62.2%) presented narrative descriptions of 
outcomes (Figure 9, overleaf), including clinical opinions or observations (n=31; 
47.0%) and patient self-report in the form of quotes or diary excerpts (n=10; 
15.2%).  With regards to quantitative outcome measures, 30.3% (n=20) of 
papers, including all four reviews, reported standard (published) outcome 
measures; 12.1% (n=8) reported author-developed measures to capture the 
specific changes Morita Therapy was expected to effect; 4.5% (n=3) reported a 
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Figure 9. Number and proportion of outcome measures employed/ types of data 
presented in papers (n=66) 
 
*Includes four reviews 
**Job/school status; life table analysis; extemporaneous speech task; extent of behaviour change 
Notes: N papers = number of papers including measure (as some papers included multiple measures, total 
is higher than total number of papers; % given is % of total number of papers (n=66) including the 
measure, thus percentages do not total 100). 
 
Six papers (9.1%) included the three or four point Morita Therapy rating scale.  
This scale is used for clinicians to assess, on the basis of their observations or 
patient-completed questionnaires, whether patients have experienced cure 
(complete disappearance of observable symptoms and subjective complaints), 
improvement (disappearance of observable symptoms with occasional 
subjective complaints), limited improvement (some reductions in both symptoms 
and subjective complaints), or no improvement.  On the three-point scale, both 
cure and improvement are considered to comprise cure. 
Quantitative outcome measures were heterogeneous: aside from the Morita 
Therapy rating scale, only seven measures were reported by more than one 
paper: an author-developed measure by Ishiyama (unpublished), reported five 
times; the Social Avoidance and Distress Scale (Watson and Friend, 1969), 
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Yale-Brown Obsessive Compulsive Scale (Goodman, Price, Rasmussen et al., 
1989), Symptom Checklist-90 (Derogatis, 1996), Hamilton Rating Scale for 
Anxiety (Hamilton, 1959) and Beck Depression Inventory (Beck, Steer and 
Brown, 1996), each reported two times.  The author-developed measures were 
not validated and papers rarely reported whether the standard outcome 
measures used were validated. 
4.3.3 Narrative account of each study design 
To summarise the range of research and findings, this section provides a 
narrative account of the papers included within each type of study design in 
terms of interventions, sample sizes, participants, outcomes, research methods 
and evidence relating to effectiveness.  Only data from research studies are 
included; clinical impressions (n=11) are not included. 
Summary tables documenting information about each paper included within 
each study design can be found in Tables 1-6 in Appendix I.  For RCTs, this 
information alongside quality assessment and statistical analyses is presented 
below.  With the exception of these reviewer-conducted analyses, it should be 
noted that the opinions of the study author(s), not those of the reviewers, are 
presented with regards to evidence relating effectiveness. 
Randomised controlled trials (RCTs) (n=5) 
Three RCTs were conducted in China; two in the USA which form parts of 
unpublished theses (Table 4, overleaf). 
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Table 4. Details of included randomised controlled trials (n=5) 
Author/ 
Year 










Research methods Outcome measures 





China Patients (n=73); 
mean age of 
intervention group 
31.2 years (SD 
6.5), mean age of 
control group 29.3 
























China Patients (n=257); 













term follow-up (12 
months). 




China Patients (n=64); 
mean age of 
intervention group 
34.5 years (SD 
14.0), mean age of 
control group 31.7 

















term follow-ups (6 
and 12 months). 
SOM: obsessive compulsive 








USA Patients (n=22); 













term follow-up (1 
month). 
SOM: social avoidance/ distress; 
fear of negative evaluation 
Author-developed measure: 
anxiety acceptance; problem 







USA Patients (n=31); 
mean age 32.3 



















term follow-up (5 
weeks). 
SOM: communication anxiety; 
social avoidance/ distress 
Author-developed measure: 
anxiety acceptance; problem 
severity; coping effectiveness 
Speech task; Heart rate 
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Interventions.  Two RCTs utilised inpatient Morita Therapy: one of twelve 
week’s duration with bed rest excluded (Chen, 2000); one of undefined duration 
including the original four phases (Qiyi and Xiongwei, 2000).  One utilised 
outpatient counselling, between two and five sessions over 20 weeks (Hou et 
al., 2000).  Few details were provided of this intervention aside from the 
inclusion of diary completion.  The two USA studies utilised group-based 
approaches informed by the Ishiyama (2011) counselling model, either three 
(Ogrisseg, 1999) or four sessions (Aposhyan, 1995). 
Sample sizes.  Sample sizes ranged from 22 to 257 (mean 89, SD 96).  Aside 
from Hou et al. (2000) (n=257), all studies included sample sizes of 73 or below.  
No studies included details of a power calculation or justified the sample size. 
Participants.  Inpatient interventions targeted schizophrenia with acute 
symptoms under control (mean age 31.2 years (SD 6.5) and 29.3 years (SD 
7.6) for Morita Therapy and control groups respectively) (Chen, 2000) and 
obsessive-compulsive disorder (mean age 34.5 (SD 14.0) and 31.7 (SD 12.4) 
for Morita Therapy and control groups respectively) (Qiyi and Xiongwei, 2000).  
Outpatient Morita Therapy targeted neurosis in adults (Hou et al., 2000).  Group 
interventions in the USA targeted communication apprehension (mean age 32.3 
years, SD 10.5) (Ogrisseg, 1999) and social phobia (mean age 26.9 years, SD 
6.5) (Aposhyan, 1995). 
Outcomes.  All studies utilised standard (published) quantitative outcome 
measures to evaluate symptom severity; social avoidance, distress or disability.  
In addition, the two USA studies included author-developed measures to assess 
anxiety acceptance, problem severity and coping effectiveness (Aposhyan, 
1995; Ogrisseg, 1999), and one included an extemporaneous speech task and 
heart rate monitoring to assess anxiety (Ogrisseg, 1999). 
Research methods.  All participants were randomised.  Control groups ranged 
from defined alternative treatments (three session stress management 
workshop (Ogrisseg, 1999); 20 sessions of acupuncture (Hou et al., 2000)) to 
wait-list (Aposhyan, 1995) and treatment as usual (defined as medication alone) 
(Qiyi and Xiongwei, 2000).  Chen (2000) did not define the control group.  All 
studies included baseline and follow-up (i.e. completed at the end of treatment, 
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or at a comparable time point for control groups with no treatment) measures.  
Four included longer-term follow-ups ranging from one to twelve months post-
treatment. 
Risk of bias.  Two studies were assessed as low risk of bias on two out of six 
domains (Chen, 2000; Hou et al., 2000); the remainder on one domain (Table 5, 
overleaf).  None were considered at high (or unclear) risk of bias from selective 
reporting: the results of all measures referred to in the studies’ methods were 
reported.  For two studies (Chen, 2000; Hou et al., 2000), whilst attrition was not 
explicitly reported, the n provided indicated all randomised participants provided 
data at subsequent time points and thus risk of attrition bias was rated as low.  
Other studies either failed to report rates of or reasons for attrition and therefore 
risk of attrition bias was rated as unclear or high.  For all studies, all remaining 
criteria were rated as either unclear or high risk.  No studies reported blinding of 
participants, personnel or outcome assessors.  No studies reported how the 
randomisation sequence was generated nor indicated the inclusion of any 
measures of allocation concealment.  In one study (Aposhyan, 1995), 
participants initially randomly assigned were allowed to change groups to 
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Table 5. Risk of bias in included randomised controlled trials 
Study 
Risk of Bias 
Summary 
assessment* 
Selection Performance Detection Attrition Reporting 

















Unclear risk. Quote: 
“patients were randomly 
divided”. No details of 
sequence generation. 
High risk.  No 
indication 
High risk.  No 
indication 
High risk.  
No 
indication 
Low risk.  Data 
suggests 0% 
attrition. 




Hou et al. 
(2000) 
Unclear risk. Quote: 
“patients were randomly 
divided”.  No details of 
sequence generation. 
High risk.  No 
indication 
High risk.  No 
indication 
High risk.  
No 
indication 
Low risk.  Data 
suggests 0% 
attrition. 







Unclear risk. Quote: 
“patients were randomly 
assigned”. No details of 
sequence generation. 
High risk.  No 
indication 
High risk.  No 
indication 
High risk.  
No 
indication 
Unclear risk.  
Attrition 
unreported. 







Unclear risk. Quote: 
“patients were randomly 
assigned”. No details of 
sequence generation. 
High risk.  No 
indication 
High risk.  No 
indication 
High risk.  
No 
indication 













High risk. Quote: “patients 
were randomly assigned”, 
but allowed to change 
groups to accommodate 
their schedules. 
High risk.  No 
indication 
High risk.  No 
indication 
High risk.  
No 
indication 








*Number of domains in which the study was considered at low risk of bias
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Evidence relating to effectiveness.  The results of standard outcome 
measures are presented alongside reviewer-conducted calculations of follow-up 
between-group differences in Table 6 (overleaf). 
Results are mixed.  Two studies show follow-up between-group differences 
which favour Morita Therapy compared to wait-list control (Aposhyan, 1995) 
and undefined control (Chen, 2000) on all outcomes.  Whilst small sample sizes 
suggest these results should be interpreted with caution, the lower margin of 
error does consistently favour the Morita Therapy group.  Hou et al. (2000) 
show consistently negligible follow-up between-group differences, with 
confidence intervals which show that the true population effect may or may not 
favour Morita Therapy compared to acupuncture. 
Two studies report mixed results: Qiyi and Xiongwei (2000) show follow-up 
between-group differences which consistently favour Morita Therapy compared 
to medication alone.  However, whilst the lower margin of error on the Yale-
Brown Obsessive Compulsive Scale favours the Morita Therapy group, the 
confidence intervals for other measures indicate the true population effect may 
or may not favour Morita Therapy.  Similarly, the follow-up between-group 
differences in Ogrisseg (1999) favour the stress management workshop on one 
measure and Morita Therapy on two measures.  Of those two, only the 
Stimulus-Response Inventory of Anxiousness-Speech has a lower margin of 
error which continues to favour Morita Therapy.  Furthermore, given the small 
sample size, it is difficult to draw any conclusions from these figures.
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Table 6. Results of standard outcome measures in randomised controlled trials with follow-up between-group differences 
 Notes: 95% CI = 95% confidence intervals around the follow-up between-group difference; SD=standard deviation
Study Outcome measure Participants 
Baseline Follow-up 
Between-group 
difference at follow-up 




Scale for the Assessment of 
Negative Symptoms 






35 42.6 7.5 
17.7 14.6 to 20.8 
Undefined control 38 60.3 5.9 
Brief Psychiatric Rating Scale 






35 26.2 4.3 
9.5 7.8 to 11.2 
Undefined control 38 35.7 2.9 
Hou et al. 
(2000) 
Hamilton Rating scale for 
depression 
Morita Therapy 129 21.46 6.27 129 12.78 5.61 
0.38 -1.0 to 1.8 
Active Control 128 22.39 6.56 128 13.16 5.72 
Hamilton Rating Scale for 
anxiety 
Morita Therapy 129 21.48 5.42 129 14.13 3.53 
-0.17 -1.1 to 0.77 





Compulsive Scale: thoughts 
Morita Therapy 31 12.30 2.78 31 4.36 2.85 
4.88 3.4 to 6.3 
Medication alone 33 12.70 3.70 33 9.24 2.75 
Yale-Brown Obsessive 
Compulsive Scale: actions 
Morita Therapy 31 11.00 3.57 31 4.39 2.07 
0.94 -0.2 to 2.0 
Medication alone 33 10.88 2.89 33 5.33 2.29 
Hamilton Rating Scale for 
anxiety 
Morita Therapy 31 29.36 7.68 31 12.45 9.16 
1.45 -2.6 to 5.5 
Medication alone 33 26.81 4.33 30 13.90 6.41 
Ogrisseg 
(1999) 
Personal Report of 
Communication Apprehension 
Morita Therapy 14 71.5 17.4 14 68.7 12.9 
0.9 
-10.8 to 
12.6 Active Control 17 73.8 17.2 17 69.6 17.9 
Stimulus-Response Inventory 
of Anxiousness-Speech 
Morita Therapy 14 35.7 6.6 14 30.9 9.9 
6.1 0.2 to 12.0 
Active Control 17 35.8 4.8 17 37.0 6.0 
Social Avoidance and Distress 
Scale 
Morita Therapy 14 9.1 7.0 14 9.2 7.1 
-1.2 -6.6 to 4.2 
Active Control 17 8.0 7.0 17 8.0 7.5 
Aposhyan 
(1995) 
Social Avoidance and Distress 
Scale 
Morita Therapy 11 20.6 5.5 11 12.8 5.3 
7.0 2.0 to 12.0 
Wait list Control 11 21.2 3.6 11 19.8 6.0 
Fear of Negative Evaluation 
Scale 
Morita Therapy 11 25.0 4.5 11 19.1 5.5 
7.8 3.8 to 11.8 
Wait list Control 11 25.6 3.5 11 26.9 3.1 
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Potential for statistical synthesis.  Further synthesis of results was deemed 
unwarranted and unfeasible given the diversity and heterogeneity of studies 
(Higgins and Green, 2011): they examined different intervention types with 
different patient diagnoses and control conditions, evaluated with a range of 
measures.  Furthermore, these studies are considered to be at high risk of bias, 
limiting the usefulness of any statistical synthesis (Higgins and Green, 2011).  
Given none of these studies were conducted within the UK nor with a 
depressed patient population, further synthesis would be unable to provide 
evidence of the effectiveness of Morita Therapy for depression in the UK. 
Non-randomised comparative studies (n=2) 
Details of non-randomised comparative studies are included in Table 1 
(Appendix I).  One forms part of an unpublished dissertation (Hanson, 2002). 
Interventions.  One study utilised the original inpatient approach, plus 
medication, for twelve months (Wang, Ma, Sun et al., 2000); one utilised 
outpatient counselling (weekly sessions over eight weeks) based on Reynolds’ 
Constructive Living approach (1995b) (Hanson, 2002). 
Sample sizes.  Wang et al. (2000) included 60 Morita Therapy participants, 60 
individuals with no history of psychosis and an undefined number in the other 
comparison group; Hanson included 80 participants (20 within each of four 
groups). 
Participants.  Wang et al. (2000) targeted patients with chronic schizophrenia, 
mean age 40.3 years (SD 7.8); Hanson (2002) targeted patients with 
depression or dysthymia, mean age 32.5 years (SD not provided, range 18-47 
years). 
Outcomes.  Both studies utilised quantitative measures: Wang et al. (2000) 
measured bone mineral content; Hanson (2002) measured symptoms and level 
of functioning using standard outcome measures and an original drawings 
method. 
Research methods.  Wang et al. (2000) collected follow-up data after 
treatment and two years later; Hanson (2002) administered measures at pre- 
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and post-treatment.  Wang et al. (2000) included two control groups who did not 
receive Morita Therapy: one group with chronic schizophrenia and one ‘normal 
comparison’ group with no history of psychosis.  Hanson (2002) included three 
control groups: one received dietary brain-chemistry treatment, one received 
combined Morita Therapy and dietary brain-chemistry treatment, and one 
received no treatment. 
Evidence relating to effectiveness.   According to Wang et al. (2000), there 
were no significant post-treatment differences between the Morita Therapy and 
normal comparison groups, whilst there were significant differences between 
the non-treatment and normal comparison groups and between the Morita 
Therapy and non-treatment groups (favouring Morita Therapy), although these 
did not persist at two year follow-up.  Hanson (2002) reported that mean post-
treatment scores, adjusted for pre-treatment scores, were statistically 
significantly better for the Morita Therapy group compared to the brain-
chemistry and non-treatment groups, and for the combined group compared to 
all other groups. 
Before-and-after studies (n=6) 
Details of before-and-after studies are included in Table 2 (Appendix I).  One 
forms part of an unpublished dissertation (Donahue, 1988). 
Interventions.  One study utilised the original inpatient approach alongside 
medication (duration undefined) (Kuroki, Tatebayashi and Tashiro, 2000).  In 
one study, patients’ significant others were trained in Morita Therapy ideas in 
order to treat patients at home using the original inpatient method (mean 
duration 72.2 days, SD 24.6) (Jiangbo, 2000). Two studies utilised outpatient 
counselling: one eight week intervention including the withdrawal of medication 
within two weeks (Tiancheng, 2000); one three session re-framing intervention 
based on Morita Therapy (Ishiyama, 1991).  Two studies utilised group 
counselling interventions consisting of weekly sessions over four (Donahue, 
1988) and five weeks (Mingyi, Chengjun, Zhongtang et al., 2000). 
Sample sizes.  Sample sizes ranged from five to 32 patients (mean 16, SD 
10.3). 
CHAPTER FOUR: SCOPING AND SYSTEMATIC REVIEW 
116 
 
Participants.  Three studies targeted anxiety disorders (Ishiyama, 1991; 
Jiangbo, 2000; Tiancheng, 2000); one cardiac neurosis (Mingyi et al., 2000); 
one shy adolescent females (Donahue, 1988); one social phobia and/or 
avoidant personality disorder (Kuroki et al., 2000). 
Outcomes.  All studies used quantitative measures; one added the clinician’s 
assessment of cure or improvement (Tiancheng, 2000) and one added one 
hour structured qualitative follow-up interviews, although further details of data 
collection and/or analysis were not provided (Ishiyama, 1991).  Four studies 
included standard outcome measures and/or author-developed outcome 
measures to assess symptoms; insight; social avoidance; difficulty in taking-
action; confidence; anxiety acceptance; problem severity; coping effectiveness; 
effect of symptoms on family life, social activities and work or study.  One study 
measured outcomes in terms of whether the patient returned to school or work 
(Kuroki et al., 2000) and one assessed the extent of behaviour change during 
treatment (Donahue, 1988).  One study (Jiangbo, 2000) utilised the three point 
Morita Therapy rating scale.  The basis on which the clinician made this 
assessment (whether this was purely observational or based on patients’ 
questionnaire responses) was unclear. 
Research methods.  All measures were completed pre- and post-treatment, 
with some repeated at various intervals during treatment.  Two studies included 
longer-term follow-ups whereby measures were completed at two and five years 
post-treatment (Kuroki et al., 2000) or qualitative interviews completed at 1.5 
months post-treatment (Ishiyama, 1991).  Various quantitative analysis methods 
were used, including inferential and descriptive statistical analyses and 
descriptive analysis of graphical data. 
Evidence relating to effectiveness.  The authors reported improvements from 
pre- to post-treatment for the majority of measures, with three studies using 
inferential statistical analysis reporting the majority of differences as statistically 
significant (Donahue, 1988; Mingyi et al., 2000; Tiancheng, 2000).  In 
Tiancheng (2000) and Jiangbo (2000), cure was considered by the authors to 
have been achieved by 37.5% (n=12) and 16.7% (n=1) respectively, and 
improvement by 40.6% (n=13) and 83.3% (n=5) respectively.  According to 
Kuroki et al. (2000), 75% of patients were in school or work at discharge, and 
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25% continued adequate social activity at five year follow-up.  According to 
Ishiyama (1991), in follow-up interviews no patients reported emotional 
deterioration and all reported general improvements in their social behaviour. 
Cross-sectional observational studies (n=5) 
Details of cross-sectional observational studies are included in Table 3 
(Appendix I). 
Interventions.  The majority of these studies reported outcomes from ongoing 
treatment centres or groups.  Two reported different data from the same 
hospital-based study utilising the original inpatient method lasting between 25 
days and six months (Suzuki, Kataoka and Karasawa, 1982; Suzuki and 
Suzuki, 1981).  One reported outcomes from the ongoing Japanese self-help 
group Seikatsu-no Hakkenkai, in which members provide each other with 
mutual support and insights based on Morita Therapy principles (Hasegawa, 
1990).  One utilised group Morita Therapy for two years (Ashizawa et al., 2000).  
One utilised outpatient counselling consisting of weekly sessions for one month 
followed by biweekly sessions for an average of 11.2 weeks, and focused on 
understanding symptoms, modifying action, externalising attention, and 
guidance for practical living (Zhen-tao, Tao-tson, Ji-uin et al., 1990). 
Sample sizes.  Sample sizes ranged from 13, to 1287 in Suzuki’s studies 
(1981; 1982).  In Hasegawa (1990), the survey was administered to 1085 group 
members. 
Participants.  Suzuki’s studies (1981; 1982) report data from Shinkeishitsu 
patients (mean age 26 years, SD not provided).  Other patients treated included 
those with chronic pain (age undefined) (Ashizawa et al., 2000); those with 
neurosis who were still functioning at work, school or home (age undefined) 
(Hasegawa, 1990); those with various DSM-III-R diagnoses who were randomly 
sampled from patients seeking treatment (mean age 26.5 years, SD not 
provided) (Zhen-tao et al., 1990). 
Outcomes.  One study used an undefined questionnaire (Hasegawa, 1990) 
and one used an author-developed questionnaire to measure degree of 
improvement in chronic pain, satisfaction with life and effect of treatment 
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(Ashizawa et al., 2000). Two administered a questionnaire to assess cure and 
improvement according to the four-point Morita Therapy rating scale (Suzuki 
and Suzuki, 1981; Zhen-tao et al., 1990).  The subsequent Suzuki study (1982) 
used life table analysis to assess the mean time taken for symptoms to improve. 
Research methods.  These studies used follow-up questionnaires/surveys.  
Two studies did not define the time point at which the survey was administered 
(Hasegawa, 1990; Zhen-tao et al., 1990); within the Suzuki studies (1981; 
1982), the survey was sent to former inpatients at least two years (on average, 
6.3 years) after discharge; in Ashizawa et al. (2000), the survey was 
administered to people attending the 100th group meeting celebration. 
Evidence relating to effectiveness.  Ashizawa et al. (2000) reported only 
correlations between questionnaire items.  According to Hasegawa (1990), 
questionnaire responses suggested patients developed insight into themselves, 
modified self-defeating ideas, changed the focus of attention towards realistic 
living, and showed signs of personal growth and symptom relief.  Zhen-tao et al. 
(1990) reported that 78.4% (n=80) reached cure or improvement; 21.6% (n=22) 
limited or no improvement.  In Suzuki and Suzuki (1981), 71% (n=914) returned 
questionnaires.  According to the authors, these indicated through patients’ 
retrospective self-evaluation that, at time of discharge, 12.1% (n=110) were 
cured or highly improved, 66.5% (n=608) were fairly improved and 19.8% 
(n=181) were unimproved; and at time of follow-up, 59.4% (n=543) were cured 
or highly improved, 36.7% (n=335) were fairly improved and 3.9% (n=36) were 
unimproved.  Suzuki et al. (1982) subsequently reported that at least 90% of 
patients improved greatly within 8 years of treatment. 
Case studies (n=26) 
Details of case studies are included in Table 4 (Appendix I). 
Interventions.  Over half of studies (n=14) utilised outpatient counselling.  One 
combined outpatient counselling with medication and sleep hygiene education 
(Itoh et al., 2000).  Duration was defined in terms of number of sessions 
attended (ranging from one to seven) or number of weeks’ or months’ treatment 
(ranging from 19 weeks to 18 months to date (treatment ongoing)).  Four 
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studies did not define duration.  Studies generally provided a narrative account 
of the implementation of Morita Therapy principles and techniques for the 
specific individual(s) treated, typically referring to Fumon, acceptance/ positive 
reinterpretation of symptoms and advice for constructive action-taking, 
sometimes within an explicitly modified form of outpatient therapy such as the 
conflict-focused model (Tamai and Tashiro, 1989).  Two studies did not provide 
details of treatment aside from what was considered to be the author’s unique 
addition to Morita Therapy: use of a narrative (Alfonso and Guthrie, 1990) or a 
model of mental operation (Tashiro, Tamai and Nakao, 1993). 
Nine studies utilised inpatient Morita Therapy.  The majority of these (n=8) 
involved the original inpatient approach; one did not provide details (Reynolds, 
1982).  Four studies provided treatment duration (ranging from 70 days to five 
months).  The remaining three studies utilised idiosyncratic forms of Morita 
Therapy: therapy by correspondence over a five month period (France, Cadieax 
and Allen, 1995); Walking Training Therapy incorporating behavioural elements 
of Morita Therapy (Kurokawa, 2006); use of Morita Therapy techniques in 
University counselling (Jamieson, 1990). 
Sample sizes.  The sample sizes ranged from one to five.  The majority of 
studies (n=20) treated a single patient. 
Participants.  The majority of interventions (n=15) targeted anxiety disorders, 
most frequently Shinkeishitsu (n=4) and social anxiety (n=4).  Six studies 
targeted subclinical issues such as test anxiety (Ishiyama, 1983); on occasion 
these were aimed at specific patient populations such as school teachers with 
nervous disorders (Terada, Ochiai, Ohta et al., 2000), University students who 
were presumed to exhibit some Shinkeishitsu traits (Jamieson, 1990) and 
bisexual patients during the ‘coming out’ process (LeVine, 1991).  Other 
presentations included childhood sexual abuse (Kelly, 1993), bulimia nervosa 
(LeVine, 1993a), insomnia (Itoh et al., 2000) and borderline personality disorder 
(Morley, 1990; Tamai, Takeichi and Tashiro, 1991).  Patient ages ranged from 
17 to 53 years. 
Outcomes.  The majority of studies reported the author/clinician’s narrative 
observations and opinions of patient outcomes.  Five studies included patient 
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self-report, three in the form of extracts from patients’ diaries completed during 
treatment which were considered to demonstrate changes in patients’ attitudes 
(Chang, 1974; Kondo, 1953; Reynolds, 1982), one in the form of the author’s 
reiteration of changes the patient reported to them (Jamieson, 1990), and one in 
the form of qualitative information, although details of how this was collected 
and analysed were not provided (Ishiyama, 1986a).  Only three studies used 
standard outcome measures, to assess obsessive compulsive symptoms 
(Tateno, Yano, Kawakami et al., 2015), the presence of eating disorders 
(LeVine, 1993a), and personality and self-concept (Kelly, 1993).  One study 
used an author-developed measure of anxiety acceptance, problem severity, 
and coping effectiveness (Ishiyama, 1986a), and one used an undefined 
measure to assess the nature of inner conflicts (Tashiro et al., 1993). 
Research methods.  The majority of studies (n=17) detailed no research 
methods.  All studies using outcome measures (n=5) included at least pre- and 
post-treatment completion of measures.  Six studies included follow-ups, 
ranging from three weeks to 40 months post-treatment. 
Evidence relating to effectiveness.  All authors (who were also the treating 
clinicians) reported positive outcomes.  Authors suggested that the narrative 
data indicated reductions in symptoms and increases in: acceptance and 
allowance of unpleasant emotions, action in the presence of unpleasant 
emotions, focusing attention on goals and daily activities, and recognition and 
acceptance of desires.  Authors reported post-treatment improvements on all 
outcome measures, with changes said to be either maintained or improved 
upon at any subsequent follow-up. 
Systematic/ narrative reviews (n=4) 
Details of reviews are included in Table 5 (Appendix I).  Two systematic reviews 
reported studies conducted in China, originally written in Chinese.  Two 
narrative reviews form part of unpublished dissertations.  Whilst some data from 
the narrative reviews may have been originally reported in English and thus 
overlap with data contained elsewhere in this review, Japanese and Chinese 
studies which were inaccessible to the reviewer formed the majority of data 
contained therein. 
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Interventions.  In both systematic reviews, Morita Therapy was defined as any 
care practice defined as Morita Therapy by the carers and involving at least two 
of the four phases, with no further details provided on the interventions 
implemented in included studies aside from duration: from six weeks to ten 
months (He and Li, 2007) and six weeks to twelve months (Wu, Yu, He et al., 
2015).  The narrative reviews collated data from a range of interventions with 
variable and/or undefined durations including original inpatient treatment, 
modified inpatient treatment omitting bed rest, outpatient counselling, self-help 
groups, patients treated at school or counselling centres or by non-mental 
health professionals (Minami, 2011a; Nakamoto, 2010).   
Sample sizes.  The systematic reviews included 449 patients from six RCTs 
(Wu et al., 2015) and 1123 patients from twelve RCTs (He and Li, 2007). 
Minami (2011a) included 49 case studies and four before-and-after designs.  
Nakamoto (2010) included 191 case studies, two secondary reports 
summarising data from other studies, and eleven quantitative studies, two of 
which were RCTs which are already included as primary studies in this review.  
The studies included within these narrative reviews were of various sample 
sizes. 
Participants.  The systematic reviews were of studies based in China with 
patients with unspecified anxiety disorder (aged 16-60 years) (Wu et al., 2015) 
and schizophrenia/ schizophrenia-like symptoms (aged 15-65 years) (He and Li, 
2007).  The narrative reviews included studies targeting a large variety of 
patient conditions and ages. 
Outcomes.  All reviews included a wide variety of standard outcome measures, 
typically evaluating symptom severity.  The majority of papers in the narrative 
reviews also reported clinician observed or patient self-reported narrative data.   
Research methods.  Both systematic reviewers included all RCTs comparing 
Morita Therapy to another intervention and targeting the relevant disorder, and 
searched a variety of databases.  Both narrative reviewers included any articles 
which contained efficacy data and searched the Japanese Journal of Morita 
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Therapy; in addition, one reviewer searched PsychINFO (Nakamoto, 2010).  
Minami (2011b) conducted a thematic analysis on narrative case study data. 
Evidence relating to effectiveness.  Wu et al. (2015) graded the quality of 
evidence as very low, noting that unclear randomisation methods, lack of 
blinding and low quality outcome reporting were common and, as such, that 
they were unable to draw conclusions as to the effectiveness of Morita Therapy 
for anxiety disorders.  Whilst considering included schizophrenia studies to be 
of medium-poor quality, He and Li (2007) reported that mental state and 
activities of daily living did tend to improve with Morita Therapy, although data 
on symptoms were inconsistent. 
Minami (2011a) reported six themes from narrative case study data: 
acceptance, symptom reduction, engagement in action in spite of symptoms, 
improved relationships, personality aspects, and experience of no significant 
effect from treatment.  Each included quantitative study reported significant 
treatment effects.  Nakamoto (2010) reported that the vast majority of included 
studies reported positive outcomes. 
Secondary reports (n=7) 
Details of papers which included brief and ad hoc reports of data collected 
within other studies (with no attempt to systematically identify nor synthesise 
studies, as per the reviews above), or those which included Morita Therapy 
studies alongside studies of other therapies, are included in Table 6 (Appendix 
I).  The information below is a summary of the primary Morita Therapy studies 
(n=38) reported within these papers (as far as possible from the details 
contained within the secondary reports), which were originally published in 
Japanese or Chinese and thus inaccessible to the reviewer first-hand. 
Interventions.  The majority of studies (n=26) reported outcomes from inpatient 
treatment, often reporting the outcomes from ongoing treatment centres.  Three 
employed the original inpatient approach; the remainder were undefined.  Two 
studies reported outcomes from Morita-based group therapy and one from a 
Morita-based self-help group.  Two reported the outcomes of a mixture of 
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inpatient and outpatient treatment, with no further details provided.  For the 
remainder of studies (n=7), the intervention was unspecified. 
Sample sizes.  For twelve studies, the sample size was not provided.  Sample 
sizes for the remainder ranged from three to 1317. 
Participants.  The patient condition was unspecified for many studies (n=19).  
The remainder related to Shinkeishitsu (n=14), other anxiety disorders (n=4) or 
post-schizophrenic depression (n=1).  The age range was only specified for one 
study (17-46 years). 
Outcomes.  The majority of studies (n=17) employed the three or four-point 
Morita Therapy rating scale to assess cure and improvement.  There was 
variation between studies in terms of whether these assessments were made 
on the basis of patient-completed questionnaires, clinical observations alone, or 
in an unspecified manner.  Other measures included the Rorschach test (n=7), 
physical tests (n=2), Social Disability Screening Schedule (n=1), projective 
drawing technique (n=1), sentence completion technique (n=1), temperament 
schedule (n=1) and extraversion-introversion index (n=1).  One study included 
mixed narrative data from clinical observations and patient self-report.  
Measures were undefined for six studies. 
Research methods.  The majority of studies (n=23) used a follow-up survey 
within a cross-sectional observational design.  One RCT, in which a twelve 
week inpatient Morita Therapy intervention plus medication was compared to 
undefined inpatient treatment plus medication for post-schizophrenic 
depression, was reported as part of a meta-analysis which otherwise included 
studies on other therapies (De Silva, Cooper, Li et al., 2013).  Eleven studies 
used a before-and-after design; one used post-treatment measures only; one 
used a non-randomised comparative design in which the comparison group 
received non-directive therapy; one reported mixed data from case studies.  
Beyond this, details of research methods were largely absent. 
Evidence relating to effectiveness.  According to authors’ accounts using the 
Morita Therapy rating scale, rates of cure were between 41-87%, rates of 
improvement between 8-45%, and rates of either cure or improvement between 
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75-100%.  The authors reported that narrative data suggested Morita Therapy 
leads to improvements in acceptance of symptoms, appreciation of desires, 
objective awareness, adaptive action-taking, productivity, lifestyles and social 
relationships; alongside reductions in maladaptive behaviours, self-
preoccupations and symptoms (Ishiyama, 1988a).  Other measures were 
reported to generally indicate positive changes, although mixed findings were 
found using the Rorschach test.  The RCT included within the meta-analysis of 
De Silva et al. (2013) was reported to show reductions in social disability from 
baseline to follow-up favouring inpatient Morita Therapy compared to undefined 
inpatient treatment: De Silva et al. (2013) calculated and reported the effect size 
as 0.66; 95% confidence intervals 0.26-1.05. 
4.4 Key findings and implications 
The aim of this review was to describe the extent, range and nature of research 
activity reported in English in the field of Morita Therapy.  Specific objectives 
were to map the fields of study, summarise the range of research and findings, 
and identify gaps in the existing literature.  Two research questions were 
specified for RCTs: (1) what is the quality of any RCTs identified?; (2) what can 
they tell us about the effectiveness of Morita Therapy for mental health 
difficulties? 
In accordance with the nature of scoping reviews, the inclusion criteria were 
deliberately broad (Arksey and O'Malley, 2005).  A total of 66 papers met the 
inclusion criteria: 44 primary studies, conducted with 3268 patients in total; four 
reviews and seven papers reporting data from other studies, including 313 
studies between them; eleven clinical impressions without any study design or 
in-depth patient information.  The mapping and narrative organisation of 
studies, alongside the assessment of quality and clinical outcomes in the RCTs, 
highlights both the heterogeneity of Morita Therapy studies and the significant 
gaps and weaknesses in the research, as summarised below. 
4.4.1 Mapping of included studies and gaps in research 
Geographical distribution.  The largest proportion of studies have been 
conducted in Japan, with a smaller number conducted in English-speaking 
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countries including the USA, Canada and Australia.  However, there is a 
complete absence of UK-based research.   
Patient population.  In line with the original use of Morita Therapy (Morita et 
al., 1998), half of studies target anxiety disorders.  Whilst two narrative reviews 
combine data on depression with other disorders, only two studies which 
uniquely target depression were identified.  These include one RCT in China, 
originally published in Chinese and thus accessed through a secondary report 
of the data, targeting post-schizophrenic depression and comparing inpatient 
Morita Therapy to undefined inpatient treatment; and one non-randomised 
comparative study in the USA targeting depression or dysthymia and comparing 
outpatient Morita Therapy counselling to dietary brain-chemistry treatment.  
Thus, no RCTs: a) target depression in Western patients; b) investigate 
outpatient Morita Therapy for depression; or c) target depression with no history 
of schizophrenia. 
Study design.  The majority of data consist of case studies and clinical 
impressions, and the vast majority of studies lack control of confounding 
variables.  Few studies ensure unbiased selection of participants, data 
collection or analysis; the majority of researchers reporting results are 
themselves Morita therapists.  Thus, these studies are highly prone to bias 
(Burns et al., 2011).  As much of this research is undertaken either within Japan 
or by Japanese clinicians who have transported Morita Therapy elsewhere, 
these findings corroborate the discussion in Chapter Three: with the ‘eminence-
based’ rather than ‘evidence-based’ model of healthcare continuing to dominate 
in Japan, high-quality clinical research is rare (Fukui and Rahman, 2002; Isaacs 
and Fitzgerald, 1999; Shimoyama, 2011; Yokota et al., 2005). 
Type of Morita Therapy intervention.  In relation to this thesis, it is noteworthy 
that only group-based Morita Therapy has been tested within an RCT in the 
West.  More generally, the ways in which Morita Therapy is implemented are 
highly variable and often not transparent, with few studies describing Morita 
Therapy in a reproducible manner.  No authors refer to the use of published 
treatment manuals, again reflecting the nature of research in Japan in which 
knowledge is largely passed through generations in an ‘apprenticeship system’ 
(Bartholomew, 1989).  Whilst case studies frequently describe their approach to 
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treatment in detail, these are highly individualised accounts with little guidance 
as to generalising the approach.  Thus, the studies highlight difficulties inherent 
in defining how Morita Therapy is implemented, attempting to replicate any 
approach, and comparing outcomes across studies. 
Measuring outcomes.  Almost half of studies rely on clinical opinion or 
observation, which is highly prone to bias (Burns et al., 2011).  A number of 
studies, including the majority of Japanese studies for which secondary reports 
were identified, use the Morita Therapy rating scale to assess whether patients 
achieve cure, improvement or no cure.  The definitions of these categories are 
broad and subjective: there is no uniform definition and the meaning of ‘cure’ 
differs across therapists; the reliability and validity of these scales has not been 
established (Ishiyama, 1988a; Reynolds, 1976).  In addition, whether these 
assessments are made on the basis of patient self-report or clinical judgement 
alone is variable and often unclear.  As such, the reliability and validity of such 
findings is highly questionable. 
There is much heterogeneity in the quantitative outcome measures 
administered and few of those used are reported to be validated.  Less than a 
third of studies include standard (published) measures and, of those, few 
studies use the same measures; thus, studies are difficult to compare. 
This review also highlights the lack of rigorous qualitative research into Morita 
Therapy.  Authors reporting qualitative information rely on clinical observations, 
anecdotal patient reports or data collection and analysis methods which are not 
reported in sufficient detail to enable either replication or assessment of rigour.  
No RCTs included qualitative studies to access patients’ accounts of therapy or 
how these relate to treatment adherence or outcomes.  Thus, whilst anecdotal 
reports provide some insights, Morita Therapy from the direct perspective of its 
recipients remains largely unexplored. 
Evidence relating to effectiveness.  The vast majority of studies claim to 
demonstrate the efficacy of Morita Therapy and appear to provide some 
evidence of potential effectiveness.  However, considering the above limitations, 
such results should be interpreted with extreme caution.  Studies which lack 
control of confounding variables are liable to overestimate treatment effects, 
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and those subject to bias are unable to establish cause and effect between the 
intervention and outcomes (Barton, 2000; Cook et al., 1992; Field and Hole, 
2003; Mulrow and Oxman, 1997; Sackett et al., 1996). 
4.4.2 Research questions regarding randomised controlled trials 
(1) What is the quality of any RCTs identified? 
A limited number of RCTs in China and the USA were identified; however, an 
assessment of internal validity indicates that there remains an absence of 
unbiased evidence for Morita Therapy.  The majority of quality criteria were 
rated as unclear or at high risk of bias and no studies were found to be of 
consistently low risk: two were at low risk in two out of six domains; three were 
at low risk on one domain.  No studies reported how the randomisation 
sequence was generated nor the use of allocation concealment, leading to 
potential selection bias (Field and Hole, 2003; Higgins and Altman, 2008).  One 
study had serious quality issues as the original participant allocation was 
changed.  Furthermore, whilst two studies appeared to experience no attrition, 
other studies failed to report either rates of or reasons for attrition, with potential 
for attrition bias (Moran and Whitman, 2014; Robinson et al., 2007).  Similarly, 
no studies included blinding of participants or personnel (admittedly rarely 
possible in the reality of testing complex interventions (Higgins and Altman, 
2008)) nor of outcome assessors, leading to potential performance and 
detection bias (Evans et al., 2011; Higgins and Altman, 2008). 
(2) What can the RCTs tell us about the effectiveness of Morita Therapy 
for mental health difficulties? 
Whilst most of the RCTs suggest the potential effectiveness of Morita Therapy 
on at least some outcome measures, albeit rarely in comparison to active 
controls, as well as being subject to bias these studies potentially lack external 
validity and precision (Higgins et al., 2011).  In the absence from all studies of a 
justification of sample size, and with sample sizes as small as eleven 
participants per group, the use of inferential statistics and statements is often 
potentially inappropriate (Coday et al., 2005; Moran and Whitman, 2014).  The 
confidence intervals calculated around the between-group follow-up differences 
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suggest the majority of results are imprecise.  Considering all limitations, 
authors’ conclusions as to the effectiveness of the approach should be 
interpreted with caution, and this absence of high-quality research creates a 
significant gap in the evidence-base for Morita Therapy. 
4.4.3 Implications for this thesis 
Quality and methodological rigour.  Whilst there is some, largely anecdotal, 
evidence to suggest Morita Therapy may have benefits for patients, the quality 
and methodological rigour of studies should be improved in order to assess the 
effectiveness of the approach.  Alongside ensuring internal validity to enable 
cause and effect to be established, studies making inferential statements should 
be sufficiently powered to do so, and those which are insufficiently powered 
should take care in interpreting results with caution and reporting confidence 
intervals to enable the precision of results to be considered. 
Standardising and manualising Morita Therapy.  In the context of much 
heterogeneity and little transparency in the implementation of Morita Therapy, 
this review indicates that further work is required to standardise and manualise 
the approach to enable wider implementation and comparisons of effectiveness 
to be made across studies.  Within the UK, further developmental work is 
required to produce a thorough treatment manual. 
Testing Morita Therapy in the UK.  The lack of UK-based research in the 
context of potential cultural differences (see Chapter Two) highlights the 
requirement to test Morita Therapy with a specifically UK-based population.  
Whilst Morita Therapy studies have been undertaken in the West, this thesis 
represents not only the first UK-based Morita Therapy study but the first RCT of 
Morita Therapy for depression in Western patients (assuming such a study 
would have been published in English).  Indeed, given the volume of Japanese 
and Chinese studies accessed through reviews and secondary reports, this 
review suggests this thesis may represent the first RCT of outpatient Morita 
Therapy for depression in the world. 
Other implications.  The lack of understanding of Morita Therapy patients’ 
views and experiences of the approach should be rectified through high-quality 
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and rigorous qualitative research, as deemed crucial in the development and 
evaluation of complex interventions (Craig et al., 2008).  Furthermore, as few 
studies have examined Morita Therapy for depression, further research is 
warranted which assesses the feasibility, acceptability and effectiveness of 
Morita Therapy for patients with this specific condition. 
4.5 Conclusion and chapter summary 
This review has highlighted the absence of UK-based research and unbiased 
RCTs of Morita Therapy, as well as a lack of qualitative research and research 
on Morita Therapy for depression.  Furthermore, this review indicates that no 
RCTs of Morita Therapy for depression have been undertaken in the West 
(assuming such studies would have been published in English).  At this time, it 
is not possible to determine whether Morita Therapy is a feasible, acceptable or 
effective treatment for UK patients with depression and anxiety.  To determine 
effectiveness, a rigorous large-scale RCT is still required.  Commensurate with 
the MRC framework (Craig et al., 2008), prior to such a trial, preparatory work is 
needed to develop a thorough UK Morita Therapy outpatient protocol, 
determine the acceptability and feasibility of Morita Therapy for a UK 
population, and inform the design of a large-scale trial.  To address the first 
point, Chapter Five presents an intervention optimisation study undertaken to 
develop a deliverable and acceptable Morita Therapy outpatient protocol for a 
UK clinical population. 
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CHAPTER FIVE.  INTERVENTION OPTIMISATION STUDY 
This chapter presents the objectives, methods and results of the intervention 
optimisation study undertaken to optimise the acceptability and feasibility of 
Morita Therapy for a UK population before proceeding to the feasibility study 
(see Chapters Six and Seven).  Further discussion of this study, including its 
strengths and limitations, is presented in Chapter Eight.  This study received 
ethical approval from the University of Exeter Medical School (reference 
15/02/066) (Appendix II) and has been reported in Sugg et al. (2017) (Appendix 
III).  This chapter is based on the published article; additional information is 
provided. 
5.1 Study objective and research questions 
The objective of this study was to develop a deliverable and acceptable Morita 
Therapy outpatient protocol (Appendix IV) for a UK clinical population. 
This study addressed four research questions: 
1. Stage One: What are the views and understandings of potential patients and 
therapists about Morita Therapy? 
2. Stage Two: What can the English-language literature on Morita Therapy 
contribute to the development of an optimal draft protocol? 
3. Stage Three: What are therapists’ views of Morita Therapy, focusing on 
operationalisability and the accessibility of the draft protocol? 
4. Stage Four: How should the protocol be optimised and on what should a 
therapist training programme focus? 
5.2 Methods/ Design 
5.2.1 Study design 
Corresponding to the person-based approach’s intervention development phase 
(Yardley et al., 2015a), the protocol was developed over four stages combining 
exploratory and explanatory components.  Stage One involved in-depth 
exploratory interviews combining qualitative and cognitive interviewing (Willis, 
1999) to investigate participants’ views and understandings of Morita Therapy.  
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In Stage Two, the resulting qualitative themes were developed into 
recommendations for optimising Morita Therapy and the Morita Therapy 
literature was synthesised in line with these to develop a draft protocol.  Stage 
Three involved repeat in-depth explanatory interviews with therapists, to 
investigate how they related to the intervention content and protocol format.  In 
Stage Four, these qualitative themes were addressed through protocol 
modification and tailoring the focus of the therapist training programme.  
5.2.2 Qualitative interviews: Participants and recruitment 
Participants were purposively sampled to reflect the feasibility study’s proposed 
population and account for factors deemed potentially relevant in forming views 
of Morita Therapy (Yardley et al., 2015a).  Thus, participants aged >=18 with 
self-reported experience of depression, whether current or historic, and a range 
of previous therapy experience (potential patient sub-group) and therapists 
trained in complex psychological interventions such as Cognitive Behavioural 
Therapy (CBT) (therapist sub-group) were sampled. 
Potential patients were recruited by email circulation to former participants at 
the University of Exeter’s Mood Disorder’s Centre (MDC) 
(http://www.exeter.ac.uk/mooddisorders/) who had consented to such contact; 
therapists by email circulation to current or former MDC therapists. 
Sample size 
In order to achieve sampling adequacy, the purpose of the study was prioritised: 
an estimation was made of the number of participants required to sufficiently 
answer the research questions by achieving both breadth and depth of 
information (Bowen, 2008; Gaskell, 2000; Marshall, 1996).  This estimation was 
informed by the concept of data saturation (the point at which the analysis of 
more data provides no new insights about the phenomenon under inquiry) 
(Glaser and Strauss, 1967; Mason, 2010; Morse, 1995) and the related findings 
of Guest, Bunce and Johnson (2006), in which the authors systematically 
documented the degree of saturation over the course of the analysis of 60 
interviews and concluded that saturation occurred within the first twelve 
interviews, after which point new themes emerged infrequently. 
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Whilst these findings suggest that twelve interviews could provide a thorough 
picture of participants’ perspectives of Morita Therapy, it is difficult to determine 
their generalisability, and an estimation of sampling adequacy was also 
informed by the heterogeneity of the population and the number of sub-groups 
to be included in the sample (Ritchie et al., 2013).  As noted, the sample 
contained therapist and potential patient sub-groups.  Given the potential for 
patients’ perspectives of Morita Therapy to be influenced by their previous 
experiences of psychological therapy, the potential patient sub-group was 
further divided based on this criterion.  In an effort to both achieve symbolic 
representation across sub-groups and capture the diversity of views within sub-
groups (Ritchie et al., 2013), the objective was to include a quota of five 
participants within each of the resulting three sub-groups (therapists; potential 
patients with therapy experience; potential patients without therapy experience).  
The final sub-group sample sizes were constrained by the number of 
participants meeting these criteria who were able to be recruited within the time 
and resource constraints of a PhD. 
5.2.3 Procedure 
Interviews were held at University of Exeter premises or the participant’s home, 
depending on participant preference, and lasted between 45 and 130 minutes.  
Interviews combined qualitative techniques with those of cognitive interviewing 
(Willis, 1999). 
Stage One 
Interviews explored perceptions of Morita Therapy in principle and practice.  
Prior to interview, participants were emailed a summary of core Morita Therapy 
principles (Appendix II) on which they were asked to provide feedback at the 
beginning of their interview.  In line with prior research investigating novel 
interventions (Johnson, Newton, Jiwa et al., 2005; Richards, Lankshear, 
Fletcher et al., 2006), the vignette method was then employed to elicit 
participants’ views and understandings of the approach in practice. 
Vignettes (audio-recordings) of Morita Therapy were available to the study team 
from a case study completed by a Morita therapist on a placement with the 
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University of Exeter, during which they implemented the counselling-based 
modal model developed during this placement (Minami, 2013).  Five audio-
recording clips, ranging from three to five minutes, were selected on the basis 
that they each captured a core element of the approach: (1) explanation of 
diaries; (2) positive reinterpretation/ desires and the vicious cycle; (3) 
normalisation/naturalisation, acceptance, metaphor use and Fumon; (4) 
encouraging action-taking with symptoms; (5) facilitating rest (see Table 7, 
p.136 for definitions of these terms).   
During interviews, these vignettes were played to participants.  Topic guides for 
potential patients and therapists (Appendix II), structured according to the order 
in which the vignettes were played, were based on Morita Therapy literature, 
the vignettes’ content and prior research addressing similar questions (Richards 
et al., 2006).  A variation of the think aloud technique (Willis, 1999) was 
employed, whereby participants were invited to voice their thoughts during or 
after each vignette, according to their preference.  In practice, the majority of 
participants provided feedback after each.  At the end of each vignette, the 
open question “what are your thoughts on that?” was asked to allow flexibility 
and enable participants’ spontaneous and/or unanticipated responses to be 
captured (Yardley et al., 2015b). 
Focused questions were also included to ensure discussion of each intervention 
element (Yardley et al., 2015b).  Individual responses were probed to 
investigate participants’ meanings, enabling both the exploration of participants’ 
views on pre-defined topics of interest and the elicitation of participants’ own 
themes (Taylor, 2011).  Furthermore, explanations of Morita Therapy concepts, 
such as fears and desires forming two sides of the same coin (Table 7), were 
provided by the interviewer as additional triggers for participants’ views and 
responses where the content of the vignettes did not convey the concept in a 
sufficiently clear or thorough way to enable participants to provide informed 
views of it.  At the end of the interview, participants were asked to share any 
views not already discussed. 
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Qualitative data analysis 
Interviews were recorded, transcribed verbatim, managed within NVivo10 (QSR 
International, undated) and analysed by HVRS (PhD candidate) using 
Framework analysis to enable an abductive approach (Ritchie et al., 2013).  
Familiarisation with the data was achieved through producing and reading 
transcripts.  A thematic framework was developed during preliminary analysis 
and subsequently as batches of transcripts were analysed, iteratively combining 
the topic guide with the overall narratives in context.  Using this framework, 
transcripts were coded at the individual level and analysed thematically across 
the whole dataset as well as in the context of each interview using a constant 
comparison approach (Thorne, 2000), whereby each piece of data (e.g. one 
statement or theme) was compared with others for similarities and differences 
(Miles and Huberman, 1994). 
To identify any sub-group differences, the Stage One analysis was undertaken 
firstly for potential patients without experience of therapy, secondly for potential 
patients with therapy experience, and finally for therapists.  Given the resulting 
convergence of views within similar thematic frameworks, data for all 
participants together were charted in analytic/framework matrices which 
summarised participants’ views on each theme/constituent theme to allow within 
and across case analyses, the exploration of relationships between themes and 
further refinement of themes; data were abstracted and interpreted to structure 
and make sense of participants’ perspectives (Miles and Huberman, 1994; 
Ritchie et al., 2013; Spencer, Ritchie, O’Connor et al., 2014).  This refinement 
and interpretation was informed by HVRS’s initial impressions of the most 
striking and important elements of the data for answering the research 
questions: these insights shaped the formation of final themes.  Appendix V 
provides examples of this analytic process.  As explanations were formulated in 
this way, negative cases were explored and explanations of variance provided 
(Dingwall, Murphy, Watson et al., 1998), ensuring perspectives which diverged 
from dominant themes were not overlooked (Yardley, 2008). 
 
 




In developing the draft protocol, the English-language clinical materials 
describing the delivery and operationalisation of Morita Therapy, including the 
one available therapy protocol (the modal model) (Minami, 2013), guidelines for 
outpatient Morita Therapy (Nakamura et al., 2010), Morita’s own account of the 
original inpatient method (Morita et al. (1998)) and other accounts by clinicians 
(Ishiyama, 2011; LeVine, 1993a; LeVine, In press; Ogawa, 2007; Ogawa, 2013) 
were examined as a guide to implementing the approach.  Aside from Morita’s 
original work, these sources were identified through an examination of the 
clinical materials produced in English by the members of the International 
Committee of Morita Therapy (http://moritatherapy.org/icmt-member-list/), who 
by virtue of this membership were known to be the key authors in the field.  The 
volume of clinical materials to refer to was restricted by the fact that thorough 
protocols detailing the precise nature of how Morita Therapy is practiced are 
rarely developed and/or published, in either English or Japanese (Kitanishi, 
2016); and no authors refer to the use of published treatment manuals within 
reports of their research activities, with few describing the intervention in a 
manner which would be reproducible (see Chapter Four). 
Grounding the development of the protocol in the available clinical materials 
ensured adherence to the fundamental, defining features of Morita Therapy 
(Table 7, overleaf), considered akin to ‘guiding principles’ (Yardley et al., 2015b) 
which were essential to include in the therapy protocol and formed the basis of 
the intervention.  With regards to elements of Morita Therapy for which multiple 
options were available within the literature, recommendations were developed 
for optimising the approach in response to the Stage One qualitative findings, 
and the delivery options contained in the literature which were considered most 
likely to address the issues raised were selected for inclusion in the therapy 
protocol.  In addition, specific Stage One interview findings were integrated into 
the protocol to address participants’ concerns and confusions, stress potentially 
valuable features of the approach and guide therapists in applying the 
techniques for this population. 
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Table 7. Key principles and practices of Morita Therapy (‘guiding principles’) 













Morita Therapy conceptualises unpleasant thoughts and emotions as part of the natural ecology of the human experience.  It draws 
upon the natural world, and the place of humans within it, to emphasise that symptoms are not subject to the patient’s control, and will 




All emotions and thoughts are accepted as they are.  Attempts to control or resist symptoms are considered to exacerbate them within 
a vicious cycle; therapists thus help patients to move away from symptom preoccupation and combat and towards acceptance and a 
focus on action.  Thus, the objectives of therapy are to shift attention and perspective, rather than controlling or ‘fixing’ symptoms. 
Rest 
Morita Therapy seeks to potentiate patients’ natural healing capacities, in contrast to resisting and exacerbating symptoms.  Patients 
sit with their thoughts and emotions as they are, to learn how they naturally ebb and flow with time if left unattended, and to build a 
natural desire to take action. 
Action-taking with 
symptoms 
Patients learn to undertake purposeful and necessary action, with or without their symptoms.  Morita Therapy thus aims to improve 
everyday functioning in spite of symptoms, with symptoms reducing as a by-product of moving from a mood-oriented to purpose-














Therapists ‘positively reinterpret’ symptoms as desires by seeing these as two sides of the same coin, aiding acceptance of symptoms 
as natural and inevitable.  For example, social anxiety represents a desire to be accepted by others. 
Normalisation 
Therapists label thoughts and emotions as ‘unpleasant’ and ‘pleasant’ but not ‘good’ or ‘bad’.  They emphasise that all emotions are 
natural, or normal, and will ebb and flow on their own so long as attempts are not made to resist them. 
Fumon (inattention 
to symptoms) 
Therapists, in an effort to shift patients’ attention away from symptom preoccupation and combat, will not focus on discussion or 
analysis of patients’ symptoms or their causes, but will ‘steer’ the conversation towards action-taking and the external environment. 
Diaries 
Patients complete daily diaries on which therapists provide comments which facilitate an acceptance of internal states and refocus 
attention on action and the external environment. 
Four-phased 
model 
In traditional inpatient Morita Therapy (Morita et al., 1998), rest and action-taking are structured within four phases: 1) complete bed 
rest; 2) light repetitive activities; 3) more challenging activities; 4) social reintegration.  The process is understood to aid experiential 
acceptance of the natural ebb and flow of thoughts and emotions, to re-orientate patients in nature and to refocus attention from 
internal to external states. 




Interviews were repeated with the therapists from Stage One, to enable them to 
reflect on the development of the approach and how well the protocol 
addressed their previous issues, plus an additional therapist recruited in the 
manner described, to also capture the views of a therapist naïve to Morita 
Therapy.  The draft protocol was emailed to therapists to read prior to their 
interview and the interview focused on discussing their thoughts on the protocol.  
The topic guide (Appendix II), based on the protocol as well as the Stage One 
findings, was structured as follows: therapists’ first impressions of the protocol, 
the extent of understanding about Morita Therapy and its delivery that they had 
obtained from the protocol, how user-friendly they perceived the protocol to be, 
how the protocol compared to other therapy protocols, their views on 
operationalising Morita Therapy in practice, areas on which they thought 
therapist training should focus, and their suggestions for improving the protocol.   
To elicit views on all components of the protocol, each protocol section was 
reviewed in turn during the interview.  A variation of the think aloud technique 
(Willis, 1999) was employed, whereby participants were invited to voice their 
thoughts as they reviewed the protocol.  Individual responses were probed to 
investigate participants’ meanings, enabling both the exploration of participants’ 
views on pre-defined topics of interest and the elicitation of participants’ own 
themes (Taylor, 2011).  At the end of the interview, participants were asked to 
share any views not already discussed.  Interviews were analysed as described 
above. 
Stage Four 
In amending the protocol in response to the Stage Three qualitative findings, 
the aforementioned Morita Therapy literature was re-examined for further 
guidance and to ensure changes were grounded in the treatment’s fundamental 
features.  The Stage Three findings also enabled the therapist training 
programme to be tailored, by highlighting key issues and content to focus on.  
 
 




Ten potential patients were interviewed.  All reported experience of depression; 
six had experience of psychotherapy and four did not (Table 8).  The majority 
were female (n=8, 80%); ages ranged from 22 to 63 years.  Four therapists 
were interviewed in Stage One and five in Stage Three.  All were trained in CBT 
and a mixture of other treatments such as Behavioural Activation; ages ranged 
from 43 to 63 years. 




Therapists    
(stage 1)        
(n=4) 
Therapists    
(stage 3)        
(n=5) 
Gender    
   Male 2 (20.0) 2 (50.0) 2 (40.0) 
   Female 8 (80.0) 2 (50.0) 3 (60.0) 
Age  
   18-30 2 (20.0) 0 (0.0) 0 (0.0) 
   30-50 4 (40.0) 2 (50.0) 3 (60.0) 
   50-70 4 (40.0) 2 (50.0) 2 (40.0) 
Ethnic origin  
   White British 10 (100.0) 4 (100.0) 5 (100.0) 
Education  
   <A-levels 1 (10.0) 0 (0.0) 0 (0.0) 
   A-levels 2 (20.0) 0 (0.0) 0 (0.0) 
   Undergraduate degree 5 (50.0) 1 (25.0) 1 (20.0) 
   Post-graduate diploma 0 (0.0) 1 (25.0) 2 (40.0) 
   Post-graduate degree 1 (10.0) 1 (25.0) 1 (20.0) 
   Doctoral degree 1 (10.0) 1 (25.0) 1 (20.0) 
Mental health difficulty    
   Depression 10 (10.0) N/A N/A 
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Notes: data are number (%) 
5.3.1 Stage One Results 
To reflect the convergence of views and understandings expressed by all 
potential patients and therapists, the results of all participants are reported 
together.  Participants’ perspectives could be understood within three key 
themes: translating principles into practice, respecting the individual and shifting 
the understanding framework.  Together, these themes capture the elements of 
the data which were most striking during data analysis and deemed most 
important in considering how to optimise Morita Therapy for this population.  
Each key theme encompassed a number of constituent themes (Figure 10, 
overleaf). 
Thus, the themes capture (1) the tension participants expressed between the 
Morita Therapy principles and how these were put into practice in the vignettes: 
the constituent themes of theme one essentially demonstrate the journey 
participants’ experienced through typically identifying with the principles on 
paper to questioning the way these were communicated and raising challenges 
as to putting them into practice; (2) each key feature of the vignettes, in terms of 
the tone and style of the therapist, which participants typically indicated could 
be modified to improve acceptability; (3) the overarching sense from 
Previous therapy experience 
   None 4 (40.0) N/A N/A 
   Cognitive Behavioural Therapy 4 (40.0) N/A N/A 
   Mindfulness-based Cognitive 
Therapy 
3 (30.0) N/A N/A 
   Behavioural Activation 1 (10.0) N/A N/A 
   Interpersonal Therapy 1 (10.0) N/A N/A 
Area(s) of clinical training  
   Cognitive Behavioural Therapy N/A 4 (100.0) 5 (100.0) 
   Behavioural Activation N/A 4 (100.0) 4 (80.0) 
   Eye Movement Desensitisation and 
Reprocessing 
N/A 1 (25.0) 2 (40.0) 
   Interpersonal Therapy N/A 1 (25.0) 1 (20.0) 
   Dialectical Behaviour Therapy N/A 1 (25.0) 1 (20.0) 
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participants that, in light of the comparisons made between Morita Therapy and 
other treatments, for the approach to be acceptable a shift in participants’ 
paradigms and expectations must be facilitated, particularly in terms of the 
notion of accepting emotions and the goals of therapy. 
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Theme one: Translating principles into practice 
This theme illustrates participants’ responses to the Morita Therapy principles 
as summarised on paper (constituent theme (a)), the extent to which these 
principles were considered present in the vignettes and to which the 
expectations they established were met in practice (constituent theme (b)).  In 
addition, the difficulties participants identified when considering the 
implementation of principles in practice (constituent theme (c)) and extent to 
which particular features of therapy were considered to be expressed with 
clarity within the vignettes (constituent theme (d)) are presented. 
(a) The underlying principles 
Generally, having read the summary of Morita Therapy, participants responded 
positively to the underlying principles (i.e. desire for life; naturalness of emotion; 
vicious cycle; the mind’s natural healing capacity through rest; focus on action-
taking; acceptance of and obedience to nature), noting that these resonated 
with them in several ways.  Firstly, participants appreciated the focus on 
learning to live with symptoms, acknowledging from their experiences the futility 
of fighting unpleasant emotions.  In this way, participants considered Morita 
Therapy a realistic and constructive approach.  For those who expressed that 
CBT was an unappealing approach, largely due to its perceived rigid structure 
and focus on changing thoughts and feelings, this was a particularly positive 
and preferable feature of Morita Therapy. 
I like that it’s about acceptance and accepting um the bad feelings you 
have rather than fighting them…because it doesn’t work... It’s realistic. 
(PT02) 
Participants also appreciated Morita Therapy’s connection to the natural world, 
in both the literal and more abstract sense.  Thus, participants often 
acknowledged that “people feel better when they’re in nature” (PT03), that the 
use of naturalistic metaphors to describe emotions made sense (with some 
participants spontaneously describing emotions in such terms), and that it is 
helpful to see oneself as embedded within a larger whole: 
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That greater sense of being one with it all… I think that’s a very positive 
thing because it diffuses one’s own emotion…it puts what you are going 
through in context. (PT06) 
Participants also valued the way in which all emotions were considered natural 
rather than some being considered unacceptable, noting that this was a 
“compassionate” (PT03), humane and inclusive approach which helped reduce 
negative judgement: 
I subscribe to the principles around emotions being a natural 
phenomenon…It bodes well if the emphasis steers away from seeing 
emotional experience as a negative, wrong thing. (TH04) 
The idea of desire for life, the concept of emotions existing as two sides of the 
same coin (with fears or unpleasant emotions being a reflection of underlying 
desires), and the explanation of the vicious cycle were all features participants 
noted made sense and resonated with their personal experiences: 
It does get into a cycle…it almost feels easier to feel sad…you do 
generally go over and over the unpleasant things. (PT08) 
Participants also valued the use of rest and the concept of the mind’s natural 
healing capacity, appreciating the need for recuperation and noting that this was 
a feature missing from other therapies: 
Giving yourself a bit of space…I don’t always think there’s that in other 
kinds of therapies, there’s not that kind of re-charging space um yeah, 
that’s nice. (PT02) 
Thus, in theory, the principles of Morita Therapy, particularly the connection to 
the natural world and concept of ‘living with’ symptoms, resonated for 
participants and largely received positive feedback. 
(b) Discrepancies between principles and practice 
A sense of a lack of explicit and apparent translation of the principles into 
practice (i.e. the therapy as delivered in the vignettes) was expressed upon 
participants listening to the vignettes.  For some, it was unclear in general which 
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principles were being communicated: “I have no idea what he was trying to get 
across there.” (PT01).  Other participants commented on how the practice did 
not meet their expectations of therapy established by the principles, expressing 
disappointment that certain appealing features were absent from the vignettes.  
This related particularly to the theoretical focus on the natural world, with 
participants also surprised not to hear the use of naturalistic metaphors in 
practice: “I liked the nature thing, but I didn’t hear that brought in.” (PT09). 
These discrepancies between principles and practice led to a sense of 
participants being unsure what Morita Therapy was based on or communicating 
overall: 
I don’t think that [the vignettes] matched this [summary of principles] at 
all, really, so I’m going away from this…still wondering what Morita 
Therapy is. (PT07) 
With regards to rest, the use of rest as explained within the vignettes (including 
a marathon metaphor) did not meet participants’ expectations of rest as 
informed by the principles, and served to confuse or lead participants astray in 
their interpretation of the meaning of rest. 
What I construed from what I read is it’s more like actually if you don’t 
feel able then rest should be the mainstay of what you’re doing, rather 
than an hour in your day or a few minutes in your marathon…I feel 
slightly less clear about the use of that natural healing. (TH04) 
A lack of information and clarity around rest provided within the vignettes led 
some participants to explicitly note that the purpose and conditions for rest were 
unclear.  Some therapists noted the danger of misrepresenting rest as a form of 
“relaxation” (TH01), whilst potential patients often began to misconstrue the 
purpose of rest in these terms: as a relaxing break from unpleasant thoughts 
and feelings, as opposed to an opportunity to experience their natural ebb and 
flow.  For such participants, their further considerations around how to 
implement rest revolved around this misinterpretation, with participants 
suggesting tools such as mindfulness techniques (PT06) for inducing relaxation. 
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That’s what people sort of artificially do by the aid of medication, shut you 
down and so I think it’s good to find natural ways in encouraging that 
rest, relaxation. (PT03) 
The sense that there was a discrepancy between the principles and practice in 
general was related to the view that Morita Therapy in practice is a subtle 
approach, with the principles being implicitly incorporated into the therapist-
patient dialogue within the vignettes rather than explicitly discussed.  For 
potential patients, this subtlety may have contributed to the view that it was 
unclear what the treatment was really about.  Following several vignettes, 
however, some participants began to recognise some of the techniques being 
implemented: 
[I]t’s implicitly doing that thing of boosting their…you know, ‘you are 
being very productive, you are getting a lot done, you do love and care 
for your children’… doing that underneath, which I quite like. (PT09) 
Therapists were more able to recognise the subtlety of the approach and thus 
more able to read into what was happening in the vignettes.  Thus, at times, 
therapists contradicted the view that the practice failed to match the principles, 
with TH03 noting that the therapy “was translated well into practice”.  
Nonetheless, in practice, a more explicit connection to nature and explanation 
of rest in particular were desired by participants in general. 
(c) Barriers to implementation 
For several features of therapy, participants acknowledged their value in 
principle whilst proceeding to note multiple difficulties around committing to 
them in practice.  For example, some participants described keeping diaries as 
“overwhelming” (PT02), “threatening” (PT06) and “daunting” (PT04), with a 
particular concern around not being able to communicate thoughts and feelings 
coherently.  In line with this sense of insecurity, participants also noted the need 
for reassurance that the diary was being completed “correctly”, and potentially a 
more structured diary to guide them.  Sometimes these concerns were specific 
to the fact that participants would not receive the therapist’s comments on their 
diaries until the following week: 
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At your first meeting you would probably hope that prospectively he 
would, you know, take a minute to review some of it and give you a bit 
more feedback so as you knew what you were doing. (PT01) 
Participants also noted a number of practical difficulties, such as memory 
problems, tiredness and dyslexia.  Such difficulties were unique to one or two 
participants, suggesting the need for a personalised and flexible approach to 
identifying and working with the individual’s concerns and capabilities. 
Therapists also noted some concerns around commenting on diaries, 
highlighting the need for further guidance around the nature of these comments: 
It’s like when you went school and you had your homework handed in… 
certainly some of the early comments can be what we might call really, 
um, defining comments… that’s a key for our training. (TH01) 
Whilst participants recognised the value of focusing attention on and 
encouraging action-taking in spite of symptoms, they also expressed tension 
between whether or not it is possible, realistic and/or helpful to take action 
despite emotions, noting that their emotions were “debilitating” (PT05). 
My emotions do sometimes completely wipe me out and it says…you 
don’t have to live by your emotions… actually I have not been able to do 
that… But I now realise that, well that’s how you never get better…you 
can feel rubbish and still get something done and it does help. (PT03) 
When considering the implementation of rest, participants again envisaged 
several struggles.  These typically centred on practicalities such as time, 
although fears of worsening rumination and difficulties ‘sitting with’ unpleasant 
thoughts and feelings were also noted. 
What would a therapist do if somebody’s doing this and they find it 
intolerable to be at the mercy of their thoughts… it might be too much. 
(PT06) 
Participants also noted that taking rest would induce feelings of guilt, and thus 
highlighted the importance of stressing the purpose and permissibility of rest, 
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exploring the reasons why people might feel guilt, and drawing a parallel to 
physical illness for which it may be considered more acceptable to rest. 
You can see yourself as a slacker or a quitter and all those things are 
very negative…it’s all about ‘how many hours do you work’…everybody 
is totally wired that way, so it’s going the opposite. (PT03) 
Furthermore, in terms of engaging in both rest and action-taking, participants 
sought more structure and clear timeframes.  Therapists expressed confusion 
and concern around how these opposing states should be balanced, and how to 
know when “enough is enough” in terms of rest (TH04). 
Um, dealing a little bit with this like paradox with action and also inaction, 
which is new… What are the parameters of rest, how is it structured…I’d 
like a little bit more structure around once you got to action. (TH01) 
Thus, participants noted practical constraints and sought specific frameworks, 
alongside expressing a sense of insecurity, fear and, at times, scepticism, for 
elements of therapy such as the diary, rest and action-taking. 
(d) Communication difficulties 
In listening to the vignettes, participants sometimes misinterpreted or were 
unclear as to the messages being conveyed, creating a sense of confusion and 
some disagreement.  This was significantly experienced in relation to the 
concept of fears and desires (or unpleasant emotions and ‘positive’ attributes) 
forming two sides of the same coin: although valued in theory, the translation of 
this concept into practice using the positive reinterpretation technique was 
subject to mixed views.  Participants did value the way in which this “flagged up 
the qualities of the patient” (TH03) and put a “positive slant” on difficulties 
(PT08).  Some participants were even able to reinterpret their own experiences 
in accordance with this: 
I really like this coin thing…it made me think of when my brother came to 
stay…I was just really anxious because I just cared too much... it’s 
almost like the more anxious you feel the more important it is, and that’s 
certainly making me think. (PT02) 
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However, a lack of clarity and specificity in positive reinterpretation led 
participants to an over-generalised conception of the two sides of the coin, 
whereby all positive emotions and experiences were viewed as present on one 
side alongside all negative emotions and experiences on the opposing side, 
appearing to induce an (inaccurate) interpretation of the message as ‘life 
generally involves both good and bad’ and one should ‘look on the bright side’.  
This led to some confusion and disagreement, with the message largely lost 
that specific unpleasant emotions (or fears) are direct inevitable reflections of, 
and contingent upon, specific qualities (or desires). 
There’s always a positive and a negative with everything, and that’s like 
two sides of the coin…I’m unemployed at the moment, which is a 
negative thing, but I’ve tried to say to people well on the positive side I’ve 
had this experience which has taught me to learn how to deal with the 
whole situation. (PT10) 
Participants also experienced a lack of clarity that emotions but not situations 
themselves were being reframed as positive, and a lack of specificity in 
reinterpreting emotions associated with depression as opposed to anxiety. 
I remember somebody saying to me once ‘nothing is either good or bad, 
it’s the way we react to it’…What I was going through with my 
parents…I’d be very interested to see how anybody could reframe [that] 
for me in an acceptable way. (PT06) 
When the concept of the two sides of the coin was explained by the interviewer 
with an increased level of clarity and specificity, participants expressed a clearer 
understanding of and more positive response to this concept.  Thus, whilst 
participants expressed some confusion and disagreement in response to 
positive reinterpretation, there was potential to recommunicate this message in 
a more helpful manner. 
Theme two: Respecting the individual 
This theme captures the extent to which Morita Therapy as delivered within the 
vignettes was considered be a well explained, transparent and individualised 
approach.  Some absence of this led to a sense of unease and a struggle to 
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relate to an approach participants considered somewhat superficial and 
oversimplified.  This is discussed in relation to the provision of transparency and 
rationale (constituent theme (a)); exploration and explanation of patients’ 
individual difficulties (constituent theme (b)); therapy structure, collaboration and 
personalisation of techniques (constituent theme (c)). 
(a) Transparency and rationale 
Participants expressed a view that, within the vignettes, there was a lack of 
disclosure as to the pathway or process of therapy being followed.  There was a 
suggestion from therapists that this lack of involvement of the patient in the 
therapy plan and expected treatment outcomes may be related to the culture in 
which Morita Therapy was developed, and that in translating the therapy to the 
UK this may not be an acceptable approach: 
[I]t sounded like a very culturally defined way of working…that goes to 
underlying philosophies or logic of the culture where there’s a stronger 
belief in Taoist or Zen type ways of life…that’s all very much going with 
the flow, here we’re not and what people are often, you know, they 
always wanna know what they’re signing, what the small print is. (TH01) 
In actuality, potential patients expressed mixed views as to whether this lack of 
transparency was acceptable or not.  Those who did not have prior experience 
of therapy were more open to this approach and the notion of ‘trusting your 
therapist’, finding the amount of rationale sufficient and acknowledging that 
further explanation might entail “second guessing” by the patient (PT02; PT04). 
This therapist here obviously knows something I don’t but I’m open, I 
mean I’m open to trying anything but it’s like they know something that 
isn’t just going by textbook. (PT10) 
However, participants who had previous treatment experience or positive views 
of CBT, as well as the therapists, expressed the need for full disclosure as to 
the overall therapy plan and discomfort with the absence of this, perhaps 
reflecting their expectations of treatment as shaped by other approaches in 
which such transparency is provided. 
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It’s a bit sort of open-ended, too open-ended, I felt he should [say] ‘look, 
we’re going to do this’… explain a bit more of the plan. (PT07) 
For such participants, there were also specific therapy features for which it was 
felt that further rationale provision was necessary to explain why patients were 
being asked to undertake potentially challenging activities, such as rest and 
diaries: 
As human beings, we need to know, we need to understand, and by 
explaining something that’s showing respect…they’re asking you to do 
something which you might find difficult…a bit threatening. (PT06) 
Similarly, a view was expressed that the therapist should explain Fumon 
(therapists’ inattention to symptoms) early in therapy to prepare patients for its 
use and underscore its purpose in moving patients away from the vicious cycle: 
Maybe that is about giving some education upfront before you start the 
therapy which is…‘often people might come into therapy wanting 
answers, wanting a deeper understanding, but sometimes that in itself 
can perpetuate problems…and therefore to anticipate that you might feel 
that’s not addressed in the therapy, but come into it anyway’. (TH04) 
In line with these views, it was suggested that if it is a necessary to manoeuvre 
therapy without the patient’s full awareness, it would be respectful to alert the 
patient to this and request that they have faith in the process: 
Even saying ‘now look, what we’ve been saying, this might not make 
sense to you but there’s a reason why we’re not going into a full 
explanation…if we could just go with it and trust the process’. (PT06) 
Thus, whilst participants expressed mixed views on the need for increased 
transparency during therapy, they also suggested that the provision of 
additional explanations and justifications might address any discomfort 
experienced by the patient in relation to this. 
 
 
CHAPTER FIVE: INTERVENTION OPTIMISATION STUDY 
150 
 
(b) Explanation and exploration 
Overall, participants expressed a view that the patient as an individual was not 
sufficiently explored within the vignettes, nor were adequate responses to their 
questions provided, leading to feelings that the approach was somewhat 
repetitive, “crude” (PT07), and lacking depth and space for the patient. 
The therapist was quite overwhelming really, he mentioned lots of 
examples…if he’d just mentioned one example and explored it with her, 
that would have been more fruitful. (TH03) 
With regards to Fumon (inattention to symptoms), the implementation of this led 
some participants to view the therapy as potentially “dismissive” (PT02) and 
lacking due acknowledgement of patients’ difficulties.  Similar views were 
expressed in relation to the normalisation technique: 
That example slightly trivialises what it feels like to be anxious…[It’s] a 
little bit flippant…[and] patronising. (PT03) 
Potential patients appeared to receive this technique within a particular 
understanding framework in which some emotions are considered ‘healthy’ and 
others ‘unhealthy’.  The blanket approach within the vignettes towards stating 
that all emotions are ‘normal’, rather than encouraging participants to re-
evaluate the latter, led them to assume the therapist was referring only to the 
former: emotions they already considered healthy or ‘normal’, and therefore 
required no intervention.  Thus, potential patients expressed a sense that 
normalisation was not applicable to the severity of their difficulties: 
It’s as if he’s talking about just uncomfortable feelings, about being 
nervous or worried about something, it was somehow at 
that…superficial, like natural level…he wouldn’t be touching my 
experience at all. (PT06) 
These views were exacerbated by the examples of anxiety utilised within the 
vignettes.  In the absence of clarification that these were intended as either 
metaphors for the function of anxiety or explanations for the origin of anxiety, 
examples such as the anxiety a person feels if they almost drop a baby were 
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interpreted literally by participants, who thus noted that if they only experienced 
anxiety in such ‘normal’ circumstances, they would not seek therapy. 
There’s a healthy level and an unhealthy level… using analogies like 
dropping a baby, I mean that’s normal for everybody whereas if she’s 
worried about just opening the front door ‘cos she thinks a burglar’s 
gonna come in, that’s not really so normal. (PT08) 
Thus, participants expressed the need to distinguish between ‘healthy’ and 
‘unhealthy’ levels of distress, and perhaps express these along a spectrum in 
order to enhance the relevance of the normalisation technique as a means of 
validating the origin and function of such emotions.  Additionally, participants felt 
more in-depth explanations of why differences exist between people, and how 
‘normal’ levels of distress become exacerbated into ‘severe’ levels, would be 
helpful.  Participants suggested that such explanations could be usefully 
provided whilst staying true to the Morita Therapy principles, through reference 
to the functionality of emotions, vicious cycle and two sides of the coin. 
Do the normalising of emotions…how fear allows you to be protective of 
yourself…that being the flip side of the coin…but I might do a bit more 
illustrating of ‘but the reason why you’re here is because some of that, 
you’re bringing in lots of judgments on yourself about the anxiety you’re 
having’ and then bringing in that vicious cycle. (TH04) 
When, as suggested, unpleasant emotions were explained by the interviewer in 
terms of positive reinterpretation and the vicious cycle, participants expressed a 
clearer understanding of the Moritian perspective which appeared to appease 
their sense of being dismissed.  Thus, whilst difficulties were noted around a 
lack of exploration and explanation of the individual patient’s difficulties, 
particularly during normalisation, suggestions were made for circumventing 
these issues through reference to other Morita Therapy principles. 
(c) Structure, personalisation and collaboration 
Participants generally expressed positive views of the lack of clear structure and 
script in the vignettes, noting that the approach had a more open and fluid style 
than they would expect from treatment: “It’s quite liberating… I like the idea of 
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having a bit more of a fluid therapy” (TH04).  For potential patients who had no 
prior experience of treatment or expressed negative views of other treatments, 
this was related to a sense that the approach was more gentle and personalised 
in comparison to other therapies, with the style described as conversational or 
“like good advice” (PT04). 
This one seems more personable, rather than scripted, which is quite 
nice, it feels like it’s more reactionary towards the person rather than 
‘today we’re going to cover these ten things on my plan’... It seems like a 
really friendly way of talking about it. (PT01) 
However, therapists and potential patients who expressed positive views of 
other therapies noted that the approach was lacking in personalisation and 
collaboration, with suggestions that this may be an issue of cultural translation 
and an area in which therapists require more guidance. 
I see this as the wise sage, guru in the room with somebody who’s, you 
know, stroking their beard and giving out wisdom and we’ve, our 
orientation over the years has been much more collaborative. (TH01) 
With regards to the use of metaphors, therapists were keen to personalise 
these more in practice.  Potential patients indicated the value of this in making 
metaphors relatable to their experiences, noting metaphors can otherwise be 
“frustrating” (PT07).  There were several other specific ways in which 
participants considered that more personalisation and collaborative working 
should be incorporated, relating to the lack of exploration of the individual’s 
particular experiences, the need to receive feedback from the patient and 
confirm their understanding, and the need to allow patients the space to answer 
questions and provide examples for themselves. 
The therapist says quite a lot and doesn’t check in to whether the client 
understands… Allow her to identify it more. (TH03) 
When participants, especially therapists, recognised the therapist and patient 
engaging in a more collaborative and individualised process, they valued this 
approach: 
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I loved the way he drew stuff out of her to illustrate the two sides of the 
coin yeah, I felt that was really well done…the way he stayed with what 
she was saying, and reflected it back. (TH03) 
Thus, whilst suggestions were made for improving the extent of personalisation 
and collaboration in the approach, participants also valued the individualised 
manner in which some discussions were undertaken, as well as appreciating a 
lack of script and directive structure within the vignettes.  
Theme three: Shifting the understanding framework 
This theme reflects the extent to which Morita Therapy was considered a 
distinctive approach in comparison to other therapies (constituent theme (a)), 
and to which participants considered Morita Therapy to converge with their prior 
expectations about what constitutes effective therapy.  This is discussed with 
particular reference to the Moritian perspective on emotions (constituent theme 
(b)) and the goals of Morita Therapy (constituent theme (c)).  The related need 
to deconstruct patients’ frames of reference and shift their expectations of 
treatment in order to helpfully present Morita Therapy to them is considered. 
(a) Familiarity and distinctiveness 
Participants noted several ways in which both Morita Therapy overall and 
certain features of the approach appeared familiar or distinct from other 
therapies, which often appeared to form the basis of their interpretation and 
understanding of Morita Therapy.  Overall, therapists acknowledged Morita 
Therapy as a novel and potentially “frame-shaking” (TH01) approach with a 
distinctive cultural framework, noting the uniqueness of the underlying 
philosophy in terms of de-focusing attention on the self, engaging in rest rather 
than immediate action-taking, and allowing emotions to run their natural course 
rather than fighting them.  Thus, therapists recognised a necessary shift in 
culturally-based preconceptions, noting challenges they felt they may face in 
delivering these messages to patients.   
The whole idea of decentralising the focus on the self, which is a very 
Western kind of philosophical preoccupation…I thought was very 
good…Seeing oneself embedded within nature and going with the 
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rhythm, the natural flow of the world and sort of the environment around 
you, is different. (TH02) 
Related to this underlying philosophy, participants also noted the appeal of a 
therapy which takes a more “spiritual”, “holistic” (TH03) and anti-diagnostic 
approach: 
I like the idea that this is very open, whereas sometimes other therapies 
you go and talk to people, and as soon as you say something that 
sounds similar to this category, you must be in this category…it’s all very 
defining, whereas this isn’t defining you or saying ‘you’re this, that or the 
other’, it’s just ‘this is life’…I prefer it for that. (PT08) 
However, potential patients were less likely to note the distinctive philosophical 
framework underlying Morita Therapy, often interpreting Morita Therapy through 
the lens of other treatment modes and attempting to ‘fit’ the approach into those 
principles.  Thus, participants, particularly those with positive views of 
mindfulness, often considered Morita Therapy as similar to mindfulness and 
suggested that mindfulness techniques may be incorporated into the approach, 
suggesting they were seeking ways in which Morita Therapy converged with an 
approach which already appealed to them: 
It obviously links in very much with mindfulness which is about not 
judging… I like the way it’s like an extension of mindfulness. (PT06) 
Alternatively, participants with positive views of CBT attempted to extract 
aspects of Morita Therapy which appeared consistent with the CBT model, and 
were thus more inclined to perceive Morita Therapy as an approach somewhat 
similar to CBT.  In such cases, the distinctive philosophy of Morita Therapy 
which could not be interpreted in line with the theory of other therapeutic 
approaches caused some confusion: 
It seems like a weird sort of hybrid of CBT and mindfulness, but with a bit 
of nature stuff and spirituality thrown in…like it wants to be a little bit 
CBT, but it wants to stick to its tradition, and it’s confused itself so 
therefore I’m confused. (PT09) 
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Some specific features of Morita Therapy were also perceived as familiar from 
other approaches.  Participants’ (mis)interpretations of the nature and purpose 
of such features demonstrated how these understanding frameworks can lead 
to some inaccurate assumptions.  In terms of action-taking, some participants 
assumed Morita Therapy would involve “working towards specific goals” in a 
similar manner to Behavioural Activation (TH02).  Similarly, participants had 
several misconceptions about the diary, such as assuming that the patient 
should record only negative thoughts and feelings, and/or that the objective was 
to uncover patterns between actions and feelings. 
I assumed the negative actually, so if I then sat down at the end of the 
day and I thought ‘right, how do I feel about myself’…I would think ‘well, I 
did that wrong’. (PT08) 
These ways in which Morita Therapy presented to participants as similar to, or 
distinct from, other approaches appeared to provide a specific framework of 
expectations and understandings in which they came to view Morita Therapy, 
thus providing context for this whole theme. 
(b) Accepting and allowing emotions 
Potential patients expressed tension between a willingness to accept and allow 
emotions, as encouraged by Morita Therapy, and seeking tools or techniques to 
change emotions.  As noted above (theme one: translating principles into 
practice), in principle participants responded positively to the notion of accepting 
unpleasant emotions as a natural and universal phenomenon, appreciating the 
permissibility of unpleasant emotions and futility of fighting them.  However, 
potential patients appeared to agree with these messages to only a certain 
degree, with objections being raised and confusion caused as they experienced 
the full extent of these principles as implemented in the vignettes.  Many such 
views were contradictory to the positive responses towards Morita Therapy’s 
principles, although potential patients did not appear to recognise this. 
If I was coming in and was on, you know, my eighth week of therapy and 
I was still experiencing all my things and you’re just saying it’s okay and 
it’s normal and it’s a sort of Buddhist thing you know, you have to 
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experience the pain and all of that goes with it, okay I get it but I’m still 
experiencing all of it… That’s great as a theoretical spiritual discussion, 
how are you gonna make me any better. (PT09) 
Thus, from the presentation of normalisation, potential patients appeared to 
value the message that unpleasant emotions were permissible, but did not 
appear to go so far as to recognise that such emotions were inevitable.  
Similarly, potential patients seemed to accept that such emotions would arise, 
but continued to expect guidance on how to subsequently ‘deal with’ them: 
Worry is going to be there, it’s how you deal with that, that’s quite 
nice…do you put your effort into worrying about the fact you’re worrying 
or do you put your energy into what can I do anyway, either to appease 
the worry, get rid of the worry, [or] work out how to fix it. (PT01) 
Thus, there appeared to be a distinction for potential patients between 
accepting that unpleasant feelings would occur, and allowing them to run their 
natural course without interference.  Such interpretations indicated possible 
constraint by prior understanding frameworks, with potential patients viewing 
the therapist’s meaning through a particular lens of definitions and distinctions.  
Thus, the Morita therapist and the potential patients did not appear to ascribe 
the same meanings to concepts such as ‘acceptance’ and ‘normality’.  This may 
be due to the use of ‘acceptance’ within other approaches such as mindfulness, 
which convey the message that unpleasant emotions will occur whilst 
concurrently providing guidance on how to intervene in them.  Thus, potential 
patients distinguished between ‘fighting’ emotions (which they agreed was 
unhelpful) and ‘managing’ emotions (which they did not consider to be mutually 
exclusive with accepting emotions), further indicating that ‘acceptance’ for these 
participants did not extend to include ‘allowance’ as intended from a Moritian 
perspective. 
The way it says to work with your moods, I found that the most helpful 
because if you’re really distressed about something actually fighting it 
doesn’t get you anywhere…[later in interview]: So it’s finding ways of 
managing that anxiety, which I presume he’s gonna talk about. (PT03)  
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Unaware of the distinctive meanings held by the therapist, potential patients 
were inclined to note that they were already aware of the messages being 
conveyed, leading them to somewhat disregard these as unable to provide any 
new understanding, and to continue to seek solutions to the ‘problem’ of 
unpleasant emotions.  Thus, potential patients expressed a somewhat 
inconsistent sense of accepting their unpleasant emotions as normal whilst 
noting that this did not make them feel better, and thus seeking concrete tools 
or techniques to do so. 
Trying to pretend like it doesn’t exist and trying not to feel like that is, that 
doesn’t work, it’s just kind of accepting it…[later in interview]: It does help 
but it doesn’t stop you having those feelings…I know it’s normal, I know 
it’s natural but…it’s like, how do I sort that out, how do I limit it. (PT02) 
Therefore, potential patients had difficulty shifting their approach towards 
unpleasant emotions in line with the Moritian perspective that they must be lived 
with: their desires to not feel this way were raised in contradiction to their own 
recognition that such feelings were a natural part of human life.  This may have 
been a demonstration of a culturally bound sense that one can or should be 
able to override the natural way of things, if only they are taught the right tools 
to exert their control:   
I’m always a person who prefers to be told that I have entire control… I 
like having a technique and practising it and seeing change and feeling 
control over the way that I think and feel and all of that, so for people like 
me it might sit a bit uncomfortably. (PT09)  
This seeking a means of control was expressed particularly strongly by potential 
patients who expressed positive views of mindfulness or CBT.  Such 
participants were particularly prone to suggesting that mindfulness techniques 
could and should be incorporated into Morita Therapy as a means of managing 
emotions.  Thus, overall, within their current frameworks of understanding and 
expectations, potential patients struggled to identify, appreciate and value the 
extent of the messages conveyed within Morita Therapy. 
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 (c) Therapy goals 
Related to the views around accepting and allowing emotions are the pre-
conceptions participants held around what the goals or outcomes of effective 
therapy should be.  For Morita Therapy, the purpose is to improve everyday 
functioning and live constructively in spite of symptoms.  Despite potential 
patients’ positive views of the holistic and anti-diagnostic nature of the therapy, 
they struggled to adopt this approach when considering the value of the therapy 
overall.  Thus, potential patients tended to focus more narrowly on mood-
orientated goals: the purpose of therapy is to feel better. 
I would see them really struggling when they don’t even have anything to 
sort of grasp onto…they’re still not feeling any better…it will be 
interesting to see if it works because initially I would say it wouldn’t. 
(PT09) 
Accordingly, the only way in which some participants appeared to be able to 
conceptualise therapy was as something providing an explanation for difficulties 
and/or a set of techniques to directly manipulate emotional experience; a 
therapy which does not offer this proved confusing, disquieting and insufficient, 
a view again reinforced by favourable views of other therapies. 
I can understand he’s saying ‘look, you’re fine because you’re getting on 
with your life and you’re doing all these things and, you know, isn’t that 
marvellous’ and she’s, but you’re still worried, um so I don’t really know, I 
don’t really understand what it’s about. (PT07) 
The specific features of Morita Therapy were thus interpreted within this 
understanding framework that the goal of therapy is to improve mood: the 
components of therapy were considered as a means to this end.  Thus, despite 
guidance on the alternative functions of such features, participants were rarely 
able to recognise the value of them, either in themselves or as a means of 
changing one’s perspective or goals.  For example, participants often 
interpreted the therapy’s connection to the natural world as a literal engagement 
in nature for the purpose of improving mood.  Similarly, PT02 considered rest 
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and action-taking as potential skills to manage anxiety, and struggled with the 
concept of shifting the goal towards constructive living: 
[A]ctually doing is an irrelevance...you have got to find some way of 
dealing with this question of ‘why the hell are we here’, which needs to 
be answered before you can be productive. (PT02) 
However, potential patients who did not have experience of other therapies 
more often noted the value of such aspects of therapy in themselves.  
Generally, these participants valued the ways in which the therapy provided 
insight and changed one’s perspective, enabled understanding of emotions 
without necessarily changing them, helped shift the focus of one’s attention, and 
potentially changed one’s relationship to emotions. 
I think it gives you more scope to understand where they land…And 
possibly why you are thinking like that…As opposed to saying that, you 
know, this can all change. (PT01) 
In line with this, PT09 in fact shifted their own perspective somewhat over the 
course of the interview, coming to a more Morita-congruent understanding of 
the approach: 
I like the um, it’s like ‘things aren’t perfect, you have this anxiety, but you 
get stuff done’, and it’s like just focus on that, cos you can’t do anything 
about that…it’s good, it makes sense…there’s all these ‘if you change 
your thoughts you’ll change your feelings’ but that doesn’t always apply, 
and I think that’s sticking in the trying to change a thing that you can’t 
change…it’s all about kind of acceptance and learning to live with and 
doing things despite and I guess the hope that the more you do that, the 
less impact it has. (PT09) 
Similarly, therapists recognised the techniques being implemented in the 
vignettes, and the value of therapy in providing insight: 
It’s quite clever I guess, I mean he’s getting her to recognise the value of 
certain emotional and cognitive aspects of people’s experience which 
people generally evaluate as being negative… This is an intervention to 
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try and get her to change her, how she actually um, her relationship with 
her emotions I think, which is good…to reframe her experience and…re-
focus her attention on different aspects of her ongoing experience and 
get [her] to start to appreciate and value that. (TH02) 
These struggles with and interpretations of the purpose and objectives of Morita 
Therapy highlighted the need to be explicit about the goals of the approach; in 
particular, the ways in which these may differ from patients’ prior experiences 
and expectations. 
Summary of Stage One Results 
The Stage One qualitative findings indicated that the core Morita Therapy 
principles were largely acceptable to participants, albeit with potential for 
improvement in how these are conveyed and structured in order to enhance the 
relevance, comprehensibility and appeal of the approach.  Theme one 
demonstrated the tension participants expressed between the Morita Therapy 
principles and how these were put into practice in the vignettes, with 
participants highlighting some disappointment with perceived discrepancies 
between principles and practice, and indicating both barriers to implementing 
elements of Morita Therapy such as rest and some failure of the vignettes to 
accurately communicate positive reinterpretation.  Theme two demonstrated 
key features of the vignettes, in terms of the tone and style of the therapist, 
which participants typically indicated could be modified to improve acceptability.  
Highlighted was the need to enhance the transparency, individualisation and 
depth of the approach to ensure participants feel acknowledged and respected.  
Finally, theme three demonstrated the overarching sense from participants that, 
in light of the both the distinctions and similarities noted between Morita 
Therapy and other treatments, there is a need to shift participants’ 
understanding frameworks and carefully manage their expectations of treatment 
in order to optimise the acceptability of the approach. 
5.3.2 Stage Two Results 
The Morita Therapy literature demonstrated a range of potential options and 
methods for implementing, communicating and structuring the key features of 
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Morita Therapy, which were thus open to tailoring to the target population.  
Overall, the delivery options could be considered to fall along a spectrum 
(Minami, 2013) from prescriptive inpatient settings adhering to a four-phased 
experiential structure (Morita et al., 1998) to exploratory outpatient counselling 
methods with no such structure, such as the active counselling method 
(Ishiyama, 2011) and modal model (Minami, 2013) (as presented in the 
vignettes), which apply and extend the guidelines for outpatient Morita Therapy 
(Nakamura et al., 2010). 
In developing the therapy protocol, the variety of options available in the 
literature were selected from in accordance with recommendations refined from 
the Stage One qualitative themes, which shaped the design of the therapy 
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Table 9. The use of Stage One findings to inform Stage Two therapy protocol development:                                     
Theme one (Translating principles into practice) 
Constituent theme(s) Recommendations for therapy 
protocol development 
Incorporation into therapy protocol design 
The underlying principles; 
Discrepancies between 
principles and practice 
 
Definition: In theory, the 
Morita Therapy principles, 
particularly the connection to 
nature, resonated positively 
for participants.  However, a 
lack of explicit translation of 
these into practice (i.e. the 
vignettes) was expressed, 
with confusion caused as to 
the nature of Morita Therapy. 
Enhance the core components and 
overarching structure of therapy to clarify 
the essence and process of Morita 
Therapy and facilitate the incorporation of 




Strengthen the use of nature in practice, 
as a positive feature for participants and a 
key principle of the approach. 
Core components were clearly delineated in an 
introductory section, to help ground therapists in 
these.  Therapy was structured according to the 
four-phased experiential approach; clear 
guidance on managing expectations was included 
in which this structure is made explicit to patients 
at the start of therapy. 
 
The central role of nature was incorporated 
throughout/ stressed in the “role of the therapist” 
section.  For therapist techniques and treatment 
phases, guidance was provided for bringing 
nature into practice: example nature metaphors; 
examples for engaging with nature; guidelines for 
discussing humans’ place within nature. 
Barriers to implementation 
 
Definition: Participants noted 
difficulties around 
implementing several features 
of therapy in practice; desired 
specific frameworks for 
elements such as the diary, 
rest and action-taking; and 
indicated some 
misunderstanding of rest. 
Therapists should be alert to the 
difficulties patients may face regarding 
diaries/ rest, and approach these with 
reassurance and flexibility.  The function 
and importance of these features should 
be stressed, to encourage patients to 
overcome challenges. 
 
Structure is required to provide clarity on 
the timeframes for rest and action-taking, 
and to address the issue of patients 
feeling incapacitated by depression. 
 
Potential fears/ barriers to engagement were 
highlighted, alongside guidance on managing 
these.  Guidance was included on stressing the 
rationale for, function and importance of these 
features. For rest, this was done with particular 
reference to drawing on physical health analogies 
and natural metaphors. 
 
The use of a phased approach provided structure 
and, as opposed to strict timeframes, included 
guidelines on the indicators for progressing to the 
next phase. 
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The diary exchange should allow time to 
thank the patient, check their 
understanding of the therapists’ 
comments and provide further guidance 
on completing the diary where needed.  
Therapists require clear guidance for 
commenting on diaries. 
 
To avoid misinterpretation of the meaning 
of rest, the rationale should be made 
clear to patients, and the conditions 
specified in detail. 
 
Clear guidelines for commenting on diaries and 







Thorough guidance for rest was incorporated, 
including instructions and conditions; warning 
points for potential misinterpretations; guidelines 
for managing expectations, preparing patients for 
the experience and managing any patient guilt. 
Communication difficulties 
 
Definition: The positive 
reinterpretation technique 
created some confusion and 
disagreement in practice. 
The purpose of positive reinterpretation 
should be made clear to therapists to 
facilitate its correct implementation.  More 
clarity/ specificity are required to convey 
the intended message and provide 
explanations for patients’ specific issues. 
Guidelines on the purpose/ use of positive 
reinterpretation were provided, including warning 
points/ specific examples of how positive 
reinterpretation may be misunderstood and for 
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Table 10. The use of Stage One findings to inform Stage Two therapy protocol development:                                    
Theme two (Respecting the individual) 
Constituent theme Recommendations for therapy 
protocol development 
Incorporation into therapy protocol 
design 
Transparency and rationale 
 
Definition: Participants expressed mixed 
views as to the perceived lack of 
transparency and rationale provided in 
the vignettes, particularly in relation to 
Fumon (inattention to symptoms). 
A middle ground should be found 
between insufficient and excessive 
explanation, in both the overall approach 
and specific features. 
 
 
An explanation of Fumon should be 
provided to patients to prepare them and 
explain its purpose. 
Guidelines for appropriately explaining 
the purpose and importance of the 
overall approach were included in the 
“beginning therapy” section, and 
provided for each therapy feature. 
 
Guidelines on explaining Fumon to 
patients were included in the “beginning 
therapy” section. 
Exploration and explanation 
 
Definition: Participants expressed a view 
that the patient as an individual was not 
sufficiently explored within the vignettes, 
nor were adequate responses to their 
questions around the differences 
between people and causes of 
difficulties provided.  This related in 
particular to Fumon, normalisation and 
related metaphors. 
A balance should be found between 
normalising and trivialising emotions.  
Appropriate empathy and 
acknowledgement should be shown, and 
the therapist should be clear that they 
are normalising emotions as opposed to 
situations.  The technique should be 
personalised to the individual’s specific 
feelings, and discussions on the 
functionality of emotion would be valued. 
 
Care should be taken with metaphors 
which may be misunderstood as 
examples of when emotions are 
acceptable.  These should either be 
personalised to address the patient’s 
specific feeling, or clarified as an 
explanation of the origin and function of 
unpleasant emotions. 
 
Within “progressive enabling”, clear 
guidelines/ warning points were provided 
for the use of normalisation and the 
incorporation of discussions on the 







Guidance was provided on the use of 
metaphors in the context of positive 
reinterpretation as well as therapy as a 
whole, which included examples/ 
warning points for how metaphors 
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The explanations for unpleasant 
emotions and differences between 
people sought by patients may be 
addressed through positive 




Therapists require clear guidance on 
balancing Fumon with validation and 
empathy. 
The importance of explaining the vicious 
cycle and exploring emotions through 
positive reinterpretation was stressed.  
The principles of nature, desire to live 
well and the vicious cycle were clearly 
delineated as the means to provide 
patients with the explanations they seek. 
 
A “role of the therapist” section was 
included which stressed the importance 
of establishing a safe space and 
therapeutic relationship through 
empathy and validation, and addressed 
how to balance this with Fumon. 
Structure, personalisation and 
collaboration 
 
Definition: Several participants noted 
that the approach was lacking in 
personalisation and collaboration, 
particularly in relation to metaphor use 
and receiving feedback from the patient/ 
allowing the patient to self-explore. 
It should be clarified that personalisation 
and collaboration are essential features 
of the approach, as per other therapeutic 
modes.  Therapists should endeavour to 
build an understanding framework with 
patients, from which the patient can self-
discover and answer questions 
themselves.  The therapist should 
engage in feedback and confirmation of 
patients’ understandings as the 
therapeutic techniques are applied.   
 
It would be valuable to personalise 
metaphors where possible. 
Within the “role of the therapist” section, 
the importance of a personalised and 
collaborative approach was stressed, 
with guidance provided on the specific 
means of implementing this. 
For each treatment phase, clarity was 
provided on the ways in which therapists 
should be directive (such as the 
requirements and conditions of the 
phase) and should not be directive (such 
as the specific action to be undertaken). 
 
Recommendations for personalising 
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Table 11. The use of Stage One findings to inform Stage Two therapy protocol development:                                    
Theme three (Shifting the understanding framework) 
Constituent theme(s) Recommendations for therapy protocol 
development 
Incorporation into therapy 
protocol design 
Accepting and allowing emotions; 
Therapy goals 
 
Definition: Participants expressed 
tension between allowing emotions, and 
seeking tools or techniques to change 
them, indicating possible constraint by 
prior understanding frameworks.  Thus, 
potential patients struggled to identify 
and appreciate the extent of the 
messages conveyed.  Related are the 
pre-conceptions participants held 
around therapy goals: some focused on 
mood-orientated goals and interpreted 
the features of therapy as only a 
potential means to this end; others 
appreciated the value of changing 
perspective, attention and relationships 
to emotions. 
Therapy needs to be received within the 
correct understanding framework to be 
effective/ relatable.  Thorough explanation 
at the start of therapy should help patients 
to appreciate how it may differ from their 
prior expectations and experiences, and 
begin to conceptualise effective therapy as 
something other than that which provides a 
set of tools for manipulating symptoms.  
Therapists should take care to explain the 
Moritian view of allowing emotions, noting 
any tools to control or manage emotions 
constitute part of the vicious cycle, and that 
Moritian ‘techniques’ instead involve 
reducing engagement in the vicious cycle. 
 
Therapists should take care to 
communicate what is and is not being 
claimed as acceptable for the patient to 
tolerate and be aware of the dangers and 
potential misinterpretations inherent in the 
normalisation/ acceptance messages.   
 
Therapists should clarify the process 
patients will move through and changes 
which may be effected for them, to ensure 
they understand the therapy goals and 
progress they can expect. 
Within the “beginning therapy” 
section, a “managing patients’ 
expectations” section was included 
with guidance on providing an 
upfront explanation of the Moritian 
view of emotions, goals of treatment, 
and ways in which treatment may 
differ from patients’ prior experiences 
and expectations. 
Throughout the protocol, the Moritian 
view of accepting emotions as 
inevitable features of human life, and 
the value of allowing them to run 
their natural course, was highlighted. 
 
 
Warning points/ guidance around 
how the messages of accepting 
natural rhythms and learning to 'be 
with' symptoms should be conveyed, 
within this understanding framework, 
were provided throughout. 
 
The use of a structured phased 
approach enables the conveyance of 
a process patients will progress 
through and the experiential learning 
they can expect to gain. 
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Familiarity and distinctiveness 
 
Definition: Participants noted several 
ways in which therapy overall and 
particular features (such as diaries) 
appeared familiar or distinct from other 
therapies, which appeared to provide a 
specific framework of expectations and 
understandings within which they came 
to view Morita Therapy. 
Therapists require a clear grounding in the 
ways in which this treatment differs from 
others, to avoid slipping into an 
inappropriate way of working.   
 
The distinctions to other treatments, 
particularly regarding diaries, should be 
highlighted to therapists and noted to 
patients within detailed instructions.   
 
Therapists should be alert to the potential 
for patients to utilise mindfulness 
techniques, and curb this with thorough 
explanation of the purpose of rest. 
A “differences between Morita 
Therapy and other therapies” section 
was included, to ensure therapists’ 
awareness of these. 
 
Specific differences to diaries used 
within other treatments were noted, 
and detailed diary instructions to 
provide to patients included. 
 
The conditions for and purpose of 
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Overall, the significant ways in which the Stage One findings informed the 
development of the therapy protocol may be summarised as follows.  The 
treatment approach was shifted along the spectrum of available treatment 
modes from the counselling-based method alone (as presented in the vignettes 
played to participants during their interviews) towards the traditional four-
phased experiential approach.  This addressed the Stage One findings by 
strengthening the core components and overarching structure of the approach, 
reinforcing the process and purpose of therapy, and balancing otherwise 
somewhat paradoxical features such as rest and action-taking within a clearly 
defined structure. 
To address the challenges highlighted by participants in relation to completing 
diaries and rest and increase the likelihood of engagement with these 
components, the need for an individualised, flexible and reassuring approach to 
identifying patients’ concerns and capabilities was stressed.  The importance of 
delivering therapy in a personalised, collaborative and well-explained manner 
was also emphasised, with the inclusion of explicit rationales for both therapy 
overall and each therapy component provided to patients.  Clear guidance and 
warning points, suggested by the qualitative findings, on implementing 
techniques such as positive reinterpretation and normalisation were 
incorporated, to address the misunderstandings indicated and concerns raised 
by participants. 
One key qualitative message was that care would be required in explaining the 
purpose of therapy and managing the ways in which it may differ from patients’ 
preconceptions and prior experiences.  Thus, one protocol inclusion was a 
“managing expectations” section, intended to facilitate a shift in patients’ 
understanding frameworks from the beginning of treatment, and ensure 
provision of the desired level of transparency and rationale. 
5.3.3 Stage Three Results 
Therapists’ perspectives in the context of the draft protocol could be understood 
within two key themes: addressing insecurities, and enhancing 
operationalisability and accessibility.  Each key theme encompassed a number 
of constituent themes (Figure 11, overleaf).  Theme one illustrates the 
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overarching sense of a lack of confidence expressed by therapists in terms of 
orientating and adhering to Morita Therapy, with each constituent theme 
capturing a way in which these insecurities manifested.  Theme two captures 
the more practical issues highlighted by therapists, with each constituent theme 
capturing an area in which the operationalisability of Morita Therapy might be 
enhanced through modification of the therapy protocol.  The challenges 
expressed within theme one often shaped the suggestions made within theme 
two. 
Figure 11. Stage Three Themes and Constituent Themes 
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Theme one: Addressing insecurities  
This theme illustrates the lack of confidence therapists’ generally expressed 
around orientating to and delivering Morita Therapy.  This captures therapists’ 
perceived level of grounding in the philosophy and principles of the approach 
(constituent theme (a)), concerns around managing patients’ expectations of 
and responses to the approach (constituent theme (b)), and suggestions for 
enhancing the structure of the approach to assuage their associated anxieties 
(constituent theme (c)). 
(a) Grasping philosophy and principles 
Therapists noted that, in general, the protocol was thorough, provided much 
understanding of Morita Therapy, and responded effectively to the issues raised 
during the Stage One interviews. 
It was very comprehensive, clear, um and it answered quite a lot of the 
issues we talked about… [The] phases worked really well and it helped 
me understand like the essence of it around the vicious cycle. (TH01) 
Considering the approach “novel” (TH02), philosophically distinct from other 
treatments, and only deliverable from a thorough grounding in the principles 
(“the therapist has to kind of embrace the philosophy before they can 
understand the structure” (TH03)), therapists often focused on the extent to 
which they felt they were able to grasp the philosophy underlying approach:  
What I’m reading I think is generally bedding in, but because it is quite 
different at the outset, and actually philosophically there’s a difference, 
it’s all about the connection to being part of nature, that’s quite different 
to well all the other therapy models that I’ve come into contact with, so 
it’s almost like I go back to ‘right, ground yourself back there again’. 
(TH04) 
Thus, therapists demonstrated some lack of confidence in their abilities and 
some concerns around orienting to, and demonstrating “fidelity to” (TH01), the 
underlying theory and ideas: 
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This is very novel and new ideas, I haven’t got much scaffolding to kind 
of actually integrate some of the philosophical ideas and some of the 
terminology… It’s something I think that would er take me a little bit of 
time to kind of integrate and orientate myself to. (TH02) 
Accordingly, therapists noted the need for the protocol to emphasise “key 
beliefs that a Morita Therapist would have” (TH01), and key Morita Therapy 
principles to adhere to, “so that you can stay rooted to those” (TH01). 
Outlining and highlighting the principles to kind of keep the therapist’s 
mind on those, and kind of bring those principles to the fore, ‘cos they’re 
very important. (TH02) 
Related to the anxiety of familiarising themselves with a new approach, 
therapists’ often sought to simplify the approach and make sense of it through 
the lens of more familiar therapies: 
The overlaps were because activity is very much a part of it, so you know 
with CBT and BA, and kind of being with the moment and the thinking 
that any emotion, negative or positive will pass, um and certainly within 
CBT the thinking is often about that. (TH05) 
Thus, whilst noting the usefulness of the current protocol, therapists expressed 
some lack of confidence around orientating and adhering to the underlying 
philosophy and principles of Morita Therapy, and suggested ways in which this 
might be assuaged, such as understanding the therapy in more familiar terms. 
 (b) Managing patients 
Therapists acknowledged the usefulness of the protocol section on managing 
patients’ expectations (“these were quite nice and instructional” (TH04)) and the 
guidance on providing rationale for engagement with the treatment elements: 
Some of the explanations to guide the therapist and also to try and I think 
guide the patient into engaging in some of these techniques and 
approaches is very good… the metaphors and analogies that are being 
CHAPTER FIVE: INTERVENTION OPTIMISATION STUDY 
172 
 
used are, are to I guess socialise the patient to these different kinds of 
methods, I thought that was very, very well thought through. (TH02) 
However, therapists also expressed trepidation around how to manage patients’ 
expectations and responses in light of the potential challenges and difficulties 
they envisaged patients presenting with, anticipating some possible 
incompatible expectations of treatment alongside a degree of reluctance and 
scepticism from patients: 
How do you apply these [principles] in different responses that patients 
might have?... Even if it’s always with a caveat ‘well, suspend disbelief at 
the moment, suspend your concerns and let’s just try it, let’s be curious 
about it’ and then that’s fine, I mean if that’s the get-out clause after 
everything, that’s fine. (TH01) 
Thus, therapists sought examples of managing typical patient responses, 
stressed the importance of role playing these during therapist training, and 
desired a summary sheet for patients prior to starting therapy in order to 
prepare them for the approach: 
Role play would be good, definitely...just to familiarise the therapists with 
the sort of territory and how to respond potentially perhaps, to any 
potential challenges or difficulties. (TH02) 
In particular, therapists often noted concerns around implementing rest and 
doubts around the rationale for this, which appeared to accentuate their 
anxieties around encouraging patients to engage with it. 
The fact that we’re encouraging rest in the early stages is, we are 
actually in some way accepting that they will avoid, and they will try, but 
is that counter to them then if they’re-, isn’t that just then part of Hakarai, 
the lying in bed, and fighting symptoms… that puzzled me a bit. (TH01) 
Accordingly, to facilitate their management of patients’ (potentially negative) 
responses to the notion of rest, therapists sought more clearly defined 
instructions for instigating rest and desired flexibility around engaging patients in 
rest dependent on patient presentation and preference. 
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Are we, irrespective if you like of the level of um disability, call it, that a 
client comes in with, is every client to go through all phases, so even if a 
client for example isn’t sufficiently incapacitated by fatigue…[if] they’re 
still functioning, are we still sort of imposing the rest phase? (TH04) 
Therapists also noted that a handout which could be provided to patients’ 
significant others could help build a support system for them during rest (TH01).  
Thus, although therapists expressed anxieties around managing patients’ 
expectations and responses, particularly in relation to the rest phase, they also 
made several suggestions for facilitating these aspects of treatment. 
(c) Seeking structure 
In order to assuage some of their anxieties around adhering to the approach 
and ensuring it was delivered within the specified eight to twelve sessions, 
therapists sought to enhance the structure of the approach through clearly 
defined timeframes for each treatment phase: 
[With] eight to twelve sessions, you’ve got the two first sessions where 
you’re setting it up… [and] six or so sessions to then pack in so it’s like, 
you know, two sessions of rest, two sessions of this, two sessions of 
that… it would need to be, yeah, very clear for the therapist. (TH02) 
Similarly, therapists desired content outlines for each therapy session. 
Whether there’s scope to have a session guide that kind of keeps the 
objectives for the early stages, so sessions one and two, or the phases 
and then um just pointers or reminders…kind of the beginner’s guide 
might be helpful in summary sheets. (TH04) 
However, therapists also acknowledged the potential incompatibility of such 
structure with the approach of Morita Therapy as a fluid treatment which 
responds to the pace of the individual patient. 
There might be a little bit of tension there between the philosophy 
underpinning this and that kind of natural, ecological movement through 
the healing process I guess and um the need to deliver this within, and 
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respond within, a certain time frame… That real kind of fragile-ness and 
subtlety about it, so that’s kind of what I liked about it…I think it would be 
a shame if that got lost. (TH02) 
Thus, therapists expressed some tension between staying true to the naturally 
progressive nature of Morita Therapy and their desire, in the context of their 
anxieties around adhering to the approach, to rely on clearly defined timeframes 
and session structures. 
Theme two: Enhancing operationalisability and accessibility  
This theme illustrates areas in which therapists felt more guidance was required 
in the protocol to enable the delivery of therapy, particularly in terms of 
providing more clarity around specific therapy features (constituent theme (a)) 
and more specificity in terms of illustrating how the approach is implemented for 
individual patients (constituent theme (b)).  Also captured are therapists’ 
suggestions for improving the format and presentation of the protocol itself 
(constituent theme (c)). 
(a) Lack of clarity 
Therapists indicated that further clarity was required in relation to certain 
aspects of Morita Therapy which currently caused them some confusion or lack 
of confidence.  Firstly, this related to balancing potentially incompatible features 
of the therapy such as direction with collaboration: 
Occasionally there feels like there’s um, slight conflict… on the one hand 
it feels as if it should be fairly non-directive, client-led approach, but then 
at other times it feels like actually there’s, I can see how one might, as a 
therapist, Morita therapist, actually need to be quite directive... maybe 
[the protocol needs] a section on when might a more directive approach 
be needed or necessary, and when it’s not. (TH04) 
Similarly, therapists noted tension between Fumon (inattention to symptoms) 
versus empathy, and acceptance versus acknowledgement of difficulties: 
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The possible tight rope on this is like normalising, um trivialising versus 
like empathising… how you do it in such a way as it doesn’t immediately 
set-up them just not turning up… They really are the kernel of our, of 
some of the training issues. (TH01) 
Secondly, noting the subtlety of the indicators of therapeutic progress as a 
means of evaluating when treatment should be terminated, and their reliance on 
the therapists’ clinical judgement, therapists suggested the need for more 
guidance in assessing these: 
It’s quite subtle, you know, ‘has the client’s lifestyle reached a 
satisfactory level of adaptation’, so how… this is very reliant on the 
therapist and also the patient’s feedback… I wonder if some thought 
needs to be around that. (TH02) 
The need for more clearly defined indicators was also expressed in relation to 
progressing through treatment phases, with therapists suggesting value in 
delineating these clearly in line with examples and treatment objectives: 
[The] means to evaluate progress feel less obvious... making sure that I 
feel clear on the purposes of each phase might then enable me to feel 
more clarity… [we need] some bullet points around that, so in summary, 
you know ‘phase one objectives are…, these are the ways in which we 
might do that, and this is what we might see’. (TH04) 
The need for more guidance regarding indicators of progress was expressed 
particularly in relation to the rest phase, which appeared to be related to 
therapists’ concerns around whether rest in practice would function as intended 
(theme one, constituent theme (b): managing patients): 
After two weeks, if there’s rest and there’s still no real progress, what do 
you do and how do you shift forward, so those kind of turning points 
along the way, how do you negotiate those if there’s no shift or there’s 
nothing happening or um and, or what indications do you use? (TH02) 
Therapists, in seeking a glossary of Japanese terms, also queried whether they 
should use these with patients, alongside noting the lack of explicit specification 
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of the number and spacing of therapy sessions in the protocol.  Thus, therapists 
indicated that further clarity was required in the protocol, particularly in terms of 
balancing therapy features and assessing indicators of progress. 
(b) Specificity in implementation 
Whilst appreciating the overall picture provided by the protocol, therapists also 
indicated a need for more specific detail and examples to facilitate the 
implementation of therapy (corresponding with the above views on assessing 
indicators of progress): “The devil is in the detail now, how you operationalise it, 
but I think it covered everything really well” (TH01). 
One of the questions I was left with was um how would it look [laughs] as 
a therapist delivering it… having a kind of dialogue of patient-therapist 
can be quite helpful, just to give, you know, the therapist an idea of how 
that, how it would look. (TH05) 
Thus, therapists appreciated the current inclusion of Stage One interview 
findings to alert them to the views and responses of individual potential patients 
(“I also liked the way that you’d reflected on what patients had said, I thought 
that was really very important” (TH01)) and desired more specific clinical 
illustrations and verbatim examples to guide them in operationalising therapy: 
Actual illustrations of some of the key interventions um and how they sit 
within the structure I think would be useful…‘cos some of the ideas are 
quite subtle and quite nuanced. (TH02) 
In particular, therapists indicated the need for specific examples to aid them in 
identifying patients’ individual manifestations of engagement in the vicious cycle 
(TH03), and selecting appropriate activities for patients to engage in: 
Where is the context for this new desire for little activities in the context 
of someone’s busy life, do you want them to go do a bit of Origami or 
crocheting in their lunch break, do you want them to go outside into the 
warm sunlight and just sit…How much joyousness does there have to be 
in the early action phase? (TH01) 
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Furthermore, therapists sought more specific guidance on how they implement 
Fumon (inattention to symptoms) in practice, noting the potential value of diary 
examples to guide them in operationalising this technique, amongst others, 
within their diary comments: 
I was really interested in the selective inattention…how [do] you express 
it in a therapy session, but also it would be useful if, maybe for the 
training, if you could do some possible diary sheets filled in…then we can 
have a chat about the types of things you would pay attention to. (TH01) 
Accordingly, therapists anticipated value in focusing on the specific 
implementation of techniques during training: “I will really value being trained to 
actually do it… when I have tried to digest the protocol, I really want that kind of 
experiential next step.” (TH04).  Thus, therapists indicated the need to address 
the detail of operationalising therapy, facilitated by clinical illustrations to guide 
them. 
 (c) Protocol presentation 
Overall, therapists considered the protocol understandable, “user-friendly” 
(TH05), “well laid-out” (TH02) and “easy to follow” (TH03).  However, they did 
consider the protocol somewhat difficult to digest and indicated the potential 
value of additional summaries and crib sheets of key therapy components: 
Even if it’s just like one side of A4 of the phases and what would be in 
there, and then you can refer back to [the protocol] to get more detail but 
yeah, just having something more summarised. (TH05) 
This connected to therapists’ perceived level of grounding in the philosophy of 
Morita Therapy and concerns around ensuring adherence to the key principles 
(theme one, constituent theme (a): grasping philosophy and principles): 
I was going for these little crib sheets: I’ve got core beliefs for therapists, 
tools… the desire for life table, and then I might have another sheet 
which might be Morita metaphors, er narrative or examples that can 
commonly be used…, indicators of progress… [and] key platforms which 
are, you know, ‘do not veer from these’. (TH01) 
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To enhance the usefulness of the protocol during treatment, therapists noted 
the need to further compartmentalise information into summaries and bullet 
points, and highlight key points such as the Stage One interview findings and 
related ‘warning points’: 
I’m wondering if there might be a way of putting a summary of each 
stage before you go into all the, er, detail... I’d find it quite difficult to 
navigate around it whilst delivering therapy… It might be good to have 
bullet points and, and [highlight] warning areas. (TH03) 
Thus, in the context of the protocol presenting as detailed and somewhat 
overwhelming, therapists indicated various ways in which key information could 
be highlighted within summary sheets and through amendments to the protocol 
design, thus potentially improving its functionality. 
Summary of Stage Three Results 
The Stage Three qualitative findings highlighted therapists’ anxieties around 
orientating and adhering to the Morita Therapy principles, and managing 
patients’ expectations and responses, with therapists at times seeking more 
clearly defined timeframes and session content outlines in order to assuage 
their anxieties.  The findings further indicated that the protocol required 
improvements in format and presentation to enhance ease of use, and 
additional guidance, specificity or clarity to address the issues raised around 
balancing features of therapy, assessing indicators of progress, and 
operationalising the approach for individual patients. 
5.3.4 Stage Four Results 
Tables 12 and 13 (overleaf) provide details of how the protocol was optimised, 
and the therapist training programme tailored, in response to the Stage Three 
findings. 
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Table 12. The use of Stage Three findings to inform Stage Four therapy protocol modification/ therapist training programme: 
Theme one (Addressing insecurities) 
Constituent theme Modification to therapy protocol Tailoring of therapist 
training programme 
Grasping philosophy and principles 
 
Definition: Therapists expressed some lack of 
confidence around orientating and adhering 
to the underlying philosophy and principles. 
A crib sheet highlighting key principles to 
adhere to was developed. 
A focus was maintained on 
grounding in the key 
principles in order to 
enhance therapists’ 
confidence in orientating and 
adhering to the approach.   
Managing patients 
 
Definition: Therapists expressed trepidation 
around managing patients’ expectations and 
responses, particularly in relation to rest, for 
which therapists sought more clearly defined 
instructions and flexibility around engaging in 
rest dependent on patient presentation and 
preference. 
Instructions for rest were clarified.  To adhere to 
the literature which deems rest fundamental to 
Morita Therapy, it was clarified that all patients, 
regardless of presentation, should engage in as 
much rest as possible.  Thus, in the event of 
patients’ reluctance to engage in rest, it was 
stressed that reiterating its importance and 
rationale should be prioritised over missing it. 
 
A pre-treatment patient ‘Morita Therapy 
Information Sheet’, to begin expectation 
management at the earliest opportunity, and 
available to provide to patients’ significant 
others in preparation for rest, was developed. 
Role plays focused on 
managing patient 
expectations and responses, 
delivering rationale and 




Definition: Therapists sought to enhance the 
structure of the approach through clear 
timeframes and session content outlines. 
To adhere to Morita Therapy practice, session 
content outlines were not provided.  Crib sheets 
were developed which clarified the session 
structure and highlighted discussions to be held 
at key points of therapy (such as transitioning 
between treatment phases). 
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Table 13. The use of Stage Three findings to inform Stage Four therapy protocol modification/ therapist training programme: 
Theme two (Enhancing operationalisability and accessibility) 
Constituent theme Modification to therapy protocol Tailoring of therapist 
training programme 
Lack of clarity 
 
Definition: Therapists 
indicated the need for further 
clarity, particularly in relation 
to balancing features of 
therapy and assessing 
indicators of progress. 
Within the “the role of the therapist” section, guidance was added 
on balancing direction with collaboration; within the “therapy 
structure” section the number and spacing of therapy sessions was 
specified; to the appendix a glossary of Japanese terms was added 
with confirmation that therapists do not need to use these. 
 
The protocol was re-structured to summarise key objectives of 
each treatment phase and link these explicitly to each indicator of 
progress, assessing indicators and example illustrations in tables 
for each phase and ending treatment. 










indicated a need for more 
specific detail, clinical 
illustrations and verbatim 
examples. 
Verbatim illustrations available from the literature were 
incorporated, specifically in identifying engagement in the vicious 
cycle and the indicators of progress. 
 
Within the details for each action-based treatment phase, the types 
of/conditions for activities to be engaged in were clarified. 
Role plays focused on 
implementing Fumon and 
identifying personalised/ 
suitable patient activities. 
 
Commenting on mock 
diaries/ discussions on 
principles to adhere to in 




considered the protocol 
difficult to digest and 
indicated the value of crib 
sheets, summaries, and 
compartmentalising/ 
highlighting key information. 
Summary sheets were developed for the vicious cycle, therapist 
beliefs, metaphors, therapeutic tools, therapist responses, session 
structure, introducing therapy, negotiating rest, and each treatment 
phase in terms of purpose, conditions and indicators of progress. 
 
Summaries/concise guidance were added; guidance was 
deconstructed into bullet points and tables; key features, tips, 
techniques and warning points were delineated in boxes; colour 
and bold text were incorporated to highlight key information. 
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To summarise the significant adaptations to the protocol:  
 Verbatim illustrations were incorporated. 
 Assessing indicators of therapeutic progress was clarified. 
 Guidance on balancing direction with collaboration was added. 
 The types of/conditions for activities to be engaged in were clarified.   
 Summary sheets, and a pre-treatment patient ‘Morita Therapy Information 
Sheet’, were developed. 
 The presentation was amended to include summaries and concise 
guidance; bullet points, tables and boxes; colour and bold text. 
 The number and spacing of therapy sessions (eight to twelve weekly one 
hour sessions, as per the modal model (Minami, 2013)) was specified. 
In addition, the proposed therapist training programme was tailored to maintain 
a focus on grounding in the key principles, include role plays in areas therapists 
indicated necessary, and incorporate the provision of diary comments 
(Appendix VI). 
The final UK Morita Therapy Outpatient Protocol (Appendix IV) comprises 
twelve sections: (1) Morita Therapy overview; (2) Morita Therapy principles: 
nature, mechanisms of psychological suffering, mechanisms of change and 
psychological wellbeing; (3) differences between Morita Therapy and other 
therapies; (4) the role of the therapist: establishing a safe space and therapeutic 
relationship, accepting and respecting nature, the Fumon stance, direction and 
progression in the therapist’s role, and experiential learning; (5) therapeutic 
techniques: guidance on the diary and the techniques of discovering and 
reactivating constructive desires, validation and normalisation, increasing 
awareness of the vicious cycle, re-evaluating behavioural patterns and 
lifestyles, accepting natural rhythms and learning to ‘be with’ symptoms, and 
metaphor making; (6) therapy structure; (7) beginning therapy and managing 
expectations; (8 – 11) guidelines for completing each treatment phase in turn; 
(12) termination and evaluation of treatment, including indicators of therapeutic 
progress; appendices which include a glossary of Japanese terms and 
information on the development of Morita Therapy and the protocol. 
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5.4 Chapter summary 
This chapter has presented the aims, methods and results of an iterative four-
stage process informed by the person-based approach to develop a Morita 
Therapy outpatient protocol with optimal acceptability and feasibility for a UK 
clinical population.  Within this process, qualitative findings were integrated with 
Morita Therapy literature in order to sensitively adapt the intervention across 
cultures whilst carefully ensuring adherence to its fundamental features.  As 
such, a therapy protocol and tailored therapist training programme were 
developed which were fit for purpose in proceeding to a UK-based Morita 
Therapy feasibility study.  Chapter Six presents the design, methods and 









CHAPTER SIX.  MIXED METHODS FEASIBILITY STUDY: METHODS 
This chapter describes the methods of the feasibility study undertaken to 
prepare for a fully-powered randomised controlled trial (RCT) of Morita Therapy 
plus treatment as usual (TAU) compared with TAU alone for the treatment of 
depression and anxiety in adults in the UK.  These methods have been reported 
in Sugg et al. (2016) (Appendix VII).  This chapter is based on the published 
article; additional information is provided. 
The chapter is organised into ten main sections: study purpose and research 
questions (6.1); study design (6.2); pilot RCT (6.3); semi-structured interviews 
(6.4); data management (6.5); analysis (6.6); ethical issues (6.7); patient and 
public involvement (6.8); dissemination protocol (6.9); study set-up and 
management (6.10). 
6.1 Study purpose and research questions 
The purpose of this study was to prepare the ground for the design and conduct 
of a fully-powered RCT of Morita Therapy plus TAU versus TAU alone, or to 
determine that such a trial is not appropriate and/or feasible. 
Seven research questions were addressed to meet this purpose: 
1. What proportion of participants approached to take part in the trial will agree 
to do so? 
2. What proportion of participants who agree to take part in the trial will remain 
in the trial at four month follow-up? 
3. What proportion of participants who agree to take part in Morita Therapy will 
adhere to a pre-defined per-protocol dose of Morita Therapy? 
4. What is the variance in participant outcomes following Morita Therapy plus 
TAU and TAU alone, and how do they correlate with participants’ baseline 
scores? 
5. What are the estimated between-group differences (and 95% confidence 
intervals) in participant outcomes following Morita Therapy plus TAU and 
TAU alone? 
6. How acceptable is Morita Therapy to participants and therapists?  




7. How do participants’ views about Morita Therapy relate to the variability in 
the number of treatment sessions they attend?  
6.1.1 Criteria for success 
Relating to the above research questions, the criteria to be met in order to deem 
a fully-powered RCT feasible to run as is (Thabane et al., 2010) were: 
1. A sufficient number of participants to populate a fully-powered trial are likely 
to be recruited and retained, i.e. we recruit at the rate anticipated in the pilot 
trial (12% of those invited) and experience an attrition rate no higher than 
20% of those randomised, in line with other National Institute of Health 
Research (NIHR) mental health trials (Rhodes, Richards, Ekers et al., 2014; 
Richards, Hill, Gask et al., 2013; Wiles et al., 2013).  Whether protocol 
modification or close monitoring during a fully-powered RCT will address any 
failure to meet these criteria will be considered (Thabane et al., 2010). 
2. The levels of engagement with and adherence to Morita Therapy are likely 
to be on par with other NIHR mental health trials (Rhodes et al., 2014), i.e. 
at least 65% of participants allocated to Morita Therapy attend at least 40% 
of treatment sessions.  Any failure to meet this criterion will be considered in 
the light of participants’ views on the acceptability of Morita Therapy in order 
to determine whether protocol modification or close monitoring are sufficient 
to deem a fully-powered RCT feasible (Thabane et al., 2010). 
3. It is likely that a Morita Therapy outpatient protocol can be produced which is 
acceptable to patients and therapists, and deliverable by therapists, as 
defined by responses to qualitative interviewing. 
6.2 Study design 
A mixed methods embedded design (Creswell and Plano Clark, 2007) 
incorporating exploratory and explanatory components was employed.  Thus, 
semi-structured interviews were embedded within a pilot RCT of Morita Therapy 
plus TAU versus TAU alone for adults with depression, with or without anxiety 
disorders.  Quantitative and qualitative components were given equal priority 
and mixed interactively at the design level to address the study purpose 
(Creswell and Plano Clark, 2007).  For these two components, data were 




collected concurrently and analysed sequentially (with quantitative data 
informing the sampling of qualitative interviews for analysis: section 6.5.2).  
Quantitative data were used to assess the feasibility of trial recruitment, 
retention and treatment adherence, and to inform the sample size calculation 
required for a fully-powered trial.  Qualitative data were collected on 
participants’ and therapists’ views of Morita Therapy.  Qualitative data on 
acceptability and quantitative data on treatment adherence were integrated to 
help explain variability in the number of treatment sessions participants 
attended, and to provide a more in-depth understanding of the feasibility and 
acceptability of Morita Therapy. 
6.3 Pilot randomised controlled trial 
6.3.1 Sample size 
A conventional power calculation is inappropriate for the purpose of a pilot trial 
(Thabane et al., 2010).  Instead, the sample size was calculated in order to 
provide useful information about the aspects of the study being assessed for 
feasibility (Thabane et al., 2010), following advice from the University of Exeter 
Medical School Institute for Health Research Health Statistics Group 
(https://medicine.exeter.ac.uk/research/healthresearch/healthstatistics/).  Thus, 
confidence intervals were constructed based on certain criteria for success 
(Thabane et al., 2010), specifically: recruiting at a rate of 12% of those invited 
and experiencing an attrition rate no higher than 20% of those randomised.  It 
was anticipated that a total of 570 potential participants would be invited to 
participate in the trial.  Thus, it was expected that 72 participants would be 
recruited into the trial, and 60 participants followed-up (30 in each arm). 
Inviting 570 potential participants was sufficient to estimate participation rates 
(as percentage of subjects invited) of 10% with a margin of error of +/- 2.46%, 
or 12% with a margin of error of +/- 2.67%, or 15% with a margin of error of +/- 
2.93%, based on 95% confidence intervals.  Recruiting 72 participants was 
sufficient to estimate follow-up rates (as percentage of participants randomised) 
of 80% with a margin of error of +/- 9.24% or 85% with a margin of error of +/- 
8.25%, based on 95% confidence intervals. 




In addition, the standard deviation of participant outcomes and the correlation 
between baseline and four month follow-up scores was calculated, to be used in 
refining future sample size calculations to incorporate the additional precision 
obtained from adjusting for baseline scores when comparing outcome scores 
between groups.  In this vein, 30 participants in each group was sufficient to 
estimate: (i) the standard deviation of continuous outcomes to within 22% of 
their true value based on the upper limit of the 95% confidence interval; (ii) a 
Pearson’s correlation coefficient between baseline and follow-up scores with a 
margin of error of +/- 0.1 if the true correlation is 0.8, or +/- 0.14 if the true 
correlation is 0.7, or +/- 0.17 if the true correlation is 0.6. 
30 participants per group is also in line with the general rule of thumb for using 
pilot studies to reliably estimate variance for participant outcomes (Browne, 
1995).  Considering these factors, 60 participants at follow-up was considered 
to be both sufficient to provide useful information and reasonable to recruit for 
within the constraints of a pilot trial.  Therefore, 72 was selected as the target 
sample size, inflating the sample by 20% to take account of predicted attrition. 
6.3.2 Participant inclusion and exclusion criteria 
Eligible participants were aged ≥18 with Diagnostic and Statistical Manual of 
Mental Disorders (DSM) (American Psychiatric Association, 2000) Major 
Depressive Disorder, with or without accompanying DSM anxiety disorder(s).  
Given the exploratory nature of this trial (and any fully-powered evaluation), and 
thus the requirement for reasonable internal validity with a homogenous and 
tightly defined population, people who were cognitively impaired, had bipolar 
disorder or psychosis/psychotic symptoms, or were substance dependent were 
identified and excluded.  Cognitive impairment was determined using the Mini-
Cog (Borson, Scanlan, Brush et al., 2000), whereby a score of 0, or 1-2 with an 
abnormal clock-face, indicated sufficient cognitive impairment to be excluded 
(Borson et al., 2000).  Bipolar disorder, psychosis and substance dependence 
were established according to the DSM. 
Participants whose risk of suicide was sufficiently acute to demand immediate 
management by a specialist mental health crisis team, and those who were 




currently in receipt of psychological therapy, were also excluded.  Psychological 
therapy included any formal standard course of psychological (talking) therapy, 
such as Cognitive Behavioural Therapy.  Ad hoc contact with a therapist or 
counsellor was not considered to meet this exclusion criterion.  Participants 
were eligible regardless of whether they were in receipt of antidepressant 
medication or had received psychological therapy in the past. 
6.3.3 Participant identification and recruitment 
The main recruitment method was through searches of General Practice 
records, conducted by Practice staff.  All Practices who were able to access the 
University of Exeter’s Mood Disorders Centre (MDC) Accessing Evidence-
Based Psychological Therapies (AccEPT) Clinic (those within the National 
Health Service Northern, Eastern and Western Devon Clinical Commissioning 
Group) were eligible to participate. 
It was anticipated that at least six Practices would undertake four searches over 
a ten month period, yielding a total of at least 24 searches.  This was based on 
other trials of depression (Kuyken, Hayes, Barrett et al., 2015; Richards et al., 
2013; Wiles et al., 2013) which indicated that each search of an average size 
Practice should yield approximately 37 potentially eligible participants. 
Record searches were limited to patients aged ≥18 and seen within the past 
three months for depression.  The resulting names were screened by the GP 
with whom the patient was registered for any patients known to meet exclusion 
criteria or for whom the GP considered the trial unsuitable.  The remaining 
patients were sent invitations to participate by Practice staff. 
Adverts were also placed on the websites of the University of Exeter Medical 
School and AccEPT Clinic; leaflets and flyers were placed in the waiting rooms 
of consenting Devon General Practices; an email invitation was circulated to 
former MDC participants who had consented to such contact.  All invitations and 
adverts included a ‘study summary sheet’ and ‘permission to contact form’ 
(Appendix VIII). 
 




6.3.4 Screening and baseline 
All people who returned their ‘permission to contact form’ were telephoned to 
assess possible eligibility using a standard two-question case-finding instrument 
for depression (Whooley, Avins, Miranda et al., 1997).  Baseline interviews were 
arranged with potentially eligible and willing participants, who were sent a 
confirmation letter and full participant information leaflet (Appendix VIII).  
Baseline interviews were held at University of Exeter premises or the 
participant’s home, depending on participant preference.  At interview, the study 
was explained in full and eligibility assessed according to the Mini-Cog (Borson 
et al., 2000) and standard clinical interview (Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders, Clinical Trials Version (First, Williams, Spitzer et 
al., 2007)) (SCID).  If eligible and once fully informed, participants were asked to 
complete a consent form (Appendix VIII) and entered into the trial.  Ineligible 
participants were returned to the care of their GP. 
6.3.5 Randomisation, allocation concealment and blinding 
Participants were allocated in a 1:1 ratio to Morita Therapy plus TAU or TAU 
alone, stratified according to their symptom severity on the nine item version of 
the Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer and Williams, 
2001), specifically whether they scored <19 or ≥19, given that a score of 19 is 
the median score of depressed participants in previous research (Rhodes et al., 
2014; Richards et al., 2013).  To maximise the likelihood of balance in the 
stratification variable across the two arms, allocation was minimised.  To ensure 
allocation concealment, randomisation was undertaken through the use of an 
externally administered, password-protected randomisation website 
independently developed and maintained by the Exeter Clinical Trials Unit 
(https://www.exeter.ac.uk/ctu/). 
The study researchers were not blinded to group allocation due to the resource 
limitations of a PhD: HVRS (PhD candidate), who was responsible for 
randomising participants, informing them of the outcome and passing the details 
of participants randomised to Morita Therapy to the AccEPT Clinic, was also, by 
necessity, responsible for collecting follow-up data and conducting qualitative 




interviews with Morita Therapy participants.  Baseline and follow-up data were 
self-reported; all research measures were applied equally to both groups.   
6.3.6 Action upon randomisation 
Upon randomisation, the study researchers wrote to the participant and their GP 
to inform them of their allocation.  For participants randomised to Morita 
Therapy plus TAU, a ‘Morita Therapy Information Sheet’ summarising the 
approach, developed during the intervention optimisation study (see Chapter 
Five) was included; and the study researchers securely and separately emailed 
a password-protected ‘Clinical Information Form’ (anonymised description of 
participants’ depressive symptoms and other relevant clinical information) and 
‘Patient Details Form’ (participant demographics) to the AccEPT Clinic 
(Appendix VIII). 
6.3.7 Trial interventions 
Morita Therapy plus treatment as usual 
Participants allocated to Morita Therapy plus TAU were asked not to engage in 
other formal courses of psychological therapy during the course of their 
treatment.  Otherwise, these participants were free to access any other usual 
care and medication in liaison with their GP. 
Morita Therapy consisted of eight to twelve one hour face-to-face weekly 
sessions delivered at the University of Exeter’s MDC AccEPT clinic 
(http://www.exeter.ac.uk/mooddisorders/acceptclinic/) by two professionally 
accredited research therapists experienced in both the delivery of complex 
psychological interventions and adopting different modes of treatment, including 
experimental treatments.  Therapists were trained in Morita Therapy over 6 
months; training included background reading, attending presentations, 
involvement in the development of the therapy protocol (see Chapter Five), and 
practical training led by DAR (primary supervisor), a clinically qualified 
academic and ten-year member of the Japanese Society for Morita Therapy.  
Practical training was experiential: role plays, diary examples, additional reading 
and peer support as per the tailored therapist training programme (see Chapter 




Five; Appendix VI).  Therapists were not accredited in Morita Therapy as there 
is no Morita Therapy accreditation process either within the UK or Japan. 
Therapists followed the UK Morita Therapy outpatient protocol developed during 
the intervention optimisation study (see Chapter Five; Appendix IV).  DAR 
provided fortnightly supervision of cases together with advice and support.  A 
qualitative checklist highlighting the key components of Morita Therapy, and key 
discussions to be held in facilitating patients’ engagement with the treatment 
phases, was used as an aide memoir to structure supervision discussions and 
the assessment of adherence and fidelity (Appendix IX).  With the patient’s 
consent, all therapy sessions were audio recorded.  The first two recordings for 
each therapist were used to confirm their adherence to the therapy protocol and 
a further 10%, stratified by length of time in treatment, were used to evaluate 
fidelity to the protocol, which informed therapist supervision.  
During therapy, patients progressed through four phases of rest and increasing 
action-taking in order to address fatigue, expand peripheral attention and move 
from a mood-oriented to purpose- and action-oriented lifestyle.  Therapists 
aided patients in re-appraising their symptoms as part of the natural ecology of 
human experience; recognising the vicious cycle of symptom aggravation 
created by fixation on symptoms, contradictions between the ‘real’ and ‘ideal’, 
and attempts to fight or control otherwise inevitable emotions; and moving from 
a position of preoccupation with symptoms to acceptance of spontaneous 
affective experiences.  Therapists continually reinforced the patient’s shift from 
self-reflection towards a focus on constructive action and the external 
environment.  Patients completed daily diaries in which therapists commented 
to increase communication and the opportunity for therapeutic reinforcement. 
Treatment as usual alone 
TAU alone was selected as the trial comparator as a reflection of the 
comparator which would be selected for a fully-powered RCT, in which the key 
interest would be whether Morita Therapy plus TAU has superior or equivalent 
effectiveness to current clinical practice in the UK, in which people have access 
to GP care and a range of other treatments.  Thus, a large scale RCT would be 
a pragmatic trial embedded within the healthcare environment in which Morita 




Therapy would be delivered, seeking to establish whether Morita Therapy could 
be useful in addition to the options currently available to depressed patients in 
the UK.  
Thus, in this study, ‘treatment as usual’ was operationalised by making no 
specific patient-level recommendation or requirement to alter the usual 
treatment received by depressed patients in the UK, and no restrictions were 
placed on the treatment options available to these participants.  GPs were free 
to treat and refer participants as would be their normal practice and participants 
were free to access any other care and services, including formal courses of 
psychological therapy such as Cognitive Behavioural Therapy.   
All participants, irrespective of their allocation, were free to choose whether they 
took antidepressant medication.  The treatments received in the course of 
participants’ treatment as usual were recorded at follow-up. 
6.3.8 Outcomes 
Given this was a feasibility study with a range of aims, there was no single 
primary outcome measure.  Rather, a variety of data were collected at baseline 
and four months post-randomisation: severity of depressive symptoms (PHQ-9 
(Kroenke et al., 2001)); severity of generalised anxiety symptoms (seven item 
Generalised Anxiety Disorder questionnaire: GAD-7 (Spitzer, Kroenke, Williams 
et al., 2006)); quality of life (Short Form 36 Health Survey Questionnaire: SF-36 
(Ware, Kosinski, Dewey et al., 2000); Work and Social Adjustment Scale: 
WSAS (Mundt, Marks, Shear et al., 2002)).   
Given Morita Therapy does not directly target symptom reduction but rather is 
intended to help patients reduce engagement in the vicious cycle and move 
towards a positon of acceptance and increased functioning in spite of 
symptoms, participants’ attitudes (including fixation on symptoms, avoidance of 
and attempts to control symptoms, and judgement towards symptoms and self) 
were measured using a questionnaire developed for measuring Morita Therapy-
specific outcomes (Morita Attitudinal Scale for Arugamama: MASA (Richards, 
Mullan, Ishiyama et al., 2011)). 




Data were collected on the flow of participants through the trial.  For Morita 
Therapy participants, therapists also informed the study researchers of the 
number of therapy sessions attended and reason for ending treatment.  An 
economic evaluation was not conducted as part of this study, although at follow-
up methods for collecting data on participants’ use of health and social care 
services as used in recent mental health trials (Rhodes et al., 2014) were 
incorporated (establishing the rates and nature of hospital visits; use of 
community, social and complementary services; use of psychotropic medication 
since baseline) in order to characterise treatment as usual and thus inform 
future calculations of the costs of each arm for a large-scale RCT. 
At four months post-randomisation, it was anticipated that treatment for Morita 
Therapy participants would be complete.  Follow-ups were held at University of 
Exeter premises or the participant’s home, depending on participant preference.  
The option of completing follow-up questionnaires via post or email was 
provided to participants who were unable or unwilling to complete a face-to-face 
interview. 
6.4 Semi-structured Interviews 
Semi-structured interviews were embedded in the pilot trial to explore 
participants’ and therapists’ views on the acceptability of Morita Therapy. 
6.4.1 Sample and setting 
All participants who were allocated to Morita Therapy plus TAU, and the two 
therapists providing Morita Therapy during the study, were invited to a post-
treatment semi-structured interview.  Participant interviews were held at 
University of Exeter premises or the participant’s home, depending on 
participant preference; therapist interviews at the AccEPT Clinic. 
6.4.2 Recruitment 
The purpose and content of the interview was explained to participants in the 
participant information leaflet, and their consent to participate was determined 
at baseline.  Therapists were sent an interviewee information leaflet explaining 
the interview prior to a pre-trial meeting at which their consent to participate was 




established.  Upon completion of Morita Therapy (delivery, for therapists), 
consenting participants were contacted to establish whether they were still 
willing to be interviewed, remind them of what would be involved and answer 
any questions.  For willing participants, an interview was arranged no sooner 
than 48 hours later and a confirmation letter was sent explaining the opportunity 
to rearrange or cancel the interview at any time. 
6.4.3 Interview process and questions 
Semi-structured interviews were undertaken to allow participants to describe 
their views of Morita Therapy, following topic guides developed for participants 
and therapists (Appendix IX).  Individual responses were also probed to 
investigate participants’ meanings, enabling both the exploration of participants’ 
views on pre-defined topics of interest and the elicitation of participants’ own 
themes (Taylor, 2011).  Interviews were audio-recorded with participants’ 
consent. 
Topic guides 
Topic guides were established on the basis of recent mental health trials 
addressing similar research questions (Hill et al., 2014; Rhodes et al., 2014; 
Richards et al., 2013) (which ask about views and experiences of treatment, 
barriers to and impact of treatment), Morita Therapy literature and the 
intervention optimisation study findings (Chapter Five).  Questions were 
designed to explore participants’ views and experiences of the underlying 
principles and concepts of Morita Therapy; its implementation, process, 
mechanisms and impact.  Following the first three participant interviews, the 
participant topic guide was amended to include additional questions based on 
the views already elicited.   
In exploring responses, views and experiences of the defining features of Morita 
Therapy in practice, such as the four phases and daily diaries, were explored in 
particular.  In addition, probe areas included elements of therapy which had 
presented as confusing or challenging during the optimisation study, such as 
rest, positive reinterpretation, normalisation, Fumon (inattention to symptoms), 
acceptance, provision of rationale, expectations of treatment and the extent to 




which Morita Therapy met these (for participants); how user-friendly and helpful 
the therapy protocol was, ways in which the protocol could be improved, and 
views on using the protocol as part of training new therapists (for therapists). 
Questions on the feasibility and appropriateness of the trial procedures were 
included to explore procedures that facilitated the efficient running of the trial 
and any considered problematic, with the particular aim of identifying any issues 
requiring resolution before proceeding to a large-scale trial.  Finally, participants 
were invited to share any views not already discussed. 
Field notes 
The interviewer (HVRS) made field notes during each interview and 
summarised these at interview completion (see Appendix X for an example).  
Field notes were used to help inform changes to the patient topic guide (see 
above), to facilitate the selection of interviews for analysis (section 6.6.2) and 
alongside transcripts during qualitative analysis. 
6.5 Data management 
6.5.1 Quantitative data management 
All data were double-data entered into Excel v.14 (Office, undated) and merged 
into one Excel database.  Inaccuracies were resolved through reference to 
original data sources (i.e. participant files).  Treatment adherence data were 
analysed within Excel.  Recruitment, retention, baseline and outcome data were 
imported into and analysed in STATA v.14 (StataCorp, 2015).  Following 
published guidance (Ware, Kosinski, Bjorner et al., 2008), Physical and Mental 
Health Component Scores were calculated from raw scores on the SF-36.  
Variables were cleaned by generating descriptive statistics and frequency data. 
6.5.2 Qualitative data management 
With participants’ permission, interviews were recorded and transcribed 
verbatim by the study researchers and a specialist in qualitative research.  
Transcribers were briefed by the study researchers and used a common 
template for transcription (Appendix X).  Transcripts were checked for 




consistency of style and accuracy.  NVivo10 (QSR International, undated) was 
used to organise the data and help ensure a systematic analysis. 
6.6 Analysis 
There were three strands of analysis: quantitative, qualitative and mixed 
methods. First, quantitative trial data and qualitative interview data were 
analysed separately.  Next, quantitative and qualitative data were integrated in 
a mixed methods analysis (Creswell and Plano Clark, 2007). 
6.6.1 Quantitative analysis 
Recruitment, retention, treatment adherence and estimates of the participant-
related data were analysed to inform the feasibility of and sample size 
calculation for a fully-powered trial. 
Underpinning principles 
All analyses were undertaken on an intention to treat basis i.e. all participants 
were analysed, in their allocated arms.  Emphasis was on quantification and 
estimation rather than hypothesis testing.  Missing data were not imputed, 
although outcome data that were missing in each arm and the reasons for 
missing data were reported.  CONSORT guidelines, including the pilot and 
feasibility extension (Eldridge, Chan, Campbell et al., 2016), were followed in 
reporting all data. 
Recruitment and retention 
Count data, expressed as a percentage of both the total number of potential 
participants invited and in relation to the preceding step in recruitment, were 
used to quantify the flow of the participants through the trial.  Margins of error 
were estimated for each parameter.  For each arm, the number of participants 
who withdrew, could not be contacted or did not provide follow-up data for 
another reason were quantified; data were expressed as a percentage of the 
total number of participants in each arm. 
 





Descriptive statistics were calculated to describe participants’ baseline 
demographic and clinical characteristics.  Frequency and percentage 
information were calculated from categorical data on participants’ gender, ethnic 
origin, level of education, marital status, history of depression, thresholds met 
on the PHQ-9 and GAD-7, secondary SCID diagnoses, current antidepressant 
use and previous psychotherapy or counselling.  Means and standard 
deviations were calculated to describe continuous data on participants’ age, 
number of children, PHQ-9 and GAD-7 total scores. 
Receipt of the intervention  
Descriptive statistics were used to describe the number of Morita Therapy 
sessions attended by participants allocated to Morita Therapy plus TAU.  The 
percentage of participants who adhered to a per-protocol dose of Morita 
Therapy (≥5 sessions), completed treatment, withdrew from treatment and 
ended treatment for other reasons were calculated.  For participants who 
withdrew from treatment, the reasons for withdrawal reported to the study team 
by the therapist were categorised and reported as the percentage of 
participants who withdrew due to patient preference, time or personal 
circumstances, moving away, the patient feeling ready to end treatment, and 
enactment of the ‘did not attend’ (DNA) protocol. 
Outcomes 
To measure the variance in participant outcomes, estimates were made of the 
standard deviation around the mean PHQ-9, GAD-7, SF-36, WSAS and MASA 
scores at baseline and four months for both groups.  The correlation between 
participants’ scores on these measures at baseline and four months was 
estimated, to refine the sample size calculation for a fully-powered trial.  
Although insufficiently powered to make inferential statements on between (or 
within) group differences and as such no p values were calculated, the 
observed differences between Morita Therapy plus TAU and TAU alone on the 
mean changes in these measures from baseline to four month follow-up, and 
the 95% confidence intervals around these figures, were also calculated.  




Descriptive statistics related to treatment response were also generated to 
describe the number and percentage of participants in each arm who 
demonstrated a ≥50% reduction in score from baseline to follow-up and/or a 
follow-up score <10 on the PHQ-9 and GAD-7 (a score of 10 representing 
moderate depression and moderate anxiety on the PHQ-9 and GAD-7 
respectively (Kroenke et al., 2001; Spitzer et al., 2006)).   
Economic data 
Descriptive statistics were used to describe the use of health services since 
baseline assessment for participants in each arm. 
6.6.2 Qualitative analysis 
The qualitative data from the semi-structured interviews were analysed to 
explore the acceptability of Morita Therapy to participants and therapists. 
Analytic sample 
The number of therapist interviews to be analysed was limited by the number of 
therapists delivering Morita Therapy within the trial.  It was anticipated that a 
subset of 18 participant interviews would be sampled for analysis.  The size of 
this sample was guided by the purpose of the study and the concepts of 
sampling adequacy and data saturation (as discussed in Chapter Five) (Bowen, 
2008; Glaser and Strauss, 1967; Mason, 2010), including the findings of Guest 
et al. (2006) which suggested that an analysis of twelve interviews could 
provide a thorough picture of participants’ views of Morita Therapy.  In addition, 
an estimation was informed by the heterogeneity of the population, and the 
number of selection criteria to be applied to/sub-groups to be included in the 
sample, alongside resource constraints (Ritchie et al., 2013). 
The sample was selected in order to achieve maximum variation according to 
criteria deemed important in addressing the research questions (Bryman, 2016).  
Thus, through utilising a combination of probability and purposive sampling 
orientations within a strategy suited to mixed methods research, the aim was to 
both capture symbolic representation and a breadth of information by including 
all key manifestations of these criteria, and explore the depth and diversity of 




views within each manifestation of the criteria (Ritchie et al., 2013; Teddlie and 
Yu, 2007).  These criteria were participants’ adherence to treatment, in order to 
facilitate the mixed methods analysis (section 6.5.3), and whether or not 
participants’ demonstrated a response to treatment (defined as a follow-up 
PHQ-9 score <10), given the potential for participants’ views of Morita Therapy 
to be confounded by the degree to which their symptoms improved.  The 
objective was to include a quota of three participants within each category/cell 
contained in this sampling matrix (Table 14). 
Table 14. Proposed sampling matrix 
  Adherence to treatment 
  Withdrew ˂ 5 
sessions 









Yes n=3 n=3 n=3 
No n=3 n=3 n=3 
 
Framework 
Interviews and field notes were analysed by HVRS using Framework analysis 
(Ritchie et al., 2013) to allow for the combination of inductive and deductive 
approaches in the development of analytic categories.  HVRS achieved 
familiarisation with the data through reading transcripts and developed an initial 
thematic framework as preliminary analysis was undertaken and subsequently 
as batches of transcriptions were analysed, iteratively combining the topic guide 
and the overall impression of the narratives in context.  Using this framework, 
transcripts were coded at the level of individual participants (by HVRS, with a 
subset double-coded by JF (second supervisor)) and then analysed thematically 
across the whole dataset as well as in the context of each participant’s interview 
using a constant comparison approach (Thorne, 2000), whereby each piece of 
data (e.g. one statement or one theme) was compared with others for 
similarities and differences (Miles et al., 2014). 
Data were then charted in analytic/framework matrices which summarised 
participants’ views on each theme/constituent theme to allow within and across 




case analyses and the exploration of relationships between themes, completed 
by HVRS in discussion with JF; throughout the analytic process data were 
abstracted and interpreted by HVRS in discussion with JF and with the aid of 
thematic maps to make sense of participants’ perspectives, understand and 
structure the relationships between themes, and conceptualise the overall 
picture of participants’ views and experiences of Morita Therapy (Braun and 
Clarke, 2006; Miles and Huberman, 1994; Ritchie et al., 2013; Spencer et al., 
2014).  Appendix X provides examples of the analytic process.  As explanations 
were formulated in this way, negative cases were explored and explanations of 
variance provided (Dingwall et al., 1998), thus ensuring all observations 
relevant to the research question were incorporated.  Data collection and 
analysis were iterative: HVRS’s interviewing style was amended to respond to 
emerging themes and explore deviant cases further in subsequent interviews as 
appropriate. 
In preparation for the mixed methods analysis, the final qualitative analysis was 
used to develop typologies of different views on the acceptability of Morita 
Therapy; original transcripts and the framework matrices informed the 
development of mini-summaries of each participant’s views of Morita Therapy. 
6.6.3 Mixed methods analysis 
Mixed methods analysis integrating qualitative and quantitative data was 
undertaken to explore how data on the acceptability of Morita Therapy relates to 
and explains treatment adherence.  Three forms of joint display were used, as 
developed from methods summarised by Creswell and Plano Clark (2007): 
(1) Joint typologies/ statistics display 
This technique was driven by the qualitative data to explore how treatment 
adherence varies for participants whose views on the acceptability of Morita 
Therapy were organised into different typologies.  Thus, typologies of 
participants’ different views and experiences of Morita Therapy were developed 
from the qualitative data, along two continuums representing the acceptability of 
the principles and process of therapy.  For each typology, data were presented 
on the number of treatment sessions attended for each participant to whom the 




typology applied and as a mean number of sessions for all participants within 
that typology.  Alongside this, data on therapist fidelity to the therapy protocol 
(assessed as detailed in section 6.3.7) were also presented where the 
qualitative data suggested challenges or confusions related to particular 
sections of the protocol or phases of therapy, such as participants’ 
understanding of the rest phase.  This allowed the exploration of whether issues 
with the acceptability of Morita Therapy related to the treatment itself or the 
therapists’ delivery of treatment, and thus aided the identification of any ‘fatal 
flaws’ (O'Cathain, Hoddinott, Lewin et al., 2015) of Morita Therapy requiring 
refinement in the future. 
(2) Joint categories/ themes display 
This technique was driven by the quantitative data to explore views of Morita 
Therapy across participants with various degrees of treatment adherence.  
Thus, categories of participants were identified by their degree of treatment 
adherence (whether they attended <5 or ≥5 treatment sessions) and reason for 
ending treatment (withdrawal or treatment completed).  For each category, 
summaries of participants’ views were presented according to the themes 
identified in the qualitative analysis, allowing the exploration of similar and 
different views on acceptability within and between these categories. 
(3) Case-oriented merged analysis display 
Data on participants’ views on acceptability and the number of treatment 
sessions they attended were integrated in a case-oriented display organised 
according to the quantitative data.  Thus, cases (individual participants) were 
positioned on a scale of treatment adherence from one to twelve sessions 
attended and presented alongside participant quotations and mini-summaries 
developed from the qualitative data to illustrate each participant’s main views on 
the acceptability of Morita Therapy.  These qualitative data were reviewed for 
similarities and differences across the number of sessions attended. 
To provide further context and enable the exploration of how the data also 
related to quantitative treatment outcomes, participants’ reasons for withdrawing 
from treatment and whether or not they demonstrated a response to treatment 




(defined as a PHQ-9 <10 at follow-up) were also presented within these 
displays and discussed within the analysis.   
6.7 Ethical issues 
This study was conducted in such a way as to protect the human rights and 
dignity of the participants, as reflected in the Helsinki Declaration (World 
Medical Association, 2001).  The study received ethical approval from the 
National Research Ethics Service South West – Frenchay (reference 
15/SW/0103) and governance assurance from the National Health Service 
Research and Development Directorate (reference CG/JL) (Appendix IX), and 
was approved by the University of Exeter Medical School following independent 
peer review. 
Participants did not receive any financial inducement to participate.  Good 
Clinical Practice Guidelines, data protection and freedom of information acts 
were conformed to.  All data were stored securely and anonymised wherever 
possible.  All identifiable participant information was stored separately to 
questionnaire data which were coded by trial ID number only.  No published 
material will contain identifiable participant information.  
6.7.1 Informed consent and withdrawal 
The study researchers were fully trained and supervised by senior academic 
and clinically qualified staff.  All information leaflets and consent forms were 
produced using the current Health Research Authority’s online guidance for 
writing such documents (http://www.hra.nhs.uk/resources/before-you-
apply/consent-and-participation/consent-and-participant-information/), and were 
based on similar materials used in other mental health trials as informed by 
Patient and Public Involvement.  
Informed consent was determined by a two phase process.  Potential 
participants received a ‘study summary sheet’ and a form on which to complete 
their contact details and confirm their permission for a researcher to contact 
them.  Those who returned this form were telephoned to assess their potential 
eligibility and answer any questions.  For those who were eligible and willing, a 
participant information leaflet was sent and a baseline interview arranged at 




least 48 hours later, to allow the participant time to reflect on their decision to 
participate and change their mind if they so wished.  Full informed consent was 
only obtained at this interview where the information leaflet was fully explained 
and the opportunity to ask questions given.  
Consent to participate in the qualitative interview was optional; participants 
could participate in the pilot RCT only.  The purpose and content of the 
interview was explained in the participant information leaflet (or interviewee 
information sheet, for therapists), and it was noted that a decision not to be 
interviewed would not affect participation in the trial.  At baseline interview (for 
participants) and the pre-trial meeting (for therapists), any questions were 
answered, the opportunity to stop and/or withdraw from the interview at any 
time explained, and steps to maintain confidentiality clarified.  Willing 
participants were asked to indicate their decision on the consent from.  Consent 
for audio recording of the interview and/or therapy sessions was also optional. 
Informed consent was treated as an ongoing process whereby participants were 
free to withdraw their consent to participate at any time; communication and 
recording systems to enable such wishes to be monitored and acted upon were 
set up.  When obtaining consent, participants were advised of this fact and that 
they may be asked to give a reason for their withdrawal but would not have to 
provide one.  Participants allocated to Morita Therapy plus TAU could withdraw 
from therapy and continue their involvement in the trial through participation in 
the follow-up and qualitative interview if they so wished.  
Should it have come to our attention that a participant lost capacity to consent 
during the study according to the Mental Capacity Act 2005 (Department of 
Health, 2005), the participant would have been withdrawn from the study as per 
information provided to participants in the participant information leaflet.  Within 
this leaflet, participants were also informed that if they should withdraw or be 
withdrawn from the study, any data already provided would be retained to be 
used confidentially in relation to the purpose for which consent was sought. 
 
 




6.7.2 Risks and benefits 
No treatment was withheld from participants taking part in this study.  All 
participants remained under the care of their GP and had access to primary 
care services in the usual way.  Participants allocated to TAU alone were 
returned to the care of their GP with no restrictions placed on treatment options.  
Participants allocated to Morita Therapy plus TAU were asked not to engage in 
other formal courses of psychological therapy during their treatment, as it is not 
considered good practice to engage in different psychological therapies 
concurrently.  Should these participants have wished to engage in psychological 
therapy elsewhere, a discussion would have been held with their therapist to 
establish which therapy option was in the participant’s best interests. 
Participants allocated to Morita Therapy plus TAU took part in an alternative 
therapeutic approach to psychopathology which is practiced in Japan and 
somewhat elsewhere.  Morita Therapy has been practiced since the 1920s and 
is not known to be associated with any risks to patients.  It is possible that 
participation in therapy focused on psychopathology may cause distress to 
some participants, however participants in the Morita Therapy arm received an 
intensive level of monitoring so that any worsening or at suicidal risk could be 
identified and directed to appropriate care.  Similarly, any impact of potentially 
distressing questions within the assessment and outcome measures could be 
addressed by following protocols for responding to risk and directing 
participants to appropriate care.  Additionally, any serious adverse events 
reported to a therapist or researcher which were thought to be treatment related 
(see Appendix IX for reporting form) would have been reported to the trial 
sponsor, Research Ethics Committee and independent oversight clinician 
(section 6.10). 
The patient information leaflet explained that participants allocated to Morita 
Therapy plus TAU would no longer be offered such therapy once they had 
received a full ‘dose’ (up to twelve sessions), but would be referred back to their 
GP with whom they could consider access to other treatments.  Participants 
were reminded of these factors throughout the study. 




The University of Exeter has insurance to cover the potential legal liability for 
any harm to participants arising from the management of this study.  Potential 
participants were also provided with information about the possible benefits and 
risks of taking part in the trial in the participant information leaflet, and given the 
opportunity to discuss this issue with the study researchers before consenting.  
Should any new information have come to light which may have affected 
participants’ willingness to participate in the study, they would have been 
informed of this in writing. 
6.7.3 Managing risk of suicide 
Inherent in the nature of the population under scrutiny is the risk of suicide.  
Good clinical practice was followed in monitoring for suicide risk during all 
appointments, and it was explained to participants that their GP or specialist 
would be contacted if deemed necessary in line with our risk protocol (Appendix 
IX).  If an acute risk was present, advice was sought from the participant’s GP 
(or the duty GP) immediately and/or locally established suicide management 
plans were followed.  All clinicians and researchers were familiar with 
established risk protocols used in previous research trials and/or within the 
AccEPT Clinic, specifically trained in risk assessment and supervised by 
experienced clinicians.  Systems were set up to ensure that senior academic 
and clinically qualified staff were notified in the event of a risk to a participant’s 
safety. 
6.8 Patient and public involvement 
The patient materials were developed on the basis of both consultation with a 
Public and Patient Involvement (PPI) Expert and similar materials used in other 
mental health trials which had received feedback from PPI groups such as the 
NIHR Collaboration for Leadership in Applied Health Research and Care, South 
West Peninsula (PenCLAHRC) (http://clahrc-peninsula.nihr.ac.uk/) PPI Group 
(PenPIG).  This feedback helped to ensure that this study respected the rights, 
safety and dignity of participants.  Ensuring that the research materials were 
sensitive and consistent with the views of people with depression also 
potentially aided participant recruitment and participants’ engagement in and 
openness during interviews. 




Following completion of the study, a former trial participant expressed interest in 
supporting the dissemination of study results and future research into Morita 
Therapy in a PPI capacity.  Thus, to ensure that the study results reached 
former participants and people with mental health issues in a way that is 
meaningful and accessible, this PPI representative has been consulted on the 
development of a summary sheet explaining the results of the study and their 
implications in lay terms.  This summary sheet has been sent to consenting 
former participants, and to the AccEPT Clinic Lived Experience Group to be 
further disseminated to patients and the public as they see fit, using their own 
conference and group meetings.  This PPI representative has also consented to 
be involved in the further dissemination of study results to patients and the 
public at relevant conferences.  National good practice guidance for researchers 
on public involvement in research and the paying of representatives 
(http://clahrc-peninsula.nihr.ac.uk/) has been, and will continue to be, followed 
where relevant. 
6.9 Dissemination protocol 
In addition to the dissemination of results to participants and the public detailed 
above, and dissemination within this thesis, the intention is to publish results in 
peer reviewed scientific journals.  Authors will be those considered to have 
made a substantive intellectual contribution to the study.  The main output from 
this study is the information required to design and seek funding to conduct a 
definitive trial of Morita Therapy.  Thus, the long term aim is to contribute to 
national guidelines for the treatment of depression and anxiety. 
The investigators and relevant authorities have access to the trial dataset.  
Furthermore, anonymised research data and outputs will be stored in the 
University of Exeter’s Open Research Exeter repository 
(https://ore.exeter.ac.uk/repository/) in order to facilitate open access to, and the 
impact of, this research. 
6.10 Study set up and management 
HVRS (PhD candidate) was the Chief Investigator, responsible for the study 
design, set-up and management.  In tasks relating to participant recruitment, 




collection of follow-up data, interview transcription and data entry, HVRS was 
assisted by a professional training year student on a twelve month placement 
with the study team (together with HVRS referred to as ‘the study researchers’).  
Trial conduct was discussed between HVRS and supervisors at monthly 
supervision meetings.  An AccEPT Clinic Protocol detailing the administrative 
and research procedures to be followed was developed by HVRS, disseminated 
to AccEPT Clinic staff and discussed during a pre-trial meeting.  HVRS handled 
all research-related queries and was in regular communication with AccEPT 
Clinic staff. 
Although the convention of a formal Data Monitoring and Ethics Committee was 
not considered appropriate for the scale of this study, an independent clinician 
acted in this capacity to review any serious adverse events thought to be 
treatment related, and any substantive protocol amendments.  Any such 
amendments would have been communicated to the relevant authorities as 
deemed necessary. 
6.10.1 Execution dates 
The preparatory period started in October 2014.  Recruitment ran from October 
2015 for approximately eleven months.  Follow-up and qualitative data were 
collected from January 2016 to January 2017.  Data analysis was conducted 
from February 2017 for five months.  The study protocol paper (Sugg et al., 
2016) was published following submission in December 2015. 
6.11 Chapter summary 
This chapter has presented the design, methods and procedures of the mixed 
methods feasibility study undertaken to prepare for a fully-powered RCT of 
Morita Therapy plus TAU compared with TAU alone for the treatment of 
depression and anxiety in adults in the UK.  Study results are described in 
Chapter Seven.
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CHAPTER SEVEN.  MIXED METHODS FEASIBILITY STUDY: RESULTS 
This chapter presents the results of the mixed methods feasibility study, 
incorporating a pilot randomised controlled trial (RCT) and embedded 
qualitative interviews, undertaken to prepare for the design and conduct of a 
fully-powered RCT of Morita Therapy plus treatment as usual (TAU) versus 
TAU alone, or to determine that such a trial is not appropriate and/or feasible.  
This chapter describes the results obtained in response to each of the seven 
research questions: 
1. What proportion of participants approached to take part in the trial will agree 
to do so? 
2. What proportion of participants who agree to take part in the trial will remain 
in the trial at four month follow-up? 
3. What proportion of participants who agree to take part in Morita Therapy will 
adhere to a pre-defined per-protocol dose of Morita Therapy? 
4. What is the variance in participant outcomes following Morita Therapy plus 
TAU and TAU alone, and how do they correlate with participants’ baseline 
scores? 
5. What are the estimated between-group differences (and 95% confidence 
intervals) in participant outcomes following Morita Therapy plus TAU and 
TAU alone? 
6. How acceptable is Morita Therapy to participants and therapists?  
7. How do participants’ views about Morita Therapy relate to the variability in 
the number of treatment sessions they attend? 
Chapter structure 
This chapter is divided into four parts.  Part one, the quantitative analysis of the 
pilot RCT data, describes the findings regarding questions one to five.  Part two, 
the qualitative analysis of the embedded qualitative interviews, describes the 
findings regarding question six.  Part three, the mixed methods analysis 
integrating data from the pilot RCT and embedded qualitative interviews, 
describes the findings regarding question seven.  Part four summarises the key 
findings in relation to each research question. 
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CHAPTER SEVEN.  PART ONE. 
Results of the quantitative analysis of pilot RCT data 
This part of Chapter Seven is organised into five main sections: participant flow 
and retention (7.1.1); baseline characteristics (7.1.2); receipt of Morita Therapy 
(7.1.3); treatment outcomes (7.1.4); economic data (7.1.5).  
7.1.1 Participant flow and retention 
The CONSORT (Eldridge et al., 2016) flow chart for the feasibility study is 
presented in Figure 13, overleaf. 
Recruitment 
Within an eleven month period between October 2015 and September 2016, 68 
participants were randomised into the trial (Figure 12): 34 (50%) to Morita 
Therapy; 34 (50%) to treatment as usual (TAU). 
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Figure 13. Feasibility study CONSORT diagram 
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As a variety of recruitment sources were utilised (see Chapter Six) and all are 
presented together in the CONSORT flow chart, Table 15 is provided to show 
the flow of participants through the trial for each recruitment source separately. 
Table 15. Participant flow according to recruitment source 
Recruitment 
source 
Number of patients (% of total n) Randomisation 
rate (as % of 













GP invite 90 
(61.6) 











13 (8.9) 13 (9.3) 10 (11.8) 9 (13.2) 69.2 
Website 
advert 
3 (2.1) 3 (2.1) 2 (2.4) 1 (1.5) 33.3 
Word of 
mouth 
9 (6.2) 9 (6.4) 9 (10.6) 8 (11.8) 88.9 
Unknown 6 (4.1) 0 (0.0) 0 (0.0) 0 (0.0) 0.0 
Notes: percentages may not always total 100 due to rounding. 
The most successful method of recruitment in terms of randomisation rate was 
word of mouth, with 88.9% (8/9) of participants opting in via this method being 
randomised.  The majority of potential participants opting into the study were 
recruited via GP record search (n=90, 61.6%; Table 15).  Prior to the participant 
recruitment period, six General Practices were recruited to undertake four 
record searches over the course of the recruitment period.  One Practice 
subsequently declined participation due to lack of time; one Practice declined to 
undertake the third and fourth searches due to the low numbers of potentially 
eligible patients previously identified.  Thus, four Practices undertook four 
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searches during the recruitment period (in October 2015, January 2016, April 
2016 and June 2016), and one Practice undertook two.  Due to below-target 
recruitment rates to date (Figure 12), an additional two Practices were recruited 
in January 2016, and undertook three searches each; one further Practice was 
recruited in April 2016 and undertook two searches.  Thus, a total of 27 record 
searches were conducted by Practices across the whole recruitment period.  
These yielded a total number of 959 potentially eligible participants and, 
following exclusions by GPs based on the study criteria and their clinical 
discretion (n=269, 28%; Table 16), study invitations were sent to 690 patients. 
Table 16. Participants excluded from invitation by GPs 
Reason for exclusion Number of patients excluded (%) 
(n=269) 
Current psychological therapy 111 (41.3) 
Substance dependence 19 (7.1) 
Not depressed 17 (6.3) 
Acutely suicidal 13 (4.8) 
Bipolar disorder or psychotic symptoms 9 (3.3) 
Cognitively impaired 7 (2.6) 
Other 78 (29.0) 
Unknown 15 (5.6) 
Notes: percentages may not always total 100 due to rounding. 
Over the recruitment period, 146 patients opted into the trial, i.e. completed and 
returned a ‘permission to contact form’ to the study team.  Of those, 4.1% 
(6/146) could not be contacted for telephone screen.  Of those contacted for 
telephone screen (140/146; 95.9%), 39.3% (55/140) were excluded at this stage 
(Table 17, overleaf).  Baseline interviews were conducted with 85 participants 
(58.2% of those who opted in (85/146); 60.7% of those assessed at telephone 
screen (85/140)).  Of those who attended baseline interview, 20% (17/85) were 
excluded at this stage (Table 17, overleaf).  In total, 46.6% of those who opted 
into the study (68/146) were randomised into the trial. 
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 N patients excluded 
(%) 
 (n=55) (n=17) 
Met study exclusion criteria 24 (43.6) 15 (88.2) 
     Current/ planned psychological therapy 13 (23.6) 0 (0.0) 
     Not depressed 10 (18.2) 9 (52.9) 
     Bipolar disorder/ mania 1 (1.8) 3 (17.6) 
     Substance dependence 0 (0.0) 1 (5.9) 
     Acutely suicidal 0 (0.0) 1 (5.9) 
     Psychotic symptoms 0 (0.0) 1 (5.9) 
Declined to proceed 26 (47.3) 2 (11.8) 
     Time commitment 9 (16.4) 0 (0.0) 
     Unable/ unwilling to travel for therapy appointments 5 (9.1) 0 (0.0) 
     Too anxious to participate 4 (7.3) 0 (0.0) 
     Personal circumstances 3 (5.5) 0 (0.0) 
     Unwilling to be randomised 2 (3.6) 0 (0.0) 
     Did not consider self eligible 1 (1.8) 0 (0.0) 
     Moving away 1 (1.8) 0 (0.0) 
     Undisclosed 1 (1.8)  
     Unwilling to consent to all clauses 0 (0.0) 1 (5.9) 
     Unwilling to complete paperwork 0 (0.0) 1 (5.9) 
Did not attend/ unable to arrange baseline interview 5 (9.1) N/A 
Notes: percentages may not always total 100 due to rounding. 
The 690 study invitations sent to potentially eligible participants identified via 
GP record search translated to 35 participants randomised into the trial, at a 
rate of 5.1% of those invited, with 33 of those randomised recruited from 
alternative sources (see Table 15).  The proportion of patients invited via GP 
record search who opted into the study by returning their permission to contact 
form was 13.0% (90/690). 
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Based on the 95% confidence interval for the recruitment rate of participants 
recruited via GP record search only, it is estimated that in a future trial the 
proportion of patients invited via GP record search who are randomised into the 
trial would be between 3.4% and 6.6%; the proportion invited who return a 
permission form would be between 10.5% and 15.5%. 
Retention 
Four month follow-up data were collected from January 2016 to January 2017 
inclusive.  The retention rate was 94% (64/68). 
The retention rate was 97% (33/34) in the Morita Therapy arm and 91% (31/34) 
in TAU.  Several participants randomised to TAU expressed some 
disappointment at the time of their allocation.  In the Morita Therapy arm, one 
participant was lost to follow-up as they could not be contacted; in TAU, two 
participants were lost to follow-up as they could not be contacted and one 
participant withdrew from the study on the basis that they had not received 
active treatment.  An additional TAU participant, after attending follow-up, 
revoked consent for their data to be included in the trial.  Thus, whilst they are 
included within the CONSORT figures, their data have not been included the 
analysis of baseline characteristics or treatment outcomes. 
The option of completing follow-up questionnaires via post or email rather than 
during face-to-face interview was used by 21.2% (7/33) of those retained in the 
Morita Therapy arm and 38.7% (12/31) in TAU.  As such, not all follow-up data 
were collected at precisely four months post-baseline assessment.  The 
average length of time between baseline assessment and completion of follow-
up data for all participants was 4.3 months (range 3.8-6.1), or 18.5 weeks.  The 
range in the intervention and control groups was 3.8-6.1 months and 4.0-5.6 
months respectively.  All but one of the participants in the Morita Therapy arm 
(33/34, 97%) ended treatment prior to providing follow-up data; this participant 
provided follow-up data between therapy sessions ten and eleven. 
From the 95% confidence interval around the retention rate, it can be inferred 
that in a future trial the proportion of randomised participants who would 
complete a four month follow-up would be between 88.3% and 99.7%. 
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7.1.2 Baseline characteristics 
At baseline, the mean age was 49.2 years (SD 15.2) (Table 18).  The majority 
of participants were female (n=41, 61%), White British (n=61, 91%) and married 
or cohabiting (n=39, 58%).  A small minority had no qualifications (n=5, 7.5%), 
19% (n=13) were qualified at GCSE or O Level, 22% (n=15) post GCSE or O 
Level, 28% (n=19) at undergraduate level and 22% (n=15) at postgraduate 
level.  At baseline, 60% of participants (n=40) were taking antidepressant 
medication.  The majority had previously experienced psychotherapy (n=49, 
73%) and/or counselling (n=29, 43%), the most common form being Cognitive 
Behavioural Therapy (n=41, 61%). 
The mean PHQ-9 score at baseline was 16.8 (SD 4.6): 31% (n=21) met the cut-
off for moderate depression, 37% (n=25) for moderately severe depression and 
27% (n=18) for severe depression.  The majority had experienced at least one 
previous episode of depression (n=54, 81%), with the mean age of depressive 
onset 27.1 years (SD 17.6) and mean length of current depressive episode 21.3 
months (SD 32.4).  The majority (n=49, 73%) had a secondary SCID diagnosis 
of a current anxiety disorder, the most common being generalised anxiety 
disorder (n=30, 45%).  The mean GAD-7 score at baseline was 12.7 (SD 4.4): 
15% (n=10) met the cut-off for mild anxiety, 42% (n=28) for moderate anxiety 
and 39% (n=26) for severe anxiety. 









Gender    
     Female 22 (64.7) 19 (57.6) 41 (61.2) 
     Male 12 (35.3) 14 (42.4) 26 (38.8) 
Age (years)    
     Mean (SD) 49.8 (14.8)  48.6 (15.9) 49.2 (15.2) 
Ethic origin    
     White British 31 (91.2) 30 (90.9) 61 (91.0) 
Continued overleaf 
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     White other 2 (5.9) 0 (0.0) 2 (3.0) 
     Mixed other 0 (0.0) 2 (6.1) 2 (3.0) 
     Asian Indian 0 (0.0) 1 (3.0) 1 (1.5) 
     Asian other 1 (2.9) 0 (0.0) 1 (1.5) 
Education    
     No qualifications 3 (8.8) 2 (6.1) 5 (7.5) 
     GCSE or O Level 7 (20.6) 6 (18.2) 13 (19.4) 
     Post GCSE or O Level 7 (20.6) 8 (24.2) 15 (22.4) 
     Undergraduate degree 9 (26.5) 10 (30.3) 19 (28.4) 
     Postgraduate qualification or higher 8 (23.5) 7 (21.2) 15 (22.4) 
Marital status    
     Married or cohabiting 23 (67.6) 16 (48.5) 39 (58.2) 
Number of children    
      Mean (SD) 1 (1) 1 (1) 1 (1) 
History of depression    
    One or more previous episodes 29 (85.3) 25 (75.8) 54 (80.6) 
     Age of onset (mean (SD)) 28.9 (17.8) 25.2 (17.4) 27.1 (17.6) 
     Duration of current episode in months     
         (mean (SD)) 
13.1 (12.8) 30.3 (43.8) 21.3 (32.4) 
PHQ-9 (depression) score    
     Mean (SD) 17.4 (4.7) 16.1 (4.5) 16.8 (4.6) 
PHQ-9 depression threshold met    
     Mild (scored 5-9) 0 (0.0) 3 (9.1) 3 (4.5) 
     Moderate (scored 10-14) 9 (26.5) 12 (36.4) 21 (31.3) 
     Moderately severe (scored 15-19) 14 (41.2) 11 (33.3) 25 (37.3) 
     Severe (scored 20-27) 11 (32.4) 7 (21.2) 18 (26.9) 
GAD-7 (anxiety) score    
     Mean (SD) 13.3 (4.8) 12.2 (4.0) 12.7 (4.4) 
GAD-7 anxiety threshold met    
     Non-clinical (scored <5) 2 (5.9) 1 (3.0) 3 (4.5) 
     Mild (scored 5-9) 4 (11.8) 6 (18.2) 10 (14.9) 
     Moderate (scored 10-14) 13 (38.2) 15 (45.5) 28 (41.8) 
     Severe (scored 15-21) 15 (44.1) 11 (33.3) 26 (38.8) 
Continued overleaf 
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Secondary SCID diagnoses (current)    
     Any anxiety disorder 21 (61.8) 28 (84.8) 49 (73.1) 
     Generalised anxiety disorder 13 (38.2) 17 (51.5) 30 (44.8) 
     Social phobia 5 (14.7) 11 (33.3) 16 (23.9) 
     Panic disorder with agoraphobia 6 (17.6) 8 (24.2) 14 (20.9) 
     Panic disorder without agoraphobia 7 (20.6) 3 (12.6) 10 (14.9) 
     Post-traumatic stress disorder 3 (8.8) 7 (21.2) 10 (14.9) 
     Obsessive Compulsive Disorder 2 (5.9) 5 (15.2) 7 (10.4) 
     Specific phobia 1 (2.9) 4 (12.1) 5 (7.5) 
     Agoraphobia without panic disorder 1 (2.9) 1 (3.0) 2 (3.0) 
Antidepressant treatment    
     Currently prescribed antidepressants 20 (58.8) 20 (60.6) 40 (59.7) 
Previous psychotherapy/ counselling 
(at least one course of) 
   
     Any psychotherapy (not including     
         counselling) 
23 (67.6) 26 (78.8) 49 (73.1) 
     Cognitive Behavioural Therapy 20 (58.8) 21 (63.6) 41 (61.2) 
     Mindfulness-based Cognitive Therapy 8 (23.5) 6 (18.2) 14 (20.9) 
     Behavioural Activation 1 (2.9) 3 (9.1) 4 (6.0) 
     Eye Movement Desensitization and      
          Reprocessing 
2 (5.9) 2 (6.1) 4 (6.0) 
     Counselling 15 (44.1) 14 (42.4) 29 (43.3) 
     Other psychotherapy 9 (26.5) 10 (30.3) 19 (28.4) 
Notes: data are number (%) unless stated otherwise; SD=standard deviation; SCID=Structured 
Clinical Interview for DSM-IV-TR Axis I Disorders; PHQ-9=Patient Health Questionnaire 9; 
GAD-7=Generalised Anxiety Disorder Questionnaire 7; percentages may not always total 100 
due to rounding; *34 participants were randomised into treatment as usual, with 33 participants’ 
characteristics included due to one participant revoking consent to include data. 
7.1.3 Receipt of Morita Therapy 
No participants in the intervention group declined to start Morita Therapy and 
70.6% (n=24) adhered to a per-protocol minimum dose (≥five sessions, 
corresponding to 40% of the maximum available twelve sessions).  The mean 
number of sessions attended for all participants was 7.7 (range 1-14; SD 4.0); 
the mean number attended for those who did and did not adhere to the 
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minimum dose was 9.8 (range 5-14; SD 2.5) and 2.6 (range 1-4; SD 1.0) 
respectively.  All but one participant ended treatment before providing follow-up 
data. 
Overall, 18 participants (52.9%) completed treatment at the social reintegration 
(final) phase, having completed between eight and fourteen sessions (mean 
10.9 sessions; SD 1.6); 15 (44.1%) ended treatment prior to the point at which 
their therapist believed they were ready to do so (categorised as ‘withdrew’), the 
majority of whom did so during the rest (first) phase (n=10; 66.7%).  The 
therapist ended treatment early, following six sessions, for the remaining 
participant (n=1; 2.9%) due to pain interfering with their ability to engage in 
treatment. 
Of those who withdrew (Table 19, overleaf), one participant (2.9%) was 
discharged following two sessions due to missing multiple sessions, as per the 
DNA protocol, and could not be contacted to determine a reason.  Nine 
participants (26.5%) withdrew having completed less than five sessions; the 
reasons provided may be categorised as patient preference (55.6%; coded red); 
time or personal circumstances (33.3%; coded yellow); moving away (11.1%; 
coded blue).  Five participants withdrew after attending five or more sessions, 
due to patient preference (40%); time or personal circumstances (20%); and the 
patient feeling ready to end treatment prior to the point at which their therapist 
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Table 19. Point of and reason for withdrawal from Morita Therapy 
No. 
sessions 
Reason for withdrawal (as reported to research team by therapist) Latest 
phase of 
treatment 




None provided, ‘Did Not Attend’ protocol enacted 
Patient did not consider the therapy suited to them or to their liking 
Patient felt unable to provide the necessary time and investment 
Patient described needing more intensive support with increased anxiety triggered by threatening neighbour 
3 
Patient felt unable to provide the necessary level of personal commitment at this time 
Patient did not consider the therapy suited to them 
Patient described difficulties with rest and diary completion 
4 
Patient felt they were making little progress and found some of the process difficult to understand 
Patient moved away 
5 
Patient felt they were not in the right place to continue therapy given their separation from their partner Light 
activities (2) Patient found rest difficult, had little support from their partner and felt they were avoiding something terrible 
7 
Patient described mood deterioration and difficulty with diary completion Heavy 
activities (3) Patient felt ready to end treatment 
8 Patient felt ready to end treatment 
Light 
activities (2) 
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7.1.4 Treatment outcomes 
Variability in outcomes 
The standard deviations around mean scores on the PHQ-9, GAD-7, Work and 
Social Adjustment Scale (WSAS), Morita Attitudinal Scale for Arugamama 
(MASA), and physical and mental component scales (PCS, MCS) of the SF-36, 
and their 95% confidence intervals, at baseline and four month follow-up, are 
provided in Table 20, overleaf.  The pooled standard deviation (SD) around the 
mean PHQ-9 score at baseline was 4.6; equivalent figures for the intervention 
and control groups were 4.7 and 4.5 respectively.  At follow-up, the pooled SD 
around the mean PHQ-9 score was 6.4; equivalent figures for the intervention 
and control groups were 6.5 and 5.7 respectively.   
The 95% confidence intervals indicate that, in a future trial, the pooled SD 
around the mean PHQ-9 score at baseline would be between 3.9 and 5.6 (from 
3.8 to 6.2 and from 3.6 to 6.0 for the intervention and control groups 
respectively); at follow-up, between 5.5 and 7.8 (from 5.2 to 8.6 and from 4.6 to 
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Table 20. Variability in outcomes at baseline and four month follow-up 
 Morita Therapy Treatment as usual All participants 
Outcome n Mean SD 95% CI n Mean SD 95% CI n Mean SD 95% CI 
PHQ-9 baseline 34 17.4 4.7 3.8 to 6.2 33 16.1 4.5 3.6 to 6.0 67 16.8 4.6 3.9 to 5.6 
PHQ-9 4 months 33 8.4 6.5 5.2 to 8.6 30 12.4 5.7 4.6 to 7.7 63 10.3 6.4 5.5 to 7.8 
GAD-7 baseline 34 13.3 4.8 3.9 to 6.4 33 12.2 4.0 3.2 to 5.3 67 12.7 4.4 3.8 to 5.3 
GAD-7 4 months 32 6.8 5.2 4.2 to 7.0 30 8.7 4.7 3.7 to 6.3 62 7.7 5.0 4.3 to 6.1 
WSAS baseline 34 22.7 7.9 6.3 to 10.3 33 22.1 7.4 6.0 to 9.8 67 22.4 7.6 6.5 to 9.2 
WSAS  4 months 32 13.5 11.0 8.9 to 14.7 30 18.0 9.4 7.5 to 12.7 62 15.7 10.5 8.9 to 12.7 
MASA baseline 34 80.7 29.3 23.6 to 38.5 33 72.7 23.0 18.5 to 30.5 67 76.8 26.5 22.6 to 31.9 
MASA 4 months 32 114.4 40.3 32.3 to 53.6 30 91.8 27.7 22.1 to 37.3 62 103.5 36.3 30.9 to 44.2 
SF-36 PCS 
baseline 
34 49.6 12.3 10.0 to 16.2 33 52.2 10.6 8.5 to 14.0 67 50.9 11.5 9.8 to 13.9 
SF-36 PCS 4 
months 
33 47.9 13.0 10.5 to 17.2 30 51.1 10.8 8.6 to 14.5 63 49.4 12.0 10.2 to 14.6 
SF-36 MCS 
baseline 
34 25.0 8.8 7.1 to 11.6 33 23.8 6.6 5.3 to 8.7 67 24.4 7.8 6.6 to 9.3 
SF-36 MCS 4 
months 
33 39.8 11.9 9.6 to 15.7 30 30.1 11.0 8.8 to 14.8 63 35.2 12.4 10.5 to 15.0 
Notes: SD=standard deviation of the mean; 95% CI = 95% confidence intervals around the standard deviation; PHQ-9=Patient Health Questionnaire 9; 
GAD-7=Generalised Anxiety Disorder Questionnaire 7; WSAS=Work and Social Adjustment Scale; MASA=Morita Attitudinal Scale for Arugamama; SF-
36= Short Form 36 Health Survey Questionnaire; PCS=Physical Component Scale; MCS=Mental Component Scale
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Correlation between baseline and four month scores 
The size of the correlations between Morita Therapy participants’ PHQ-9, GAD-
7, WSAS, MASA and MCS scores at baseline and follow-up were all in the 
medium range (Spearman’s Rho ranging from 0.37 to 0.45), with the PCS 
correlation in the large range (Spearman’s Rho 0.78), according to commonly 
used guidelines (Cohen, 1988).  For TAU, the equivalent correlations were in 
the large range (Spearman’s Rho ranging from 0.51 to 0.76), with the exception 
of the MCS, which was in the medium range (Spearman’s Rho 0.39).  The 95% 
confidence intervals associated with each correlation are provided (Table 21). 
Table 21. Correlation between participant scores at baseline and four months 
Association Participants n Rho 95% CIs p 
PHQ-9 at 
baseline and 4 
months 
All 63 0.42 0.19 to 0.61 <0.001 
Morita Therapy 33 0.37 0.04 to 0.64 0.032 
Treatment as usual 30 0.71 0.47 to 0.85 <0.001 
GAD-7 at 
baseline and 4 
months 
All 62 0.40 0.17 to 0.59 0.001 
Morita Therapy 32 0.40 0.07 to 0.66 0.022 
Treatment as usual 30 0.51 0.18 to 0.73 0.004 
WSAS at 
baseline and 4 
months 
All 62 0.52 0.31 to 0.68 <0.001 
Morita Therapy 32 0.45 0.12 to 0.69 0.009 
Treatment as usual 30 0.76 0.55 to 0.88 <0.001 
MASA at 
baseline and 4 
months 
All 62 0.58 0.39 to 0.73 <0.001 
Morita Therapy 32 0.45 0.12 to 0.69 0.009 
Treatment as usual 30 0.73 0.50 to 0.86 <0.001 
SF-36 PCS at 
baseline and 4 
months 
All 63 0.68 0.52 to 0.80 <0.001 
Morita Therapy 33 0.78 0.59 to 0.88 <0.001 
Treatment as usual 30 0.58 0.27 to 0.78 <0.001 
SF-36 MCS at 
baseline and 4 
months 
All 63 0.42 0.20 to 0.61 <0.001 
Morita Therapy 33 0.43 0.10 to 0.67 0.012 
Treatment as usual 30 0.39 0.04 to 0.66 0.033 
Notes: Rho=Spearman’s Rho; 95% CI = 95% confidence intervals around Spearman’s Rho; 
PHQ-9=Patient Health Questionnaire 9; GAD-7=Generalised Anxiety Disorder Questionnaire 7; 
WSAS=Work and Social Adjustment Scale; MASA=Morita Attitudinal Scale for Arugamama; SF-
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36= Short Form 36 Health Survey Questionnaire; PCS=Physical Component Scale; 
MCS=Mental Component Scale 
Between-group differences in treatment outcomes 
This study was not powered to detect clinically meaningful differences in the 
effectiveness of Morita Therapy versus TAU, thus inferential statements on 
between (or within) group differences cannot be made and no p-values have 
been calculated. 
From baseline to follow-up, participants’ symptoms of depression (PHQ-9) 
reduced in both groups: averaging 9.0 points (SD 5.9) in the Morita Therapy 
arm; 3.5 points (SD 4.2) in TAU.  Participants’ symptoms of anxiety (GAD-7) 
also reduced in both groups: averaging 6.6 points (SD 5.6) in the Morita 
Therapy arm; 3.3 points (SD 4.3) in TAU.  Participants’ acceptance and 
allowance of symptoms (MASA) increased in both groups: averaging 32.8 
points (SD 37.2) in the Morita Therapy arm; 17.2 points (SD 19.0) in TAU. 
Participants’ impairment in functioning (WSAS) reduced in both groups: 
averaging 9.7 points (SD 9.7) in the Morita Therapy arm; 3.7 points (SD 6.5) in 
TAU (Mundt et al., 2002).  Participants’ mental health function (MCS) increased 
in both groups: averaging 14.7 points (SD 11.3) in the Morita Therapy arm; 6.6 
points (SD 10.3) in TAU (Ware et al., 2008).  From baseline to follow-up, 
participants’ physical health function (PCS) did not improve: the mean reduction 
was 1.7 points (SD 6.6) in the Morita Therapy arm; 2.2 points (SD 8.5) in TAU. 
Depressive symptoms (PHQ-9) reduced from baseline to follow-up by an 
average of 5.5 points more in the Morita Therapy group compared to TAU.  
Based on this sample and the confidence intervals provided (Table 22, 
overleaf), it can be said with 95% certainty that the true mean reduction in 
participants’ PHQ-9 scores from baseline to four month follow-up will be greater 
following Morita Therapy, compared to TAU, by somewhere between 2.9 and 
8.1 points.  To put these findings in context, the published minimum clinically 
important difference on the PHQ-9 is 2.59 to 5.00 (Löwe, Unützer, Callahan et 
al., 2004). 
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Baseline 4 months 
Change from 
baseline to 4 months 
Between-group 
difference 
n Mean SD n Mean SD n Mean SD Mean 95% CI 
PHQ-9 
All 67 16.8 4.6 63 10.3 6.4 63 -6.3 5.8 
-5.5 -8.1 to -2.9 Morita Therapy 34 17.4 4.7 33 8.4 6.5 33 -9.0 5.9 
Treatment as usual 33 16.1 4.5 30 12.4 5.7 30 -3.5 4.2 
GAD-7 
All 67 12.7 4.4 62 7.7 5.0 62 -5.0 5.2 
-3.3 -5.8 to -0.7 Morita Therapy 34 13.3 4.8 32 6.8 5.2 32 -6.6 5.6 
Treatment as usual 33 12.2 4.0 30 8.7 4.7 30 -3.3 4.3 
WSAS 
All 67 22.4 7.6 62 15.7 10.5 62 -6.8 8.8 
-5.9 -10.1 to -1.7 Morita Therapy 34 22.7 7.9 32 13.5 11.0 32 -9.7 9.7 
Treatment as usual 33 22.1 7.4 30 18.0 9.4 30 -3.7 6.5 
MASA 
All 67 76.8 26.5 62 103.5 36.3 62 25.3 30.6 
15.5 0.4 to 30.7 Morita Therapy 34 80.7 29.3 32 114.4 40.3 32 32.8 37.2 
Treatment as usual 33 72.7 23.0 30 91.8 27.7 30 17.2 19.0 
SF-36 
PCS 
All 67 50.9 11.5 63 49.4 12.0 63 -1.9 7.5 
0.6 -3.2 to 4.4 Morita Therapy 34 49.6 12.3 33 47.9 13.0 33 -1.7 6.6 
Treatment as usual 33 52.2 10.6 30 51.1 10.8 30 -2.2 8.5 
SF-36 
MCS 
All 67 24.4 7.8 63 35.2 12.4 63 10.8 11.5 
8.1 2.7 to 13.6 Morita Therapy 34 25.0 8.8 33 39.8 11.9 33 14.7 11.3 
Treatment as usual 33 23.8 6.6 30 30.1 11.0 30 6.6 10.3 
Notes: SD=standard deviation of the mean; 95% CI = 95% confidence intervals around the mean between-group difference; PHQ-9=Patient Health 
Questionnaire 9; GAD-7=Generalised Anxiety Disorder Questionnaire 7; WSAS=Work and Social Adjustment Scale; MASA=Morita Attitudinal Scale for 
Arugamama; SF-36= Short Form 36 Health Survey Questionnaire; PCS=Physical Component Scale; MCS=Mental Component Scale
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Improvement in depression and anxiety 
Depressive symptoms reduced by 50% or more from baseline to follow-up for 
66.7% (22/33) of Morita Therapy participants and 13.3% (4/30) of TAU 
participants (Table 23).  At follow-up, 66.7% (22/33) of Morita Therapy 
participants scored below the threshold for moderate depression (PHQ-9 <10) 
compared to 30.0% (9/30) in TAU.  Anxiety symptoms reduced by 50% or more 
from baseline to follow-up for 53.1% (17/32) of Morita Therapy participants and 
33.3% (10/30) of TAU participants.  At follow-up, 75.0% (24/33) of Morita 
Therapy participants scored below the threshold for moderate anxiety (GAD-7 
<10) compared to 53.3% (16/30) in TAU. 
Table 23. Treatment response (≥50% reduction in score from baseline to four 
























































































































All 63 26 (41.3) 31 (49.2) 32 (50.8) 
Morita Therapy 33 22 (66.7) 22 (66.7) 23 (69.7) 
TAU 30 4 (13.3) 9 (30.0) 9 (30.0) 
GAD-7 
All 62 27 (43.5) 40 (64.5) 40 (64.5) 
Morita Therapy 32 17 (53.1) 24 (75.0) 24 (75.0) 
TAU 30 10 (33.3) 16 (53.3) 16 (53.3) 
Notes: TAU=treatment as usual; PHQ-9=Patient Health Questionnaire 9; GAD-7=Generalised 
Anxiety Disorder Questionnaire 7 
7.1.5 Economic data 
Participants’ use of health services (in addition to Morita Therapy) since 
baseline assessment is presented in Table 24 (overleaf).  These data were 
collected for exploratory purposes and in order to define TAU, therefore the 
costs associated with these services are not presented. 
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Table 24. Service use at four month follow-up 
Service Participants n % No. contacts Duration of 
contacts 
(minutes) 





Morita Therapy (n=32) 14 43.8     
TAU (n=31) 14 45.2     
Psychological 
therapy 
Morita Therapy (n=32) 0 0.0 - - - - 
TAU (n=31) 5 16.1 5.4 4.4 68.0 47.6 
Counselling Morita Therapy (n=32) 0 0.0 - - - - 
TAU (n=31) 3 9.7 6.3 2.1 60.0 0.0 
Hospital 
admission 
Morita Therapy (n=33) 2 6.1 1.5 0.7   




Morita Therapy (n=32) 9 28.1 2.1 1.5   
TAU (n=31) 9 29.0 2.1 3.0   
A&E attendance Morita Therapy (n=32) 3 9.4 1.0 0.0   
TAU (n=31) 3 9.7 1.3 0.6   
GP appointment Morita Therapy (n=32) 20 62.5 4.8 4.0 12.0 2.4 
TAU (n=31) 17 54.8 2.5 2.0 12.8 6.2 
GP home visit Morita Therapy (n=32) 2 6.3 1.0 0.0 12.5 3.5 
TAU (n=31) 0 0.0 - - - - 
GP telephone 
contact 
Morita Therapy (n=32) 10 31.3 3.5 5.0 6.9 4.5 
TAU (n=31) 5 16.1 2.4 1.7 5.0 3.1 
Practice nurse Morita Therapy (n=32) 7 21.9 3.6 5.3 9.3 6.7 
TAU (n=31) 10 32.3 1.6 1.1 12.0 5.8 
Psychiatrist Morita Therapy (n=32) 0 0.0 - - - - 
TAU (n=31) 1 3.2 12 0.0 50.0 0.0 
Occupational 
therapist 
Morita Therapy (n=32) 2 6.3 2.5 0.7 35.0 35.4 
TAU (n=31) 1 3.2 5.0 0.0 45.0 0.0 
Social worker Morita Therapy (n=32) 1 3.1 5.0 0.0 60.0 0.0 
TAU (n=31) 0 0.0 - - - - 
Advice service Morita Therapy (n=32) 2 6.3 1.0 0.0 75.0 21.2 
TAU (n=31) 1 3.2 1.0 0.0 60.0 0.0 
Helpline Morita Therapy (n=32) 1 3.1 1.0 0.0 60.0 0.0 
TAU (n=31) 2 6.5 25.0 0.0 30.0 0.0 
Chiropractor Morita Therapy (n=32) 5 15.6 3.8 3.0 29.0 17.5 
TAU (n=31) 3 9.7 2.0 1.7 41.7 10.4 
Acupuncture Morita Therapy (n=32) 1 3.1 1.0 0.0 30.0 0.0 
TAU (n=31) 1 3.2 9.0 0.0 60.0 0.0 
Physiotherapist Morita Therapy (n=32) 1 3.1 3.0 0.0 60.0 0.0 
TAU (n=31) 1 3.2 4.0 0.0 60.0 0.0 
Mental Health 
support worker 
Morita Therapy (n=32) 1 3.1 1.0 0.0 60.0 0.0 
TAU (n=31) 1 3.2 6.0 0.0 60.0 0.0 
Notes: SD=standard deviation of the mean; TAU=treatment as usual; A&E=Accident and 
Emergency; GP=General Practitioner 
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Service use was comparable across the two arms with the exception of 
psychological therapy, which was proscribed in the Morita Therapy arm (0% in 
the Morita Therapy arm; 16.1% (n=5) in TAU) and counselling (0% in the Morita 
Therapy arm; 9.7% (n=3) in TAU).  Compared to baseline assessment, 
antidepressant medication use reduced in both groups (58.8% (20/34) to 43.8% 
(14/32) and 60.6% (20/33) to 45.2% (14/31) in the intervention and control 
groups respectively). 
Thus, whilst antidepressant medication use and use of other services is 
comparable across the Morita Therapy and TAU groups, all participants in the 
Morita Therapy group received psychological therapy (i.e. Morita Therapy) 
whereas 8 participants (26%) in the TAU group received either psychological 
therapy or counselling.  This data may be used to inform calculations of the 
Excess Treatment Costs (i.e. the additional costs of providing Morita Therapy in 













CHAPTER SEVEN: MIXED METHODS FEASIBILITY STUDY: RESULTS 
PART TWO: QUALITATIVE RESULTS 
227 
 
CHAPTER SEVEN.  PART TWO. 
Results of the qualitative analysis of embedded qualitative interviews 
This part of Chapter Seven provides the results of the qualitative analysis 
undertaken to answer the question: how acceptable is Morita Therapy to 
participants and therapists?  This part is organised into five main sections: 
participants (7.2.1); the acceptability of Morita Therapy to participants (7.2.2); 
the acceptability of Morita Therapy to therapists (7.2.3); a summary of 
participants’ views on the acceptability of the trial procedures (7.2.4); 
connecting threads across participants’ and therapists’ views of Morita Therapy 
(7.2.5).  
7.2.1 Participants 
Post-treatment qualitative interviews were conducted with consenting Morita 
Therapy participants (n=28/34; 82.4%) and the two therapists who delivered 
Morita Therapy during the pilot trial.  Six Morita Therapy participants did not 
participate in an interview because they either could not be contacted to 
arrange an interview (n=3; 8.8%); declined an interview (n=2; 5.9%) or had 
moved away (n=1; 2.9%).  Interviews lasted between 24 and 93 minutes.  
Data from 16 participant interviews were purposively sampled for analysis.  This 
sample size was constrained by the number of participants meeting criteria for 
each category within the proposed sampling matrix (Table 25 includes the 
available number of participants and number included in the analysis within 
each category). 
Table 25. Final sampling matrix 
  Adherence to treatment 
  Withdrew ˂ 5 
sessions 
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Thus, all participants who withdrew from treatment or completed treatment but 
did not demonstrate a response (i.e. follow-up PHQ-9 score <10) were included 
in the analysis, yielding ten interviews (Table 26, overleaf).  An additional six 
interviews were selected from the 14 available from participants who completed 
treatment and demonstrated a response.  These were selected on the basis of 
additional criteria deemed potentially relevant in forming views of Morita 
Therapy: the presence or not of co-morbid generalised anxiety disorder (three 
participants per quota); participants’ experience or not of Cognitive Behavioural 
Therapy (three per quota); participants’ gender (three per quota) and therapist, 
of the two available (three per quota).  The selection of a specific six 
participants from this category enabled the fulfilment of these criteria.  Thus, the 
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Current co-morbid anxiety conditions 
MT16 Completed  1 Yes M TH01 CBT; Counselling None 
MT33 Completed  1 Yes M TH02 None None 
MT43 Completed  5 Yes F TH02 None GAD; Panic disorder 
MT45 Completed  6 Yes M TH01 CBT GAD; Panic disorder 
MT55 Completed  4 Yes F TH02 CBT None 
MT63 Completed  2 Yes F TH01 Mindfulness GAD; Panic disorder with agoraphobia 
MT58 Completed 18 No F TH01 CBT; Mindfulness GAD 
MT37 
Withdrew  ≥ 
5 
1 Yes F TH01 Counselling GAD; Panic disorder 
MT19 
Withdrew  ≥ 
5 
17 No M TH01 CBT; Counselling None 
MT28 
Withdrew  ≥ 
5 
24 No M TH01 Counselling Panic disorder with agoraphobia; PTSD 
MT51 
Withdrew  ≥ 
5 
17 No M TH02 CBT; Counselling GAD; Panic disorder; Social phobia 
MT15 Withdrew ˂ 5 6 Yes F TH02 CBT; Counselling None 
MT50 Withdrew ˂ 5 9 Yes F TH01 Mindfulness None 
MT54 Withdrew ˂ 5 5 Yes F TH02 CBT; Counselling GAD 
MT17 Withdrew ˂ 5 11 No F TH02 CBT; Mindfulness Panic disorder with agoraphobia 
MT61 Withdrew < 5 12 No M TH02 CBT; Counselling 
Panic disorder with agoraphobia; Social 
phobia; OCD 
Notes: PHQ-9=Patient Health Questionnaire 9; treatment response defined as post-treatment PHQ-9 score <10; CBT=Cognitive Behavioural Therapy; 
GAD=Generalised anxiety disorder; PTSD=post-traumatic stress disorder; OCD=obsessive-compulsive disorder
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7.2.2 The acceptability of Morita Therapy to participants 
Participants’ views relating to the acceptability of Morita Therapy were 
understood within five key themes: (1) the impact of incompatible expectations 
and understandings; (2) identifying with the principles of Morita Therapy: 
receptivity and relevance; (3) approaching and understanding Morita Therapy 
as a process; (4) facilitating the process: (overcoming) challenges and barriers; 
(5) the value and impact of Morita Therapy.  Each theme encompassed a 
number of constituent themes (Figure 14, p.232).  These themes were 
developed in order to explore and explain the relationships between the 
constituent themes and the acceptability of Morita Therapy, within a model of 
how Morita Therapy was experienced by different participants.  Figure 14 
illustrates the relationships (and conflicts) between themes and how these 
shape an overall picture of engagement with, and acceptability and impact of, 
Morita Therapy. 
During analysis it was clear that participants’ views comprised different 
categories which manifested as important in assessing acceptability.  
Particularly salient was the sense that participants’ expectations and 
understandings either facilitated or hindered their engagement with Morita 
Therapy.  To capture this, the first three themes essentially convey different 
typologies of participants’ approaches towards and experiences of treatment.  
Whilst these themes are not mutually exclusive, participants’ accounts typically 
fell within either theme one or themes two and three.  Thus, participants who 
brought expectations of treatment which were inconsistent with Morita Therapy 
generally misunderstood the approach and considered it to be unacceptable 
(theme one), with a failure to both identify with the Morita Therapy principles 
and understand treatment as a process to progress through.  In contrast, those 
whose prior expectations and experiences facilitated their identification with the 
principles (theme two) typically engaged with the approach from the offset, with 
their overwhelmingly positive experiences of treatment tied to their 
understanding of Morita Therapy as a process (theme three) and leading to 
positive accounts of the value and impact of Morita Therapy (theme five). 
Theme four (facilitating the process: (overcoming) challenges and barriers) 
describes the difficulties participants experienced in engaging with Morita 
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Therapy on a practical rather than conceptual level.  Whilst whether such 
difficulties amounted to barriers to continuing treatment was often moderated by 
themes one, two and three (participants with incompatible expectations and 
understandings of treatment were less likely to tolerate such difficulties), this 
theme also captures how for some participants the principles of Morita Therapy 
may be acceptable (i.e. they identify with the principles as per theme two) whilst 
the process of treatment is not.  Thus, the relationship between this theme and 
the preceding themes highlights a key thread throughout participants’ accounts 
and this model of Morita Therapy: the distinction between Morita Therapy in 
principle and practice.  Overall, whilst an ability to identify with the principles 
manifested as highly important in seemingly essentially priming participants for 
the approach, the challenges of translating these principles into a process which 
is feasible to engage with (as per theme four) further shapes the acceptability of 
treatment. 
Thus, these are not five discreet, nor equally weighted, themes.  The themes 
were developed so as to explore and explain the views of participants with 
varying experiences of Morita Therapy in depth.  This model of Morita Therapy 
is therefore not intended to provide a representative account of acceptability 
across the themes: theme one, in which the most negative views are described, 
is dedicated to the accounts of a minority of participants who discontinued 
treatment and were therefore purposively sampled for analysis in order to gain 
insights into any issues with the acceptability of Morita Therapy, thus facilitating 
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Figure 14. Final thematic map (embedded qualitative interviews: participants) 
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Theme one: The impact of incompatible expectations and understandings 
This theme captures a mismatch between Morita Therapy and the expectations 
of and hopes for treatment held by some participants, who were typically either 
seeking a solution for symptoms (constituent theme (a)) or hoping to explore 
and express themselves (constituent theme (b)).  Included are the ways in 
which these preconceptions of treatment can feed participants’ construction of 
rationales for treatment which are inconsistent with Morita Therapy (constituent 
theme (c)).  As such, Morita Therapy fails to achieve its assigned purpose, 
and/or fails to provide participants with the approach they seek.  For these 
participants, Morita Therapy is thus generally not perceived as an acceptable or 
helpful approach.  This theme contrasts with other themes: participants’ 
accounts typically fall either within this theme or themes two, three and five. 
(a) Seeking a solution for symptoms 
Several participants expressed a desire for therapy to “resolve the[ir] problems” 
(MT19) through providing a cure, answers or techniques to remove symptoms. 
People are looking for answers, really… [to] help them to stop these sort 
of thoughts or feelings. (MT61) 
One participant acknowledged the influence of previous treatment experience 
on such expectations, essentially expressing his socialisation into a model of 
using techniques to manage emotions as a barrier to Morita Therapy: 
It might be better off to use Morita for young – for people who are just 
starting out in depression… they haven’t had that NHS kind of – I don’t 
know – bombard them with all these different techniques. (MT51) 
Accordingly, these participants expressed resistance to the underlying premise 
of Morita Therapy to allow unpleasant thoughts and emotions as natural and 
inevitable: their goal was to eliminate the unpleasant: 
It’s like a computer; you would replace the chip, why can’t you do it in 
your head?  It would just make you feel better… Why can’t I be happy all 
the time instead of having one day good, one bad! (MT28) 
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These participants typically appeared to view the therapist as a holder of expert 
knowledge and abilities: someone who should ‘fix’ them or impart powerful 
techniques.  Accordingly, there was an expression of high expectations of 
treatment and a sense of handing responsibility for improvement over to the 
therapist:  
I was just looking for – to be like trained in different techniques that would 
be vastly different to anything I’d ever seen before or experienced.  And it 
would be, sort of, almost ground breaking… [However,] I was almost 
encouraged to come up with [techniques] myself, and I found that I was 
almost thinking, well, you’re the therapist, you’re experienced and you’re 
professional, you should be telling me, not me telling you. (MT51) 
Accordingly, there was often little understanding of how Morita Therapy might 
work, and a sense of little belief that it was the responsibility of the patient to 
know this: 
I don’t know what the idea was, I don’t know whether it was a case of 
trying to find out more about the person on an unconscious level or what.  
I’ve no idea, I’m not a psychiatrist so I don’t know. (MT61) 
Indeed, there was a sense that, particularly as a treatment deriving from a 
different culture, this was a somewhat esoteric approach presumably offering 
something which cannot be understood by the layman: 
From what I understood it was, um, originated out of oriental thinking and 
the way that they approach life is from a left handed point of view… Left 
handed people in the Far East have a completely different way of looking 
at things… I don’t know, it’s a method that’s supposed to help me get 
better but I don’t understand how these things work. (MT19) 
In the context of their expectations of Morita Therapy and hopes for treatment, 
one participant stated: 
There has to be some kind of trance-like therapy that you could put 
somebody in and encourage that sort of regression… [Within remote 
tribes] you’d eat this root and then you’d almost have like an out of body 
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LSD experience and you’d have to really face all of your demons… he 
went through that, yeah, it looked horrible but it sorted him out. (MT51) 
This account demonstrates a desire for a somewhat mystical treatment 
approach which induces an inner revelation with little effort on the part of the 
patient.  As a Japanese approach, the appeal of Morita Therapy appeared 
somewhat shaped by these ‘other culture’ preconceptions which are not 
consistent with the reality of Morita Therapy.  Thus, these participants 
expressed the desire for treatment to provide a (possibly esoteric) solution or 
techniques for eliminating symptoms, and as such they did not identify with the 
premise of Morita Therapy. 
 (b) Exploring and expressing the self 
Several participants expressed hopes and expectations that treatment would 
provide exploration, analysis and discussion of their difficulties, which again 
shaped their views of Morita Therapy, particularly the Fumon technique 
(therapists’ purposive inattention to symptoms). 
I was hoping it was like a situation where I could open myself up… 
analysing why, you know, how I’m feeling…or why you feel bad. (MT61) 
Accordingly, these participants found Fumon uncomfortable, with a sense that 
this stifled their self-expression and the desire for someone to talk to and 
understand them: 
It’s like, talk about it and understand… that’s why I use the Samaritans, 
it’s like they just talk and all my feelings are coming out… I need 
someone to understand what’s in my head. (MT28) 
At times the challenges of Fumon were explicitly shaped by participants’ 
previous treatment experiences, in which the therapist did discuss and analyse 
difficulties: 
I definitely struggled with it because that is the way that it has always 
been done with anyone I’ve ever seen.  And […], I don’t know, I guess 
you’re looking for something to fill that void. (MT51) 
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Indeed, one participant who would have liked to continue counselling but was 
unable to afford it found that this treatment style was unable to provide them 
with the approach they sought, and somewhat hindered their relationship with 
their therapist: 
The relationship between me and [the counsellor] was so important to 
everything, and I don’t know if it was the – if it was [name of therapist] or 
if it was the programme itself, but I just felt like I didn’t click with them... I 
felt like, a bit like they were just saying ‘oh, shut up’… it didn’t give me a 
good feeling about the whole thing. (MT54) 
Fumon was typically referred to in relation to therapists’ diary comments, with 
this creating a sense of dismissal of participants’ diary accounts (“It made it feel 
that it wasn’t important.” (MT19)) and thus feelings of being unable to share in 
the way that they desired: 
I didn’t put down how I was feeling that day, or how the week had been 
going, and that’s ‘cos it wasn’t asked.  Sometimes I feel that issue’s got 
to be talked about, it’s got to be brought out and dealt with. (MT28) 
Thus, participants seeking this exploratory and analytical approach felt 
somewhat “shut down” (MT54) by and disappointed in Morita Therapy. 
(c) Failing at the wrong job: the substitution of rationale 
For participants whose accounts fall within the constituent themes above, there 
was a tendency for the aforementioned expectations of treatment to shape 
misunderstandings of the purpose of Morita Therapy.  In particular, participants 
typically substituted the rationale for rest (which is, primarily, to experience the 
natural ebb and flow of thoughts and emotions) with one more consistent with 
their preconceptions.  For example, a participant who sought techniques and a 
cure expressed the following views of rest: 
I was given very little information and very little in the way of kind of 
techniques and training and then sent out there to be alone with my 
feelings… If it was that easy we’d all just go and lie in a room with the 
lights off and we’d just conquer it that way. (MT51) 
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Indeed, such participants generally viewed all elements of the Morita Therapy 
process (such as phase two light activities) as means to overcome symptoms, 
whether successful or unsuccessful: “It’s brilliant for distraction from flying... the 
colouring really works” (MT58).  Alternatively, one participant, whose 
expectations of treatment focused on in-depth self-analysis, potentially on “an 
unconscious level”, had the following recollections of rest: 
They said that we were gonna sort of analyse your sleeping thing and 
arrange for you to sleep for a certain time… Actually planning something 
like that was really like, well, ‘this isn’t gonna work’. (MT61)  
Thus, participants were assigning a Morita Therapy incongruent purpose to rest; 
the achievement of which rest was not intended or able to fulfil.  In turn, 
participants expressed a sense of “lost faith” (MT51) in treatment.  Running 
through such misunderstandings was also a construction of the concepts and 
process of Morita Therapy as relevant to emotions but not thoughts.  For 
example, in considering the ‘natural ebb and flow’ (which, in Morita Therapy, 
incorporates all internal states) several participants believed this referred only to 
emotions.  Thus, some participants who struggled more with unpleasant 
thoughts considered Morita Therapy somewhat irrelevant to their needs: 
I understood the principle of the emotions flowing and life getting in the 
way and putting the blocks in the way, um, but I just could not feel the 
flow… I’m a logician rather than an emotional person… emotion doesn’t 
take, it doesn’t even get included in the analysis. (MT19) 
Accordingly, some participants experienced ongoing thoughts as a barrier to 
engaging with Morita Therapy: within their misconstrued rationale for rest, these 
participants believed they should be deliberately “switching off” thoughts (MT19) 
in order to experience emotions in the way that they were ‘supposed to’ 
(“sensing emotion on an on-demand basis.” (MT19)): 
I understood that it was for, if emotions came, then if you’re there on your 
own they would come and then you would notice them go.  I found it 
really difficult to allow myself to do it, um, without being distracted by 
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what I should be doing, where I should be doing it, the house is a mess – 
I found it really difficult just to shut off, like, your mundane stuff. (MT58) 
This understanding also was shaped by participants’ hopes for treatment: it was 
typically those who sought to permanently ‘turn off’ unpleasant thoughts and 
“relax” (MT28) who understood rest as a time to do so.  Whilst the idea of this 
appealed to participants, as rest progressed and this assigned objective 
remained unmet, participants experienced an increasing sense of “pressure” to 
achieve the unachievable alongside a sense of both themselves and the 
therapy having “failed” (MT19): 
Trying to wipe them [thoughts] out, it just doesn’t, you can’t, there’s just 
certain things you couldn’t, and the more I tried the more I used to get 
frustrated. (MT28) 
Somewhat ironically, this view tallies with the intended message of the rest 
phase: that emotions and thoughts naturally ebb and flow and cannot be 
controlled by will.  However, for such participants these experiences led to 
frustration as opposed to a lesson learned: their views and understandings of 
Morita Therapy were shaped by their inaccurate and unmet expectations of 
treatment, which ran counter to the principles of the approach. 
Theme two: Identifying with the principles of Morita Therapy: receptivity 
and relevance 
This theme explores how the acceptability of Morita Therapy is linked to 
participants bringing insights, experiences and expectations to treatment which 
facilitate their identification with the Morita Therapy principles, such as the 
underlying premise of accepting unpleasant thoughts and emotions (constituent 
theme (a)) and/or particular elements of treatment (constituent theme (b)).  This 
theme contrasts with theme one (‘the impact of incompatible expectations and 
understandings’), with each theme capturing different ways in which different 
participants embarked upon their journey with Morita Therapy. 
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(a) Readiness to accept 
In recalling what appealed to them about Morita Therapy before treatment, 
many participants expressed a sense of readiness to accept symptoms as part 
of oneself and life; a fundamental principle of Morita Therapy: 
What attracted me was…it was a way of getting back to nature and 
realising that it’s a part of you and part of the human experience, and 
stop catastrophising everything. (MT63) 
Some participants expressed prior understandings that their difficulties could 
not be controlled or removed (“I knew I couldn’t change things” (MT37)), and/or 
came to treatment with experiences and insights which allowed the concept of 
the ebb and flow of thoughts and emotions to resonate with them: 
Learning to accept that those are my difficulties and yes they’ll come and 
go, like they explained it a bit like the weather and kind of storms will 
pass and it sounds quite cliché but that is exactly how I’ve experienced it. 
(MT15) 
In contrast to participants seeking a solution for symptoms (theme one, 
constituent theme (a)), some explicitly noted approaching treatment without an 
expectation of a cure, and described the importance of this in terms of shaping 
their experiences of therapy: 
With the NHS, I felt that I was going to be cured, that was the impression: 
that they were going to cure me.  Well, with this, it teaches you how to 
live with it, which is much more sensible because I came away from the 
NHS feeling a lot worse because I’d failed. (MT55) 
Thus, understandings were often shaped by previous treatment experience, 
typically cognitive behavioural therapy (CBT) and counselling, which 
participants felt through “being focused on your past and trying to stop you 
having these thoughts and feelings” (MT50) had failed to resonate with them: 
CBT focuses on trying to change your way of thinking whilst Morita 
Therapy actually focuses on accepting your feelings and um putting it 
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into perspective and I found that a lot easier to understand and connect 
with. (MT16) 
Similarly, many participants came to treatment with insights into themselves and 
their symptoms which enabled them to easily identify with the concept of the 
‘vicious cycle’ (the exacerbation of symptoms through a fixation on and attempts 
to control or remove them):  “[The vicious cycle is] the really big one for me, 
yeah, because I know I do that.” (MT58).  Again, these understandings were at 
times expressed in relation to other treatment approaches, which some 
participants believed had ‘fed into’ this vicious cycle: 
[Morita Therapy] just reinforced what I’d already sort of hooked onto as a 
major problem for me… [CBT] was sort of feeding my need to fix 
myself… I came away from CBT going ‘I’ve got to stop thinking these 
things, I’ve got to think differently’ and you don’t have that kind of control 
over your thoughts, I don’t think. (MT45) 
Thus, often through an understanding of the role that certain perceptions and 
behaviours play in maintaining their symptoms, these participants were 
equipped to move away from the notion of ‘fixing’ or curing symptoms and 
towards a position of accepting and allowing them, thus engaging with the 
underlying premise of Morita Therapy. 
(b) Attraction to the features of Morita Therapy 
There was a sense from many participants that, aside from the underlying 
premise of acceptance, specific elements of Morita Therapy ‘grabbed’ them 
from the offset and encouraged them to engage with the approach.  Different 
features manifested as salient for different participants.  Often, participants were 
attracted to “the use of the natural world” (MT43).  For some, this appealed in 
the sense of “getting back to nature” (MT63); for others, the appeal was more 
literal, typically shaped by already finding enjoyment in nature: 
I’m very much into the natural world, anyway, ‘cos I’m a gardener, I 
belong to Greenpeace and, so that was not hard to get into. (MT55) 
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For these participants, both understanding human nature in relation to the wider 
natural world and the more literal engagement with nature inherent in Morita 
Therapy were highly valued features.  In contrast, several participants whose 
accounts fell within theme one (‘the impact of incompatible expectations and 
understandings’) found this way of understanding human nature a difficult 
concept to connect with: 
The idea would be to look at the emotion as like a season, but it’s a bit 
easier to kind of sit and go through summer, winter, autumn and spring 
than it is to just sit there and just – and, you know, depression can be 
quite severe… it’s quite difficult to just sit there and believe that you 
could just cope with it like you could do a snowstorm. (MT51) 
This excerpt is illustrative of a major distinction between participants whose 
accounts fall within themes one and two: those whose expectations and 
understandings were incompatible with Morita Therapy struggled to connect 
with the elements of treatment, such as understanding human nature through 
reference to the natural world, in general; whereas others demonstrated a level 
of readiness for Morita Therapy and described the ways in which such elements 
of treatment resonated for them.  Other ways in which the approach appealed to 
participants within this theme included its focus on action-taking, with a sense 
that this sounded helpful and/or complimented participants’ habits: 
Where I’m reasonably sensible with anxiety is I do do things… I won’t 
avoid things… So that’s why I actually – if I was designing a therapy, I 
would probably come up with something similar to Morita. (MT45) 
For some participants, understanding their difficulties as reflections of 
underlying desires (or “goals” (MT16)) was also appealing and pertinent: 
We were just talking about the flip side, which I can really – which I really 
saw… I can remember sitting down when they were talking to me and 
thinking yes, this – I understand what you’re talking about. (MT58) 
Similarly, the concept of working with ‘the authentic self’ was appealing and 
beneficial for several participants: 
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The thought of somebody nurturing you and slowly trying to find what 
things you’re looking for and what your values are and what little things 
you can go and do that are true to your authentic self... That’s what I’ve 
been looking for, for the last twenty years! (MT50) 
Thus, some participants welcomed the holistic focus on activity, values and 
overall objectives, as opposed a narrower symptom-focus.  Overall, different 
elements of Morita Therapy resonated for different participants, attracting them 
to the approach and seemingly facilitating their engagement with treatment. 
Theme three: Approaching and understanding Morita Therapy as a 
process 
This theme captures how participants who found Morita Therapy acceptable 
and beneficial tended to understand the components of treatment as a part of a 
progressive journey.  Broadly speaking, this theme contrasts with theme one 
(‘the impact of incompatible expectations and understandings’) in terms of ‘tools 
for learning versus learning tools’: the acceptability of Morita Therapy was 
linked to participants’ understandings of the treatment components as part of a 
naturally unfolding and experiential process (constituent theme (a)) which 
provided accumulative opportunities for learning and re-focusing attention 
(constituent theme (b)) and for owning responsibility for change (constituent 
theme (c)), as opposed to expecting a somewhat passive receipt of treatment 
and attempting to isolate each treatment component as a potential technique for 
overcoming symptoms (as per theme one). 
(a) Allowing a natural progression 
Many participants spoke of Morita Therapy in terms of providing an experiential 
progression which unfolded naturally and gently.  Within this, participants 
conveyed a sense of helpful balance in the process: the four-phased structure 
and therapist guidance was coupled with an individualised progression and lack 
of directive instructions.  This process enabled participants to gradually and 
safely ‘build up’ themselves and their activity levels: 
It gave you structure and really made it secure, it helped you to build 
your self-confidence up again so for someone like me where my 
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confidence was low, just being able to re-build the confidence levels and 
just being able to um build up on things gradually. (MT16) 
Similarly, several participants referred to the value of Morita Therapy, often in 
comparison to other treatments they had tried, as a natural and gentle process: 
It’s a completely different way from the NHS way, I can tell you that.  It’s 
a gentle way… It was just this brilliant, gradual process, it sort of – the 
first stage broke me down, and then it was re-building me. (MT55) 
Within this, participants appreciated the way in which they were able to take 
small “bite-sized” (MT43) steps during treatment, which felt “doable” (MT43).  
This process was aided by proceeding through the phases at a pace which felt 
natural to them: 
There was no timeframes for me either, it’s just a case of when I thought 
I was ready or when [name of therapist] thought I was ready, then we’d 
go to the next phase, it wasn’t a case of, um, two weeks of this, two 
weeks of that, two weeks of that, it was an open-ended book, so it could 
take as long as it needed. (MT33) 
Thus, participants expressed a sense of the treatment progressing according to 
their individual state, with a nondirective level of therapist guidance which 
enabled “self-realisation” (MT63).  In line with this, some participants highlighted 
the importance of Morita Therapy in providing an experiential, rather than purely 
intellectual, process.  As one participant noted: “the treatment was working 
without me realising” (MT33). 
I’ve been allowed to discover it, guided gently and then I had to discover 
it for myself.  And I think if you find it for yourself, and aren’t following lots 
of instructions, it’s almost like nature teaches you... It’s kind of hit me at a 
bit of a visceral level… Everybody’s told me it’s normal, the counsellor 
told me it was normal, but nobody guided me how to feel it… [Morita 
Therapy] let me feel it and showed me that feeling it was normal. (MT63) 
Coupled with this was a sense that, whilst the precise purpose and process of 
therapy was initially unclear at times, this became more apparent through actual 
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engagement with treatment.  Indeed, some participants acknowledged this as a 
necessary element of treatment in order to allow the learning process to 
naturally unfold in the absence of the imposition of expectations: 
It’s much better that you don’t tell them and then it’s like – well, ‘is this 
supposed to be happening’, and you realise it’s a natural process… It 
was better that I didn’t know what to expect...otherwise you don’t know if 
it’s involuntarily gone into your mind or whether you’re really 
experiencing it.  And I know I was really experiencing it! (MT55) 
Linked to these perceptions was a sense of needing to approach Morita 
Therapy with a degree of open-mindedness: 
I tried to keep an open mind, I mean, obviously, I couldn’t quite see how 
it might work [laughs] um, so I thought I’ll just go with it. (MT43) 
Thus, for many participants, the ability to allow themselves to trust in the 
process and learn from the experiences provided enabled them to receive 
Morita Therapy as a gentle, individualised and, at times, powerful treatment 
approach. 
(b) Methods for transition and learning 
Many participants spoke of Morita Therapy in terms of providing accumulative 
opportunities for learning about human nature and for transitioning from a 
position of fixation on and interference with symptoms (i.e. the vicious cycle) to 
an acceptance of symptoms and external focus of attention.  Key to this was the 
incorporation of methods, such as rest, the diary, and natural world metaphors, 
for learning that “all emotions pass, happy, joy, sad, all those wonderful 
emotions, everything passes” (MT63): 
Being with your thoughts and then learning that thoughts come and go 
and feelings come and go, so they’re not gonna be there forever… You 
relate it to different seasons of the year, and storms come, but they pass, 
and the sea goes calm and all of those sorts of things, you realise that 
happens with you naturally as a human being. (MT50) 
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Similarly, participants found these aspects of treatment helpful as a means of 
highlighting how the vicious cycle manifests for them: 
I remember [rest] and all those thoughts and feelings that kept coming 
and going, and that was a really big moment I think for me, in kind of 
realising how much I do battle with my own feelings. (MT15) 
Participants also described some elements of treatment, such as phase two 
(light activities), as a means of refocusing attention from internal to external 
states: 
The second stage is looking at lighter, repetitive activities, um, and trying 
to focus very much on those activities and you then find yourself looking 
outside rather than looking in… The connection with nature, I think I 
started noticing a lot more, and actually looking out and looking around 
more, and using that as a way to draw myself out of myself. (MT43) 
This facilitation of movement away from the vicious cycle was also expressed in 
relation to Fumon (therapist’s inattention to symptoms): 
What was good about what [therapist] was doing was they would go 
‘Stop’ as soon as I started that conversation, ‘You’re now scratching the 
itch’, you know, ‘Your mind wants to fix it and we’re gonna sit here and fix 
it for half an hour, and fixing it’s the problem, right?’  So they would stop 
me immediately from that, and I did go away from – after a couple of 
sessions, thinking ‘What they’re actually saying is I’m just wasting my 
time’. (MT45) 
Participants also understood the phases of treatment, as well as the diaries, as 
methods for highlighting and enabling action-taking: 
As you went through the phases and actually started to introduce 
different things and get a bit more active in different ways, that all 
helped... I was able to use Morita as a framework to help structure things 
to get me back up, so I could get back into doing job applications. (MT16) 
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When viewed in this way, the components of Morita Therapy as well as the 
overall process were considered largely acceptable, albeit at times somewhat 
challenging: 
Phase One was a long time [laughs]!  But it had to be, it had to be.  But 
yeah, as I say, it worked.  It wasn’t pleasant but when I got to the end of 
it I could see we’d done it…‘cos I learned that you can get through it and 
come out the other side. (MT55) 
Thus, for these participants there was a sense that the elements of Morita 
Therapy were not judged in terms of how enjoyable they were in themselves, 
nor in terms of how successful they were as tools for managing symptoms, but 
in terms of how successful they were in ‘doing their job’ as methods for learning 
and transition; in contrast to theme one (‘the impact of incompatible 
expectations and understandings’), this accurate understanding of the purpose 
of Morita Therapy appeared crucial in relation to participants’ willingness to 
tolerate challenging components of treatment, and how successful participants 
considered Morita Therapy to be. 
(c) Ownership of responsibility: making you think 
In contrast to theme one (‘the impact of incompatible expectations and 
understandings’), which indicated some participants’ desire for a somewhat 
passive role, many participants described the value of Morita Therapy partially 
in terms of the process ‘making them think’.  This was often expressed in 
contrast to participants’ preconceptions and previous treatment experiences, in 
which there was a tendency for abdication of responsibility: 
[My private therapist] was more like getting professional advice as to how 
to deal with the problems, rather than a therapy, as such.  It had become, 
for me, a way of going ‘What do you think I should do?’. (MT63) 
The therapists’ facilitation of participants’ own thinking processes was 
expressed particularly in relation to their provision of diary comments: 
I quite liked it towards the end of the treatment, instead of [therapist’s 
name] making comments they would help me comment on my own 
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thoughts so I can understand, er, how to apply the Morita Therapy… and 
just the way they sometimes wrote questions which was quite useful, so 
like triggers for discussion or triggers for thoughts. (MT16) 
There was thus a welcome sense that, rather than the therapist providing 
answers and imparting knowledge, they instead provided subtle cues and 
suggestions which encouraged participants to take responsibility for their own 
learning and application of the Morita Therapy principles: 
With the use of the diary, it’s just picking out the salient points that are 
making you think… Instead of saying ‘you need to do this’, it’s a case of 
‘there’s your diary from last week, go through – read it back and have a 
look at my comments’, and you start picking up on certain things… [My 
therapist] was allowing me to pick up on very subtle signals, you know, 
so - in trying to do that for myself. (MT33) 
Participants also spoke of the therapist “challenging” them (MT43) in order to 
facilitate a shift in perspective, re-evaluation of themselves and their lives, and a 
sense of self-efficacy. 
I want to walk on my own with Morita in mind, was actually what I said, it 
just came out, which is what I think is really important. (MT63) 
Thus, this ownership of responsibility encouraged by Morita Therapy through 
challenging and making participants think appeared to equip some participants 
to proceed post-treatment with a sense of self-sufficiency. 
Theme four: Facilitating the process: (overcoming) challenges and 
barriers 
This theme presents the difficulties associated with engaging in the phases and 
process of Morita Therapy, including the more practical rather than conceptual 
elements of treatment such as: fear and discomfort (constituent theme (a)), 
needing safety and support from others (constituent theme (b)), needing 
sufficient therapist guidance and reassurance (constituent theme (c)), and the 
burden and commitment of treatment (constituent theme (d)).  Whilst the fear 
and discomfort described by participants related to some unique features of 
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Morita Therapy, the challenges described in other constituent themes, such as 
the time needed to attend appointments, may well apply to many forms of 
psychological therapy. 
Included are the ways in which these difficulties were minimised and managed 
for participants, and the factors which shape whether and how the challenges of 
therapy become barriers to therapy.  This latter issue links closely with the 
expectations and understandings captured in previous themes: participants who 
held incompatible expectations and understandings of treatment (theme one) 
were less likely to tolerate the challenges of treatment than those who identified 
with the principles (theme two) and accurately understood the purpose of the 
treatment components (theme three).  Nonetheless, for a subset of participants 
who did identify strongly with the Morita Therapy principles (as per theme two), 
the challenges of engaging with treatment were such as to warrant their 
discontinuation with treatment.  Thus, the relationship between this theme and 
the preceding themes highlights the distinction throughout participants’ 
accounts between identification with the principles of Morita Therapy and the 
feasibility of engaging with the process of therapy itself. 
 (a) Fear and discomfort 
Participants often spoke of the fears they had held around what elements of 
Morita Therapy would involve, and the discomfort they had experienced when 
engaging with such elements.  This was most significantly expressed in relation 
to rest, and typically connected to participants having avoided their thoughts 
and feelings for some time (often by “keeping busy” (MT17) or “battling negative 
emotion” (MT51)) and/or fearing a reduction in activity levels and thus 
potentially “going backwards” (MT15).  Participants also described the 
experience itself, in terms of being alone with their thoughts and feelings, as 
uncomfortable: 
That first stage of it, I hated… Your thoughts start racing around, the 
sleep doesn’t come and [name of therapist] said, you know, ‘Just go with 
it, let it all come out’, ‘cos before I tried my hardest to block it off.  After 
nine days I thought ‘Oh heck!’.  It was horrible. (MT55) 
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For one participant, the completion of the diary also induced a sense of 
discomfort, in terms of their reluctance to focus attention on themselves: 
The main reason [for discontinuing treatment] was having to write about 
myself, my daily life and my daily routine and stuff.  I don’t even like 
myself, so I’m not really that keen on writing about myself. (MT61) 
Most participants spoke of the challenges of the rest phase.  Whether or not 
these challenges were acceptable to participants, or developed into barriers to 
continuing therapy, was linked to the participant’s expectations, understandings 
and approach to treatment: those who assigned alternative and incorrect 
purposes to rest which it failed to meet (as per theme one) were disinclined to 
tolerate this phase; those who were more open-minded and understood rest as 
a means of learning (as per theme three) tended to persevere with this phase.  
As noted in theme three (‘approaching and understanding Morita Therapy as a 
process’), for participants in the latter category, there was accordingly an 
acknowledgement that rest was a necessary component of treatment, despite 
its challenges: “I think the first phase was the hardest, definitely the hardest, but 
I think that’s the one you’ve got to break through.” (MT31). 
In terms of facilitating the process in light of these challenges, several 
participants spoke of the importance of timetabling in rest periods.  There was 
also a sense from some participants of commitment to the trial and treatment, 
“will power” (MT63) and an unwillingness to “give up at the first hurdle” (MT31), 
which encouraged them to endure these challenges.  Thus, whilst participants 
often spoke of the fear and discomfort they experienced in relation to rest in 
particular, they also suggested some important factors in overcoming these 
challenges. 
(b) Safety and support from others 
Several participants spoke of the importance of feeling safe, supported and 
encouraged by their significant others during Morita Therapy.  This manifested 
particularly in relation to the rest phase, with several participants noting the 
value of including their partner in the therapy session in which rest was 
explained: 
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My husband was really up for it, he was very supportive… If I’d have 
done it on my own I might have given in, perhaps, a few times, but it was 
helpful, I think, including your partner. (MT55) 
Indeed, some participants described a lack of support from significant others or 
“difficulties with their partner” (MT15) as factors in their decision to discontinue 
therapy, indicating that an increased sense of external support might have 
enabled their engagement: “[If] my wife had been around then I would’ve had 
the encouragement to pursue it” (MT19). 
For one participant, the lack of safety and support they felt within several 
relationships led them to discontinue therapy, despite having identified with the 
principles and being keen to engage, highlighting the particular importance of 
creating a safe space for participants to undertake rest and indicating the need 
for a certain degree of stability in participants’ lives to enable their engagement 
with treatment: 
Because of my neighbour who was being threatening and harassing, I 
didn’t feel safe to sit in that environment twenty-four seven… and my 
Mum started drinking terribly badly, so that all got so bad I just thought ‘I 
need to do something quickly with my life’. (MT50) 
One participant also expressed some challenges in terms of explaining Morita 
Therapy to family and colleagues: 
Trying to explain to the Western culture that’s so work focused and so 
structured, that actually it’s – you need to rest, is really – and I think it’s 
contrary to quite a lot of other therapies… I could see [it] would be off-
putting actually just to explain to people what it is that you’re 
doing…generally everyone was really interested, even my mum, who’s 
still a bit ‘Oh I don’t know about these Eastern philosophies!’ (MT43) 
Thus, some concerns around support from others related to the treatment 
having originated from a different culture and a sense of potential judgement, 
particularly around engaging with rest as a notion which runs counter to typical 
Western practices.  Overall, participants indicated the importance of a safe and 
supportive environment for facilitating their engagement in Morita Therapy. 
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(c) Providing guidance and reassurance 
Participants at times recalled discomfort with a lack of clear instruction and 
sufficient reassurance being given around elements of treatment.  This 
manifested particularly in relation to the diary: 
One thing I struggled with was having just a blank canvas in the diary… I 
found it quite hard to understand exactly what was needed. (MT16) 
This discomfort often related to participants’ concerns that they were ‘doing it 
correctly’, indicating a need for the therapist to assuage such fears: 
Because it’s an anxiety and depression thing as well, [say] ‘don’t worry if 
you - don’t think you’re doing it wrong, try not to overthink that and just to 
actually go with it and see what happens, because there’s no wrong or 
right way’. (MT43) 
In the context of therapy sessions feeling somewhat intensive and providing a 
lot of information to digest, participants also spoke of means of and resources 
for facilitating their understanding of the therapy and its requirements: 
What might have helped was if I had taken a note, because it’s a very 
emotional time when you’re having the therapy... I think they gave me a 
handout actually, for the rest phase, and that was really useful. (MT63) 
I quite like the idea that you could, on a more practical basis, that you 
could have copies of the audio.  Because often what you find is you have 
– you go in, and because you’re concentrating so much on what the 
therapist is saying, sometimes you forget little things. (MT50) 
I didn’t want to tell them that I’d zoned out… maybe breaking it down a 
bit and then, I don’t know, asking me for examples or something after 
each [principle]. (MT15) 
Thus, whilst many participants were comfortable with trusting the process and 
allowing the rationale to unfold with time (theme three, constituent theme (a): 
allowing a natural progression), participants also indicated that providing audio-
recordings and handouts, ensuring regular input from the participant within the 
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therapy room, providing a more detailed “framework” (MT17) for diary 
completion and assuring participants that there is no ‘correct’ way of doing this 
were potential ways of minimising any challenges associated with a lack of clear 
guidance and reassurance. 
(d) Burden and commitment 
There was a sense from many participants that Morita Therapy felt onerous and 
required a large commitment.  Some participants spoke of the difficulty of 
attending treatment sessions themselves, and appreciated the therapist’s 
flexibility in accommodating their commitments: 
We were able to adjust times and actually have a fairly regular time, 
which worked most of the time but occasionally it, it had gotten to the 
challenge of trying to work out the best way of meeting up. (MT16) 
At times these types of challenges were expressed in relation to elements of 
treatment, typically rest and the diary, which participants often struggled to “find 
the time” for (MT58/ MT43). 
I’m very lucky that I was retired, um, all the time I was thinking – I was 
trying to think how I would have dealt with it if I was still at work… it 
would be a very hard therapy to roll out from that point of view. (MT63) 
For several participants, this time commitment amongst work and caring 
responsibilities was a key factor in their decision to discontinue therapy, 
regardless of whether they identified with the principles and/or accurately 
understood the purpose of these treatment elements.  Participants who were 
keen to proceed with therapy expressed feelings of “I can’t divide myself in four 
different ways” (MT37) and being unable to “give it the time that it required” 
(MT17), generally suggesting a lack of their own time coupled with an 
understanding that dedicating a significant time to Morita Therapy was the only 
way to engage in it “in a meaningful way” (MT54). 
For participants with incompatible expectations and understandings of treatment 
(theme one) who struggled to understand the purpose of the treatment 
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elements, the requirements of therapy at times created a sense of burden and 
pressure to achieve: 
It’s all the things you have to do that got to me, you know – it was 
pressurising me into doing it, every day you had to remember certain 
things… Then more and more, every week there’s a bit more added and 
that’s when it became too much. (MT28) 
Thus, in the absence of understanding Morita Therapy as a process alongside 
the failure of treatment components to achieve their assigned (incorrect) 
purpose (such as reducing symptoms), participants appeared to consider these 
components as somewhat devoid of meaning and simply extra things which 
they ‘had to do’, creating a sense of pressure to “perform” (MT19) for a therapy 
which was not working for them.  Whilst this sense of pressure was only 
expressed by participants who held incompatible expectations and 
understandings of treatment, the overall commitment required by Morita 
Therapy was a barrier for participants who did and did not identify with the 
principles alike.  
Theme five: The value and impact of Morita Therapy 
This theme captures the ways in which participants identified the value of Morita 
Therapy for them, and the impact treatment had on them and their lives, in 
terms of providing a preferable alternative to other therapies (constituent theme 
(a)), the value of acceptance (constituent theme (b)), transformation from 
dwelling to doing (constituent theme (c)), empowerment and liberation 
(constituent theme (d)) and effect on symptoms and mood (constituent theme 
(e)).  Participants whose accounts fall within theme one (‘the impact of 
incompatible expectations and understandings’) rarely described any benefits of 
treatment, suggesting the impact of Morita Therapy is somewhat contingent 
upon holding compatible expectations and understandings.  It is therefore the 
views of those who identified with the Morita Therapy principles (theme two) 
and/or approached Morita Therapy as a process (theme three), and thus 
proceeded to find Morita Therapy beneficial, which are represented within this 
theme. 
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(a) A preferable alternative 
Participants often made comparisons between Morita Therapy and other 
treatments they had tried, typically describing Morita Therapy as preferable to 
(mindfulness-based) CBT and counselling.  With a sense that Morita Therapy is 
realistic and accepting, participants welcomed a move from “thinking positively” 
towards “accepting that not everything is positive” (MT43) and considered the 
naturalisation of unpleasant experiences “less judgemental and conflicting” than 
CBT (MT17).  Typically, participants contrasted the accepting and allowing 
stance of Morita Therapy with the controlling and combative stance of CBT: 
You just go with the emotions, you know, instead of fighting with it, I think 
with CBT you tend to try and control what you’re doing whereas this was 
totally the opposite way round. (MT33) 
Through taking an experiential approach towards accepting emotions, 
participants expressed a sense of Morita Therapy having made fundamental 
and instinctive changes to their perspective through an internalisation of the 
principles, and (mindfulness-based) CBT, in comparison, being a “tool-kit” 
approach (MT43): 
I’m hoping that I can – not so much manage it better but live with it 
better… CBT managed it and it was very easy to forget… I have done 
other work in the past but this seems to have struck a chord of change 
within, not just a ‘Right, this is a strategy’… That never, ever worked for 
me. It’s something fundamentally, I hope, I feel very optimistic, has 
changed with my acceptance of these feelings. (MT63) 
There was thus a sense that Morita Therapy was a more “holistic” (MT43), in-
depth, pervasive and potentially sustainable and life-changing approach: that 
patients are not “seen as a bunch of symptoms” (MT15) and are offered more 
than “short-term fixes” (MT63): 
This has such a different focus and way of looking at things.  It’s not a 
sticking plaster like CBT, it’s getting more to the root of yourself and 
reconnecting to things… It’s more interesting and engaging. (MT43) 
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It’s more of a philosophy to take you through life, a long term thing. Um, 
and I think that’s where people will benefit from it, whereas some forms 
of therapy are just very intense and just about the there and now, and 
then you have to keep going to get the benefit, whereas this just kind of 
goes with you and grows with you, I guess, over time. (MT50) 
Related to this, participants noted the value of Fumon (therapists’ inattention to 
symptoms) in shifting their attention away from difficulties, in comparison to 
other treatment approaches which explicitly focus discussion on these 
elements: 
It’s a really good thing, [name of therapist] didn’t let me go backwards… 
when I went on [to the past] they changed the subject.  Whereas in the 
NHS one, that’s what they concentrate on. (MT55) 
Accordingly, through the learning they acquired from Morita Therapy, some 
participants reflected on other treatment approaches as potentially unhelpful in 
terms of focusing on symptoms and offering only techniques: “I’ve talked things 
to death and I’ve realised that counselling can become scab picking” (MT63).  
Amongst participants who completed treatment, one exception to this view was 
expressed by the single participant who did not respond to treatment: whilst 
valuing Morita Therapy, this participant also indicated some incompatible 
expectations and understandings in terms of seeking a cure and isolating 
components of therapy as techniques (“[I use] nature more as a tool now” 
(MT58)), and in turn intended to seek further counselling in order to focus on 
overcoming their difficulties and “getting rid of that baggage” (MT58).  This 
exception aside, participants who completed treatment generally valued Morita 
Therapy in comparison to other approaches they had tried. 
 (b) Relinquishing control: the value of acceptance 
The impact of Morita Therapy for participants often centred on their re-
evaluation of emotions and thoughts, leading to an acceptance and allowance 
of both pleasant and unpleasant experiences and a sense of relinquishing 
attempts to control the uncontrollable.  Critical to this attitude was the 
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knowledge, obtained through Morita Therapy, that symptoms ebb and flow and 
pass: 
It’s a therapy that says [your thoughts] can’t be changed and once you 
get to grips with that and learn that they’re just all part and parcel of the 
natural world and they will come and go…you become much more 
comfortable with those difficult times, and actually they go away a lot 
quicker. (MT50) 
Connected to this attitude of acceptance, participants also felt that Morita 
Therapy had normalised emotions as natural phenomena experienced by 
everyone: 
I realised that other people are feeling this as well, even though I can’t 
see it… I’m stopping feeling as if this is just me. It’s normalised. (MT63) 
Similarly, participants felt that Morita Therapy had made all emotions and 
symptoms permissible, demonstrating that it is “okay to be with” them (MT33) 
as opposed to needing to resolve them: 
It’s about giving yourself permission not to treat all the signals that’s 
going on in here as serious and prompt and, you know, needing to be 
dealt with... I don’t need to take the emotion so seriously; the urge to do 
something about it so seriously.  So Morita has reinforced that it’s okay to 
do that. (MT45) 
Participants also often referred to acceptance within the context of nature: 
through either their own (frequently spontaneous) use of natural world 
metaphors for understanding symptoms, or more explicit references to having 
come to view themselves as “part of the circle of life” (MT33).  Often, 
participants expressed an attitude of acceptance in terms of “what will be will 
be” (MT33) and “it’s just how it is” (MT43), demonstrating not only an 
acceptance of thoughts and emotions but a sense of “letting go” (MT45) of 
concern around all aspects of life which they felt they were unable to predict or 
control: 
CHAPTER SEVEN: MIXED METHODS FEASIBILITY STUDY: RESULTS 
PART TWO: QUALITATIVE RESULTS  
257 
 
I don’t worry about things, not anymore... [Name of therapist] has taught 
me to let things go, there’s nothing you can do to change anything, if it’s 
going to happen it will happen, you’ve just got to go with it and take the 
rough with the smooth... realising that has helped me. (MT37) 
As a result of this changed perspective on thoughts, emotions and life more 
generally, participants expressed less judgemental and more accepting 
attitudes towards both themselves and others; for example: “I’m less critical of 
others” (MT63), “I’m definitely more understanding of a lot more people now” 
(MT33).  In terms of their depression, participants noted: “I’m less likely to give 
myself a hard time for having a bad day” (MT17) and “[Morita Therapy] taught 
me how to not be ashamed of it” (MT55).  Thus, more widely, participants noted 
the positive impact of the acceptance, normalisation and permissibility of 
difficulties on their self-image and relationships. 
 (c) Transformation: from dwelling to doing 
Participants expressed changes in their attention and behaviour which 
incorporated a shift from fixating on symptoms and engaging in the vicious cycle 
towards focusing outwardly on action and the external environment, essentially 
describing having moved from ‘living in their head’ to ‘engaging with life’: 
For me it has been, yeah, to concentrate on what actually needs to be 
done… to get away from the ‘Should I be doing this?’…and actually 
break things down into – ‘is there anything that I need to do now?’  That’s 
been helpful, and I think just getting out of the cycle of depression, it’s 
because you’re doing things rather than just dwelling on them. (MT43) 
Participants often expressed a sense of having learned to pay less attention to 
(fixing) symptoms, being “more present” (MT43) in the moment and “getting 
more involved” (MT33) with others, activity and life: 
It’s about moving your focus away from what’s going on inside to carrying 
on what’s going on in the real world… my mind is completely outside of 
myself, I’m looking forward and I’m interested in what I’m doing and I’m 
taking full part in it, and to be honest with you I don’t even think about 
anxiety. (MT45) 
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Similarly, participants were more engaged with nature and the external 
environment, which typically brought them joy: 
I’ve really enjoyed actually getting out, observing, thinking about nature, 
animals, and the observation side of things…I tend to spot a lot of things, 
which I may have done anyway but I think just noticing it more, but 
maybe questioning it less. (MT43) 
Participants also referred to changes in the impetus for action-taking, in terms of 
now being motivated by the action itself rather than a desire to control or avoid 
symptoms: 
[I think] ‘I’m gonna do this thing even if I’m feeling bad’ and [I’m] not 
trying to use the activity to distract myself or push those feelings away, 
which is what I was doing, more kind of doing it and accepting how I feel. 
(MT15) 
Thus, there was an overall sense of transition from participants’ lives being 
dictated by their symptoms to being dictated by activity and external factors. 
 (d) Empowerment and liberation 
Running through participants’ accounts of acceptance and transition was a 
sense of empowerment through freedom from former restrictions, fears, 
judgements and struggles. 
It shows you that there’s a cycle of things, they come and go, and so 
you’re not scared of them anymore, or doing unhealthy behaviour to try 
and stop them. (MT50) 
Indeed, one participant discontinued therapy largely because it facilitated an 
understanding that she did not require help with her difficulties, stating: “I think 
I’d go as far as to say that I’m not as scared, if [the depression] does come 
back” (MT15).  Similarly, by relinquishing attempts to ‘fix’ unpleasant emotions 
through understanding them as inevitable, participants expressed a sense of 
relief and liberation of energy: 
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I accept that it’s almost, um, honestly being able to stop trying to cure 
yourself and just, yeah, give up that struggle. I remember…thinking ‘Oh 
yeah, I can actually just pack all this cr*p in’, ‘cos it’s just self-
perpetuating worry… It’s a feeling of – a little bit of relief. (MT45) 
Participants also felt empowered to take action through learning that they can 
do so regardless of how they are feeling.  As such, some participants felt able to 
tackle activities (such as driving (MT63)) which they had not done for years.  
Often, the ability to take action in the presence of unpleasant emotions had 
helped enable participants to make drastic changes in their lives: 
Changing jobs in the middle of the therapy…I think it was partly Morita 
helping, it gave me the confidence to try and make those changes which 
I, without it I don’t think I would have. (MT16) 
This empowerment through acceptance often manifested itself in terms of 
increased self-confidence and a sense of “feel[ing] better equipped” (MT43) to 
dictate and manage situations: 
I would have thought ‘Oh gosh, I’ve got to drive to [place]… What’s 
gonna happen when I get to [the bridge]?’, ‘cos that’s one of my 
dreads… Now I just think, I’ll get there, if I can go then I’ll go, if I can’t I’ll 
just sit there and reverse or whatever I’ve got to do, but handle the 
situation. (MT37) 
Similarly, participants noted feeling “a lot more in control” (MT16) in terms of 
having an increased sense of power and autonomy over their lives.  This 
appeared to have manifested through a redirection of efforts and altered 
ownership of responsibility: through accepting what cannot be controlled 
(internal states) and focusing attention on what can be controlled (behaviour): 
Through the process you appreciate that it’s part of the natural world to 
actually feel the way you do and stop fighting your feelings, ‘cos you 
can’t change your feelings, but you can change the way you actually 
act… I’ve definitely got more control over what’s happening day-to-day, 
um, more inclination to actually do things.” (MT43). 
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Overall, there was a sense of joy, power and liberation inherent in the 
acceptance of difficulties, taking of action and related improvement in 
symptoms: “The visceral thing for me has been the joy, sheer joy of actually 
being able to take action without – and overcoming the fear” (MT63). 
 (e) Effect on symptoms and mood 
When prompted with questions on whether Morita Therapy had helped them 
with their difficulties, participants often stated “a lot”, with some describing 
specific ways in which their symptoms had improved: “I’ve been able to come 
off my medication and actually feel a lot more positive and actually feel a lot 
better.” (MT16).  However, participants’ spontaneous accounts of the impact of 
treatment typically focused on their changed outlooks and behaviours, with 
reductions in symptoms generally considered secondary to this or described 
through the lens of acceptance.  Thus, a sense of priority was given to adopting 
Morita Therapy principles over reducing symptoms (as is the intention of Morita 
Therapy): “My view now is totally different...I’ve seen a different side of it now” 
(MT37). 
[Depression has] definitely lifted and even though things might still be a 
bit gloomy, that’s just the way they are, but there’s good things 
happening as well, and yeah, I feel a lot better about life. (MT43) 
[My friends] said ‘You just seem different, I don’t know what it is, you’re 
normally faffing and worrying and –’, of course, I worry, but it’s 
normalised life for me. (MT63) 
Thus, whilst many participants often referred to (an acceptance of) some 
continued unpleasant thoughts and emotions, they typically noted these were of 
reduced duration due to their reduced engagement in the vicious cycle and 
increased action-taking: 
My anxiety’s gone, my depression’s gone and I’m in a much better place.  
I had a bad little patch…but then a day later I was absolutely fine, so 
instead of being stuck in that cycle for weeks, it was only like a couple of 
days. (MT50) 
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Similarly, participants also described more frequent pleasant experiences, and 
more thorough engagement with and enjoyment of these, particularly as this 
time was no longer being spent trying to analyse, anticipate and pre-empt 
unpleasant experiences: 
I get many more of those [good days] than I used to get.  Probably more 
good days than bad days… Those periods of anxiety are shorter, they’re 
no less intense, but they’re shorter, um, and when they stop I can enjoy 
the rest of the day, because there’s no point in going back over what 
happened this morning. (MT45) 
In considering the value and impact of Morita Therapy, a common and revealing 
sentiment was “I wish people had access to it” (MT43).  Thus, whilst indicating 
increased acceptance of difficulties, participants also conveyed the positive 
impact this had on their symptoms and mood as a by-product, and considered 
Morita Therapy a valuable approach in the treatment of depression and anxiety.  
A summary of the acceptability of Morita Therapy to participants 
Participants’ views relating to the acceptability of Morita Therapy were 
understood within five key themes.  Firstly, the ways in which expectations and 
understandings of treatment which are incompatible with Morita Therapy shape 
participants’ views of acceptability were explored.  This theme highlighted key 
inconsistencies between Morita Therapy and the hopes of some participants 
that treatment would provide a solution for their symptoms, and/or an 
opportunity to explore and express themselves.  Included were the ways in 
which these preconceptions can feed participants’ construction of Morita 
Therapy-incongruent rationales for treatment, such as misunderstanding rest as 
an opportunity for overcoming symptoms.  As such, for these participants, 
Morita Therapy failed to achieve its assigned purpose, and/or failed to provide 
them with the approach they seek, and was generally not perceived as 
acceptable or helpful. 
Secondly, in contrast to theme one, the ways in which participants’ prior 
insights, experiences and expectations could facilitate engagement with Morita 
Therapy by allowing them to identify with its principles was discussed, 
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highlighting the importance of such identification in shaping views on 
acceptability.  This theme stressed the role of participants’ readiness to accept 
unpleasant thoughts and emotions, as per the underlying premise of Morita 
Therapy, and highlighted how various elements of treatment, such as the 
connection to the natural world or focus on the authentic self, might ‘grab’ 
participants from the offset and encourage them to engage with the approach. 
Thirdly, the ways in which some participants approached and understood the 
treatment elements as a part of a progressive journey were explored.  Thus, the 
acceptability of Morita Therapy was linked to participants’ understandings of the 
treatment components as part of a gentle, naturally unfolding and experiential 
process which provided accumulative opportunities for learning about human 
nature, re-focusing attention from internal to external states, and owning 
responsibility or ‘making them think’.  For these participants, treatment 
components were judged in terms of how well they achieved these purposes, 
rather than in terms of how enjoyable or successful in overcoming symptoms 
they were, and thus challenging components such as rest were typically 
considered worthwhile.  This theme also contrasted theme one, in which 
participants tended to seek a somewhat passive role in treatment and 
attempted to isolate each treatment component as a potential technique for 
overcoming symptoms. 
Fourthly, the difficulties associated with engaging in the process of Morita 
Therapy, including the more practical rather than conceptual elements of 
treatment, were presented.  Key challenges were the fear and discomfort 
participants experienced around rest in particular, and factors which may be 
relevant in many forms of psychological therapy such as needing safety and 
support from others, needing sufficient therapist guidance and reassurance, and 
the burden and commitment of treatment.  Also discussed were factors which 
shaped whether these challenges amounted to barriers to continuing treatment, 
highlighting that whilst participants’ expectations and understandings of 
treatment often moderated the extent to which they were willing to tolerate such 
challenges, the practice of Morita Therapy still presented as unacceptable for 
some participants despite their strong identification with the principles. 
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Finally, the value and impact of Morita Therapy, as expressed by participants 
who identified with the principles of therapy and/or approached therapy as a 
process, were discussed.  These included participants’ accounts of Morita 
Therapy providing a preferable alternative to other therapies such as CBT; the 
value of the acceptance, normalisation and permissibility of difficulties; a sense 
of transformation from participants’ lives being dictated by symptoms to being 
dictated by activity and external factors; expressions of empowerment and 
liberation from former restrictions, fears, judgements and struggles; and the 
effect of therapy on symptoms and mood as a by-product of such changes. 
Together, these themes provide a model of how different participants 
experienced Morita Therapy.  Highlighted throughout participants’ accounts, 
and key to how the themes relate to each other in forming an overall picture, is: 
 
1. The importance of participants’ expectations, understandings and receptivity 
to the Morita Therapy principles in terms of facilitating their engagement with 
treatment.  Thus, the first three themes captured typologies of experiences, 
and how these shaped acceptability, with a particular contrast established 
between those who hold expectations and understandings of treatment 
which are incompatible with Morita Therapy (theme one) versus those who 
identify with the principles (theme two) and accurately understand the 
purpose of the treatment components as part of a process (theme three).   
2. The distinction between Morita Therapy in principle and practice.  Thus, 
whilst the importance of identification with Morita Therapy on a conceptual 
level was stressed, theme four captured the challenges of engaging with 
Morita Therapy on a more practical level.  Whilst participants who did not 
identify with the principles were less likely to tolerate these challenges, it 
was also true that for some the practicalities of treatment were unacceptable 
despite their identification with the principles; therefore, it appears that it is 
one thing to connect to the Morita Therapy principles, and another to be able 
to engage in the process. 
The implications of these key considerations around moderators of acceptability 
and the challenges of translating principles into practice will be discussed in 
Chapter Eight. 
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7.2.3 The acceptability of Morita Therapy to therapists 
Therapists’ views relating to the acceptability of Morita Therapy were 
understood within four key themes: (1) Morita Therapy as beneficial; (2) Morita 
Therapy in practice: room for improvement?; (3) applying Morita Therapy to 
different patients; (4) facilitating therapy delivery.  Each theme encompassed a 
number of constituent themes (Figure 15, overleaf). 
Figure 15 illustrates the overall picture of and relationships between these 
themes.  Therapists generally spoke highly of Morita Therapy, especially the 
principles and particular components of the approach, and noted the positive 
benefits of Morita Therapy for many patients (theme one).  However, some 
challenges and uncertainties were experienced in relation to operationalising 
treatment and applying the principles in practice (theme two).  Thus, a key 
thread throughout therapists’ accounts is the distinction between Morita 
Therapy in principle and practice: whilst the value of the principles is stressed 
within theme one, the challenges therapists encountered, for both themselves 
and patients, in translating these principles into practice is highlighted within 
theme two. 
These challenges were often noted in the context of applying Morita Therapy to 
different patient presentations and responses: therapists highlighted patient 
variability, considered the suitability of Morita Therapy for different patients and 
stressed the importance of patients grasping the Morita Therapy principles as a 
moderator of their views of and responses to treatment (theme three).  Within 
the analysis of the interviews it was clear that this patient variability was a key 
factor connecting themes one and two: therapists often referred to the same 
components of treatment as both potentially beneficial and potentially 
challenging, depending on the patient in question.  Finally, in particular light of 
these challenges, therapists noted several ways in which the delivery of Morita 
Therapy had been, and could be, supported and facilitated (theme four). 
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Figure 15. Final thematic map (embedded qualitative interviews: therapists) 
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Theme one: Morita Therapy as beneficial 
This theme illustrates how therapists generally spoke positively about Morita 
Therapy as both a treatment approach and a particular perspective on human 
nature and mental health.  Therapists highly valued the worldview offered by 
Morita Therapy and the principles of the approach (constituent theme (a)), 
noted specific components of treatment which they considered particularly 
helpful in translating these principles into practice (constituent theme (b)) and 
described the impact and benefits of Morita Therapy for many patients 
(constituent theme (c)). 
(a) Embracing the principles 
In general, therapists spoke highly of the underlying worldview and principles of 
Morita Therapy, expressing their enjoyment of learning about and delivering the 
approach:  “I thought it was a great overall journey, I really enjoyed it” (TH02).  
Particularly valued by therapists were principles around working with authentic 
human nature, accepting and allowing unpleasant emotions as natural 
phenomena and focusing on action-taking. 
I like the authenticity of it, the fact that it’s about bringing us back to being 
features, organisms of this planet and therefore, you know, the things 
that we experience are so natural.  I like the steer away from – we’ve got 
to fix all the things that are uncomfortable. (TH01) 
Therapists thus appreciated the move away from the approach of fixing 
symptoms and towards an approach of acceptance and connection to nature, 
and considered this valuable in helping patients with their difficulties. 
Morita Therapy is a sustainable therapy…which embraces a unique 
engagement with nature as an underpinning that we are part and parcel 
of nature and that we can’t change it...  there is a value in accepting the 
natural rhythms of life. (TH02) 
Therapists also noted how the Morita Therapy principles chimed with their 
personal beliefs and lifestyles, suggesting this identification with the principles 
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and “a strong belief in some of the logic” (TH02) was an important part of 
delivering Morita Therapy. 
It fits, probably, with my outlooks on life, some of my ways of living, some 
of my desires, um, as a therapy, and that helps… the fact that I am a 
lover of the natural world…[and] have a real acceptance of the fact that 
we do have a whole repertoire of emotions as human beings. (TH01) 
Indeed, therapists suggested the Moritian perspective had impacted upon their 
own life and views, and potentially on their future therapeutic practice: 
I sit more comfortably now with my own emotions, I fight it less… and I’m 
more, I think, akin with the people that I love, as a consequence of that… 
I will probably pay more attention to emotion in therapy and probably 
project through my questions and enquiry and therapy approach, um, a 
sense of how natural emotions are. (TH01) 
Thus, therapists valued the underlying principles of Morita Therapy, particularly 
those centred on authenticity and naturalness, and noted their own identification 
with and embracing of such principles. 
(b) Valued components 
Therapists highlighted several components of Morita Therapy in practice which 
they found particularly valuable in delivering the approach and facilitating 
patients’ engagement with the principles, such as diaries, Fumon (inattention to 
symptoms) and working with desires.  Therapists noted that the diaries were 
features which “people found hugely helpful” (TH02) in terms of reflecting on 
their own changes during treatment and receiving therapist comments.   
It was a really beautiful way of reinforcement: repeat, repeat, repeat, I 
found myself kind of really – and thought this would be incredibly 
repetitive for people – but actually a number of times they would 
feedback that that was useful. (TH01) 
Therapists also noted that the diaries were a “really useful tool” (TH01) for them 
which they found highly informative: 
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You can see a lot of the way that people actually do process and 
ruminate through the diary… [they] do give you a window into them 
thinking out loud. (TH02)  
Whilst therapists experienced some concern around Fumon (inattention to 
symptoms) potentially lacking empathy, they also reflected that this technique 
had worked well and been well received by patients in practice: “I think it’s 
valuable, um, I used it probably quite compassionately, or I hope I did” (TH02).  
Therapists indicated they became more adept at and “comfortable with using it 
as [their] experience went on” (TH01), and noted the importance of explaining 
the technique to patients at the start of therapy as a means of preparing and 
anchoring patients. 
Corresponding with their appreciation of the Moritian focus on authenticity, 
therapists also valued working with patients’ desires, noting how this allowed 
patients to reframe their fears and reflect on their authentic goals and values. 
The other fundamental thing that’s been helpful is this desire and fear 
mechanism… you can actually help move people along a journey by 
getting them to reflect on their desires. (TH02) 
Overall, therapists also stressed the importance of Morita Therapy providing an 
experiential approach through the treatment phases: 
My sense is that the experiential part is necessary in order a) for people 
to feel physically the physical wave of emotion, the ebb and flow, but also 
to have that experience of what happens when I don’t do the behaviour 
that I normally do that perpetuates this cycle. (TH01) 
Thus, therapists emphasised diaries, Fumon, working with desires and the 
overall experiential phased approach as central to and valuable in delivering 
Morita Therapy. 
(c) Impact for patients 
Therapists indicated the benefits of Morita Therapy for many of their patients, 
noting that “a lot of people just had this sense of – I can only call it acceptance 
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really” (TH02).  More specifically, therapists highlighted the value of Morita 
Therapy in facilitating patients’ acceptance and allowance of unpleasant 
emotions and ability to live more natural and meaningful lives with increased 
action-taking and “psychological flexibility” (TH02). 
People would have, in the main, been able to embrace the principle 
around emotions being natural… people have been able to embrace a 
more natural way of living, and that may be about just being a bit more 
authentic, that might be actually allowing the feelings that they have 
rather than pursuing expectations about how they think they should be... 
People have been able to therefore move on from that point and lead 
more meaningful lives in line with their desires. (TH01) 
Therapists also stressed the particular benefits for patients of connecting to 
nature, which they noted manifested differently for different patients, with some 
engaging in nature in an explicit, physical way and others connecting more to 
natural world metaphors: “people grasped nature in different ways” (TH01). 
[Patients] did actually get the sense of wellbeing about the natural 
world... [they realised] they could actually be, and gain a great deal from 
being, outside and being in the natural world, being part of it. (TH02) 
With regards to the benefits of the treatment in practice, therapists noted in 
particular the important lessons and concepts patients learned through their 
engagement with phases one (rest) and two (light activities). 
One and Two are gateway[s]… they give them the Eastern frame, rather 
than the Western frame, so, like: we don’t fix it, you endure it and you be 
with it... Everyone learned that you can be with it. (TH02) 
As a by-product of their identification with the principles, therapists also 
suggested that patients’ symptoms typically reduced: 
For patients who really grasped the principles I would say they would, as 
a kind of side-line almost, they will have experienced improvement in 
their symptoms that were giving them distress…they would be less 
distressed and more fulfilled, less preoccupied, less ruminative. (TH01) 
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Thus, therapists indicated that, through their engagement with principles and 
practice of Morita Therapy, many patients were able to live more authentic and 
meaningful lives in which they accepted their difficulties and also experienced 
reduced symptoms. 
Theme two: Morita Therapy in practice: room for improvement? 
This theme illustrates the challenges in implementing and engaging with Morita 
Therapy in practice, which therapists highlighted for both themselves and 
patients (constituent theme (a)), and areas in which therapists indicated their 
uncertainty or a lack of clarity in terms of how to operationalise Morita Therapy 
(constituent theme (b)).  Included within these constituent themes are 
suggestions therapists made for how these difficulties might be circumvented. 
(a) Challenges 
Therapists described multiple challenges in operationalising components of 
Morita Therapy in practice, such as the diaries, treatment timeframes, and 
treatment phases.  These challenges related to both therapists’ experiences of 
delivering treatment, and patients’ experiences in engaging with treatment.  
With regards to diaries, therapists highlighted their cumbersome size, patients’ 
occasional practical difficulties such as dyslexia, and some lack of patient 
understanding of the instructions.  Furthermore, therapists noted the challenges 
of engaging patients with their diary comments in a meaningful way: 
For some people it didn’t work particularly well… quite often they would 
read through my comments and go, like, ‘Yeah, yeah, I can see that, 
yeah, I can ‘, but not many would actually say ‘I don’t understand what 
you’ve written there’… there weren’t so many people that would pick up 
on it and question it or reflect critically. (TH01) 
In terms of the timeframes for treatment (session length and number), therapists 
indicated that this felt constrained: “It always felt like we were on a relatively 
limited timeframe” (TH01).  As such, therapists considered whether a more 
flexible timeframe might be helpful in ensuring patients have “an adequate dose 
of experiencing the principles of Morita Therapy” (TH01), particularly during 
each treatment phase, and whether the option for longer treatment sessions 
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might enable their facilitation of patients’ experiential engagement with therapy 
through in-session rest periods and/or engagement with nature. 
In relation to the rest phase specifically, therapists highlighted various 
challenges that patients encountered, often related to the time commitment, 
ensuring an appropriate environment and the need for supportive significant 
others.  These challenges were considered compounded by the fear and 
discomfort that sitting with unpleasant experiences induced for patients.  Also 
highlighted were the challenges some patients faced in understanding the 
purpose of rest, particularly in the context of rest presenting as “frame-shaking” 
(TH02) compared to the approach of other treatments in which increasing 
activity is prioritised. 
It was hard to be too prescriptive for people around rest in terms of 
hours… lifestyles got in the way a lot, um, people’s discomfort with 
embarking on it, particularly people, perhaps, who lived alone… It’s a bit 
overwhelming and because it comes so early in therapy it’s often hard for 
people to grasp ‘why, why am I doing this?’ (TH01) 
In terms of phase two (light activities), therapists similarly noted challenges in 
relation to identifying appropriate activities and ensuring sufficient time was 
devoted to these to enable patients to learn the intended lessons.  A particular 
challenge was highlighted around the purposes of phase two, with therapists 
discussing patients’ difficulties in understanding the relevant distinctions: 
absorbing attention within the external environment versus distracting 
themselves from unpleasant experiences; progressing through activities as a 
learning process versus discovering enjoyable hobbies. 
Sometimes we get a little bit lost in people – ‘oh yeah, I really enjoy 
knitting so I shall do that’…half of me never really understood whether 
they were getting back into the sort of hobby or whether they were really 
actually utilising it [as intended]. (TH02) 
Finally, therapists indicated difficulties in relation to the concept of fears and 
desires forming two sides of the same coin, both in terms of what they felt able 
to convey and what they felt patients could understand. 
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I found it quite a hard thing to convey, um, or never quite knew when to 
come in with it… It’s quite a difficult construct. (TH01) 
Overall, therapists indicated several challenges both they and patients 
experienced whilst engaging with Morita Therapy in practice, highlighting 
difficulties associated with operationalising the diaries, treatment phases and 
timeframes, and the concept of underlying desires in particular. 
 (b) Therapist uncertainty 
Therapists indicated several ways in which they experienced uncertainty in 
operationalising Moritian concepts in practice, typically related to the treatment 
phases and indicators of therapeutic progress.  With regards to the latter, 
therapists struggled to identify whether those specified within the therapy 
protocol were being experienced by patients. 
More clarification around those would have been helpful.  There were 
times, I think, where treatment concluded because we’d got to Session 
Twelve, rather than there being clear indicators that sufficient progress 
had been made in experiencing and embodying the principles… That, 
sometimes, was quite hard to feel like there was clear evidence. (TH01) 
Similarly, therapists struggled to identify when patients had undertaken an 
“adequate dose” (TH02) of rest, and when they had learned the intended 
lessons of this phase.  Thus, therapists suggested that tools to quantify the 
amount of rest undertaken, potentially as a diary section, and to assess 
“embodiment of the ebb and flow of emotion” (TH01) would be valuable.  
Therapists also noted uncertainty around changes they identified within 
patients’ diary accounts, in terms of whether these reflected genuine changes in 
patients’ outlooks or whether “they’re just trying to please the therapist” (TH02). 
Furthermore, in the absence of both a patient “problem framework” (TH02) 
presented to therapists at the start of treatment and enquiring directly with 
patients about their symptom levels, therapists struggled to identify the extent to 
which patients’ symptoms had been addressed during therapy.  Therapists 
indicated some discomfort with relying on patients’ understanding and 
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internalisation of the principles, which in itself was difficult to assess, as an 
indicator that patients had been adequately helped with their difficulties. 
You’ve got to be very, very sure that an understanding of the concepts or 
an understanding of principles equals, um, a good outcome… I’m still to 
this day really not that clear on the sort of outcome indicators. (TH02). 
In relation to the phases overall, therapists indicated some uncertainty around 
distinguishing between phases two, three and four.  Often this uncertainty 
related to a lack of clarity as to the purpose of each phase, alongside whether 
patients must progress through these phases sequentially or not.  Related to 
this was some uncertainty around the purpose and nature of activities to be 
engaged in during each phase, such as whether phase two activities should be 
enjoyable and/or maintained beyond engagement in phase two. 
The distinction between [phases] two and three is most difficult… 
whether [in phase three] they then drop their activities in two or they keep 
them going, or whether the activities serve their purpose… I mean, do 
they do them forever? (TH02) 
Therapists also suggested some uncertainty around whether, through the 
experiential nature of therapy, the more cognitive elements of the vicious cycle 
(such as patients’ discrepancies between how things ‘are’ and how things 
‘should be’) would be sufficiently addressed for patients.  Therapists suggested 
that more guidance on managing this gap between the ideal and real, such as 
examples of relevant metaphors, would be helpful. 
We could do some distortion work, or challenge that through thinking… 
are they continuously going to do the crochet when they’re actually 
preoccupied with rumination…around gaps in the way ‘I should be’’? 
(TH02) 
Therapists similarly noted that they struggled, when working with “unrealistic 
desires” (TH02), to know whether these should be mediated or simply brought 
to the patients’ awareness.  Thus, therapists indicated that they experienced 
some lack of clarity in delivering features of Morita Therapy, particularly in terms 
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of assessing indicators of progress, operationalising the treatment phases, and 
addressing the cognitive components of patients’ distress. 
Theme three: Applying Morita Therapy to different patients 
This theme illustrates the ways in which, throughout their accounts of Morita 
Therapy and particularly in relation to the challenges they experienced in 
delivering the approach, therapists indicated much variability in patients’ 
responses to and understandings of the treatment components (constituent 
theme (a)).  This patient variability connects themes one (‘Morita Therapy as 
beneficial’) and two (‘Morita Therapy in practice: room for improvement?’): 
therapists often referred to the same components of treatment as both 
potentially beneficial and potentially challenging, depending on the patient in 
question.  Constituent theme (b) presents therapists’ views on the suitability of 
Morita Therapy for different patients and the factors deemed important in 
whether patients benefitted from the approach. 
(a) Managing variability in response 
In considering the suitability and usefulness of the components of Morita 
Therapy for patients, therapists often referred to variability in patient’s 
responses to and understandings of treatment, indicating that broad 
generalisations were difficult to make.  Often these views were expressed in 
relation to patients’ understanding of and learning acquired from the treatment 
phases.  For example, in relation to the purpose of phase two (light activities): 
Some people grasped that… others used it as a kind of fix, so it was 
about ‘when I feel really unsettled, I pick up the colouring’. (TH01) 
Furthermore, therapists indicated that this variability amongst patients required 
them to adopt an individualised and flexible approach, which was at times 
challenging, and that for different patients they struggled in different ways to 
know how best to apply and optimise the components of therapy.  For example, 
in terms of engaging patients in rest: 
I tried different things, right the way down to, you know, sitting in a chair 
resting… Some people got [the learning from rest] without the titration 
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and a lot of it, and some got it with a lot of it, and some I was trying to get 
them to do it right up to Week Four and it was basically not – evidently 
they weren’t getting anything from it. (TH02) 
Thus, this patient variability was also linked with the challenges and 
uncertainties therapists experienced in relation to aspects of treatment such as 
establishing the necessary dose of rest and assessing indicators of therapeutic 
progress (theme two: Morita Therapy in practice: room for improvement?).  
Other components of Morita Therapy with regards to which patient variability 
was stressed were diaries and the understanding of fears and desires forming 
two sides of the same coin. 
Diaries were incredibly variable, and some of that depended on people’s 
ability to, simply, write, and how literate they were… you can get one full 
side of really neat, intense writing versus four or five words. (TH01) 
The two sides of the coin was quite a hard concept for some people to 
grasp… There were some really [sighs] helpful moments for some 
people, where actually it was something I could readily see how it would 
apply and then for other people I found it harder as a concept to say, 
yeah, this is where this is so relevant. (TH01) 
Thus, therapists indicated much variability across patients around the ability to 
apply, understand and benefit from the components of Morita Therapy, creating 
a requirement for an individualised approach which was challenging to adopt. 
 (b) Suitability of Morita Therapy 
In considering patient variability and the suitability of Morita Therapy, whilst 
struggling to discriminate between particular patient characteristics as potential 
predictors or moderators of response, one factor which therapists consistently 
deemed important was patients’ ability to grasp the principles. 
I don’t know that you could pinpoint ‘this characteristic is a make or break 
for Morita Therapy’… there’s something about an ability – my sense is – 
an ability to relate… if it didn’t conceptually gel with people, that they 
might just walk away from it. (TH01) 
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Therapists connected this ability to relate to the principles with patients’ 
readiness to accept difficulties rather than seeking to cure them, a degree of 
“openness” to treatment (TH01) and a level of prior insight which allowed them 
to identify with the vicious cycle in particular.  Therapists also highlighted 
patients’ orientation towards nature as an important factor in embracing the 
principles. 
The characteristics of some of the people who actually got a lot from it, 
there was a lot of bias coming into the room with them tending towards a 
sort of naturalistic view of the world…and actually really very much 
seeing a positive place for themselves outside of – in nature. (TH02) 
Therapists also indicated the importance of a degree of “emotional intelligence” 
(TH01) and perseverance in the context of Morita Therapy presenting some 
challenging experiences for patients. 
Where they were prepared to come back and say, you know, how hard 
this is… Those people, actually, were the ones who are showing you 
they want to try and learn, they’re prepared to share their distress with 
the therapist and be, perhaps, more authentic. (TH01) 
Related to the importance of understanding the principles, therapists considered 
whether the experiential aspects of Morita Therapy are necessary in order to 
embed the principles or whether patients’ conceptual identification with the 
principles might be sufficient.  These considerations linked to patient variability 
(constituent theme (a): managing variability in response): therapists typically 
concluded that different patients appeared to embed or benefit from the 
principles in different ways (if at all). 
How necessary is it to go through that [rest], I don’t know… For some 
people, I think it was definitely – it helped assimilate the whole principles, 
the basis of it.  For others, they might have conceptually grasped it 
sufficiently and then applied the principle during other activities... To hear 
that message about the naturalness of emotions…I think [that alone] can 
be quite a helpful intervention, but not for everybody. (TH01) 
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Therapists also suggested patient characteristics for which Morita Therapy 
might be less suitable, typically related to patients’ understandings and 
expectations of treatment.  Thus, therapists indicated that those who sought a 
“more talking framework” (TH02) or “wanted to be treated for their symptoms” 
(TH01) were less likely to find Morita Therapy beneficial.  Therapists also 
indicated patients’ current coping mechanisms and cognitive patterns as 
important factors in their response to treatment, suggesting that where patients 
struggled with a “gap between the way things are and the way things should be” 
(TH02) or “entrenched ways of managing emotion” (TH01) such as “avoidance” 
(TH01) and “rumination” (TH02), Morita Therapy was more challenging to 
deliver.  Overall, the importance of grasping the principles (whether cognitively 
or experientially), identifying oneself in terms of the vicious cycle, connecting 
with nature and seeking a treatment approach in line with that of Morita Therapy 
were considered important to the effectiveness of the approach. 
Theme four: Facilitating therapy delivery 
This theme illustrates therapists’ views on how their delivery of Morita Therapy 
had been facilitated and supported by their supervisor and the study researcher, 
namely through trial management, therapist training and supervision 
(constituent theme (a)) and the therapy protocol itself (constituent theme (b)).  
Included are the suggestions therapists made for improving the protocol and 
further supporting therapists delivering therapy in the future. 
(a) Supporting therapists 
Therapists indicated that they had felt well equipped for and supported 
throughout therapy, in terms of the trial management, therapist training and 
supervision.  Regarding the trial, therapists commented that it was “organised” 
(TH01) and “worked really well” (TH02), noting that the risk, adverse events and 
‘did not attend’ protocols were appropriate.  Whilst indicating the usefulness of 
the assessment information passed from the study researcher to the AccEPT 
Clinic, therapists suggested that the provision of more detailed information on 
patients’ “current difficulties” capturing “how the clients saw their problems” 
(TH01) would have further facilitated their delivery of treatment in order to 
provide them with a form of ‘problem statement’ at the start of treatment.   
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In terms of training, therapists indicated that all necessary aspects had been 
addressed and stressed the importance of the training session in focusing on 
the key principles and how these are operationalised in practice: 
It was really helpful having the sessions with yourself and [supervisor] at 
the outset to try and thrash out the ‘how’, you know, ‘how’ and ‘what’, 
really.  So, what the principles were, what the therapy was about, what 
its aims and objectives were, but then the ‘how’ of well, how are we going 
to do this in sessions. (TH01) 
Therapists also noted the importance of supervision, particularly in allowing 
“room for thoughtful discussion” (TH02), providing an opportunity to discuss the 
specific application of Morita Therapy to individual patients in the context of 
patient variability (theme three: applying Morita Therapy to different patients), 
and aiding adherence to the key principles: 
One of the values of what [supervisor] could do was just bring it back to 
the principles, really, and I think that was really helpful. (TH02) 
Similarly, therapists valued both themselves and their supervisor listening to 
tapes of therapy delivery to check fidelity to the protocol with the aid of the 
fidelity checklist developed by the study team. 
Having those sessions recorded [and] listened back through to kind of 
see, you know, were we keeping sort of fidelity to the principles and how 
those sessions were intended to go was helpful. (TH01) 
Therapists also noted the usefulness of the fidelity checklist as an aide memoir 
during therapy sessions, to facilitate their adherence to the key elements of the 
approach.  Overall, therapists indicated that they felt well equipped and 
supported by the study researcher, supervisor, and materials provided. 
(b) The therapy protocol 
Therapists indicated the usefulness and appropriateness of the therapy protocol 
both in terms of embedding the principles of Morita Therapy before starting 
treatment and as a more practical guide to implementing the approach during 
treatment.  In terms of the protocol as a learning and training aid: 
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The detail was really helpful at the start when we were trying to get our 
heads around ‘how’s this gonna work, how does it translate into practice’ 
and the embellishment around – so the principles and trying to get a kind 
of theoretical, conceptual understanding. (TH01) 
In terms of the protocol as a practical guide and aide memoir during treatment 
to facilitate the structuring of sessions and fidelity to the approach: 
I don’t think it deviated too much from the way we were asked to deliver 
it, really, we actually did stay with the general content, which is all credit 
to you, really, the manual was put together really well... it was a constant 
aide memoir really for me, throughout therapy. (TH02) 
Therapists also noted the value of the protocol in allowing the approach to be 
flexible and individualised for different patients, particularly in the context of 
patient variability (theme three: applying Morita Therapy to different patients): 
[One thing] I like about it is that it tries to really impart the necessary 
components of Morita Therapy without being too prescriptive about every 
single thing that you need to do within a session, for example, and allows 
a bit of clinical judgement and creativity to get the intervention to fit the 
client, in a way that perhaps other protocols don’t. (TH01) 
Therapists also commented that the changes made to the therapy protocol 
during the intervention optimisation study (see Chapter Five) responded well to 
their feedback, such as providing summary sheets and more eye-catching 
guidance: 
Your response to our request of ‘can we get some summary sheets’, now 
they lived in my blue to-hand folder and these were really, really 
helpful… Warning points [and] traps that therapists might fall into, it’s 
helpful to have highlighted those. (TH01) 
Therapists did make some suggestions for additions to the protocol such as a 
summary sheet describing Morita Therapy overall and further clinical examples 
illustrating individualised manifestations of the vicious cycle and different 
options for conveying fears and desires to cover a wider range of patient 
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presentations.  In considering the usefulness of the protocol for future therapist 
training, therapists similarly considered it fit for purpose whilst suggesting the 
potential addition of diary examples.  Thus, whilst suggesting minor additions to 
the protocol, therapists considered the protocol comprehensive and appropriate 
for both learning the background and principles of Morita Therapy and 
operationalising the approach in practice. 
A summary of the acceptability of Morita Therapy to therapists 
Therapists’ views relating to the acceptability of Morita Therapy were 
understood within four key themes.  Firstly, therapists’ views of Morita Therapy 
as a positive and beneficial approach were presented.  Therapists’ generally 
spoke positively about Morita Therapy as both a treatment approach and a 
particular perspective on human nature and mental health.  Therapists highly 
valued the worldview and principles underpinning Morita Therapy, alongside 
noting specific treatment components such as diaries, Fumon (inattention to 
symptoms) and working with desires which they considered particularly helpful 
in translating these principles into practice.  Therapists also described the 
impact and benefits of Morita Therapy for many patients, particularly in terms of 
acceptance, connection to nature, and related improvements in symptoms. 
Secondly, therapists described several challenges, for both themselves and 
patients, encountered in operationalising Morita Therapy in practice.  Key 
difficulties involved the use of diaries; strict number and length of treatment 
sessions; discussions of fears and desires forming two sides of the same coin; 
and the implementation of treatment phases in terms of ensuring an adequate 
dose, choosing appropriate activities and facilitating patients’ accurate 
understanding of the purpose of those activities.  Therapists also indicated 
several areas in which they had experienced uncertainty in operationalising 
therapy, typically related to distinguishing between treatment phases and 
identifying indicators of therapeutic progress. 
Thirdly, throughout their accounts and particularly in relation to the challenges 
they experienced, therapists indicated much variability in patients’ responses to 
and understandings of the components of the approach.  This patient variability 
connected themes one and two: therapists often referred to the same 
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components of treatment as both potentially beneficial and potentially 
challenging, depending on the patient in question.  Whilst therapists struggled to 
generalise in terms of potential predictors or moderators of response to Morita 
Therapy, they consistently highlighted the importance of patients grasping the 
principles of the approach and indicated certain patient presentations for which 
they had found Morita Therapy more difficult to deliver. 
Finally, therapists noted ways in which their delivery of Morita Therapy had 
been facilitated by their supervisor, the study researcher and materials they had 
been provided with.  Whilst making suggestions for minor additions to the 
therapy protocol, therapists indicated that they had been well equipped and 
supported through the training, supervision and trial procedures in place.  In 
particular, therapists indicated the usefulness and appropriateness of the 
therapy protocol both in terms of embedding the principles of Morita Therapy 
and as a practical guide to implementing the approach during treatment. 
7.2.4 A summary of participants’ views on the acceptability of the trial 
procedures 
A descriptive account of participants’ views on the trial procedures is 
summarised below.  An in-depth qualitative analysis including participant quotes 
is not included as this was not considered necessary to meet the objective of 
collecting this information (to identify any issues with the trial procedures which 
would require addressing before proceeding to a large-scale trial). 
Trial management 
Participants commented that trial participation was straightforward and not very 
onerous, although one participant noted that there were a lot of questionnaires.  
Participants noted that the trial was well run, organised and efficient.  One 
participant suggested that paying participants’ travel expenses would be helpful.  
Participants valued the communication received and flexibility offered for 
appointments.  Trial information was considered informative and succinct. 
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Whilst some discomfort was expressed due to a desire to receive Morita 
Therapy, generally participants were comfortable with randomisation, often due 
to understanding the need to randomise from a scientific perspective and/or a 
willingness to participate in the trial in order to potentially help others.  However, 
there was a mixture of participants who did and did not understand the nature 
and purpose of randomisation.  Several participants had not understood the 
difference between being eligible for the trial and being randomised, and some 
had not realised that they would be asked to complete follow-up questionnaires 
if randomised to treatment as usual. 
AccEPT Clinc 
Participants noted that it was easy to arrange therapy appointments and that, 
whilst not offering sufficient parking, the clinic building was pleasant.  Some 
unique difficulties were expressed: one participant was unable to enter the 
building for arranged out-of-hours appointments and their clinic discharge letter 
was sent to the wrong GP; one participant commented that the clinic 
receptionist could have been more enabling for patients, such as being 
forthcoming with directions. 
Morita Attitudinal Scale for Arugamama (MASA) 
Although generally considering the MASA questionnaire relevant to the changes 
they experienced during treatment, participants indicated that the clarity of the 
questionnaire could be improved.  Firstly, the questionnaire specified no 
timeframes within which to consider the relevance of each statement.  
Secondly, the wording of some statements was considered confusing and/or 
ambiguous, such as which ‘situation’ to consider for the statement “I thought 
about the situation all the time”.  Some participants would have also preferred 
labels which they understood, rather than, for example, “SKS Subscale”.  
Finally, some participants disagreed that some statements with which 
agreement was intended to score ‘negatively’ were indeed negative from a 
Moritian perspective.  For example, agreement with the statement “I have 
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thoughts that I cannot stop” was considered to show a helpful awareness of 
their lack of control, as opposed to an unhelpful desire to stop thoughts. 
Summary 
Care should be taken in ensuring participants’ understanding of the 
randomisation process, and minor amendments to the MASA questionnaire 
would be helpful.  However, overall, participants indicated that the trial was well 
run and raised no issues which suggest that the procedures of a large-scale trial 
should not mirror this pilot trial. 
7.2.5 Connecting threads across participants’ and therapists’ views of 
Morita Therapy 
There are several key threads running through both the participant and therapist 
data on acceptability which are brought together in this section in order to 
demonstrate the convergence of views between participants and therapists, and 
the key findings in relation to the overall question: how acceptable is Morita 
Therapy to participants and therapists?.  Figure 16 (overleaf) presents these 
links, including relevant constituent themes, colour-coded as referred to in each 
section below.  Although both participants and therapists spoke about some 
aspects of treatment which the other group did not, no clear disagreements 
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Figure 16. Connecting threads across participant and therapist data on acceptability 
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Value and impact 
Participants and therapists spoke of the value and impact of Morita Therapy in 
similar terms (Figure 16, coded orange).  Thus, therapists and many 
participants valued the underlying principles of Morita Therapy such as 
accepting and allowing symptoms as natural phenomena, working with the 
authentic self and focusing on action-taking.  Similarly, they both described the 
impact of Morita Therapy in terms of the value of acceptance, a freedom from 
former restrictions and/or progression towards more active and meaningful 
living, and an improvement in symptoms as a by-product of such changes. 
Moderators of acceptability 
A key issue running through the accounts of both therapists and participants is 
the importance of patients relating to the Morita Therapy principles (Figure 16, 
coded red), with therapists also indicating the importance of the principles 
chiming with their own beliefs and lifestyles in facilitating their delivery of 
therapy.  Participants highlighted the ways in which their prior experiences, 
insights and expectations essentially primed them for such identification, and 
this ability to identify with the principles manifested as a key moderator of 
acceptability: the accounts of participants who found Morita Therapy acceptable 
fell within this typology, whereas the accounts of participants who did not find 
Morita Therapy acceptable fell within the typology captured by theme one, 
whereby participants held expectations and understandings of treatment which 
were incompatible with Morita Therapy and ran counter to the principles. 
Therapists similarly highlighted patients’ ability to grasp and internalise the 
Morita Therapy principles as the defining factor when considering potential 
moderators of acceptability and engagement.  As per the participant data, 
therapists connected this ability to relate to the principles with patients’ prior 
insights into their symptoms, orientation towards nature, extent of openness 
towards treatment, and readiness to accept difficulties.  Data from both 
participants and therapists further indicates that this identification with and 
grasping of the Morita Therapy principles is central to whether or not patients 
benefitted from treatment: “For patients who really grasped the principles I 
CHAPTER SEVEN: MIXED METHODS FEASIBILITY STUDY: RESULTS 
PART TWO: QUALITATIVE RESULTS  
286 
 
would say they would, as a kind of side-line almost, they will have experienced 
improvement in their symptoms” (TH01). 
In indicating certain patient presentations for which they had found Morita 
Therapy more difficult to deliver, therapist data also supports the participant 
typology capturing how incompatible expectations and understandings of 
treatment are associated with viewing Morita Therapy as unacceptable.  Thus, 
therapists highlighted that patients who “wanted to be treated for their 
symptoms” (TH01) or sought a “more talking framework” (TH02) were less likely 
to find Morita Therapy beneficial. 
Principles versus practice 
The distinction between Morita Therapy in principle and practice, and the 
challenges of translating the principles into practice, ran through both 
participants’ and therapists’ accounts (Figure 16, coded purple).  Whilst 
therapists described several components of delivering Morita Therapy which 
had at times facilitated their translation of the principles into practice, they also 
indicated that these same components could pose challenges for both 
themselves and patients in practice, largely depending on the patient in 
question.  Similarly, participants highlighted the challenges of engaging with the 
process and practicalities of therapy.  Key difficulties raised by both participants 
and therapists related to engaging with the treatment phases, especially rest, 
and completing diaries. 
Understanding the purpose 
Some of the challenges therapists described in relation to patients’ 
understanding of treatment components such as the phases also chime with the 
participant data (Figure 16, coded pink).  Thus, therapists indicated that some 
patients grasped the purpose of each treatment component as a means of 
progressing through a learning process, whereas others “used it as a kind of fix” 
(TH01).  This concurs with the analysis of participant data: participants who 
found Morita Therapy acceptable and were more likely to tolerate the 
challenges of engaging with the approach tended to accurately understand the 
treatment components as part of a progressive process providing opportunities 
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to learn and refocus attention; those who did not find Morita Therapy acceptable 
tended to mistakenly attempt to isolate each treatment component as a 
potential technique for overcoming symptoms. 
Experience versus intellect 
In considering how to sufficiently embed the principles for patients alongside 
potentially overcoming some of the practical challenges highlighted, whilst 
noting that “the experiential part is necessary” (TH01) for patients to learn 
important lessons therapists also suggested that some patients might be able to 
embed the principles (thus benefitting from treatment) without engaging in the 
whole process.  This is potentially supported by the accounts of multiple 
participants who spoke of the value and impact of having learned about the 
Morita Therapy principles without having engaged in treatment beyond the rest 
phase (e.g. MT15; MT50); however, similarly to the therapists (Figure 16, coded 
green), many participants did stress the importance of a degree of experiential 
progression.  Thus, the means by and degree to which the principles of Morita 
Therapy are most helpfully translated into practice remains an issue for further 
discussion. 
Trial procedures 
Both therapists and participants, whilst making suggestions for minor 
improvements, signified that the trial procedures were largely acceptable.  
Therapists indicated that they had been well equipped and supported through 
the trial, training, supervision and therapy protocol; patients indicated that the 
trial was well run and raised no issues which suggest that the procedures of a 
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CHAPTER SEVEN.  PART THREE. 
Results of the mixed methods analysis of the relationship between 
treatment adherence and acceptability 
This part of Chapter Seven reports the results of the mixed methods analysis 
undertaken to answer the question: how do participants’ views about Morita 
Therapy relate to the variability in the number of treatment sessions they 
attend?.  The results are presented using three forms of joint display: a 
typologies and statistics display to explore how treatment adherence varies for 
participants whose views on acceptability are organised into different typologies 
(7.3.1); a categories and themes display to explore views across participants 
with various degrees of treatment adherence (7.3.2); a case-oriented merged 
analysis display to integrate views and the number of treatment sessions 
attended for each participant (7.3.3).  A summary of key findings is provided in 
section 7.3.4. 
7.3.1 Typologies and statistics display 
This technique was driven by the qualitative data.  Thus, firstly, typologies of 
participants’ views on the acceptability of Morita Therapy were developed from 
the qualitative data (Figure 17, overleaf).  Five typologies were derived from the 
16 interviews analysed.  Whilst the size of each typology within Figure 17 
represents the number of participants whose views fall within that typology, it 
should be noted that a sub-sample of interviews were selected for analysis on 
the basis of treatment adherence amongst other factors, and that these 
‘weightings’ are therefore only applicable within this sample and are not 
considered generalisable beyond this.  Each typology is described in detail 
alongside example participant vignettes to illustrate the key features which 
define each typology. 
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Figure 17. Typologies of acceptability 
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The typologies are displayed along two continuums of acceptability relating to 
(a) the principles and (b) the practice of Morita Therapy, reflecting how this 
distinction between Morita Therapy in principle and practice ran through 
participants’ qualitative accounts: the qualitative analysis indicated both the 
importance of participants holding compatible expectations and understandings 
of treatment which enabled their identification with the Morita Therapy 
principles, and the challenges of translating these principles into a process 
which is feasible for participants to engage with.  Thus, the x axis (from 
unacceptable principles to acceptable principles) represents the extent to which 
the Morita Therapy principles, such as the connection to nature, focus on 
action-taking and desires, and concept of the vicious cycle, as well as the 
underlying premise of accepting and allowing unpleasant thoughts and 
emotions, were considered acceptable by participants; the y axis (from 
unacceptable practice/ process to acceptable practice/ process) represents the 
extent to which the process and practice of Morita Therapy, such as 
engagement in the four phases and completion of daily diaries, were considered 
acceptable by participants. 
Secondly, for each typology, data are presented on treatment adherence for 
participants to whom the typology applies (Table 27, overleaf).  Data are 
organised by typology: the number of treatment sessions attended by 
participants for whom both the principles and practice were unacceptable are 
presented at the top of the table; the number of treatment sessions attended by 
participants for whom both the principles and practice were acceptable are 
presented at the bottom of the table.  To provide further context for this 
information and enable the exploration of how the data also relate to 
quantitative treatment outcomes, participants’ reasons for withdrawing from 
treatment and whether or not they demonstrated a response to treatment 
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Table 27. Joint typologies (acceptability) and statistics (adherence) display 




Reason for withdrawing from treatment                           





protocol?2 Each Mean 
Principles: unacceptable 
(incompatibility with 





Discomfort with writing about self in diary; failure of 
rest to meet expected purpose 
No Yes 
MT19 5 
Pressure of completing phases in absence of 
therapy fulfilling expected purpose 
No Yes 
MT51 5 
Lack of techniques provided; challenges of rest in 
context of not fulfilling expected purpose 
No Yes 
MT28 7 
Pressure of completing phases in absence of 
therapy fulfilling expected purpose 
No Yes 
Principles: mixed (some incompatible 
expectations); Process/practice: mixed 
treatment related and non-treatment 
related challenges (insurmountable) 
MT54 1 N/A 
Time difficulties with rest/diary; difficulties with 






Principles: mixed (some incompatible 
expectations); Process/ practice: 
acceptable (some challenges; 
tolerated/ worthwhile) 
MT58 9 N/A N/A No N/A 
Principles: acceptable (strong 
identification with principles); 
Process/practice: mixed treatment 








MT50 2 Safety issues (personal relationships) during rest Yes N/A 
MT15 3 




Time difficulties with attending sessions; no longer 
felt need for therapy 
Yes N/A 
Principles: acceptable (strong 
identification with principles);  
Process/ practice: acceptable (some 
challenges; tolerated/ worthwhile) 
MT33 9 
10.8 
N/A Yes N/A 
MT63 10 N/A Yes N/A 
MT45 11 N/A Yes N/A 
MT55 11 N/A Yes N/A 
MT16 12 N/A Yes N/A 
MT43 12 N/A Yes N/A 
1Treatment response defined as follow-up PHQ-9 score <10; 2Therapist fidelity to the protocol assessed where issues with the acceptability of the 
principles/ understanding of treatment were indicated i.e. where an incorrect purpose was assigned to rest. N/A=not applicable.
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Typology one. The typology that appears at the bottom left of Figure 17 
represents the views of participants (MT19; MT28; MT51; MT61) who 
considered both the principles and practice of Morita Therapy unacceptable.  
These participants all expressed understandings of, expectations or hopes for 
treatment which were incompatible with Morita Therapy, such as seeking a 
solution for symptoms (with their accounts comprising participant qualitative 
theme one: the impact of incompatible expectations and understandings).  They 
also expressed challenges of engaging with treatment which they considered 
insurmountable, such as the pressure of completing the activities associated 
with the treatment phases (see participant qualitative theme four: facilitating the 
process: (overcoming) challenges and barriers).  Rarely were such challenges 
expressed as insurmountable because they were in the context of participants’ 
demanding personal circumstances, such as a lack of time to complete the 
phases; rather, participants within this typology focused on the challenges of 
treatment regardless of their personal circumstances. 
Example vignette.  MT61 approached treatment hoping for an 
opportunity to open-up and express themselves, and seeking answers to 
enable them to stop unpleasant thoughts and feelings.  They struggled to 
identify with the principles of Morita Therapy, with neither the ebb and 
flow of emotions nor understanding emotions through reference to nature 
resonating for them.  They also misunderstood the purpose of rest as an 
opportunity for the therapist to analyse their sleep, potentially to find out 
more about them on an unconscious level, and felt that it was unrealistic 
to schedule and report on their own sleep in this way.  They withdrew 
from treatment after three sessions due to the discomfort of writing about 
themselves in the diary, in the context of disliking themselves. 
Table 27 indicates that these participants who found both the principles and 
practice unacceptable attended, on average, five treatment sessions (range 3-
7) of a maximum of twelve before withdrawing from treatment for treatment-
related reasons.  None of these participants demonstrated a response to 
treatment.  For this typology, participants’ incompatible expectations of 
treatment were associated with inaccurate understandings of treatment (in all 
cases, relating to the purpose of the rest phase) (see participant qualitative 
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theme one).  Therefore, to explore whether these misunderstandings were a 
product of the therapists’ particular explanation of therapy, as opposed to the 
UK Morita Therapy protocol itself, therapist fidelity to the therapy protocol was 
assessed for each relevant therapy session.  It was found that in all cases 
therapists showed fidelity to the therapy protocol in explaining the rest phase 
(Table 27), and thus a lack of therapist fidelity does not account for these 
misunderstandings. 
Typology two. In contrast to typology one, the typology that appears at the top 
right of Figure 17 represents the views of participants (MT16; MT33; MT43; 
MT45; MT55; MT63) who considered both the principles and practice of Morita 
Therapy acceptable.  These participants all identified with and were receptive to 
the Morita Therapy principles, such as the underlying premise of accepting and 
allowing unpleasant thoughts and emotions and/or components of the approach 
such as the connection to nature (as per participant qualitative theme two: 
identifying with the principles of Morita Therapy: receptivity and relevance).  In 
addition, whilst typically expressing some challenges of engaging in treatment 
such as the discomfort of rest (see participant qualitative theme four: facilitating 
the process: (overcoming) challenges and barriers), these participants 
considered them tolerable and worthwhile.  These views appeared to be 
facilitated by these participants’ accurate understandings of the elements of 
treatment as part of a progressive process for learning and re-focusing 
attention, as opposed to features which should be enjoyable or effective in 
reducing symptoms (as per participant qualitative theme three: understanding 
and approaching Morita Therapy as a process). 
Example vignette.  MT63 was attracted to and identified strongly with the 
underlying premise of therapy in terms of re-orientating in nature and 
understanding unpleasant thoughts and emotions as part of the natural 
human experience.  Whilst noting that sitting alone with their thoughts 
was a terrifying experience, they understood the purpose of rest and 
learned the futility of engaging in the vicious cycle, as per their normal 
coping strategies.  Thus, they considered these challenges worthwhile in 
terms of the lessons they learned.  They also described the diary and 
spending time in nature in terms of teaching them how all things naturally 
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pass.  They highly appreciated therapy as a natural process of self-
discovery which the therapist gently guided them through, and noted the 
value of an experiential approach which affected them on visceral, 
emotional and intellectual levels.  They experienced a strong impact of 
therapy in terms of normalising difficulties, increasing action-taking, 
decreasing self-criticism and symptoms.  Compared with other 
treatments, such as MBCT, they felt that Morita Therapy had 
fundamentally changed their attitude towards and acceptance of 
difficulties, as opposed to providing strategies for tackling symptoms 
which potentially contribute to the vicious cycle. 
Table 27 indicates that these participants who found both the principles and 
practice acceptable attended, on average, 10.8 treatment sessions (range 9-
12).  All of these participants completed treatment and demonstrated a 
response to treatment. 
Typology three. The typology that appears on the right of the x axis and middle 
of the y axis of Figure 17 represents the views of participants (MT15; MT17; 
MT37; MT50) who, whilst similarly identifying with the Morita Therapy principles 
as per participant qualitative theme two (‘identifying with the principles of Morita 
Therapy: receptivity and relevance’), experienced more significant challenges 
with the process and practice of therapy (see participant qualitative theme four: 
facilitating the process: (overcoming) challenges and barriers).  Typically, these 
challenges related to the time commitment of therapy, as well as difficulties with 
the discomfort and fear associated with rest, which these participants 
considered insurmountable in the context of their personal circumstances such 
as work and family commitments.  Thus, unlike the views of participants within 
typology one, these participants were keen to continue treatment (which 
connected to their identification with the principles) and generally accurately 
understood the components of treatment as part of a process for learning and 
re-focusing attention (as per participant qualitative theme three: understanding 
and approaching Morita Therapy as a process) but found it unfeasible to 
engage with the treatment at this point in their lives. 
Example vignette.  MT50 found that all of the principles strongly 
resonated with them: understanding human emotion as cyclic and 
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through reference to nature, both learning to be with unpleasant thoughts 
and emotions and learning to take small steps of action, and nurturing 
one’s authentic self.  Accordingly, they had hoped treatment would help 
them to be more at ease with their feelings and to take more action which 
was true to their values.  They expressed an accurate understanding of 
the purpose of therapy as a process for learning.  They engaged in one 
day of rest and, whilst noting the discomfort of the experience, also noted 
the valuable lesson they had learned in terms of realising unpleasant 
thoughts and emotions come and go.  They would have liked to continue 
therapy but withdrew after two sessions as they felt unsafe resting at 
home in the context of a threatening neighbour.  They expressed a 
significant impact of treatment in terms of knowing difficulties will pass, 
like the weather, and thus having more acceptance and less fear of their 
symptoms, consequently finding they pass more quickly.  They noted 
that Morita Therapy is a philosophy for life whereas other treatments 
offer short-term fixes and risk highlighting and exacerbating symptoms. 
These participants who found the principles acceptable and practice 
unacceptable withdrew because of the practical challenges of engaging with 
treatment in the context of their personal circumstances, alongside at times 
feeling that they no longer required therapy (Table 27).  They attended, on 
average, 3.5 treatment sessions (range 2-7) and all but one (MT17) 
demonstrated a response to treatment, although MT17 did show an 
improvement in symptoms.   
Typologies four and five. Within the sample of interviews analysed, the 
typologies in the middle of the x axis of Figure 17 were more anomalous, 
representing two participants (MT58; MT54) with mixed views on the 
acceptability of the principles: some identification with and/or positive views of 
the principles were expressed, whilst some incompatible expectations and 
hopes for treatment were also held, and thus the accounts of these participants 
fell within both participant qualitative themes one (‘the impact of incompatible 
expectations and understandings’) and two (‘identifying with the principles of 
Morita Therapy: receptivity and relevance’). 
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Firstly, MT58 (typology four) expressed identification with certain principles such 
as the vicious cycle and conceptualising fears and desires as two sides of the 
same coin.  However, they also sought to overcome their difficulties through 
treatment, and tended to isolate each treatment component such as light 
activities and nature as potential tools for tackling or distracting from symptoms.  
They expressed challenges of engaging with treatment related to these 
inaccurate understandings of the purpose, such as struggling to engage in rest 
without being distracted.  However, they considered the challenges tolerable 
and did not refer to difficulties in the context of demanding personal 
circumstances.  They indicated some benefits of treatment, such as reduced 
self-criticism and engagement in the vicious cycle, but intended to seek 
counselling in order to work through some challenges of their past and 
continued to hope that they would overcome their difficulties in the future.  
MT58 completed treatment at nine sessions but did not demonstrate a response 
to treatment (Table 27). 
Secondly, MT54 (typology five) expressed interest in the theory and ideas of 
Morita Therapy, and stated they were interested in therapy involving a process.  
However, they had been receiving private counselling which they could no 
longer afford; thus, ideally they would have continued this type of treatment.  As 
such, they struggled with Fumon (therapists’ inattention to symptoms), feeling 
that this shut them down and inhibited their ability to build rapport with the 
therapist.  They also expressed significant challenges associated with the time 
commitment of rest and diary completion in the context of their childcare 
commitments.  Whilst disappointed not to continue with treatment, they 
withdrew for these reasons after attending one session (Table 27).  Although 
demonstrating a response to treatment, they attributed this to changed life 
circumstances rather than therapy. 
Summary. Overall, the two continuums (acceptability of principles; acceptability 
of practice) utilised in the development of typologies of participants’ views both 
appear to play a role in explaining treatment adherence as well as being 
associated with whether participants respond to treatment.  With regards to 
treatment adherence, generally participants who experienced significant 
challenges in engaging with the process of therapy in the context of their 
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personal circumstances attended the fewest number of sessions, withdrawing 
for these reasons regardless of the extent to which they identified with the 
principles.  Participants who did not identify with the principles and, largely in 
light of this, found the process of treatment unacceptable (regardless of their 
personal circumstances) generally attended more sessions, but did not 
complete treatment.  Participants who identified with the principles and 
experienced challenges of the treatment in practice which they considered 
worthwhile attended the most sessions, and all completed treatment. 
In terms of treatment response, participants’ views on the principles and extent 
to which they identify with these appear to be a key factor, over and above the 
number of treatment sessions attended or challenges experienced with the 
process of therapy.  Thus, those participants who strongly identified with the 
principles generally demonstrated a response to treatment, largely regardless of 
treatment adherence; those who did not find the principles acceptable or had 
mixed views on the acceptability of the principles did not respond to treatment, 
again largely regardless of treatment adherence. 
7.3.2 Categories and themes display 
This technique was driven by the quantitative data.  Thus, categories of 
participants defined by their treatment adherence were identified, and similar 
and different views on the acceptability of Morita Therapy within and between 
these categories are presented (Table 28, overleaf).  Categories of treatment 
adherence include those who completed treatment at the top of the table, those 
who withdrew from treatment having attended five or more sessions (the 
minimum treatment dose), and those who withdrew from treatment having 
attended fewer than five sessions at the bottom of the table. Participants’ views 
are presented in terms of the five themes identified in the participant qualitative 
analysis; constituent themes from the qualitative analysis are referred to as 
relevant within each cell.  To ease identification of the extent to which 
participants within each category of treatment adherence expressed views 
associated with each qualitative theme, references to the (number of) 
participants with views captured within that theme are included in bold text. 
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Identifying with the 





Therapy as a process 
Facilitating the process: 
(overcoming) challenges 
and barriers 
The value and impact of 
Morita Therapy2 
Completed 








from all but 
MT58) 
Single entry (MT58): 
hoped to become “a 
whole new person” and 
sought tools to 
overcome difficulties; 
misunderstood rest as 
a time when they 
should turn off 
thoughts. 
All participants 
indicated a readiness 
to accept difficulties; 
this was less 
apparent with MT58 
although they 
identified strongly 
with the vicious 
cycle.  The features 
of connecting to 
nature, action-focus 
and/or working with 
desires resonated for 
all.  
All participants except 
MT58 understood the 
elements of treatment as a 
means of learning, 
enabling action and/or 
refocusing attention. Most 




willingness to trust the 
process; and valued the 
therapy making them think. 
MT33/ MT55/ MT63 valued 
the experiential focus.    
All participants except 
MT45 indicated 
challenges, particularly 
in terms of the time 
commitment and fear 
and discomfort around 
rest. All considered 
challenges worthwhile in 
the context of the 
learning they facilitated. 
All participants 
described the value of 
accepting unpleasant 
thoughts and emotions, 
related sense of 
empowerment/ liberation, 
and positive impact on 
mood/ symptoms. Most 
indicated a transition from 
dwelling on symptoms to 
activity and external 
focus. All except MT58 
described the therapy as 
preferable to other 
approaches e.g. CBT/ 
counselling. 









Theme dominated by 
entries from MT19/ 
MT28/ MT51: all sought 
a cure or “resolution” of 
difficulties, and self-
expression or analysis.  
All misconstrued the 
purpose of rest in these 
terms and generally 
believed they should be 
“switching off” rather 
than experiencing 
thoughts during rest. 
Single entry (MT37): 
readiness to accept. 
Others indicated 
some attraction to 
the use of the natural 
world, but rarely as a 
way of understanding 
emotions. 
Single entry (MT37): 
sense of open-
mindedness/ allowing 
purpose to unfold through 
engagement with therapy; 
appreciation of the therapy 




in terms of the time 
commitment and 
pressure of activities.  
MT51 also described the 
challenges of rest in the 
absence of techniques 
to manage thoughts/ 
emotions.  Challenges 
were not considered 
worthwhile. 
Single entry (MT37): 
preferred approach to 
other therapies; indicated 
an acceptance of 
difficulties, decreased 
avoidance and worry, and 
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(MT61): sought a 
solution to difficulties 
and in-depth analysis; 
understood rest as an 
analysis of sleep. MT54 




(MT15/ MT17/ MT50): 
readiness to accept 
difficulties alongside 
identification with 
elements of therapy 
such as the 




had some interest in 
ideas/ process. 
Significant entries (MT15/ 
MT50); minor entry 
(MT17): understood rest 
and natural world 
metaphors as means of 
learning about the nature of 
emotions.  MT50 also 
valued the gradual, 
nurturing, experiential 
process. 
All participants indicated 
significant challenges, 
typically in the context of 
their personal lives i.e. an 
inability to dedicate the 
required time to therapy 
or unavailability of a safe 
space for rest. MT61 was 
unwilling to write about 
self in diary. Challenges 
were barriers to treatment 
(i.e. participants’ reasons 
for discontinuing therapy). 
Significant entries 
(MT15/ MT17/ MT50): 
described the value of 
accepting emotions, a 






taking.  MT15/ MT50 
also described a 
positive impact on 
mood/ symptoms. 
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The results indicate that participants who completed treatment very rarely 
expressed incompatible expectations or hopes for treatment (the single 
participant who did so was the single participant in this category who did not 
respond to treatment (MT58)), instead all indicating identification with the 
principles, particularly in terms of a readiness to accept difficulties as well as a 
connection to other significant features of therapy such as the natural world.  All 
participants (except MT58) indicated an understanding of therapy as a process 
and means of learning, enabling action and/or refocusing attention, and typically 
appreciated the gradual and individualised nature of this process as well as 
indicating an open-mindedness towards treatment and an enjoyment of therapy 
‘making them think’.  Several participants appreciated the experiential nature of 
treatment.  Most participants experienced challenges with the process and 
practical elements of treatment, but considered these tolerable and/or 
worthwhile in terms of the changes they induced.  All of these participants 
described the value and impact of Morita Therapy in terms of acceptance, 
empowerment and effect on symptoms; most indicated a transition ‘from 
dwelling to doing’ and described Morita Therapy as preferable to other 
approaches such as CBT. 
The views of participants who withdrew having attended five or more sessions 
may be seen in contrast to the views of those who completed treatment.  These 
participants’ views dominated the theme ‘the impact of incompatible 
expectations and understandings’: most of these participants sought or 
expected a different approach, which shaped their (largely negative) views of 
Morita Therapy.  Accordingly, whilst occasionally expressing a positive view of a 
feature of Morita Therapy such as the connection to the natural world, these 
participants rarely expressed a strong identification with or receptivity to the 
principles of therapy.  The one exception to this (MT37) is shown by the single 
participant in this category who responded to treatment despite withdrawing; 
similarly, MT37 is the only participant within this category who indicated an 
open-mindedness towards treatment and an appreciation of the treatment 
‘making them think’, and the only participant who described the value and 
impact of Morita Therapy.  All of these participants expressed significant 
treatment-related challenges which were not considered worthwhile, typically 
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relating to the time commitment and feeling a sense of pressure and failure 
around the completion of activities associated with the treatment phases. 
For participants who withdrew having attended fewer than five sessions, views 
were more mixed.  One participant in this category (MT61) expressed significant 
incompatible expectations and understandings of treatment, whilst one other 
(MT54) expressed minor incompatible expectations and understandings.  The 
other three participants (MT15; MT17; MT50) expressed a strong identification 
with the principles of therapy, particularly in terms of a readiness to accept 
difficulties alongside a connection to other elements of treatment; these 
participants also indicated an understanding of therapy as a process and means 
of learning, with MT50 in addition appreciating the gradual and experiential 
nature of this process.  These same participants also described the value and 
impact of Morita Therapy, particularly in terms of acceptance and 
empowerment.  All of these participants indicated significant challenges with the 
practicalities of engaging with treatment, such as time difficulties, typically in the 
context of their personal circumstances and commitments, which in all cases 
accounted for their withdrawal from treatment.   
7.3.3 Case-oriented merged analysis display 
Data on participants’ views on acceptability and the number of treatment 
sessions they attended are integrated in a case-oriented display, organised 
according to the quantitative data (Table 29, p.304).  This table positions 
participants on a scale of treatment adherence (from one to twelve sessions 
attended) alongside summaries of their qualitative data and whether they 
demonstrated a response to treatment (defined as a PHQ-9 <10 at follow-up).  
The qualitative data presented reflect that contained within the typologies 
(section 7.3.1) and categories (section 7.3.2) tables discussed above, and has 
been further classified into views which are ‘positive’, ‘mostly positive’, ‘mostly 
negative’ and ‘negative’.  
For participants who attended five or fewer sessions (n=7) views were mixed, 
as reflected in the discussions above.  Three of these participants (MT17; 
MT50; MT15), who attended either two or three sessions, expressed mostly 
positive views of therapy, indicating a strong identification with the principles 
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and a good understanding of the purpose of therapy as a process for learning.  
They all expressed a reluctant withdrawal from treatment due to significant 
difficulties engaging with therapy in the context of personal circumstances and 
commitments, such as time constraints and unsafe home environments in which 
to undertake rest.  Two of these participants demonstrated a response to 
treatment, whereas MT17 described some impact of treatment and did show 
improved quantitative scores. 
The remaining four participants (MT54; MT61; MT19; MT51) who attended 
between one and five sessions all expressed negative or mostly negative views 
of therapy which are comparable in nature and dominated by incompatible 
expectations of treatment and a lack of identification with the principles, 
although MT54 showed more interest in the process and theory of the 
approach.  Thus, all of these participants sought to overcome their symptoms 
and/or a more counselling-based mode of discussing their difficulties.  Similarly, 
they showed misunderstandings of the purpose of treatment, misinterpreting 
rest in particular as a means of relaxing, switching off unpleasant thoughts or 
receiving a form of sleep-analysis.  These participants all expressed treatment-
related challenges such as the pressure of completing the phases, difficulties 
with Fumon (therapists’ inattention to symptoms) or discomfort completing the 
diary, which led to their withdrawal from therapy.  MT54 also struggled with the 
time commitment of therapy in the context of their personal circumstances.  
Only one (MT54) of these participants responded to treatment; however, they 
did not attribute this improvement to therapy. 
One of two participants who attended seven sessions (MT37) expressed mostly 
positive views of therapy, comparable to the views expressed by those who 
attended more sessions (see below).  This participant identified with the 
principles and expressed some understanding of the purpose of therapy as a 
process.  They reluctantly withdrew from treatment due to the time commitment, 
demonstrated a response to treatment and considered the approach preferable 
to CBT.  The other participant (MT28) who attended seven sessions expressed 
mostly negative views of therapy.  They held incompatible expectations and 
understandings of treatment, seeking a means to remove unpleasant thoughts 
and understanding rest as a time to switch off such thoughts.  They withdrew 
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due to a sense of pressure to engage with the practical elements of treatment, 
and did not demonstrate a response to treatment. 
Participants who attended nine or more sessions all expressed either positive or 
mostly positive views of Morita Therapy which are similar in nature, indicating 
strong identification with the principles and the acceptability of both the 
principles and practice of therapy.  Despite some challenges of engaging with 
treatment, particularly in terms of the time commitment and discomfort of rest, 
all but one (MT58) of these participants understood the purpose of the 
treatment elements as a means of learning and/or refocusing attention, and 
appreciated and understood Morita Therapy as a progressive process.  Thus, 
all of these participants considered the practical challenges worthwhile.  All but 
one (MT58) of these participants demonstrated a response to treatment; MT58 
was the only participant who held some incompatible expectations of treatment 
in terms of seeking tools, and thus tended to isolate the treatment elements as 
a means of overcoming or distracting from symptoms.  These participants 
generally expressed a preference for Morita Therapy in comparison to other 
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Table 29. Case-oriented merged analysis display 
ID Views of Morita Therapy1 
No. sessions attended Treatment 
response2 
  1 2 3 4 5 6 7 8 9 10 11 12  
MT54 
Mostly negative. Interest in ideas/ process (“it was interesting that 
there was a process… I was interested in the ideas behind it”). 
However, incompatible hopes for treatment (“I’d also been seeing a 
[counsellor]… he was really great, but I couldn’t afford that anymore”) 
and some inaccurate understandings of rest (“they’re telling me that 
I’m really anxious and I need a holiday”). Withdrew due to difficulties 
with Fumon (“I felt that I was being shut down”) and the time 
commitment of rest (“getting a deep rest with childcare 
responsibilities was just impossible”). No impact. 






Mostly positive. Attracted to principles of acceptance, understanding 
through nature and action-focus (“it sounded like a nice way of 
looking at things… living with it and getting on with things”). Identified 
with emotions as cyclic (“I know from my experience that my 
depression comes and goes”). Understood therapy as a process for 
“building yourself up”. Withdrew due to difficulties attending sessions 
around work (“even though I wanted to do it…I just don’t have the 
time”). Some impact in terms of changed perspective and increased 
acceptance (“[It] made me look at things slightly differently… I’m less 
likely to give myself a hard time for having a bad day”). Preferred to 
CBT as “less judgemental and conflicting”. 
 •           No (though improved) 
MT50 
Mostly positive: “It is a very valuable form of therapy”. Principles of 
acceptance, nature and authentic self resonated (“it really 
resounded…your thoughts and feelings as part of a circle that comes 
and goes”). Attracted to experiential process with “small steps” of 
action-taking. Good understanding of purpose of rest (“you realise 
your anxiety gets to a certain point…but it doesn’t get any further and 
it’s not the end of the world, it just goes!”). Withdrew “because of my 
neighbour who was being threatening and harassing, I didn’t feel safe 
to sit in that environment” during rest. Impact in terms of increased 
acceptance/ decreased symptoms (“you might feel bad, just be with it 
and it will pass. So that’s been really helpful… I’ve improved quite 
markedly”). Preferred to therapy which focuses on symptoms as 
“that’s just gonna highlight them and make them worse”; whereas 
Morita Therapy is “a philosophy to take you through life”. 
 •           Yes 
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Mostly positive. Identified with acceptance/vicious cycle (“learning to 
accept that those are my difficulties and yes they’ll come and go… 
that is exactly how I’ve experienced it”). Difficulties with lack of 
support from partner and discomfort of rest, though understood the 
purpose (“all those thoughts and feelings that kept coming and going, 
that was a really big moment…in realising how much I do battle with 
my own feelings”). Withdrew because “trying to get the rest period 
into my life was quite difficult” and “I realised how far I’ve actually 
come” so no longer felt need for therapy. Some impact through 
reduced fear/ engagement in the vicious cycle, and increased activity 
(“it definitely helped me already in terms of just that mind-set of ‘don’t 
try and push everything away all the time’ and you can still do things 
even if things are feeling difficult for you”). 
  •          Yes 
MT61 
Negative. Significant incompatible expectations (“I was hoping that it 
would give me a chance to express myself”; “people are looking for 
answers…to stop these thoughts or feelings”). Significant inaccurate 
understandings of rest (“they said that we were gonna analyse your 
sleeping thing and arrange for you to sleep… [perhaps] trying to find 
out more about the person on an unconscious level”). Principles did 
not resonate (“I can see the similarities, but does nature have a 
brain?”). Withdrew due to diary (“I don’t even like myself, so I’m not 
really that keen on writing about myself”). No impact. 
  •          No 
MT19 
Mostly negative. Some identification with connection to nature as a 
“nature boy”, but significant incompatible expectations (“I was hoping 
to find a way to resolve the problems that I had… I can’t think of any 
other goals other than to make one feel better”). Significant 
inaccurate understandings: rest misunderstood as a time to “switch 
off” thoughts and force emotion (“I couldn’t do the quiet time… I 
couldn’t do the sensing emotion on an on-demand basis”). Difficulties 
with Fumon in the diary as it “made it feel like [diary entry] wasn’t 
important”. Withdrew because “I couldn’t jump through the hoops that 
were being set… I felt pressurised”. No impact. 
    •        No 
MT51 
Mostly negative. Attracted to concept of “grounding yourself within 
nature” but “as a way of trying to calm and relax yourself”; nature 
metaphors did not resonate. Significant incompatible expectations 
(was looking to be “trained in different techniques that would be 
vastly different... almost ground breaking”). Related significant 
inaccurate understandings (e.g. with regards to rest: “if it was that 
easy we’d all just go and lie in a room with the lights off and we’d just 
conquer it that way”). Difficulties with Fumon as “you need someone 
to fill that void”. Withdrew because of a lack of techniques imparted 
    •        No 
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by the therapist and “I needed answers, I wanted to understand how I 
could correct it”. No impact. 
MT28 
Mostly negative. Significant incompatible hopes to stop unpleasant 
thoughts (“it’s like a computer, like it would only replace the chip, why 
can’t you do it in your head? It would just make you feel better”) and 
have someone to talk to (“I need someone to understand what’s in 
my head”), thus difficulties with Fumon. Significant inaccurate 
understandings: rest misunderstood as a time to “relax” by “letting go” 
of unpleasant thoughts, but “the thoughts just didn’t go”. Withdrew 
because “it was pressurising me into doing it… every day you had to 
remember certain things”. Very minor impact on attitude towards 
others: “If someone upsets me I just let it go…it does help you – it 
makes you, like, it learns you to let it go”. 
      •      No 
MT37 
Mostly positive: “I enjoyed it”. Identification with nature metaphors 
and underlying premise (“I knew I couldn’t change things, I mean, 
nobody can change what’s going on with the weather”). Some 
appreciation of therapy as a process for making you think and 
refocusing attention (“it’s things to take your mind off of what’s going 
on in your head”). Withdrew due to time difficulties in attending 
sessions (“it was becoming just impossible…I can’t divide myself in 
four different ways”). Significant impact in terms of changed outlook, 
increased activity/ acceptance, and decreased symptoms (“I don’t 
tend to worry about things… If it happens it happens”). No longer felt 
need for therapy. Preferred to CBT as “less superficial”. 
      •      Yes 
MT58 
Mostly positive: “It has definitely helped”. Some incompatible 
expectations (“I was just hoping that it would either, ideally, stop the 
depression altogether… [or] give me the tools to carry on”). Vicious 
cycle strongly resonated (“[that’s] the really big one for me - yeah, 
because I know I do that”). Difficulties with rest in terms of time 
commitment and discomfort (“I found the resting really, really 
difficult”). Misunderstood rest as a time to “switch off” thoughts and 
limited understanding of therapy as process, instead seeking “tools” 
(“[I use] nature more as a tool now”; “it’s brilliant for distraction from 
flying… the colouring really works”). Some impact in terms of 
increased acceptance/ activity, and decreased symptoms (“the 
vicious cycle, most of the time, doesn’t last as long as it would have”). 
However, still seeking counselling to “deal with baggage”. 
        •    No 
MT33 
Mostly positive: “It definitely worked”. Few expectations; natural world 
metaphors resonated (“‘cos of my hobby, so - enjoying the 
outdoors… using the weather as a way of describing Morita Therapy 
for me really worked”). Appreciated therapy as a process (with “no 
        •    Yes 
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timeframes”) for refocusing attention, learning to “be with” and 
“making you think”. Good understanding of therapy purpose (“it’s 
learning to – you can’t fight the weather, you can’t fight nature, so 
why fight the emotions”). Minor time difficulties with rest, but thought 
worthwhile (“the first phase was the hardest…but I think that’s the 
one you’ve got to break through”). Significant impact in terms of 
increased acceptance/ activity, and improved mood (“I’m not 
depressed anymore”). Noted distinction to CBT (“you just go with the 
emotions, instead of fighting with it…with CBT you tend to try and 
control what you’re doing whereas this was totally the opposite”). 
MT63 
Mostly positive: “It’s phenomenal”. Attraction to acceptance/ natural 
world element (“it was a way of getting back to nature and realising 
that it’s a part of you and part of the human experience”). Appreciated 
as an experiential “natural progression” which “hit me on a bit of a 
visceral level”. Good understanding of purpose (“I’ve been allowed to 
discover it, guided gently and then…it’s almost like nature teaches 
you”). Difficulties with rest but considered worthwhile for learning (“it 
was terrifying… [but] I can see why it was useful… Having to sit with 
uncomfortable emotions has made me realise that they pass”). 
Significant impact in terms of increased acceptance/ activity (e.g. “it’s 
normalised life for me”), and preferred to MBCT/counselling which 
were “short-term fixes” and “can become scab picking” (“I have done 
other work in the past but this seems to have struck a chord of 
change within, not just a ‘Right, this is a strategy’”). 
         •   Yes 
MT45 
Positive: “If I was designing a therapy, I would probably come up with 
something similar”. Significant prior insight into vicious cycle (“It just 
reinforced what I already hooked onto as a major problem for me”); 
acceptance, action-taking and Fumon strongly resonated (“It makes 
sense to me, the way my mind works, that I’m struggling against 
something I don’t need to struggle against”). Appreciated therapy as 
a process and good understanding of purpose (“we did one of those 
walk around the trees and just look, you know, in other words it’s 
pointless, this urge to fix this”; “it’s about moving your focus away 
from what’s going on inside to carrying on what’s going on in the real 
world”). Significant impact in terms of increased acceptance/ external 
focus, and decreased symptoms (“I’m interested in what I’m doing 
and I’m taking full part in it…I don’t even think about anxiety”). 
Preferred to CBT which “was feeding my need to fix myself”. 
          •  Yes 
MT55 
Mostly positive: “I don’t know how it works, but it does”. Few 
expectations; preferred not to know much. Vicious cycle/ connection 
to nature resonated (“I’m very much into the natural world, anyway”). 
          •  Yes 
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Difficulties with rest but considered worthwhile as understood the 
purpose (“that first stage of it, I hated… [But] I learned that you can 
get through it and come out the other side”). Appreciated therapy as 
a “brilliant, gradual process, it sort of – the first stage broke me down, 
and then it was, rebuild me”. Significant impact in terms of changed 
perspective, increased activity and improved mood (“it’s just made 
me look at things in a completely different way… It taught me how to 
not be ashamed of it”). Preferred to CBT which entails unrealistic 
expectations (“with the NHS, I felt that I was going to be cured…with 
this, it teaches you how to live with it, which is much more sensible”). 
MT16 
Mostly positive. Acceptance, the ebb and flow, and connection to 
nature resonated (“what I found really useful is to be able to relate 
how you’re feeling to patterns or what happens in nature”). 
Appreciated therapy as a process which “gave you structure” to 
“gradually build up your activity levels” and make you think. Good 
understanding of the purpose to “let your feelings actually become 
part of you rather than battling your feelings”. Minor difficulties with 
time commitment of sessions and diary as “cumbersome” and “a 
blank canvas”. Significant impact in terms of improved “confidence”/ 
mood, and job change (“[I’ve] come off my medication and actually 
feel a lot more positive and actually feel a lot better”). Preferred to 
CBT which “focuses on trying to change your way of thinking whilst 
Morita Therapy actually focuses on accepting your feelings and 
putting it into perspective and I found that a lot easier to understand”. 
           • Yes 
MT43 
Mostly positive: “I wish people had access to it”. Was “interested in 
the theory and attracted to the…natural world element”. Appreciated 
therapy as a helpfully “bite-sized” process for learning, accepting 
difficulties and enabling action (“through the process you appreciate 
that it’s part of the natural world to actually feel the way you do, and 
stop fighting”). Good understanding of purpose (“it’s trying not to 
control your feelings and having that rest and just seeing what 
happens, and that they come and go”). Minor difficulties in terms of 
“explaining therapy to others”, diary as “onerous” and rest (“there 
were periods when it was quite upsetting”). Significant impact in 
terms of increased acceptance/ action-taking (“getting out of the cycle 
of depression, it’s because you’re doing things rather than just 
dwelling on them”). Preferred to CBT as “a much more holistic way, 
and I felt that CBT was a bit of a toolkit”. 
           • Yes 
1CBT=Cognitive Behavioural Therapy; MBCT=Mindfulness-based Cognitive Behavioural Therapy; 2Treatment response defined as post-treatment 
PHQ-9 score <10.
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7.3.4 Summary of the key mixed methods findings 
Three forms of joint display were utilised to explore the relationship between 
participants’ treatment adherence and views of Morita Therapy: a typologies 
and statistics display; a categories and themes display; a case-oriented merged 
analysis display.  Data on treatment response (whether participants scored 
PHQ-9 <10 at follow-up) was also presented to aid further interpretation.  All 
mixed methods techniques supported similar findings. 
Firstly, participants with mixed views on acceptability, typically expressing a 
strong identification with the Morita Therapy principles alongside significant 
challenges of engaging with treatment in the context of personal circumstances, 
attended the least sessions, generally withdrawing at session two or three due 
to the challenges noted.  However, possibly in light of the principles resonating 
for such participants, they typically demonstrated a response to treatment.  
Secondly, participants with predominately negative views, which generally 
related to them holding incompatible expectations or hopes for treatment, 
considered both the principles and practice of therapy unacceptable, attending 
between one and seven sessions before withdrawing for treatment-related 
reasons.  None of these participants demonstrated a response to treatment.   
Thirdly, participants with predominantly positive views of therapy, indicating the 
acceptability of both the principles and practice (typically a strong identification 
with the principles alongside some tolerable/worthwhile challenges of engaging 
with treatment) attended the most sessions.  All completed, and demonstrated a 
response to, treatment.  Only one participant who completed treatment did not 
strongly identify with the principles, and they did not demonstrate a response.  
Thus, whilst the acceptability and challenges of engaging with the process of 
therapy (and whether or not such challenges are in the context of demanding 
personal circumstances) appears strongly related to treatment adherence, the 
extent to which participants identify with and are receptive to the Morita Therapy 
principles (or, in contrast, hold incompatible expectations and/or understandings 
of treatment) appears to be a factor in treatment adherence which is also 
strongly associated with whether participants demonstrate a response to 
treatment, largely regardless of the number of treatment sessions attended. 
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CHAPTER SEVEN.  PART FOUR. 
Summary of feasibility study results 
The feasibility study was designed to address seven research questions.  Study 
results with respect to each question are summarised below. 
(1) What proportion of participants approached to take part in the trial will 
agree to do so? 
Recruitment methods performed reasonably well.  The number of participants 
recruited (n=68) was very close to target and 5.1% of patients invited via GP 
record search were randomised.  Based on the 95% confidence intervals, it is 
estimated that in a future trial the randomisation rate from GP searches alone 
would be between 3.4% and 6.6%. 
(2) What proportion of participants who agree to take part in the trial will 
remain in the trial at four month follow-up? 
The performance of retention procedures was strong with a 94% (64/68) 
retention rate overall; 97% (33/34) in the Morita Therapy arm and 91% (31/34) 
in TAU.  Based on the 95% confidence intervals, it is estimated that in a future 
trial the retention rate would be between 88.3% and 99.7%. 
(3) What proportion of participants who agree to take part in Morita 
Therapy will adhere to a pre-defined per-protocol dose of Morita Therapy? 
Adherence to the minimum dose of Morita Therapy (≥5 sessions) was 70.6% 
(n=24).  The mean number of sessions attended for all participants was 7.7 
(range 1-14; SD 4.0); the mean number attended for those who did and did not 
adhere to the minimum dose was 9.8 (range 5-14; SD 2.5) and 2.6 (range 1-4; 
SD 1.0) respectively. 
(4) What is the variance in participant outcomes following Morita Therapy 
and TAU, and how do they correlate with participants’ baseline scores? 
At four month follow-up, the pooled SD was 6.4; 6.5 and 5.7 for the intervention 
and control groups respectively.  Based on the 95% confidence intervals, it is 
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estimated that in a future trial the pooled SD on the PHQ-9 score at follow-up 
would be between 5.5 and 7.8.  The magnitude of correlation (using 
Spearman’s Rho) between participants’ baseline and follow-up PHQ-9 scores 
was 0.42 for all participants (95% confidence intervals 0.19-0.61); 0.37 and 0.71 
in the intervention and control groups respectively.  These figures can be used 
to inform sample size calculations for a future trial. 
(5) What are the estimated between-group differences (and 95% 
confidence intervals) in participant outcomes following Morita Therapy 
and TAU? 
This study was not powered to enable inferential statements on between-group 
differences to be made.  In this study, PHQ-9 scores reduced from baseline to 
follow-up by an average of 5.5 points more in the Morita Therapy group 
compared to TAU.  Based on the 95% confidence intervals, it can be said with 
95% certainty that the true mean reduction in participants’ PHQ-9 scores from 
baseline to four month follow-up will be greater following Morita Therapy, 
compared to TAU, by somewhere between 2.9 and 8.1 points. 
(6) How acceptable is Morita Therapy to participants and therapists? 
The qualitative results indicated that Morita Therapy was generally acceptable 
to therapists and many participants, with both emphasising the value and 
impact of the approach.  The analysis of participant interviews highlighted: (1) 
typologies of participants’ views, suggesting potential moderators of 
acceptability, in which the importance and impact of participants’ identification 
with the Morita Therapy principles alongside the central role of their 
expectations and understandings of treatment was stressed; (2) a distinction 
between the principles and practice of Morita Therapy, indicating the challenges 
and implications of translating the principles into a process which is feasible for 
patients to engage with. 
The analysis of therapist interviews supported these findings: therapists (1) 
highlighted patients’ ability to grasp the Morita Therapy principles as the 
defining factor when considering potential moderators of acceptability and 
outcome; (2) illustrated the tension between their strongly positive views of the 
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principles and the difficulties they experienced with operationalising these in 
practice, particularly in the context of much variability across patients in their 
ability to apply, understand and benefit from the components of Morita Therapy.  
Both participants and therapists made some suggestions for tackling the 
practical challenges moving forwards, with therapists raising the possibility of 
some patients embedding the principles, and thus benefitting from treatment, 
without engaging in the process.  Finally, therapists suggested ways in which 
the delivery of Morita Therapy could be supported and facilitated, indicating the 
appropriateness and usefulness of the UK Morita Therapy outpatient protocol. 
(7) How do participants’ views about Morita Therapy relate to the 
variability in the number of treatment sessions they attend? 
The mixed methods results indicated that: (1) the acceptability and challenges 
of engaging with the practice and process of Morita Therapy, and whether or 
not such challenges were experienced by participants in the context of 
demanding personal circumstances, appears strongly related to treatment 
adherence: participants who experience more practical challenges generally 
attend fewer treatment sessions; (2) the extent to which participants identify 
with and are receptive to the Morita Therapy principles (or, in contrast, hold 
incompatible expectations and/or understandings of treatment) appears to be a 
factor in treatment adherence which is also strongly associated with whether 
participants demonstrate a response to treatment, largely regardless of the 
number of treatment sessions they attend: participants who describe strongly 
identifying with the principles typically respond to treatment in anywhere 
between two and twelve sessions. 
Thus, both the qualitative and mixed methods data suggest key factors in 
acceptability, treatment adherence and outcomes appear to be patients’ 
identification with the Morita Therapy principles, and the challenges of 
translating these principles into practice.  The implications of these findings are 
discussed further in Chapter Eight, overleaf.
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CHAPTER EIGHT.  DISCUSSION AND CONCLUSIONS. 
This chapter summarises the key findings of this thesis, in which the 
optimisation and investigation of the feasibility and acceptability of Morita 
Therapy as a treatment for depression and anxiety in the UK has been reported.  
The substantive, methodological and theoretical contributions of this thesis are 
presented; strengths, limitations and alternative methodological approaches are 
discussed.  Recommendations for future research and a discussion of clinical 
implications are provided.  This chapter concludes with a discussion of the 
personal learning obtained through the completion of this thesis (for which the 
first-person voice is adopted) before summarising key conclusions. 
8.1 Summary of results  
This thesis has presented a programme of work informed by the development 
and feasibility phases of the MRC framework (Craig et al., 2008).  Firstly, a 
scoping and systematic review was undertaken (Chapter Four) to describe the 
extent, range and nature of Morita Therapy research activity reported in English.  
66 papers met the inclusion criteria: 44 primary studies, conducted with 3268 
patients in total; four reviews and seven papers reporting data from other 
studies, including 313 studies between them; and eleven clinical impressions.  
The identified gaps in research and methodological weaknesses of studies have 
been discussed in depth in Chapter Four.  To summarise, previous studies are 
highly prone to bias, none have been conducted in the UK, and no RCTs: a) 
targeted depression in Western patients; b) investigated outpatient Morita 
Therapy for depression; or c) targeted depression with no history of 
schizophrenia. 
The review also highlighted heterogeneity and lack of reference to published 
treatment manuals in the implementation of Morita Therapy.  As such, further 
work was required to develop a UK Morita Therapy outpatient protocol.  This 
was achieved within an intervention optimisation study (Chapter Five) in which, 
through an iterative process combining literature synthesis with qualitative 
research, a therapy protocol and tailored therapist training programme were 
developed which were fit for purpose in proceeding to a UK trial of Morita 
Therapy.  In line with key qualitative findings, this protocol was structured 
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according to the four-phased model of Morita Therapy, included detailed 
guidance and warning points, and supported therapists in managing patients’ 
expectations of treatment. 
Subsequently, a mixed methods feasibility study was conducted to prepare for a 
fully-powered randomised controlled trial (RCT) of Morita Therapy plus 
treatment as usual (TAU) versus TAU alone (Chapters Six and Seven).  This 
study demonstrated that it is possible to recruit participants in a trial of Morita 
Therapy (n=68) and to retain them at four month follow-up (94% retention rate).  
Furthermore, adherence to the minimum dose of Morita Therapy (70.6%) and 
remission in depressive symptoms following Morita Therapy (66.7%) were on a 
par with other psychological therapies.  Whilst qualitative and mixed methods 
analyses indicated potential moderators of acceptability and treatment 
adherence, Morita Therapy was broadly acceptable to therapists and 
participants.  Thus, overall, the data indicates that patients in the UK can accept 
the premise of Morita Therapy and find the approach beneficial, and that it is 
feasible to conduct a large-scale UK-based trial of Morita Therapy. 
8.2 Contribution to knowledge 
8.2.1 Substantive contribution 
This thesis has made several original contributions in the field of Morita 
Therapy.  Firstly, the review is the first to describe all Morita Therapy literature 
containing clinical or empirical data written in English, regardless of study 
design or publication status.  Secondly, the first UK Morita Therapy protocol, 
optimised for this population, has been developed.  Finally, the feasibility study 
has contributed important information towards the development and evaluation 
of Morita Therapy in the UK, supporting inferences about the suitability of the 
UK Morita Therapy outpatient protocol and providing robust and relevant 
evidence on the feasibility of a fully-powered RCT.  This study represents not 
only the first study of Morita Therapy in the UK but the first RCT of Morita 
Therapy for depression within English-speaking countries (assuming any 
previous such studies would have been published in English).  Indeed, given 
the volume of Japanese and Chinese studies accessed through reviews and 
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secondary reports, the review findings suggest that this study may represent the 
first RCT of outpatient Morita Therapy for depression in the world. 
8.2.2 Methodological contribution 
As mixed methods studies typically involve the integration of data only at the 
point of discussion, despite such methods running the risk of producing invalid 
conclusions which cannot be easily interrogated (Borglin, 2015), the feasibility 
study is unusual for including mixed methods analysis.  As such, it provides an 
example of how a research question can be designed to specifically address the 
integration of data, how such integration can be undertaken with rigour, and 
how such integration generates additional learning, thus adding value through 
producing “a whole…that is greater than the sum of the individual qualitative 
and quantitative parts” (Fetters and Freshwater, 2015) (p.116).  Thus, a strong 
methodological contribution has been made to the field of health services 
research, in light of the current dearth of explicit examples of both the use and 
usefulness of integrative mixed methods analysis (Fetters and Freshwater, 
2015; Guetterman, Fetters and Creswell, 2015). 
Furthermore, the potential value of integrative mixed methods analysis in the 
field of individualising depression treatment has been demonstrated, with the 
current mixed methods findings suggesting potential moderators of adherence 
and outcomes in Morita Therapy (section 8.4.2).  This mixed methods approach 
allows the researcher to move beyond quantitative only techniques of 
regression currently applied in this field, by relating information on both 
outcomes and treatment adherence directly to participants’ views and 
experiences themselves.  Without this process, it would not have been possible 
to understand the relationship between participants’ personal circumstances, 
expectations, understandings, identification with treatment and treatment 
adherence/ outcomes in the current study.  Thus, such methods have been 
shown to have promise in understanding moderators and predictors of 
treatment response highly relevant to this wider research field. 
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8.2.3 Theoretical contribution 
In the context of the contrast between traditional Eastern and Western 
worldviews and their relationship with approaches towards suffering (see 
Chapter Two), the findings of this thesis are relevant to a broader discussion 
concerning the way in which mental health, and perhaps health care more 
widely, is approached in the West.  Through the application of an Eastern 
philosophical framework with Western patients, Morita Therapy can be 
considered to challenge culturally constituted expectations and understandings 
of (ab)normality, (un)naturalness, mental health and healing (Busfield, 2001a; 
Ishiyama, 1994).  Thus, the holistic and phenomenological emphasis of Morita 
Therapy on rest, experience, acceptance and the naturalness of unpleasant 
thoughts and emotions challenges the dualistic and ‘disease-based’ emphasis 
of Western approaches on activation, intellect, control, and the medicalisation of 
unpleasant thoughts and emotions (Bakx, 1991; Blocker and Starling, 2010; 
Chang and Rhee, 2005; Craib, 2002; Fujita, 1986; Green et al., 2002; 
Knoblauch, 1985; Murase and Johnson, 1974; Suzuki, 2010; Tseng, 2005; 
Williams, 2001). 
Whilst authors have suggested that such features of Morita Therapy require 
dilution for a Western population (Ishiyama, 1994; Ogawa, 2013; Ohara, 1990; 
Reynolds, 1995a; Tanaka-Matsumi, 2011; Tseng, 1999), according to the 
current qualitative findings not only did many participants find this approach 
acceptable, but it was precisely this distinctly Eastern perspective and method 
which were of value to them.  Many participants described a highly valued shift 
from perceiving unpleasant experiences as phenomena in need of cure and 
control, as per Western worldviews, towards perceiving them as natural 
phenomena which do not require resolution, as per Eastern worldviews (Murase 
and Johnson, 1974; Reynolds, 1982; Tseng, 2005).  For many participants this 
shift was described as fundamental, sustainable and pervasive: they 
experienced a change in their outlook towards not only their symptoms, but 
themselves, others and the world more broadly, suggesting that adopting such 
a perspective may have potential to induce enduring and far-reaching benefits 
beyond the ‘management’ of symptoms. 
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If participants find value in reappraising their understandings of mental health 
based on Western worldviews, it might follow that it is this worldview which 
should be reappraised more broadly: in the context of the continued and/or 
worsening prevalence, chronicity and recurrence of depression and anxiety (see 
Chapter One), perhaps there is scope for a more fundamental shift in how 
mental health is approached in the West.  If better health is correlated with the 
experience of positive mood/affect only for those within cultures in which 
positive affect is considered highly desirable (i.e. Western cultures) (Yoo, 
Miyamoto, Rigotti et al., 2017), perhaps it is unwise to place such a value on 
positive affect; perhaps a wider cultural acceptance of negative affect as 
something not undesirable or in need of resolution, and a societal de-
prioritisation of ‘the pursuit of happiness’ (Flora, 2009) in favour of ‘going with 
the flow’ of all emotional experiences, might contribute to the prevention of poor 
mental health in individuals in the West.  The findings of this thesis thus 
potentially support the arguments of those who express discontent with the 
Western approach towards medicine and psychiatry more generally (Robertson 
and Walter, 2013), not only challenging the pathologisation of arguably natural 
experiences, but indicating the potential value of holistic and phenomenological 
approaches towards healing in general. 
8.3 Strengths, limitations and alternative methodological approaches 
8.3.1 Scoping and Systematic Review 
A strength of the review is that a broad and inclusive approach to identifying all 
literature relevant to the objective, and a rigorous and transparent method for 
identifying and mapping the literature, were adopted.  A wide variety of 
electronic databases were searched, supplemented with extensive additional 
efforts to identify papers from grey literature and other sources.  As such, it was 
possible to identify gaps in the evidence base alongside summarising a large 
body of research. 
However, it is possible that some relevant data was not included in the review 
as not all full texts could be accessed (n=19) (although a screening of abstracts 
confirmed none of these studies were RCTs nor targeted depression) or they 
were contained in volumes of the Japanese Journal of Morita Therapy which 
CHAPTER EIGHT: DISCUSSION AND CONCLUSIONS 
318 
 
were not available despite requests made to the Journal Editor.  In addition, 
only English papers were included in the review.  Whilst alternative options 
were considered in order to enable access to a wider range of literature, such 
as translating foreign-language papers or collaborating with contacts in Japan 
and elsewhere, the resources and/or time required for such alternatives were 
beyond the scope of this PhD.  Although this led to the exclusion of many Morita 
Therapy papers, it is assumed that this does not impact upon the conclusion 
that no Morita Therapy studies have been undertaken within the UK.  
Furthermore, whilst not ensuring all relevant papers were included, a 
reasonable overall picture of the Japanese and Chinese literature was 
presented through the inclusion of secondary reports. 
Given the extensive variation in how Morita Therapy is implemented and, at 
times, integrated into other approaches (see Chapter Two), there was some 
difficulty and compromise inherent in determining the definition of eligible 
interventions.  Whilst a broad and inclusive approach was taken by including all 
papers in which authors defined the intervention as Morita Therapy or Morita-
based Therapy, those studies in which Morita Therapy was combined with other 
approaches (e.g. Constructive Living (Reynolds, 1995b)) were excluded given 
both the need for a clear definition and the resource limitations of a PhD.  
However, it is possible that this reliance on the author’s definition of their 
intervention drew a rather arbitrary line in the sand.  Indeed, one included study 
implemented Morita Therapy as per the Reynolds (1995b) Constructive Living 
approach, as the author had defined the approach as Morita Therapy.  It is 
possible some excluded studies may have incorporated more elements of 
traditional Morita Therapy than those included studies which were explicitly 
labelled as such and yet implemented interventions very loosely based on 
Morita Therapy techniques or principles. 
In organising the literature thematically according to study design, this aspect of 
the included studies was prioritised at the expense of, for example, intervention 
type or patient condition.  Although this information was reported, presentation 
of the findings along such lines may have highlighted different aspects of the 
literature.  However, study design was considered the most meaningful unit of 
analysis in order to present an overview of all research and findings, and a 
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further strength of the review is the consistent approach to reporting taken by 
applying a template to each study design, allowing both the overall 
heterogeneity of studies and the key methodological weaknesses to be 
presented. 
Finally, the ability to further synthesise the RCT results and thus form more 
reliable conclusions as to the effectiveness of Morita Therapy was constrained 
by the heterogeneity of RCTs in terms of intervention type, control condition, 
patient population and outcome measures, alongside the finding that these 
studies were at high risk of bias.  Such factors deemed further synthesis 
unwarranted and unfeasible (Higgins and Green, 2011).  Indeed, given none of 
these studies were conducted within the UK nor with a depressed population, 
further synthesis would have been unable to provide evidence as to the 
effectiveness of Morita Therapy for depression and/or in the UK. 
8.3.2 Intervention Optimisation Study 
A strength of the optimisation study was that it showcased best practice in 
intervention development by transparently illustrating a systematic and iterative 
approach which prioritised the perspectives of those who will deliver and 
receive the intervention.  Through integrating the views of potential patients and 
therapists with Morita Therapy literature, it was possible to sensitively optimise 
Morita Therapy across cultures whilst carefully ensuring adherence to the 
fundamental features of the approach.   
As discussed in Chapter Two, the extent to which Morita Therapy can be 
optimised and still termed ‘Morita Therapy’ is open to debate.  Whilst some 
argue that the approach requires considerable modification for a Western 
population (Ishiyama, 1994; Ogawa, 2013; Ohara, 1990; Reynolds, 1989; 
Reynolds, 1995a; Tanaka-Matsumi, 2011; Tseng, 1999), others contend that 
such adaptation entails the displacement of essential, defining elements 
(LeVine, 1998; Ogawa, 2013; Ohara, 1990).  Such authors urge those adapting 
Morita Therapy to ensure the principles, goals and progressive experiential 
process, centred on the four phases, remain intact (Kondo, 1998; LeVine, 1998; 
Ogawa, 2013).  A strength of the optimisation study was that it addressed such 
concerns by grounding the UK protocol in the Morita Therapy literature and 
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maintaining a purist stance towards Morita Therapy, as far as possible in an 
outpatient context.  Thus, the distinctive principles, goals, philosophical basis 
and experiential approach, including the four phases, were retained and indeed 
enhanced through the optimisation of the intervention. 
Furthermore, the extent to which the philosophical, cultural and experiential 
basis of the approach needs to be diluted for a Western population has been 
thus far largely an assumption (LeVine, 1998).  Through this process, such 
assumptions have begun to be set aside: this represents the first study to 
directly seek and accommodate the views of UK-based patients and therapists 
themselves in an empirically driven and patient-centred approach towards 
developing Morita Therapy. 
In line with the person-based approach, this development process was thus 
grounded in “a sensitive awareness of the perspective and lives of the people 
who will use [it]” (Yardley et al., 2015a) (p.1), utilising cognitive interviewing 
techniques, written materials and vignettes of therapy in order to elicit views on 
every intervention element, and repeating interviews to check acceptability and 
accessibility.  Without undertaking this study, it would not have been possible to 
understand the expectations, understandings and needs of stakeholders, and 
the ways in which these may shape their delivery of and engagement with the 
intervention.  This process may be considered analogous to that deemed good 
practice by the James Lind Alliance, in which patients and clinicians are brought 
together within the research process to ensure consideration of their priorities 
(Partridge and Scadding, 2004), and is aligned with branches of health services 
research which deem working with patients essential in order to bridge the 
translational gap between clinical practice and patients’ acceptance and uptake 
of interventions (e.g. 'The Third Gap', University of Exeter Medical School). 
This process thus enabled progression to the feasibility study with a therapy 
protocol which, whilst adhering to the essence of Morita Therapy, has enhanced 
acceptability and feasibility for a UK population, thus maximising the likelihood 
of a successful outcome in the feasibility study (Yardley et al., 2015a).  Whilst 
this was key in the specific cross-cultural adaptation of Morita Therapy as a 
novel intervention within the UK, a generalisable approach to optimising 
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interventions which is likely to be relevant and interesting to others in both the 
development and evaluation of complex interventions has been presented. 
In terms of limitations, HVRS (PhD candidate) conducted all interviews and was 
involved in the protocol development process.  Thus, particularly in the repeat 
interviews, although questions were posed to deliberately elicit negative views, 
participants may have been reluctant to express criticism of the draft protocol.  
However, participants did freely indicate ways in which the protocol was 
currently confusing, insufficient or inaccessible.  In addition, in the absence of 
vignettes demonstrating a variety of treatment models, it was not possible to 
elicit participants’ views on all available implementation options so as to select a 
favoured approach, and instead their feedback on the modal model (Minami, 
2013) was used to guide the positioning of the UK version along the available 
spectrum of approaches.  Furthermore, although the interview sample was 
diverse in age, gender and therapy experience and may well represent those 
most likely to be interested in receiving Morita Therapy, certain sectors of the 
UK population such as ethnic minority groups were clearly underrepresented. 
8.3.3 Feasibility Study 
Study design 
A strength of the feasibility study is the suitability of the methods for such a 
study.  The study purpose and research questions accorded with The National 
Institute for Health Research Evaluation Trials and Studies (2015) definition of a 
feasibility study, endorsed by Arain et al. (2010).  The pilot trial and qualitative 
interviews were designed to allow key clinical, methodological and procedural 
uncertainties associated with a large-scale trial to be tested using appropriate 
quantitative, qualitative and mixed methods, and criteria for success were 
specified a priori (Thabane et al., 2010).  Findings have been described in line 
with guidance for reporting the results of feasibility studies (Eldridge et al., 2016; 
Thabane et al., 2010). 
To embrace the complexity of developing and evaluating interventions and 
provide a comprehensive understanding of the intervention in question, it is 
contended that no one method will suffice (Borglin, 2015).  Thus, a further 
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strength of this study is the explicit commitment to a mixed methods approach 
(Hill et al., 2014; O'Cathain, Murphy and Nicholl, 2008).  The embedded mixed 
methods design reflected key decisions which were reached on the levels of 
interaction, priority, timing and procedures in the mixing of the quantitative and 
qualitative components (Creswell and Plano Clark, 2007).  Guidance on 
maximising the impact of qualitative research in feasibility studies (O'Cathain et 
al., 2015) was carefully considered, and the study has been described in line 
with guidelines for Good Reporting of a Mixed Methods Study (O'Cathain et al., 
2008). 
Quantitative components 
Precision and accuracy of data 
Margins of error associated with the recruitment rate, retention rate and 
variability in the primary outcome for a future trial (PHQ-9) in the pilot trial were 
less than the margins of error for the same parameters considered acceptable 
for the purpose of this study (Sugg et al., 2016).  Thus, key parameters have 
been calculated with an acceptable level of precision to help determine the 
feasibility of and sample size required for a fully-powered trial. 
Outcome data were collected at four months post-baseline.  Given only one 
participant (following a high number of therapy session cancellations) provided 
follow-up data prior to ending treatment, conducting follow-ups at four months 
appears appropriate moving forwards.  Thus, pilot data on retention, variability 
in outcomes and correlations between scores is likely to represent an accurate 
estimation of such figures in a fully-powered trial. 
Potential bias 
Due to the resource limitations of a PhD, the study researchers were not 
blinded to group allocation.  Whilst baseline and follow-up data were self-
reported, and all research measures were applied equally to both groups, it is 
possible that this introduced detection bias into the study, and it will impact on 
the judgement of this study against quality criteria relevant, for example, in 
conducting a systematic review (Evans et al., 2011; Higgins and Altman, 2008).  
To avoid such implications in the future, it is of course crucial that good practice 
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is followed in any large-scale trial by ensuring that researchers collecting follow-
up data are blinded to group allocation. 
Furthermore, the option of completing follow-up questionnaires via post or email 
rather than during face-to-face interviews was used by more participants in TAU 
(12/31) than the Morita Therapy group (7/33), and led to some variability around 
the data collection time point: follow-up data was completed between 3.8-6.1 
and 4.0-5.6 months after baseline for Morita Therapy and TAU participants 
respectively.  Thus, some differences between the groups in terms of how and 
when outcomes were measured were present, which may also have introduced 
detection bias (Higgins and Altman, 2008).  Whilst provision of the option to 
complete follow-up questionnaires via post or email may have facilitated a 
higher retention rate, in any future trial efforts should be made to engage all 
participants in the same methods of data collection at the same time points. 
Finally, whilst retention rates were comparable across the two arms, the rate of 
withdrawal was higher in TAU (3/34) than Morita Therapy (1/34).  To avoid the 
potential bias which arises from differential attrition, with withdrawal potentially 
more likely within a control group in which enthusiasm for participation may be 
lower, additional strategies such as maintaining more frequent contact with TAU 
participants should be employed in any large-scale trial (Higgins and Altman, 
2008; Hunt and White, 1998; Moran and Whitman, 2014; Robinson et al., 2007).  
Furthermore, Patient and Public Involvement (PPI) could be utilised in this area 
to better understand how to maintain TAU participants’ engagement in the trial. 
Qualitative components 
Sample 
Qualitative data was analysed from 16 participants.  The overall sample size, 
and the sample size of each sub-group (e.g. those who completed treatment but 
did not respond), was constrained by the number of participants in the pilot trial 
who fulfilled the sampling criteria.  Nonetheless, it was possible to explore the 
views of participants who, together, fulfilled all the manifestations of treatment 
adherence and response that were intended to be sampled.  Only additional 
participants who completed and responded to treatment were not sampled, and, 
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as analysis continued to the point at which no new themes were emerging and 
both the breadth and depth of data were explored, data saturation and sampling 
adequacy were considered achieved (Bowen, 2008; Guest et al., 2006).  On 
this basis, it is suggested that the analysis of 16 purposively sampled participant 
interviews had potential to generate a good understanding of the acceptability of 
Morita Therapy, and key insights were gained in relation to issues with 
acceptability in particular. 
Two therapists were interviewed, as dictated by the number of therapists 
delivering treatment in the trial.  Thus, whilst their views were explored in-depth 
and provided several insights into how the delivery of Morita Therapy might be 
facilitated, involving a larger number of therapists may have generated new or 
different results and it is difficult to determine the extent to which the views of 
these therapists are transferable to the broader context of therapists who might 
deliver Morita Therapy in the future. 
Data collection and analysis 
Qualitative data were analysed using Framework analysis, thus ensuring a 
systematic, transparent and rigorous process (Barbour, 2001; Gale, Heath, 
Cameron et al., 2013; Parkinson, Eatough, Holmes et al., 2016; Ritchie et al., 
2013).  This approach was flexible enough to abductively explore views on 
predefined topics, such as components of Morita Therapy considered 
challenging within the optimisation study, whilst remaining open to discovering 
unexpected views (Gale et al., 2013; Pope and Mays, 2006b; Ritchie et al., 
2013).  The use of matrices also allowed the depth of each participant’s views 
to be explored in the context of their whole account, as well in the context of the 
data set as a whole (Ritchie et al., 2013).  This within and across case analysis, 
alongside the interpretation of data, enabled the development of a detailed 
account of acceptability within a model of how Morita Therapy was experienced 
by different participants, incorporating both exploratory and explanatory 
insights. 
However, there were potential limitations in the use of this approach, alongside 
the use of post-treatment interviews.  The analysis may not have readily 
reflected how participants’ views changed over time; for some factors deemed 
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important in the acceptability of Morita Therapy, such as understanding the 
purpose of the treatment components, temporal challenges were encountered: 
it was difficult to ascertain the extent to which such understandings had been 
held early in treatment and thus shaped views on acceptability, versus the 
extent to which such understandings had resulted from participants’ 
engagement in treatment.  Whilst some participants claimed, for example, very 
early identification with the Morita Therapy principles, this is difficult to confirm 
with only retrospective accounts.  However, there does remain a distinction 
between the qualitative accounts of those who found Morita Therapy more and 
less acceptable which cannot be accounted for by receipt of the intervention 
alone: those who found Morita Therapy less acceptable did typically attend five 
treatment sessions, thus receiving the approach, suggesting the views of those 
who found Morita Therapy acceptable were not shaped purely by receipt of the 
intervention.  Nonetheless, in the future it may be informative to capture the 
views and values of participants before as well as after treatment, to assess the 
nature of this relationship in more depth. 
Furthermore, as this study was embedded within a PhD, only one researcher 
conducted data analysis.  In any future trial, one would of course wish to follow 
good practice in involving at least two independent researchers in data analysis, 
enabling the consideration of differing perspectives and enhancing the 
credibility and reliability of data interpretation (Barbour, 2001; Ritchie et al., 
2013).  However, the rigour of the approach was enhanced through an 
engagement in reflexivity and PhD supervision, with JF (second supervisor) 
second coding a proportion of raw data and reviewing coding frameworks until 
consensus on emerging themes and the further interpretation of data could be 
achieved, thus providing opportunities for others’ perspectives to be appreciated 
(Barbour, 2001; Houghton, Casey, Shaw et al., 2013; Ritchie et al., 2013). 
Mixed methods components 
A strength of the mixed methods analysis is that it combined different data types 
in ways that were systematic, transparent and rigorous, thus producing 
conclusions which can be readily traced and understood.  Furthermore, by 
manipulating and integrating data through multiple techniques (representing 
participants’ experiences using typologies; grouping individuals into categories; 
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ordering data within a case-oriented display), it became possible to identify new 
relationships between acceptability, attendance and outcomes; insights which 
were strengthened through the use of different techniques (both quantitatively 
and qualitatively driven; operating at the levels of both categorised data and 
individual participant data) which all supported similar findings.  Thus, the mixed 
methods analysis generated insights which would not have been possible from 
a separate examination of quantitative and qualitative results alone, and are 
unlikely to have been possible from a comparison of quantitative and qualitative 
results within only this discussion (as per typical mixed methods studies 
(Borglin, 2015)), thus facilitating a more complex picture of the acceptability of 
Morita Therapy (Creswell and Plano Clark, 2007).   
A potential limitation of the mixed methods analysis relates to the number and 
range of included cases.  Whilst little guidance is currently available on the 
appropriate sample size for mixed methods analysis, and an equivalent concept 
to qualitative data saturation (Morse, 1995) is yet to be developed, it is likely 
that considerations of the study purpose and heterogeneity of data are relevant.  
In the current study, the sample reflected those included in the qualitative 
analysis, and thus was subject to the same constraints regarding the number of 
participants in the pilot trial who fulfilled the qualitative sampling criteria.  
However, the qualitative interviews were sampled for analysis with the 
subsequent mixed methods analysis in mind: as much variation in treatment 
adherence was sampled for as possible, with only additional participants who 
completed and responded to treatment not sampled.  Nonetheless, the results 
were based on a limited amount of data and may not reflect the relationship 
between acceptability and adherence in full, or be transferable to other contexts 
such as different therapies for depression or Morita Therapy with a different 
patient population. 
Therapist characteristics 
The trial therapists were highly experienced in both the delivery of complex 
psychological interventions and adopting different modes of treatment.  To help 
ensure the transferability to a large-scale trial of a) the views of these therapists 
about Morita Therapy and b) the views of patients generated in response to 
Morita Therapy delivered by these therapists, it will be important to ensure that 
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therapists with comparable levels of skill and experience are employed.  Both 
the therapy protocol and therapist training programme were developed in 
response to the views of a larger number of therapists, suggesting their 
appropriateness for therapists more broadly.  Following the same training 
procedures, using the same (or a similar) protocolised form of Morita Therapy, 
and continuing the provision of expert supervision should also help to constrain 
opportunities for the delivery of Morita Therapy in a large-scale trial to vary 
greatly from the feasibility study. 
The therapists in the current study also had an interest in Morita Therapy and 
identified strongly with the approach, alongside holding a commitment to both 
the research team and the testing of new treatments within their roles in a 
research clinic.  Such therapeutic allegiance (Luborsky, Singer and Luborsky, 
1975) may effect treatment delivery and thus influence outcomes, adherence 
and patients’ views (Falkenström, Markowitz, Jonker et al., 2013; McLeod, 
2009).  As it cannot be assumed that therapists with such allegiance and 
commitment may be relied upon moving forwards, this raises an issue for any 
future testing and implementation of Morita Therapy.  In this vein, one objective 
of a large-scale trial may be to train therapists without this degree of therapeutic 
allegiance, to inform an assessment of the potential for the wider 
implementation of Morita Therapy in the UK. 
8.3.4 Overall thesis 
A strength of this overall thesis was embedding the work within the MRC 
framework (Craig et al., 2008).  Throughout the studies an iterative and flexible 
approach towards assessing and optimising intervention feasibility and 
acceptability has been engaged in and, through responding to the feasibility 
study findings on acceptability and its relationship to adherence, this iterative 
and patient-centred process can be continued in the future development and 
evaluation of Morita Therapy.  Furthermore, in the development and testing of 
Morita Therapy, the principles of care laid out in the forthcoming NICE 
guidelines for depression (Section 1.4, In Consultation) have been observed: a 
thorough treatment protocol was developed and followed; frameworks for 
assessing therapist competence and adherence which included monitoring of 
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audio-recordings were included; therapists received regular high-quality 
supervision; and participant treatment adherence was evaluated. 
Patient and public involvement (PPI) 
It is acknowledged that a greater utilisation of PPI may have strengthened this 
thesis and, through the completion of this thesis, an awareness of PPI as good 
practice has been obtained.  Within the optimisation study, the involvement of 
potential patients with experience of depression as participants was prioritised 
over PPI as this was considered to provide the greatest potential value in 
optimising an approach which was unfamiliar to patients and distinct from 
current treatments.  Whilst PPI informed the development of participant 
materials, given that prior to this thesis no one had received Morita Therapy 
within the UK, the opportunities for PPI engagement in the feasibility study were 
somewhat limited and perhaps not given due attention.  Since undertaking the 
trial one participant who received Morita Therapy has been involved in the 
dissemination of results, and if the trial were to be conducted again the 
incorporation of a steering group comprising PPI representatives with 
experience as service users, if not as Morita Therapy recipients, is 
recommended. 
8.3.5 Alternative methodological approaches 
Despite the aforementioned strengths of the methods employed in this thesis, 
alternative approaches may have provided other insights and benefits.  For 
example, an alternative design for the feasibility study is a non-randomised 
comparative trial: if all participants had received Morita Therapy, qualitative data 
could have been collected from an increased number and potentially wider 
range of participants, potentially generating new or different results.  However, 
this approach would not have allowed the procedural uncertainties associated 
with conducting a large-scale RCT to be addressed. 
From an epistemological perspective, within this thesis an evidence-based 
research paradigm informed by a Western scientific epistemology and coherent 
with a biomedical theory of disease (McKenzie, 2012; Tonelli and Callahan, 
2001) has been applied to a therapy based on an Eastern epistemology and 
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theory of disease.  Thus, the methods are aligned with a realist and reductionist 
approach which prioritises (and deems possible) objective, empirical, statistical 
evidence; whereas the therapy has a holistic focus on the embodied 
experiences of the individual and a vitalistic perspective (the notion that living 
systems possess a nonphysical and non-measurable life force, i.e. ‘desire for 
life’ in Morita Therapy) (Barry, 2006; Coulter and Willis, 2004; Jagtenberg et al., 
2006; McKenzie, 2012; Shea, 2006; Tonelli and Callahan, 2001).  This arguably 
produces an “internal inconsistency” (Tonelli and Callahan, 2001) (p.1218) 
between the therapy and research method: some authors claim that the 
philosophy and methods of complementary and alternative medicine, consistent 
with those of Morita Therapy, are incompatible with those of evidence-based 
medicine (EBM) (Jagtenberg et al., 2006; Keshet, 2009; Quah, 2003; Tonelli 
and Callahan, 2001).  Indeed, some authors argue that the application of EBM 
to such approaches necessitates the medicalisation of the approach, thereby 
robbing it of its essential, alternative philosophy (Barry, 2006; Churchill, 1999). 
Thus, it is arguable that alternative methods are more consistent with the 
philosophy underpinning Morita Therapy (Verhoef, Lewith, Ritenbaugh et al., 
2005): for example, embodied and inter-subjective data would be more 
accepted within anthropological approaches (Barry, 2006).  Case studies may 
also prioritise each participants’ unique phenomenological experience and allow 
for a richer exploration of the ways in which different aspects of the patient, 
treatment and context relate to each other (McLeod, 2008; Verhoef et al., 2005; 
Williams and Garner, 2002).  This method is commensurate with the Japanese 
research tradition: case studies are typically preferred by Japanese Morita 
therapists for allowing an appreciation of each unique case (Ishiyama, 1988a).  
Thus, such methods would have also aligned this study more closely with the 
Japanese culture of research, potentially facilitating stronger relationships 
between Japanese and UK Morita Therapy researchers.  However, given the 
limitations discussed in Chapter Three, case studies would not have been 
deemed credible within the dominant Western research paradigm, and even 
some Japanese Morita therapists advocate the investigation of Morita Therapy 
using more experimental methods; indeed, the lack of such research has likely 
contributed towards the lack of international recognition of the approach to date 
(Ishiyama, 1988a; Ishiyama, 1994). 
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Additionally, the theory and methods of Morita Therapy centre on phenomena 
which are not easily subjected to measurement, presenting another difficulty 
from an EBM perspective (Coulter and Willis, 2004; McKenzie, 2012; Tonelli 
and Callahan, 2001; von Peter, 2013): vitalism (‘desire for life’), experience and 
embodiment are all deemed essential in the healing process.  It might be 
argued that qualitative interviews, as per the feasibility study, are ill-equipped to 
explore such features.  Such methods rely on verbalisation and thus 
intellectualisation which, particularly from an Eastern perspective, are 
inaccurately discriminative and unable to convey the truth of experiences: 
putting experiences into words changes them through the processes of 
introspection and self-reflection (processes Morita Therapy deliberately 
attempts to reduce) (Blocker and Starling, 2010; Chang and Rhee, 2005; 
Kapleau, 2000; Watts, 1961).  Whilst such methods may capture participants’ 
cognitive understandings of Morita Therapy, they are less able to capture their 
internalisation of the principles, intuitive sense (if any) of accepting oneself as 
part of nature, or changes arising from the embodied self (von Peter, 2013). 
Even expressing such notions using the English language, as opposed to 
Japanese, constrains them: there may exist some dissonance between 
concepts relevant to Morita Therapy and the culturally constituted narratives 
available within the UK.  For example, the English definition of the term ‘nature’ 
lends itself to literal expressions of being in nature, perhaps as a means to 
improve mood (as at times expressed by participants), with the opportunity for 
articulating a sense of being of nature limited by a lack of equivalent term for the 
Japanese kācho fugetsu (“oneness with nature” (Ogawa, 2007) (p.46)) 
(Davidson, 2001; Watts, 2012); similarly, an equivalent concept for kappatsu 
(‘spontaneity’; ‘responsiveness to the environment’; “going with the flow” 
(Ogawa, 2007) (p.67)) does not exist in English, and is thus an inevitably 
challenging concept for UK participants to express (and, perhaps, understand). 
Alternative qualitative methods may have facilitated a better understanding of at 
least some of these components.  For example, an analysis of participants’ 
diary accounts using discourse analysis (Brown and Yule, 1983) might allow for 
a more direct exploration of participants’ experiences and the ways in which 
they relate to themselves, others and nature, as well as capturing changes over 
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time.  Indeed, Japanese Morita therapists have used diaries to help understand 
patients’ perception of daily events and subjective processes of change 
(Ishiyama, 1988a).  Whilst observation and the analysis of verbal and visual 
data (for example, therapy sessions) through methods such as ethnographic 
content analysis (Altheide, 1987) may also be similarly informative, they are 
also subject to the constraints of language discussed. 
In addition, the choice of feasibility study outcome measures was informed by 
the way in which effectiveness is constructed within the Western biomedical 
model (Barry, 2006): in order to be of relevance in the UK, it is necessary to 
show that Morita Therapy reduces symptoms.  Whilst Morita therapists do seek 
to relieve suffering, and consider symptoms to reduce as a by-product of 
therapy, Morita Therapy is not intended to be curative in that, within the 
philosophy underpinning it, symptoms are not medicalised.  Indeed, this seeking 
of a cure, or resistance to suffering, is the very mechanism of psychopathology 
in Morita Therapy (Fujita, 1986; Morita et al., 1998; Ogawa, 2013). 
Finally, whilst EBM prefers one form of medical knowledge, provided by 
experimental research (Tonelli and Callahan, 2001), given the results of this 
feasibility study it appears that it has been possible for a (potentially) effective 
treatment to be developed in Japan through rationalism, clinical observation and 
case studies: such methods clearly can produce valid and meaningful 
knowledge (Tonelli and Callahan, 2001).  However, as noted, to establish 
Morita Therapy in an evidence-based culture, it is necessary to follow the 
methods deemed legitimate within that culture: to address bias, generalisability 
and proof of efficacy, despite the aforementioned tension with the philosophy 
underpinning the treatment (Tonelli and Callahan, 2001).   
Furthermore, the feasibility study methods have not overlooked the importance 
of outcomes aside from reducing symptoms, nor of participants’ subjective 
perspectives by reducing all data to quantitative averages: outcomes included 
attitudes and quality of life; qualitative and mixed methods were utilised to 
understand individuals’ subjective meanings and views, and how these relate to 
treatment engagement and outcomes, including illuminating the role of 
participants’ expectations (Verhoef, Casebeer and Hilsden, 2002; Verhoef et al., 
2005; Williams and Garner, 2002).  Thus, efforts have been made, whilst 
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working within the EBM model, to embrace the value of different forms of 
knowledge and means of knowledge generation. 
8.4 Future research directions 
8.4.1 A fully-powered evaluation of Morita Therapy 
The feasibility study specified three ‘criteria for success’ to be met in order to 
deem a large-scale trial feasible, and to determine whether protocol 
modification and/or close monitoring during such a trial would be required 
(Thabane et al., 2010).  Each criterion will now be considered in turn. 
Criterion (1): recruitment and retention 
“A sufficient number of participants to populate a fully-powered trial are likely to 
be recruited and retained, i.e. we recruit at the rate anticipated in the pilot trial 
(12% of those invited) and experience an attrition rate no higher than 20% of 
those randomised”. 
The attrition rate was 6%, thus fulfilling this standard.  It was possible to recruit 
close to target (68/72) with a randomisation rate from GP invite of 5.1% and 
33/68 of participants recruited through other sources such as flyers and email 
circulations to former participants.  It was also necessary to extend the 
recruitment period, albeit by only one month and in order to accommodate a lull 
in recruitment over the Christmas period, which could be accounted for in any 
future trial planning.  One additional Practice was also recruited to undertake 
record searches, and three more record searches were undertaken than 
originally anticipated (i.e. 27 rather than 24).  Whilst the rate of randomisation 
from GP invite alone was lower than anticipated on the basis of other 
depression trials (Richards et al., 2016; Richards et al., 2013), 5.1% is slightly 
higher than that found in alternative trials in the field (e.g. 2.2% (Kuyken et al., 
2015); 4.4% (Wiles et al., 2013)). 
The impact of this recruitment data on the feasibility of a large-scale trial is tied 
to the sample size required.  To recruit 266 participants (see below), it is 
anticipated that 5216 patients would need to be invited via GP record search; 
thus, based on the pilot data, 51 average sized Practices would need to 
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participate.  As per the current study, additional participants may also be 
identified through advertising and approaching former trial participants.  The 
procedures may also be amended to improve the recruitment rate.  For 
example, telephone reminders to non-responding patients invited via record 
search may be incorporated, as a particularly successful method for increasing 
recruitment (Harris, Carey, Victor et al., 2008; Nystuen and Hagen, 2004; 
Treweek et al., 2010), although data on the feasibility of such a method was not 
collected as part of the current study.  In addition, further PPI could be utilised in 
this area to better understand how to recruit participants. 
Related to the recruitment rate, the rate of GP exclusions (28%) was 
comparable to that found in other depression trials (averaging 31%) (Kuyken et 
al., 2015; Richards et al., 2013; Wiles et al., 2013).  In a large-scale trial, 
incorporation of methods to record reasons other than the study exclusion 
criteria which GPs have for excluding patients (accounting for 29% of 
exclusions in the current study) might facilitate an assessment of external 
validity (Jenkinson, Winder, Sugg et al., 2014).  To the same end, potential 
participants who chose not to opt-in to the study may also be asked to provide 
the study team with sufficient information to enable the characterisation of non-
responders and thus an assessment of the generalisability of findings (Moran 
and Whitman, 2014). 
Criterion (2): treatment adherence 
“The levels of engagement with and adherence to Morita Therapy are likely to 
be on par with other NIHR mental health trials i.e. at least 65% of participants 
allocated to Morita Therapy attend at least 40% of treatment sessions”. 
No participants declined to start Morita Therapy and 70.6% of Morita Therapy 
patients attended ≥five sessions, corresponding to 40% of the maximum 
available twelve sessions.  This is comparable to adherence to psychological 
therapies in similar trials (e.g. Richards et al., 2016) and fulfils this criterion. 
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Criterion (3): acceptability 
“It is likely that a Morita Therapy outpatient protocol can be produced which is 
acceptable to patients and therapists, and deliverable by therapists, as defined 
by responses to qualitative interviewing”. 
Whilst highlighting the importance of participants’ identification with the Morita 
Therapy principles in light of their expectations and understandings of 
treatment, and ability to commit to the practical elements of the approach, the 
qualitative data indicated that Morita Therapy was broadly acceptable to 
therapists and acceptable to many participants.  In the context of the treatment 
adherence data and the impact of Morita Therapy indicated by many 
participants, it is suggested that the views of a minority of participants who 
found Morita Therapy less acceptable should not prevent the conduct of a large-
scale trial using the UK Morita Therapy outpatient protocol, and that this 
criterion has been met. 
However, therapist data and some participant data did highlight several minor 
ways in which the therapy protocol and practice of Morita Therapy might still be 
improved in order to enhance acceptability and facilitate therapists’ delivery of 
treatment (Table 30, overleaf), which may be incorporated for a large-scale trial.  
The potential for more major modifications to the therapy protocol, in response 
to the typologies of acceptability, adherence and outcomes identified through 
the mixed methods analysis, is discussed in section 8.4.2. 
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Table 30. Possible modifications to the UK Morita Therapy outpatient protocol in response to qualitative data 
Qualitative data Suggested action/ modification to protocol 
Participants  
 Diaries described as cumbersome 
 Unclear/ vague instructions for diary completion 
 Difficulties following and recalling content of therapy 
sessions 
 Reduce size of diary, with two pages to be completed per day 
 Provide therapists with additional guidance for explaining the diary to patients 
 Provide session summary handouts; ensure regular patient input is sought during 
sessions 
Therapists  
 Preference for more flexible number of therapy sessions to 
ensure objectives of treatment phases can be met 
 Challenges of not being provided with a patient ‘problem 
statement’ at the start of treatment 
 Difficulties critically engaging patients with diary comments 
 Difficulties identifying indicators of therapeutic progress 
 
 
 Difficulties distinguishing between phases two, three and 
four 
 Seeking additional guidance for managing patients’ 
cognitive discrepancies between the ‘ideal’ and ‘real’, and 
for working with ‘unrealistic’ desires 
 Consider extending the maximum number of sessions from twelve to fourteen 
(though note implications for follow-up time point in a future trial) 
 Consider whether provision of more detail on how patients perceive their difficulties 
is consistent with the non-symptom focus of Morita Therapy 
 Consider means to engage patients e.g. example questions to ask them 
 Include more clinical illustrations/ examples; incorporate section for recording the 
duration of rest in the diary; consider tools for assessing patients’ internalisation of 
principles 
 Clarify purpose of each phase and constituent activities 
 
 Consider whether more direct discussion and verbal challenging of these 
components is consistent with the experiential nature of Morita Therapy; clarify if not 
 Suggested summary sheet describing Morita Therapy 
overall; addition of diary examples and further clinical 
examples of manifestations of the vicious cycle and options 
for conveying fears and desires as two sides of the same 
coin 
 Include as suggested 
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Sample size for a large-scale trial  
Pilot trial data were also collected on the variability in outcomes and correlation 
between baseline and follow-up scores.  Alongside data on the minimum 
clinically important difference (MCID) on the primary outcome measure in a 
future trial (PHQ-9), this data can be used to inform an estimate of the sample 
size required for a fully-powered evaluation designed to assess whether Morita 
Therapy plus TAU is superior to TAU alone. 
The published PHQ-9 MCID is 2.59 to 5.00 (Löwe et al., 2004).  Estimating a 
between-group difference corresponding to the lowest MCID (2.59) and using a 
90% power level allows for the most conservative estimate of the required 
sample size: taking a higher MCID value and/or lower power level (e.g. 80%) 
would reduce the number of participants required.  Thus, to provide 90% power 
to detect a between-group difference of 2.59 based on a two-sided 5% 
significance level, using the PHQ-9 standard deviation (6.4) and taking account 
of the correlation between baseline and follow-up PHQ-9 scores (0.42) found in 
the pilot trial, 133 participants per group would be required.  Whilst the pilot data 
suggests that the retention rate will be between 88.3% and 99.7%, this 
calculation allows for 20% attrition. 
Applying the pilot recruitment rate from GP invite alone (5.1%), it is 
subsequently estimated that 5216 potential participants would need to be 
invited to participate in order to recruit to target using GP record searches as 
the only recruitment method (Figure 18, overleaf).  As these calculations 
assume recruitment via GP record searches alone, Figure 18 includes a level of 
attrition between opt-in and randomisation that is higher than that experienced 
in the pilot trial (as higher proportions of eligibility were found for those opting 
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Figure 18. Estimated recruitment and retention in a fully-powered superiority 
trial of Morita Therapy plus TAU versus TAU alone to achieve a target sample 
size of n=266 via GP record search only
 
The potential value of Morita Therapy 
In addition to data pertaining to the feasibility and acceptability of Morita 
Therapy, the findings of the feasibility study also provide information on the 
potential value of Morita Therapy as a treatment for depression and anxiety.  
Whilst the study was insufficiently powered to enable inferential statements to 
be made, the observed differences between groups on the PHQ-9 (the primary 
CHAPTER EIGHT: DISCUSSION AND CONCLUSIONS 
338 
 
outcome in a large-scale trial) showed that depressive symptoms reduced from 
baseline to follow-up by an average of 5.5 points more in the Morita Therapy 
group compared to TAU alone (95% confidence intervals from 2.9 to 8.1).  This 
(and, indeed, the lower margin of error) exceeds the PHQ-9 MCID and, 
although requiring caution in interpretation in light of the small sample size and 
related risk of overestimating the treatment effect (Conn, Algase, Rawl et al., 
2010; Nagendran, Pereira, Kiew et al., 2016; Thabane et al., 2010), does 
provide evidence of the possible effect of Morita Therapy plus TAU compared to 
TAU alone (Robb, 2013). 
Similarly, 66.7% of Morita Therapy participants achieved remission in their 
depressive symptoms at follow-up: a figure similar to or exceeding remission 
rates for current NICE recommended treatments for depression (around one 
half to two thirds of patients – see Chapter One).  Furthermore, the qualitative 
accounts of many participants highlight the distinctiveness and value of Morita 
Therapy in comparison to other available treatments (participant qualitative 
theme five, constituent theme (a): a preferable alternative), supporting the 
argument set forward at the beginning of this thesis that Morita Therapy has the 
potential to provide patients with a meaningfully distinct treatment alternative, 
thus facilitating true patient choice as enshrined in the forthcoming NICE 
guidelines for depression (In Consultation).  All such factors support the 
potential value of Morita Therapy and of continuing research in this area. 
8.4.2 Investigating potential moderators in Morita Therapy 
Whilst the quantitative findings suggest that, on a population level, Morita 
Therapy may be equivalent in effectiveness to other psychological therapies, 
the qualitative and mixed methods findings provide early indications of who 
might benefit most from Morita Therapy on an individual level.  Thus, potential 
moderators of acceptability, adherence to treatment and whether or not patients 
demonstrate a clinical response to treatment were suggested. 
The qualitative findings first highlighted (1) the importance of patients coming to 
treatment with expectations and understandings which allow them to identify 
with the principles of Morita Therapy and understand the purpose of the 
treatment; (2) the challenges of translating the principles into a process which is 
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feasible for patients to engage with.  The mixed methods analysis advanced 
these findings through techniques which suggested that (1) the extent to which 
participants identify with the principles and consider them acceptable (or, in 
contrast, hold incompatible expectations and understandings of treatment) is a 
factor in treatment adherence which also appears strongly associated with 
treatment outcomes, largely regardless of treatment adherence: participants 
who described strongly identifying with the principles typically responded to 
treatment in anywhere between two and twelve sessions; (2) the acceptability of 
the practice and process of Morita Therapy, and whether related challenges are 
experienced in the context of demanding personal circumstances, appears 
strongly related to treatment adherence: participants who experienced more 
practical challenges generally attended fewer treatment sessions. 
Overall, the findings suggest that patients with incompatible expectations of 
treatment may be unlikely to benefit from Morita Therapy, and patients with 
demanding personal circumstances may be unlikely to remain in treatment.  
Whilst generated from a relatively small dataset, these findings provide tentative 
insights which have possible implications in terms of both the nature of Morita 
Therapy and the nature of research in the field in the future.  Potential options 
and considerations are outlined below. 
Assessment of moderators within a process evaluation 
To improve our understanding of the role of patients’ personal circumstances, 
expectations and readiness to identify with the Morita Therapy principles, such 
data might be collected as part of a large-scale trial of Morita Therapy.  Any 
such trial should incorporate a process evaluation (Moore, Audrey, Barker et al., 
2015a) to investigate the mechanisms of change in Morita Therapy and the 
influence of context on outcomes.  Analyses to investigate the relationship 
between the potential moderators, adherence and outcomes may be 
incorporated. 
The means of collecting such data on moderators require consideration.  It may 
be possible to identify or develop questionnaires which capture patients’ 
relevant expectations, values and circumstances.  Such questionnaires might 
be used as stand-alone measures of possible moderators, or may be used to 
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map participants’ responses onto the typologies identified in the feasibility 
study.  Alternatively, pre-treatment qualitative interviews might allow exploration 
of participants’ more implicit expectations and values, if deemed necessary to 
identify to which typology participants belong.  A key consideration includes the 
(possible) need for participants to understand a sufficient amount about Morita 
Therapy in order to provide the required information, which may potentially be 
provided to participants via written material or during an orientation session.  
Whichever methods are selected, it is important to ensure that all measures are 
applied equally to both Morita Therapy and TAU participants in order to avoid 
performance bias (Higgins and Altman, 2008), unless an orientation session 
which is part of the Morita Therapy treatment is developed, and thus to consider 
the potential burden placed upon TAU participants who do not proceed to 
receive treatment following the collection of this data. 
Development of a ‘low-intensity’ option 
The findings might inform further development of the UK Morita Therapy 
outpatient protocol in an effort to overcome the practical challenges of engaging 
with treatment, and thus improve treatment adherence, for people for whom 
engaging in the process is unfeasible in the context of their personal 
circumstances.  Given that such participants in the current study all highly 
identified with the Morita Therapy principles, were keen to continue treatment 
had it not been for their personal circumstances, and showed improvements in 
treatment outcomes, there seems potential value in developing a form of ‘low-
intensity’ Morita Therapy, in a similar vein to the low-intensity versions of 
Cognitive Behavioural Therapy (CBT) developed to improve access to 
evidence-based therapies by reducing the commitment required in traditional 
CBT to one based more on briefer self-help interventions with remote therapist 
support (Bennett-Levy, Richards, Farrand et al., 2010).  Such an option might 
allow relevant patients to continue attending therapy sessions without engaging 
in the full therapy process, and thus potentially gain increased benefits from 
treatment. 
Whilst the qualitative data highlighted the importance of the experiential process 
in Morita Therapy, particularly in terms of the lessons learned from rest, 
therapists suggested that some patients might benefit from talking with their 
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therapist about the principles of the approach alone.  Furthermore, participants 
fitting this typology within the current study all benefitted from treatment after 
only engagement in a (typically limited) amount of rest.  Thus, there may be 
scope to a) curtail the amount of rest participants undertake, to save time; b) 
provide a safe space for participants to undertake rest in the therapy room, 
where relevant; and/or c) consider whether the subsequent treatment phases 
might be removed or reduced.  Any such changes to the UK Morita Therapy 
outpatient protocol would need to be subjected to further assessment of 
feasibility and acceptability, and exactly who such an approach would be 
suitable for requires further definition. 
A possible clinical algorithm 
Based on the current study findings; potentially the findings of further research 
into moderators of acceptability, adherence and outcomes in Morita Therapy; 
and possible modifications to the UK Morita Therapy outpatient protocol (as 
detailed above), it may be possible in the future to develop a clinical algorithm 
for delivering Morita Therapy (Figure 19, overleaf).  Thus, patients with 
expectations of treatment which are incompatible with Morita Therapy (and who 
may therefore be less likely to benefit from treatment) might be advised of 
alternative treatment approaches better suited to them; patients for whom 
engagement with the full process of Morita Therapy is unfeasible despite 
identification with the principles (and who may therefore be less likely to remain 
in treatment) might be offered the ‘low-intensity’ version. 
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Figure 19. Potential Morita Therapy clinical algorithm based on possible 
moderators of acceptability, adherence and outcomes
 
A patient preference trial 
The current results highlight the potential importance of patients’ expectations of 
and hopes for treatment in relation to treatment outcomes.  Similar results have 
been found with regards to other psychological therapies.  For example, in a 
trial of CBT versus psychodynamic therapy, among patients who had not found 
therapy helpful, those who received CBT described dissatisfaction with not 
being able to talk more extensively about their emotions and relationships (i.e. a 
more psychodynamic approach), and those who received psychodynamic 
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therapy described dissatisfaction with not being offered structured problem-
solving (i.e. a more CBT approach) (Nilsson, Svensson, Sandell et al., 2007).  
As per the current study, such accounts illustrate the ways in which different 
patients construct ‘helpful’ treatment in different ways, and suggest the 
importance of patients’ expectations of and hopes for treatment in relation to the 
effectiveness of the approach (McLeod, 2011; Nilsson et al., 2007). 
To further such findings and test them in relation to different treatments, patient 
preference trials may be undertaken (Howard and Thornicroft, 2006).  As per 
the comprehensive cohort design (Olschewski and Scheurlen, 1985), such trials 
may compare two treatments, allowing participants with strong preferences to 
select their preferred treatment whilst others are randomised, thus enabling 
investigation of the influence of preferences on intervention effectiveness.  
However, it should be kept in mind that important differences between 
preference and randomised participants may compromise the value of such a 
trial (von Essen, 2015). 
Furthermore, in the qualitative findings of the current study (and potentially 
those of Nilsson et al. (2007)), participants’ expectations of and hopes for 
treatment were fairly implicit: for example, some claimed to find elements of 
Morita Therapy, such as ‘living with’ difficulties, appealing and yet, in their 
criticisms of the approach, revealed their desire for techniques to remove their 
difficulties.  Thus, whether such participants have prior identifiable ‘preferences’ 
for treatment which might be accounted for within a preference trial is 
questionable. 
Towards the individualisation of treatment 
The current results have potential value in the field of individualising treatment, 
or matched care.  As noted in the introduction, research on the effectiveness of 
current psychotherapies reveals that they are broadly equally effective on a 
population level (McLeod, 2011; Stiles et al., 1986) and the current findings 
regarding remission rates in Morita Therapy are compatible with this.  However, 
on an individual level, treatment effectiveness varies; thus, it is argued that 
research should focus on which treatments are effective for which patients 
(Cuijpers and Christensen, 2017; Kiesler, 1966; Paul, 1967; Stiles et al., 1986). 
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However, there is currently little evidence to guide such treatment choice 
(Cuijpers, 2014; Cuijpers and Christensen, 2017; Goddard, Wingrove and 
Moran, 2015; NICE, 2009).  Progress has been made with the development of a 
method for integrating predictive information that, applied retrospectively, 
allowed for the identification of an optimal treatment for patients that would have 
led to superior clinical outcomes (the Personalised Advantage Index), although 
this method requires further evaluation (DeRubeis et al., 2014; Huibers, Cohen, 
Lemmens et al., 2015).  If the results of further research corroborate the 
relationship proposed by this study (and other research (e.g. Nilsson et al. 
(2007)) between expectations of treatment/ ability to identify with the underlying 
principles of an approach and outcomes, it may ultimately be possible to include 
an assessment of such factors within this clinical algorithm.  Furthermore, the 
current findings suggest value in using mixed methods (as discussed in section 
8.2.2), in addition or as an alternative to these currently purely quantitative 
techniques, in order to relate information on outcomes directly to participants’ 
views and experiences, and potentially incorporate such findings into a future 
model of individualisation in depression treatment. 
8.4.3 Exploring the Morita Therapy diaries 
As Morita Therapy is a complex intervention with multiple components (Craig et 
al., 2008) future research may focus on discerning which of these components, 
whether comprising common or specific therapeutic factors (Luborsky et al., 
2002; Rosenzweig, 1936), are the ‘active ingredients’ of Morita Therapy 
(Campbell et al., 2000).  In terms of specific therapeutic factors, Morita Therapy 
includes both theoretical and operational components which are distinct from 
other psychological treatments and therefore of particular interest.  One such 
distinctive and potentially important component is the patients’ completion of 
daily diaries, in which therapists provide comments for patients to reflect on 
(see Appendix XI for an example diary page). 
Diaries have formed a fundamental feature of Morita Therapy since the original 
inpatient treatment approach, in which diaries provided the main method of 
communication between therapist and patient (Kora, 1995; LeVine, 1998).  The 
qualitative findings of the feasibility study indicate a role for the diaries in 
highlighting the transient nature of emotions and ‘making participants think’, and 
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other research suggests that diaries (whilst different in nature from the Morita 
Therapy diaries) may facilitate psychological recovery (Aitken, Rattray, Hull et 
al., 2013).  Further research, such as a component study (Simon, Bosworth and 
Unger, 2001) or process evaluation within a large-scale trial (Moore et al., 
2015a), may therefore be undertaken to investigate the role of the diaries as a 
potentially important mechanism of change in Morita Therapy. 
Furthermore, completed diaries from the feasibility study may provide a rich 
source of data for additional analyses.  As noted (section 8.3.5), methods such 
as discourse analysis (Brown and Yule, 1983) and ethnographic content 
analysis (Altheide, 1987) may be utilised to explore features of Morita Therapy 
which are difficult to capture within qualitative interviews, and an analysis of 
participants’ diary accounts in terms of both their style and content might 
illuminate any changes experienced by participants over time: how participants 
position themselves in relation to nature; any shift from internal to external 
attentional fixation, or from ‘self’-orientation towards ‘action’-orientation.  
Additionally, an analysis of therapists’ comments might be informative in terms 
of understanding how therapists are implementing Morita Therapy, particularly 
the distinctive and defining elements of the approach such as Fumon 
(inattention to symptoms), and methods such as conversation analysis (Sacks, 
1992) may illuminate how therapist comments interact with participants’ diary 
entries and any changes they indicate (McCabe, Skelton, Heath et al., 2002). 
8.4.4 Other possible research directions: treatment-resistant depression 
Whilst the current study was designed to investigate the feasibility and 
acceptability of Morita Therapy for patients suffering with depression, the 
findings also provide some early and tentative insights into the potential value of 
Morita Therapy for patients suffering with treatment-resistant depression (TRD) 
more specifically (those who do not respond to NICE recommended first-line 
treatments).  Whilst much of the disease burden of depression is attributable to 
TRD (Greden, 2001; Malhi et al., 2005), there is currently little evidence to guide 
the management of these patients (Stimpson, Agrawal and Lewis, 2002) and 
few alternatives aside from combining psychotherapy with medication, 
augmenting medication or trying another NICE recommended psychotherapy 
(NICE, In Consultation).  However, as an example of one such option, one 
CHAPTER EIGHT: DISCUSSION AND CONCLUSIONS 
346 
 
recent large-scale trial showed only 55% of non-responders to ADM alone 
responded to CBT as an adjunct to ADM, with only 40% achieving remission 
(Wiles et al., 2013). 
Thus, there is an absence of a specific and effective pathway within the NICE 
guidelines to be followed for those with TRD.  In this context, it makes sense to 
test treatments which offer patients, for whom establish treatments have failed, 
a fundamentally different way of approaching mental health.  As such, Morita 
Therapy, in light of the distinctive philosophical underpinnings of the approach, 
might offer a meaningful alternative for these patients.  This is supported by 
elements of the qualitative data within the current feasibility study (i.e. 
participant theme five, constituent theme (a): a preferable alternative), in which 
many participants who had received other treatments referred to their 
preference for Morita Therapy and valued the distinctive focus of the approach 
(on allowing as opposed to controlling symptoms) in contrast to their previous 
experiences of treatment.  Although further feasibility work would need to be 
undertaken with this specific population, there are therefore signals within the 
current study which support the potential value of Morita Therapy in this field. 
8.4.5 Improving quality and methodological rigour 
Whilst the current feasibility study has provided sufficient data to enable the 
evaluation of Morita Therapy in the UK to proceed, these findings relate only to 
one patient condition within one culture.  In order to advance the wider 
assessment of the effectiveness of Morita Therapy, the scoping and systematic 
review findings suggest that the quality and methodological rigour of studies in 
the field should be improved.  More experimental studies which ensure internal 
validity should be conducted to enable researchers to establish whether a 
causal relationship between Morita Therapy and outcomes exists (Burns et al., 
2011), and studies making inferential statements about effectiveness should be 
sufficiently powered to do so, ensuring external validity and the precision of 
results (Higgins et al., 2011).  Those which are insufficiently powered should 
take care in interpreting results with caution and reporting confidence intervals 
to enable the precision of results to be taken into account. 
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8.4.6 Standardising and reporting of Morita Therapy 
The scoping and systematic review demonstrated much variation and little 
transparency in the implementation of Morita Therapy.  Further research in the 
field would be facilitated by sufficient standardisation of Morita Therapy (whilst 
allowing therapists to respond to individual patients) and adequate reporting of 
implemented interventions, to enable replication and comparisons to be made 
across studies.  To this end, the Morita Therapy field may benefit from the 
application of standard health services research methods and tools which 
provide frameworks for the development and reporting of interventions (e.g. 
Craig et al., 2008; Hoffmann, Glasziou, Boutron et al., 2014). 
8.5 Clinical implications 
This thesis was undertaken primarily to inform the conduct, design and 
development of a fully-powered evaluation of Morita Therapy.  However, the 
study findings may also be of immediate interest to patients, clinicians and 
health service providers. 
As per the comments above, Morita therapists, who typically report their own 
studies, may wish to consider the use of less ‘biased’ and more transparent 
data collection and reporting procedures, and standard outcome measures, to 
improve the methodological rigour of studies and potential to replicate and 
compare them.  Clinicians may also be interested in the views of (potential) 
patients and therapists about Morita Therapy, particularly as an approach which 
contrasts with typical Western treatments.  Morita therapists in particular may 
be interested to know that, during the optimisation study, it was considered 
more appropriate for a UK population to shift the approach towards the original 
four-phased Morita Therapy model, including rest, and away from a counselling-
based model alone.  Such findings, alongside the views of participants who then 
received this version of Morita Therapy, suggest Morita Therapy may not 
require as much modification to achieve cultural accommodation in the West as 
many authors have previously deemed necessary, yet not empirically tested 
(Ishiyama, 1994; Ogawa, 2013; Ohara, 1990; Reynolds, 1989; Reynolds, 
1995a; Tanaka-Matsumi, 2011; Tseng, 1999). 
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Finally, the feasibility study findings on the relationship between patients’ 
expectations and understandings of treatment and treatment 
adherence/outcomes may be of immediate interest to clinicians who, whilst not 
currently in a position to offer Morita Therapy specifically, may wish to take such 
factors into account in deciding between current treatment options.  This is both 
supported by, and in a position to further develop, the forthcoming NICE 
guidelines for depression (In Consultation) which, whilst stressing that patient 
preferences be taken into account, provide little guidance for doing so and do 
not necessarily incorporate the more implicit expectations and understandings 
of treatment suggested as important by the current qualitative and mixed 
methods results. 
8.6 Personal learning 
Completing this thesis has provided an invaluable learning experience.  I have 
had the opportunity to consolidate my skills in time management, independent 
working and problem-solving through applying these to the management of a 
large-scale research project.  I have learned that, whilst research is at times 
invigorating and highly rewarding, it can also be laborious and monotonous.  
This process has reaffirmed for me the importance of dedication and 
perseverance, particularly in the context of the demands and stress of trial 
management and recruitment. 
Furthermore, whilst I appreciate that there are always more skills and 
knowledge to be gained, I have learned to trust in my own abilities and instincts 
in the interpretation of research: if something appears interesting or important to 
me, it generally is to others too.  I have also gained insights into the challenges 
of managing other staff members which have highlighted the importance of both 
working with a team on which one can rely, and adapting my own working 
practices in order to respond to the needs and abilities of other team members.  
I will take this learning forwards in the development of my leadership skills and 
ability to delegate work effectively. 
My work with participants during assessments and qualitative interviews has 
also provided valuable insights.  I have come to appreciate the challenges and 
importance, for both parties, of clearly establishing appropriate boundaries: the 
CHAPTER EIGHT: DISCUSSION AND CONCLUSIONS 
349 
 
tension between being an approachable and patient researcher who builds 
necessary trust and rapport, and not being considered a therapist or support 
system for participants.  I now have a heightened awareness of what might be 
‘taken for granted’ knowledge for those with a scientific background, which I will 
heed in future work with participants.  I have also learned the emotional impact 
that such research can have on the researcher, in terms of communicating in-
depth with participants experiencing depression, and the associated feelings of 
empathy and responsibility.  Moving forwards, I will hold more realistic 
expectations around this personal toll, ensuring for example that an appropriate 
limit is placed on the number of participant appointments scheduled per day. 
The research topic has also provided a philosophical perspective which has 
helped me to examine my own assumptions and understandings of the world.  
Through learning about Morita Therapy and its foundations, my understanding 
of depression and traditional Eastern and Western approaches towards mental 
health has changed and grown; my assumptions about what constitutes 
‘effective’ treatment, and the ways in which notions of ‘control’ may or may not 
be helpful, have been re-evaluated.  As well as my outlook having changed, my 
awareness of how one’s outlook is culturally situated has been heightened: I am 
more able to appreciate that no one is a ‘value-free’, independent and objective 
being; that differing viewpoints may be equally valid. 
In the future I hope to maintain and build upon these insights by developing my 
skills in critical engagement and self-reflection: continuing to question and 
challenge my own and others’ perspectives; remaining aware of and open to 
alternatives.  Similarly, I have also gained significant value from working with 
two supervisors with different backgrounds, perspectives, and priorities.  Whilst 
at times balancing these perspectives can be challenging, this experience has 
been invaluable in teaching me different ways of approaching and interpreting 
research, and I will seek to develop interdisciplinary collaborations which 
facilitate this stimulating and reflective way of working in the future. 
Finally, in attempting to balance due respect for the origins of Morita Therapy 
and the Japanese tradition with applying methods and developing a treatment 
which are acceptable in the UK, I have gained insights into the importance of 
cultural sensitivity and ways in which this might be fostered which I will take with 
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me, particularly in attempts to strengthen communication and collaboration with 
members of the Japanese Society for Morita Therapy in the future. 
8.7 Conclusions 
This thesis encompassed a scoping and systematic review, intervention 
optimisation study and mixed methods feasibility study to optimise and 
investigate the feasibility and acceptability of Morita Therapy as a treatment for 
depression and anxiety in the UK. 
In light of the lack of UK-based research and relevant unbiased randomised 
controlled trials (RCTs) highlighted within the review, a fully-powered UK-based 
RCT is required to establish whether Morita Therapy plus treatment as usual 
(TAU) is superior to TAU alone in the treatment of depression and anxiety in a 
UK population.  The results of this thesis support the feasibility and acceptability 
of conducting such a trial.  Thus, patients in the UK are able to accept the 
premise of Morita Therapy and find the approach beneficial, and a definitive 
RCT may be planned for with minor modifications to the pilot trial protocols.  
Future research may also build upon the insights obtained within this thesis 
regarding potential moderators of acceptability, treatment adherence and 
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Appendix I:  Summary tables of papers included in the scoping and systematic review 
 
Table 1  Non-randomised comparative studies (n=2) 
Author(s)
/ Year 





Research methods Outcome measures 
Wang et 
al. (2000) 
China Patients (n 
not provided), 
mean age 








duration 12 months 
(n=60) 
Quantitative.  Post measures.  Follow-
up (2 years).  Control group 1: non-
Morita Therapy (n/ further details not 
provided); control group 2: individuals 
with no history of psychosis (n=60). 
SPA-4 series analyser 
















duration 8 weeks 
Quantitative.  Pre/post measures.  
Control group 1:  dietary brain-
chemistry treatment (n=20); control 
group 2: combined Morita 
psychotherapy and Brain-Chemistry 























Table 2  Before-and-after studies (n=6) 
Author(s)/ 
Year 

















Home care by 
family/partners 




72.2 days (SD 
24.6) 
Quantitative.  
Pre/post measures.  
No control. 
Morita Therapy 3 point rating scale: (A) complete 
cure (complete disappearance of observable 
symptoms with or without occasional subjective 
complaints); (B) improvement (some reductions in 
symptoms and subjective complaints); (D) no 
improvement 
Author-developed outcome measure: obsessional 
behaviour/ideas, insight, personality, pain, anxiety; 
effect on family life, social activities, work/study 












sessions over 5 
weeks 
Quantitative.  
Pre/post measures.  
No control. 
Standard outcome measure: anxiety 
Author-developed outcome measure: cardiac 
symptoms 


















Pre/post measures.  
Follow-up (2 and 5 
years post-






















study period of 14 
weeks.  No control. 
Standard outcome measure: shyness 
Author-developed outcome measure: anxiety 
intensity; difficulty in taking action; level of 
confidence; degree of emotional disturbance; 
anxiety acceptance; problem severity; coping 
effectiveness 








Table 2  Before-and-after studies (continued) 
Author(s)/ 
Year 


























intervals of 5-10 
days as well as 
immediately before 
and after each 





treatment.  No 
control. 
Standard outcome measure: problem severity 
(primary); social avoidance/ distress (auxiliary); 
neurotic symptoms (auxiliary) 
Author-developed outcome measure (primary): 
interpretation of anxiety; coping effectiveness 



























week of treatment 
and eighth week of 
treatment.  No 
control. 











Table 3  Cross-sectional observational studies (n=5) 
Author(s)
/ Year 













Neurotic subtype of 
shinkeishitsu who are still 
functioning at work, 
























anxiety (n=7), phobia 
(n=7), adjustment 













Morita Therapy 4 point rating scale: (A) 
complete cure (complete disappearance of 
observable symptoms and subjective 
complaints); (B) improvement (disappearance 
of observable symptoms with occasional 
subjective complaints); (C) limited improvement 
(some reductions in both symptoms and 










































closely related (n=243): 


















Morita Therapy 4 point rating scale: (A) 
complete cure (complete disappearance of 
observable symptoms and subjective 
complaints); (B) improvement (disappearance 
of observable symptoms with occasional 
subjective complaints); (C) limited improvement 
(some reductions in both symptoms and 








Table 3  Cross-sectional observational studies (continued) 
Author(s)
/ Year 



































Author-developed outcome measure: degree of 
improvement in chronic pain; satisfaction with 


















Table 4  Case studies (n=26) 
Author(s)/ 
Year 
Country Sample Patient diagnosis/ 
condition 
Intervention summary Research methods Outcome measures 
Chang 
(2011) 
Japan Patients (n=3), 
aged: (1) not 
provided; (2) 
not provided; 
(3) 19 years 
(1) Neurasthenia; 
(2) Neurasthenia; 
(3) Anxiety (fear of 
gaze) 
Original inpatient Morita 
Therapy; duration 
undefined 
Qualitative Clinical opinion 
LeVine 
(1993a) 
Australia Single patient, 
aged 27  years 
Bulimia nervosa Outpatient counselling; 5 
sessions over 4 weeks 
Quantitative and 
qualitative.  Pre/post 
measures.  Follow-up (2 
months post-treatment). 
Standard outcome 





Canada Single patient, 
aged 27 years 
Social anxiety Outpatient counselling; 
duration undefined 
Qualitative.  Follow-ups 
(face-to-face at 3 weeks; 
via phone at 8 weeks/ 2 
years post-treatment). 
Clinical opinion 
Tateno et al. 
(2015) 
Japan Patients (n=2), 
aged: (1) 30  





Original inpatient Morita 
Therapy; duration up to 5 
months 
Quantitative and 











aged: (1) 30  
years; (2) 25  




disorder; (2) Social 
anxiety disorder; 
(3) Chronic anxiety 
(1) outpatient counselling 
(6 sessions over 12 
weeks); (2) original 
inpatient Morita Therapy, 
duration undefined; (3) 
outpatient counselling 
(10 sessions) 




Canada Single patient, 
aged 28  years 
Shinkeishitsu Outpatient counselling; 
duration undefined 
 
Qualitative Clinical opinion 
France et al. 
(1995) 
Canada Single patient, 
aged 35  years 
Stress Letter therapy process; 
duration 5 months 








Table 4  Case studies (continued) 
Author(s)/ 
Year 
Country Sample Patient diagnosis/ 
condition 
Intervention summary Research methods Outcome measures 
Itoh et al. 
(2000) 
Japan Single patient, 






plus medication and 
sleep hygiene education; 
duration undefined 





(n=2), age not 
provided 
None (presumed to 
potentially exhibit 
Shinkeishitsu traits) 
Use of Morita techniques 
in University counselling; 
duration undefined 
Qualitative Patient self-report 
Kurokawa 
(2006) 
Japan Single patient, 
aged 43  
years 
Panic disorder Form of outpatient Morita 
Therapy termed Walking 
Training therapy; 
duration 6.5 years at 
present (ongoing) 
Qualitative Clinical opinion 
LeVine (1991) Australia Single patient, 
aged 26  
years 
Bisexual patient in 
the 'coming out' 
process 
Outpatient counselling; 7 
sessions 
Qualitative Clinical opinion 
Moriyama 
(2000) 
Japan Single patient, 






Qualitative Clinical opinion 
Morley (1990) Canada Single patient, 







Qualitative Clinical opinion 
Nakamura 
(2016) 
Japan Single patient, 
aged 25  
years 
 
Social anxiety Original inpatient Morita 
Therapy; duration 
undefined 
Qualitative Clinical opinion 
Shioji et al. 
(2000) 
Japan Single patient, 
aged 29  
years 
Social phobia Original inpatient Morita 
Therapy; duration 101 
days 








Table 4  Case studies (continued) 
Author(s)/ 
Year 




Research methods Outcome measures 
Tamai and 
Tashiro (1989) 
Japan Single patient, 
aged 18  years 
Shinkeishitsu Outpatient counselling; 
duration 19 weeks with 
regular follow-ups over 
8 months 
Qualitative.  Follow-ups 
(undefined time points). 
Clinical opinion 
Tamai et al. 
(1991) 
Japan Single patient, 





duration 70 days 
Qualitative Clinical opinion 




aged: (1) 31; 
(2) 49; (3) 51; 
(4) 40; (5) 41 
Nervous disorder Original inpatient 
Morita Therapy; 
duration 3-4 months 
Qualitative Clinical opinion 
Ishiyama (1983) Canada Single patient, 
aged 40  years 
Test anxiety Outpatient counselling; 
1 session 
Qualitative.  Follow-ups 






Canada Single patient, 






Qualitative.  Follow-ups 





Kelly (1993) Canada Single patient, 






duration 6 months 
Quantitative and 
qualitative.  Pre/post 






Tashiro et al. 
(1993) 
Japan Single patient, 






duration 18 months to 
date 
Quantitative and 
qualitative.  Pre/current 
(18 month) measures 
(treatment ongoing). 
Undefined outcome 
measure: nature of 
inner conflicts 
Clinician opinion 
Kondo (1953) Japan Single patient, 
aged 27  years 
Homophobia and 













Table 4  Case studies (continued) 
Author(s)/ 
Year 
Country Sample Patient diagnosis/ 
condition 






aged: (1) 17  
years; (2) 19  
years; (3) 27 
years 
Shinkeishitsu Inpatient Morita 
Therapy; no further 
details provided 
Qualitative Patient self-report 
(diary excerpt) 
Chang (1974) Japan Single patient, 
aged 33  
years 
Shinkeishitsu Original inpatient Morita 
Therapy; duration 
undefined 




Canada Single patient, 
aged 42  
years 
Social anxiety (fear 
of speaking in 







weekly plus immediately 
before/ after each 
session.  Follow-ups (14, 




















Table 5  Systematic/ narrative reviews (n=4) 
Author(s)
/ Year 













Various Anxiety disorder 
(n=270); schizophrenia 
(n=86); mood disorder 
(n=34); somatoform 
disorder (n=24); eating 
disorder (n=2); 
adjustment disorder 
(n=7); pain disorder 
(n=4); sleep disorder 
(n=1); substance 
abuse disorder (n=1); 
personality disorder 








bed rest); durations 
varied 
Quantitative and qualitative.  Author 
searched the latest ten volumes of 
the Japanese Journal of Morita 
Therapy, from 2006 to 2010 
(current).  All articles were included 
except socio-historical and 
theoretical/conceptual articles which 



















social phobia; anxiety; 
social withdrawal; 























Quantitative and qualitative.  
Authors searched Psycinfo and The 
Japanese Journal of Morita Therapy 
published from 1990 to 2008.  Only 
articles which clearly demonstrated 
the effectiveness of Morita Therapy 











Table 5  Systematic/ narrative reviews (continued) 
Author(s)
/ Year 
Country Sample Patient diagnosis/ 
condition 
Intervention summary Research methods Outcome 
measures 






Anxiety disorder Morita therapy defined as 
any care practice defined 
as Morita therapy by the 
carers and involving at 
least two of the four 
phases.  Duration of 
included interventions 
varied from 6 weeks to 
12 months. 
Quantitative.  Authors searched 
Cochrane Collaboration Depression, 
Anxiety and Neurosis Group’s 
Specialised Register (CCDANCTR), 
Dissertation Abstracts International 
(DAI), Chongqing VIP Database, 
Wanfang Database, China Hospital 
Knowledge Database, China 
Biology Medicine disc, Cochrane 
Central Register of Controlled Trials 
(CENTRAL), World Health 
Organization International Clinical 
Trials Registry Platform (ICTRP) 
and Sagace.  All relevant 
randomised controlled trials 
comparing Morita Therapy with any 


















Morita Therapy defined 
as any care practice 
defined as Morita by the 
carers and involving at 
least two of the four 
phases.  Duration of 
included interventions 
varied from 6 weeks to 
10 months. 
Quantitative.  Authors searched the 
Cochrane Schizophrenia Groups 
Trials Register, the Chongqing VIP 
Database, and the Wanfang 
Database for all relevant references 
(July 2008).  All randomised clinical 
trials comparing Morita Therapy with 















Table 6  Secondary reports (n=7) 
Author(s)
/ Year 











Japan Various Taijin Kyofusho (fear of 
interpersonal relations) 
Undefined Quantitative.  
Methods 














Undefined Quantitative.  
Methods 





Japan Various Shinkeishitsu Inpatient Morita 
Therapy; Morita-




Follow-up survey.  
Time point 
undefined. 


















Japan Various Shinkeishitsu; phobic-











time points.  No 
control. 
 
Standard outcome measures: various 













Table 6  Secondary reports (continued) 
Author(s)
/ Year 









Japan Various Shinkeishitsu; 

















Standard outcome measures: various 
Morita Therapy 3 point rating scale: (A) 
complete cure (complete disappearance of 
observable symptoms with or without 
occasional subjective complaints); (B) 
improvement (some reductions in 
symptoms and subjective complaints); (D) 
no improvement 
Clinical opinion 































Appendix II: Intervention optimisation study management and data 
collection 
This appendix provides a copy of supporting documents used during the 
management of and data collection for the intervention optimisation study, 
specifically: 
 University of Exeter Medical School ethics approval letter 
 Summary of core Morita Therapy principles 
 Topic guide for potential patients 
 Topic guide for therapists (round 1) 




























Topic guide for potential patients 
Morita Trial Qualitative Interview Topic Guide 
Phase one (participants) 
Introduction 
Thank you very much for meeting with me today.  We really appreciate your time.  Once I’ve 
explained the study to you and answered any questions you may have, the interview itself 
should last about one hour so we should be finished by….  Is that going to be ok for you? 
So I’m a PhD student at the University of Exeter Medical School working with Professor Dave 
Richards.  As I mentioned in your invitation, I’d like to find out what you think about a therapy 
for depression which is called Morita therapy and is quite new to the UK.  This is so that we can 
make sure as far as possible that the therapy will be appropriate for people and will be 
understood by people in the ways that we hope, before we move onto trialling the therapy 
here. 
I appreciate that you may not have heard anything about this therapy before now so in order 
to find out your views of it I have written a flyer explaining some of the theory and principles 
of MT and we can discuss your thoughts are about that.  Then I will play some recordings of 
the therapy being delivered in practice, to show some real life attempts to try and implement 
some of those MT principles which I will have explained. 
So when we’re listening to those recordings, I’m interested in what you think of the approach, 
what messages you think the therapist is trying to convey, whether you think something is 
unclear or doesn’t make sense, and how you might feel if you were receiving therapy in that 
way.  I’m also really interested in what principles of MT you think the therapist is trying to 
implement in the recording.  I’ll ask you to listen to the recording whilst being in charge of 
pausing it, so that if anything comes to mind whilst you’re listening to it you can pause it and 
tell me there and then so that I can capture your initial reaction.  Does that sound ok?   
I just want to make clear that this is not in any way a test of your understanding, but rather a 
test of the therapy so please do be as critical as you like and if there is something you don’t 
understand that’s exactly the kind of information it is important for us to capture so please 
don’t feel there is a right answer that we’re looking for.  The recordings are not perfect 
attempts to implement the principles and sometimes the message seems to be communicated 
better than others, so I’m just interested in what you think he’s trying to convey and perhaps if 
you have any suggestions for how he might have done that better.  Also, if you have nothing to 
say or add that’s really important for us to know too so a non-answer is still a completely valid 
response.  
The recordings are of a therapist called Masa and his client Kitima.  I should just note that 
Kitima has given permission for us to use these recordings in this way.  Before starting a 
recording I’ll give you some context about what they’re talking about, and then once we’ve 
finished a recording I’ll ask you some specific questions about it before moving onto the next 




conversation doesn’t seem to flow quite right that’s probably why!  There are 5 recordings in 
total but if we’re running out of time we don’t have to listen to them all, and you can let me 
know at any time if you’d like to stop the interview.    
Just to confirm that everything you say is kept strictly confidential, but the one exception to 
that is if you tell me anything which makes me think you may be at risk of harming yourself or 
someone else in which case I will need to follow our protocols for reporting that.  Is that OK?   
I have a CONSENT FORM here for us to complete before we start.  The main things on there 
are whether you happy for our interview to be audio-recorded?  I’ll let you know when I start 
recording.  When I transcribe the interview I will take out any information that might identify 
you personally.  And for my write up if I include any direct quotes I can either label them as 
anonymous or replace your first name with a pseudonym if there’s a particular name you 
would like to choose?  
I’ll also be taking some notes during the interview.  There is also an option to receive a 
summary of the results of our study once we have finished the trial if you would like to, so I 
can send those by email or by post if you prefer (get address if via post and interviewing at St 
Luke’s). 
Before I start can I also just CONFIRM/ COLLECT DEMOGRAPHIC AND BACKGROUND 
INFORMATION.   
Is there anything that you would like to ask before we begin?   
As we go through the questions, if anything is unclear, please do ask me to explain. 
Ready to begin? 
I’m going to start recording now. 
Switch on recorder and introduce the recording by stating the date and time of the interview 
and the interviewee’s first name. 
Ask them to confirm that the study has been explained to them and they have given their 
consent to participate. 
Morita therapy explanation: 
Morita therapy is a talking therapy for various mental health issues including depression and 
anxiety, which has roots in Zen Buddhist philosophy and has been developed and practiced for 
a long time in Japan and somewhat elsewhere but has not been tried in the UK before.  Later 
this year I will be running a pilot trial where the therapy will be delivered here, on a face to 
face and one to one basis, for a one hour session per week over 8 to 12 weeks.  The treatment 
is quite flexible, so rather than having a strict manual of what will be covered in each session, 
the therapist responds directly to what the patient presents with at the time. 
CHECK READ PAGE AT HOME – IF NOT, READ OUT OR ASK PARTICIPANT TO READ TO 
THEMSELVES 




 Is there anything you particularly like or dislike about it? 
 What stands out about the approach to you? 
 How do you think you might feel about receiving that type of therapy? 
 In what ways do you think the approach sounds distinctive or different to other 
therapies you may be aware of? 
Now that we’ve discussed some of the principles of MT, I’ll move onto the recordings to show 
some examples of a therapist trying to implement those in practice.  
General probes: 
 What is your initial reaction to that clip? 
 What’s your interpretation of what the therapist was saying? 
o How well do you think he was getting that message across? 
o Do you have any suggestions for how he might have communicated that 
better?  
 Do you think there are any distinctive principles of MT which were demonstrated in 
that clip?  What do you think those were? 
 What did you think about the approach of the therapist? 
 If you had been the patient in that scenario, how do you think you would have felt? 
 
Clip 1: Diary 
Context: they are talking about her completing a therapeutic diary – show example 
 What is your understanding of the purpose of the diary? 
 Do you think it is clear what is expected from the client? 
 How easy or difficult do you think it would be for you to complete something like that? 
 
Clip 2: Positive reinterpretation/ judgement towards symptoms/ touch of vicious cycle 
Context: talking about the anxiety she suffers from and how she wants to have no worry at all 
 What did you think about the idea that anxiety and fear show desire to be safe and 
caring?   
 How helpful was the metaphor about the feelings being two sides of the same coin in 
explaining this idea? 
 
Clip 3: Naturalness/ baby metaphor/ touch of vicious cycle and Fumon approach 
Context: follows on from their discussions about anxiety 
 What do you think of the idea that anxiety is natural and healthy?  How do you think 
you would feel if a therapist approached your difficulties in this way? 
 What did you think of the way the therapist tried to get this idea across? e.g. saying 
that he doesn’t see an anxious person, he just sees a human? 
 What did you think of his reaction to her saying that she thought other people were 





Clip 4: Control/ anxious action taking 
Context: they have labelled the inner self-critical voice the ‘dictator’ which they refer to 
 How helpful did you find the therapist’s explanation that “You can’t control that 
certain feelings are coming but you can control what you do with them?”  How would 
you feel if a therapist approached your difficulties in this way? 
 What do you think the therapist is trying to achieve by pointing out all the actions she 
has been able to do? 
 
Clip 5: Rest/ marathon metaphor 
Context: talking about her not being able to study and write enough 
 What did you think about the therapist saying that he was giving her a “job to rest”?  
How would you feel about a therapist approaching you in that way? 
 How helpful do you think the approach and the metaphor about running a marathon 
was in encouraging rest and relaxation? 
 This wasn’t referred to specifically but how would you feel about being asked to draw 
up and commit to a schedule of rest for yourself? 
 
Concluding questions: 
 Overall, what did you think of the approach? 
 Are there any things that stand out on reflection? Why? 
 Do you think you would like to be involved in that type of therapy?  
 Do you have any thoughts about the principles you read through compared to hearing 
some of those put into practice – did they seem to relate well to each other/ anything 
surprising hearing them in practice? 
 What are the main ways in which you think MT is distinctive or different to other types 
of therapy you may know of? 
 Is there anything else that you would like to add? 
 
FINISH 
Finally, are there any other comments that you would like to make about taking part? 
Thank you. 
Stop recording and tell them that the recorder has been switched off.   
Explain that they will receive a short summary of results after the pilot study if they have 







Topic guide for therapists (round 1) 
Morita Trial Qualitative Interview Topic Guide 
Phase one (therapists) 
Introduction 
Thank you very much for meeting with me today.  We really appreciate your time.  Once I’ve 
explained the study to you and answered any questions you may have, the interview itself 
should last about one hour so we should be finished by….  Is that going to be ok for you? 
So I’m a PhD student at the University of Exeter Medical School working with Professor Dave 
Richards.  As I mentioned in your invitation, I’d like to find out what you think about a therapy 
for depression which is called Morita therapy and is quite new to the UK.  This is so that we can 
make sure as far as possible that the therapy will be appropriate for people and will be 
understood by people in the ways that we hope, before we move onto trialling the therapy 
here. 
I appreciate that you may not have heard anything about this therapy before now so in order 
to find out your views of it I have written a flyer explaining some of the theory and principles 
of MT and we can discuss your thoughts are about that.  Then I will play some recordings of 
the therapy being delivered in practice, to show some real life attempts to try and implement 
some of those MT principles which I will have explained. 
So when we’re listening to those recordings, I’m interested in what you think of the approach, 
what messages you think the therapist is trying to convey, whether you think something is 
unclear or doesn’t make sense, and how you might feel if you were asked to deliver therapy in 
that way.  I’m also really interested in what principles of MT you think the therapist is trying to 
implement in the recording.  I’ll ask you to listen to the recording whilst being in charge of 
pausing it, so that if anything comes to mind whilst you’re listening to it you can pause it and 
tell me there and then so that I can capture your initial reaction.  Does that sound ok?   
I just want to make clear that this is not in any way a test of your understanding, but rather a 
test of the therapy so please do be as critical as you like and if there is something you don’t 
understand that’s exactly the kind of information it is important for us to capture so please 
don’t feel there is a right answer that we’re looking for.  The recordings are not perfect 
attempts to implement the principles and sometimes the message seems to be communicated 
better than others, so I’m just interested in what you think he’s trying to convey and perhaps if 
you have any suggestions for how he might have done that better.  Also, if you have nothing to 
say or add that’s really important for us to know too so a non-answer is still a completely valid 
response.  
The recordings are of a therapist called Masa and his client Kitima.  I should just note that 
Kitima has given permission for us to use these recordings in this way.  Before starting a 
recording I’ll give you some context about what they’re talking about, and then once we’ve 
finished a recording I’ll ask you some specific questions about it before moving onto the next 
one.  Some of the clips are drawn together from different moments in therapy so if the 




total but if we’re running out of time we don’t have to listen to them all, and you can let me 
know at any time if you’d like to stop the interview.    
Just to confirm that everything you say is kept strictly confidential, if you’re happy for me to 
record the interview I will remove any identifiable information when I transcribe it.    
I have a CONSENT FORM here for us to complete before we start.  For my write up if I include 
any direct quotes I can either label them as anonymous or replace your first name with a 
pseudonym if there’s a particular name you would like to choose?  
I’ll also be taking some notes during the interview.  There is also an option to receive a 
summary of the results of our study once we have finished the trial if you would like to, so I 
can send those by email or by post if you prefer (get address if via post and interviewing at St 
Luke’s). 
Before I start can I also just CONFIRM/ COLLECT DEMOGRAPHIC AND BACKGROUND 
INFORMATION.   
Is there anything that you would like to ask before we begin?   
As we go through the questions, if anything is unclear, please do ask me to explain. 
Ready to begin? 
I’m going to start recording now. 
Switch on recorder and introduce the recording by stating the date and time of the interview 
and the interviewee’s first name. 
Ask them to confirm that the study has been explained to them and they have given their 
consent to participate. 
Morita therapy explanation: 
Morita therapy is a talking therapy for various mental health issues including depression and 
anxiety, which has roots in Zen Buddhist philosophy and has been developed and practiced for 
a long time in Japan and somewhat elsewhere but has not been tried in the UK before.  Later 
this year I will be running a pilot trial where the therapy will be delivered here, on a face to 
face and one to one basis, for a one hour session per week over 8 to 12 weeks.  The treatment 
is quite flexible, so rather than having a strict manual of what will be covered in each session, 
the therapist responds directly to what the patient presents with at the time. 
CHECK READ PAGE AT HOME – IF NOT, READ OUT OR ASK PARTICIPANT TO READ TO 
THEMSELVES 
 What are your thoughts on what you’ve heard of the approach so far? 
 Is there anything you particularly like or dislike about it? 
 What stands out about the approach to you? 
 How do you think you might feel about delivering that type of therapy? 
 In what ways do you think the approach sounds distinctive or different to other 





Now that we’ve discussed some of the principles of MT, I’ll move onto the recordings to show 
some examples of a therapist trying to implement those in practice.  
General probes: 
 What is your initial reaction to that clip? 
 Do you think there are any distinctive principles of MT which were demonstrated in 
that clip?  What do you think those were? 
 What did you think about the approach of the therapist? 
o How would you feel approaching a client in that way? 
 Would you want to do anything differently? 
 What’s your interpretation of what the therapist was saying or what message he was 
trying to convey? 
o How well do you think he was getting that message across? 
o Do you have any suggestions for how he might have communicated that 
better?  
Clip 1: Diary 
Context: they are talking about her completing a therapeutic diary – show example 
 What is your understanding of the purpose of the diary? 
 In writing comments, what do you think you’d be trying to achieve in terms of the 
principles we discussed? 
 Do you think it is clear what is expected from the client? 
 How would you feel about asking a client to make that commitment and explaining the 
purpose of it to them? 
 Does this sound similar to something you might do in other treatments? 
o How is it different to a diary in other treatments? 
 
Clip 2: Positive reinterpretation/ judgement towards symptoms/ touch of vicious cycle 
Context: talking about the anxiety she suffers from and how she wants to have no worry at all 
 What did you think about the idea that anxiety and fear show desire to be safe and 
caring?   
 How helpful do you think metaphors and his choice of metaphors are? 
 
Clip 3: Naturalness/ baby metaphor/ touch of vicious cycle and Fumon approach 
Context: follows on from their discussions about anxiety 
 What did you think of the way the therapist tried to get this idea across? e.g. saying 
that he doesn’t see an anxious person, he just sees a human? 
 What did you think of his reaction to her saying that she thought other people were 
more stable and able to manage anxiety better? 
 
Clip 4: Control/ anxious action taking 




 How helpful did you find the therapist’s explanation that “You can’t control that 
certain feelings are coming but you can control what you do with them?”  How would 
you feel approaching a client’s difficulties in this way? 
 What do you think the therapist is trying to achieve by pointing out all the actions she 
has been able to do? 
 
Clip 5: Rest/ marathon metaphor 
Context: talking about her not being able to study and write enough 
 What did you think about the therapist saying that he was giving her a “job to rest”?  
How would you feel approaching a client in this way? 
 How helpful do you think the approach and the metaphor about running a marathon 
was in encouraging rest and relaxation? 
 This wasn’t referred to specifically but how would you feel about asking a client to 
draw up and commit to a schedule of rest to be shared with you as a therapist? 
 
Concluding questions: 
 Overall, what did you think of the approach? 
 Are there any things that stand out on reflection? Why? 
 Do you think you would like to be involved in delivering that type of therapy?  
o Where do you think you would need more guidance in particular? 
 Do you have any thoughts about the principles you read through compared to hearing 
some of those put into practice – did they seem to relate well to each other/ anything 
surprising hearing them in practice? 
 What are the main ways in which you think MT is distinctive or different to other types 
of therapy you may know of? 
 What did you think about his use and choice of metaphors? 
 A lot of the focus in the clips was on anxiety, how do you see this relating to 
depression? 
 Is there anything else that you would like to add? 
 
FINISH 
Finally, are there any other comments that you would like to make about taking part? 
Thank you. 








Topic guide for therapists (round 2) 
Morita Trial Qualitative Interview Topic Guide 
Phase one Round Two 
Introduction 
Thank you very much for meeting with me today.  We really appreciate your time.  Once I’ve 
explained the study to you and answered any questions you may have, the interview itself 
should last about one hour so we should be finished by….  Is that going to be ok for you? 
So I’m a PhD student at the University of Exeter Medical School working with Professor Dave 
Richards. We’re running a pilot trial later this year where we will be testing a psychotherapy 
called Morita Therapy. Morita Therapy is new to the UK, so I’m also holding interviews with 
therapists and potential patients to help us develop the treatment and the manual itself and 
make sure it is suitable for the people who will be delivering and receiving the treatment here.  
The purpose of today’s interview is to look specifically at the draft therapy manual so that I can 
find out what your views are on that in terms of how comprehensive the manual is, how user-
friendly it is, and things like that. Does that sound ok?   
So just to be clear that this is not in any way a test of your understanding, but rather a test of 
the therapy and the manual so please do be as critical as you like and if there is something you 
don’t understand that’s exactly the kind of information it is important for us to capture so 
please don’t feel there is a right answer that we’re looking for.   
Just to confirm that everything you say is kept strictly confidential, if you’re happy for me to 
record the interview I will remove any identifiable information when I transcribe it.    
I have a CONSENT FORM here for us to complete before we start.  For my write up if I include 
any direct quotes I can either label them as anonymous or replace your first name with a 
pseudonym if there’s a particular name you would like to choose?  
I’ll also be taking some notes during the interview.  There is also an option to receive a 
summary of the results of our study once we have finished the trial if you would like to, so I 
can send those by email or by post if you prefer (get address if via post and interviewing at 
Uni). 
Before I start can I also just CONFIRM/ COLLECT DEMOGRAPHIC AND BACKGROUND 
INFORMATION.   
Is there anything that you would like to ask before we begin?   
As we go through the questions, if anything is unclear, please do ask me to explain. 
Ready to begin? 




Switch on recorder and introduce the recording by stating the date and time of the interview 
and the interviewee’s first name. 
Ask them to confirm that the study has been explained to them and they have given their 
consent to participate. 
So I sent you the draft therapy protocol over email, did you have a chance to read through 
that before today? 
 What were your first impressions of the protocol? 
 How much understanding of Morita Therapy itself were you able to gain from the 
protocol? 
o Do you have any comments about the approach itself? 
 Generally, how much understanding did you feel you were able to gain in terms of how 
Morita Therapy should be delivered by a therapist? 
o In what ways would you need more guidance as a therapist? 
o Did you feel there were any gaps or lack of detail in any particular areas? 
o Was there anything in that didn’t make sense or you found confusing? 
 How user-friendly do you think the protocol is? 
o What are your thoughts on the overall structure, like the order of the 
sections? 
o How easy or difficult do you think it would be to use and navigate through the 
protocol in practice whilst seeing patients? 
 How does the protocol compare to something you may use for a different therapy? 
o Are there any ways in which those manuals were more helpful or easier to 
understand? 
 In terms of the phases of treatment, how operationalisable do you think these are? 
o Is it clear when to move from one phase to the next? 
 Is there anything that stands out as being an area to pay particular attention to during 
therapist training or as suggestions for additional reading? 
 Do you have any other suggestions for improving the protocol? 
 Is there anything else that you would like to add? 
FINISH 
Finally, are there any other comments that you would like to make about taking part? 
Thank you. 
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Appendix IV: The UK Morita Therapy Outpatient Protocol 
Appendix IV of this thesis has been embargoed by the author due to 
commercial sensitivities and to protect ongoing research which the author 
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Appendix V: Intervention optimisation study data analysis 
This appendix provides examples of the analytic process in the development of 
themes on potential patients’ and therapists’ views and understandings of 
Morita Therapy. 
1. List of initial codes following first-cycle descriptive coding 
Positive links to nature 
Taking nature literally 
Nature not coming through in practice 
De-centralising the self and being part of something bigger 
Challenges/ barriers to action-taking 
Positive responses to action-taking 
Action as “constructive” 
Rest as appealing/ helpful 
Mind’s natural healing capacity 
Rest as distinctive 
Permission and guilt around rest 
Concerns/ challenges of rest 
     Depression/ rumination/ unhelpful avoidance 
     Practical 
     Cultural 
What is rest? Purpose/definition 
Balancing rest with action 
Instructions for rest 
Marathon metaphor 
Purpose of/ instructions for diaries 
Inaccurate assumptions regarding diaries 
Therapist comments/ exchange of diaries 
Struggle/ challenges of diaries 
Suggested changes to diaries 
Naturalness of emotion 
Normalisation as validating/ reassuring 
Normalising versus trivialising 
Healthy versus unhealthy levels of distress 
Explaining differences between people/ causes of difficulties 
Positive reinterpretation creating positive slant/ stressing attributes 
Coin metaphor 
Overgeneralisation in positive reinterpretation 
Disagreement and confusion in positive reinterpretation 
Holistic/ person-centred/ non-diagnostic 
Gentle/ kind/ compassionate 
Fluidity and lack of structure 
Providing rationale and explanation 
Personalisation 
Collaboration 
Directive versus non-directive 
Subtle/ implicit approach 
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Fumon – dangers 
Communication difficulties/ lack of clarity 
Resonation of/ identification with underlying principles 
The vicious cycle 
Principles versus vignettes 
Acceptance/ relinquishing control/ not fighting 
     Where are the tools? 
     Balance/ keeping on an even keel 
Paradigm shift 
Managing expectations 
Comparisons to other treatments 
     CBT 
     MBCT 
     Other 
     Distinctiveness 
Constructive/ realistic approach 
Enabling understanding 
Application to depression 
Metaphors and analogies 
Supporting the therapists 
 
2. Initial impressions of striking/ important elements of the data for 
answering the research questions  
Principles versus clips  
o Participants typically identify with principles 
o Some unsuccessful communication/ translation into practice 
o Participants demonstrate acceptance of inability to control 
thoughts/ emotions in principle but still seek coping mechanisms 
and manipulation of thoughts/ emotions in practice.   
 A lack of this and the exploration/explanation of difficulties 
is potentially perceived as undermining the severity of 
symptoms 
 Potential challenges with implementation – diaries/ rest/ action-taking 
 Thoughts/ difficulties around tone/ style of practice 
 Paradigm shift/ distinctive elements of therapy 
o Preparing patients for the approach/ managing expectations  
o Similarities/ differences to other treatments 
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3. Codes categorised into initial thematic framework following second 
cycle pattern coding 
1. Key components: Nature/ action-taking/ rest/ diaries 
     De-centralising the self 
     Naturalness of emotions 
     Challenges/ barriers 
     Action as “constructive” 
     Permission and guilt in rest 
     Meaning and purpose of rest/ diaries 
2. Therapist techniques 
     Fumon - dangers 
     Metaphors and analogies 
     Normalisation  
          Allowing negative emotions 
          Trivialising and healthy vs unhealthy levels 
          Explaining differences between people/ causes of difficulties 
     Positive reinterpretation 
          Lack of clarity/ communication difficulties 
               Overgeneralisation 
               Reframing emotions not situations 
          Disagreement 
          Positive responses 
3. Structure and style 
     Providing rationale and explanation 
     Conversational/ lack of structure 
     Collaboration 
     Personalisation 
     Subtle/ implicit approach 
4. Underlying approach 
     Anti-diagnostic 
     Constructive, realistic and pragmatic 
     Holistic and spiritual 
5. Therapy goals 
     Acceptance 
     Seeking tools/ management/ balance 
     Insight and enabling understanding 
6. Other 
     Resonation of/ identification with underlying principles 
     The vicious cycle 
     Principles versus vignettes 
     Paradigm shift 
     Comparisons to other treatments 
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4. Modified thematic framework following review and refinement of coded 
data during continued second cycle pattern coding 
1. Therapy in practice 
     Challenges/ barriers to implementation 
     Confusion/ communication difficulties 
          Positive reinterpretation 
     Lack of depth and explanation 
          Fumon 
          Normalisation 
2. Structure and style 
     Providing rationale and explanation 
     Conversational/ lack of structure 
     Collaboration 
     Personalisation 
3. Underlying principles and approach 
     Resonation of/ identification with underlying principles 
     Discrepancies between principles and vignettes 
     Anti-diagnostic, holistic and spiritual 
     Paradigm shift 
     Comparisons to other treatments 
4. Therapy goals 
     Acceptance and allowance 
     Seeking tools 
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5. Example framework matrix (‘structure and style’) 
 
Providing rationale and explanation 
Conversational/ lack of 
structure 
Collaboration Personalisation 
TH 02         
TH 03 
  Seems to be some CBT 




philosophy similar to 
GAD model but without 
the same structure - 
emphasis less on 
diagram, more on 
metaphor. 
 
Seems to evolve without 
a clear pathway. 
Background feels similar to 
person-centred therapy. 
 
Explored fact she needed a 
rest well i.e. collaboratively - 
but then told her what she 
needed to do, and would 
have been better to let her 




- better to stick with one 
example and explore that 
with the patient. 
Therapist says a lot without 
checking patient's understanding 
or taking examples from them. 
 
Liked when illustrations of the two 
sides of the coin were drawn from 
patient herself - could do more of 
that. 
 
Liked when therapist stayed with 
what the patient was saying and 
reflected that back to her. 
TH 04 
May need to deal with people feeling that 
their questions aren't being addressed 
(e.g. Fumon) - suggests giving education 
upfront around how focusing on gaining 
a deeper understanding can perpetuate 
problems = good quote - managing 
expectations from start. 
 
The approach is subtle - sometimes 
directive and sometimes the principles 
are interwoven implicitly – “will be a skill 
to develop”. 
DIARY - less structured 
than CBT. 
 
Liberating to have a 
more fluid therapy (but 
feels like a novice). 
How directive is it? 
Compared to CBT 
(collaboratively working), is 
MT steering more 
didactically? How much 
does patient determine how 
much rest they need?                                 
In some instances, more 
directive than would have 
expected, and yet very 
subtle in other instances. 
 
Conversation around action 
quite directed by therapist. 
Repetitive - should elicit more from 
patient - e.g. what do you think 
value/ function of worry is? 
 
Keen to personalise nature 
metaphors in practice so they feel 
most pertinent to the patient. 
TH 01 
People need to understand upfront: new 
approach which may appear counter to 
expectations. 
 
Suggests may need more preamble 
around explaining the purpose of 
  Interpreted as Wise Sage/ 
Guru (culturally defined?) 
giving out wisdom and not 
deviating from principles, 
rather than Western 
treatment which is more 
Hard to make a connection for the 
individual patient when it's a very 
directive/ guru driven approach. 
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therapist comments in DIARY. collaborative/ seeking 
permission. 
 
Didn't check patient's 
understanding/ interpretation 




ACTION - therapist not as 
directive as behaviour 
therapist here.  MT is 
appealing in that sense - this 
is more of a reflective piece 
between therapist/patient. 
 
REST - therapist is being 
more directive here, which is 
distinctive to other 
treatments. 
PT 10: no 
therapy 
experience 
"Therapist obviously knows something I 
don't" - but she is open to this. 
More 'open' than other 
treatments - not text 
book, step by step 
instructions (positive 
point). 
    







DIARY explanation needs more - likes to 
know why she's doing something/ to 
have an end goal for more motivation. 
 
If you're not using goals (e.g. to feel 
better), better to be upfront about that 
rather than just ignoring them - therapy 
shouldn't be doing things the patient is 
not aware of. 
 
REST - needs more explanation to know 
why you're doing it/ assurance that it 
works. 
"Wishy washy" - not 
concrete enough/ not 
clear enough what to do 
or take away from the 
session. 
 
It's like a friendly chat - 
hard to identify therapist 
and patient - seems to 
go easily. 
 
Worried that people 
won't see markers and 
progress strictly laid out 
and so won't see the 
point. 
It's like a lecture - I'm telling 
you this rather than you 
telling me something. Not 
the feedback you usually 
hear in therapy. 
More personalised metaphors 
would help.  Therapy shouldn't 
only use abstract metaphors - 
should relate directly to patient. 
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PT 04: no 
therapy 
experience 
DIARY - unsure of purpose but does not 
think it necessary to know more as then 
you second guess/ get ahead of 
yourself. 
 
Subtlety - it's like e-learning: getting 
somebody to learn something without 
knowing they've learned it. 
Doesn't feel like therapy, 
feels like "good advice".  
This is positive as he 
would feel some 
resistance to something 
which feels like therapy. 
  Got the tone right - more personal 
than previous therapies - not one 
size fits all. 
PT 01: no 
therapy 
experience 
  Friendly way of talking 
about it - more 
conversational and 
reflective rather than 
homework-based. 
 
More personable rather 
than scripted according 
to the therapist's plan. 
Re: Giving the patient a job 
to REST - being made to do 
something by someone else 
as opposed to giving it to 
yourself means you're more 
likely to do it. 
Liked discussion around ACTION 
as patient was talking - it was 
about the individual patient rather 
than a "story or quip". 
 
More personable/ reactionary 
towards the patient rather than 





DIARY - comfortable with explanation 
given - bullet points are sufficient. 
No strict structure is a 
positive. 






DAIRY - purpose not very clear - should 
have explained more e.g. why they're 
doing it and how long it will be for - too 
open-ended. 
 
Generally, should have explained the 
'plan' more. 
CBT is more structured - 
MT is open-ended. 
Re: Giving the patient a job 
to REST - saying 'listen to 
me' - would be better if the 
patient "owned" the job 
herself. 
Repeated the same ground a lot - 
not much to make the patient 
think/ didn't explore her particular 
anxieties enough/ not opening her 
up to the possibilities. 
 
Metaphors = frustrating as not 




DIARY - needs more information as can 
be threatening - explain why they're 
doing it and why it will help the patient. 
 
Generally - need to understand why 
you're doing things to be respectful. And 
can note that some things may not make 
sense but that there is a reason for it 
(even if you don't explain the reason). 
 
REST - should explain why it may be 
difficult (e.g. conditioned not to rest) and 
that it is important/ should assure them 
    Didn't paint a full picture - 
repetitive without eliciting from the 
patient what would happen if she 
didn't worry/ didn't unpack what 
worry meant to her - superficial/ 
didn't get to know patient/ didn't 
allow enough space for patient - 
imposing and disrespectful. 
 
Discussion around ACTION was 
better as actually focused on what 
the patient did. 
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that it has a basis in something that 





DIARY - would probably want to know 
more about why they're doing it but if 
told they don't need to know they would 
accept that. 




    ACTION - less imposed by 
therapist than in BA (positive 
point). 
 
Gentle approach - didn't 





Generally - Not sure more explanation is 
necessary as don't want to be second 
guessing. 
 
But would find it helpful to have the 
background info (explanation of 
principles) to give context to what he is 
saying generally/ to explain why some 
questions are not being addressed (e.g. 
Fumon). 
 
Appreciates some people may be able to 
trust process and may be distracted by 
too much info/ others may need more 
info to focus on principles. 
    Types of ACTION are not set in 







6. Final themes following within-case and cross-case analysis using 
framework matrices, as informed by initial impressions of/ insights into 
the most important and striking elements of the data 
1. Translating principles into practice 
 The underlying principles 
 Discrepancies between principles and practice  
 Barriers to implementation 
 Communication difficulties 
2. Respecting the individual 
 Transparency and rationale 
 Explanation and exploration 
 Structure, personalisation and collaboration 
3. Shifting the understanding framework 
 Familiarity and distinctiveness 
 Accepting and allowing emotions 





















Appendix VI: Morita Therapist Training Programme 
Morita Therapist Training Programme 
(1) Discussion: Morita Therapy principles 
 Nature 
o The natural healing capacity of the mind – law of emotion 
o The ebb and flow of emotions as a natural phenomenon 
 Vicious cycle 
o Preserving energy 
o Two sides of the coin 
o Desire for life 
 Doing rather than introspecting 
 Looking out rather than looking in 
 Fumon – selective reinforcement 
o Acknowledge negative experiences but do not explore content 
o Promoting good behaviour rather than eradicating bad behaviour 
 Purpose orientated living rather than mood orientated living 
 Rest 
o Rest when you are ill 
o Priming principle – you need to go through this phase in order to 
stop fighting/ come back into line with the natural world  
o ‘Riding the storm’ (sitting with/ endurance) rather than ‘sunbathing’ 
(relaxing) 
 Emerging desire for life 
o The person will take the right kind of action from within 
 Acceptance (of ‘first-level’ emotions) 
 Experiential learning (through 4 phases) 
o Re-programming your relationship with your emotions (and the 
world) 
 NB: Goals  
o Always break goals into small steps 
o Help people to create the (intrapersonal) conditions in which they 
may achieve their goals 
o Optimising their potential to achieve whatever is meaningful to 
them 
(2) Discussion: Operationalising the principles: the vehicles 
 Nature as the ‘golden thread’ 
o Try ‘nature dots’ 
o Check in every session: ‘how have I brought this in?’ 
o At the end of treatment: consider with the patient how they will 
maintain this sense of being part of/ connected to the natural 
world 
 Not focusing on the way they feel 
 Activities which provide space to look outwards 
 
 Diaries 
o Selective reinforcement 




o Noting experiences of the law of emotion 
o Ask patients to write about their day (whatever seems important to 
them) rather than what they did/thought/felt 
o Be clear on the Fumon approach first 
o Exchange: 
 When they hand in their newly completed diary, be thankful 
and scan for risk issues/ completeness but do not discuss 
content 
 When you hand back their diary with your comments on, 
ask them to quickly look over your comments and reflect on 
these/ raise any issues they may have 
 
 The rest phase 
o In the inpatient setting, patients would rest for a week 
o The purposes of rest are: 
 To experience the ebb and flow of emotions.  Thus, 
habituation is presumably one of the key goals of rest.  
Whether or not multiple 30 minute bouts of rest would be 
sufficient to achieve habituation is unclear. 
 Removing patients from unhelpful expectations/ routines 
 A return to natural biorhythms/ Allowing recovery from 
fatigue 
 The emergence of a desire to move on – boredom 
and attention turning outwards following saturation 
o The general indicator of progress in the rest phase is the drive to 
action – as long as this drive is coming from the right place (from 
interest/ curiosity/ boredom NOT mood driven i.e. to escape 
unpleasant emotions) 
o The therapist may wish to send a letter to the patient’s GP to 
advise them that they will be engaging in rest and may require a 
sick note 
o If the patient absolutely cannot commit to rest, return to the key 
principles: explore in what ways they may be helped to become 
more outward looking/ part of nature – could try 30 minute bouts 
of rest/ could try attention focused activities 
 
 The action phases/ connecting people with the natural world 
o Use ways of connecting to nature that make sense for the 
individual e.g. if someone already visits the gym, suggest 
exercising in a park. 
o Not all activities need to be nature orientated – the priority is for 
people to move their attention outwards, so anything they already 
do which fits this criterion may be used. 
 
 NB: Praise – try to resist this! Paying attention (selectively) should be 
reinforcement enough 
 NB: Empathy – go easy on empathising with difficult feelings. Empathise 






(3) Guidelines: ROLE PLAY EACH SESSION 
(3)(a) Session 1: Introducing the therapy 
1. Acknowledge they are part of a research project they volunteered for 
2. Briefly introduce history of Morita Therapy  
a. Over 90 years of practice 
b. Originally from Japan and now used somewhat elsewhere e.g. 
Canada/ Australia 
c. Do not move into Morita principles yet 
3.  Acknowledge that Morita Therapy is a treatment for mood and anxiety 
problems 
a. Ask patients to explain a little about why they are seeking therapy 
b. Gather enough information to elicit examples for illustrating desire 
for life and ways in which they are caught in the vicious cycle (e.g. 
“do you find yourself preoccupied with those feelings?”/ “do you 
find yourself doing more or less of anything when you feel that 
way?”) 
4. Reframe their issues through an explanation of Morita Therapy principles 
a. Use their own examples 
b. Nature 
i. We’re not above/ separate to nature: as a natural organism 
we’re subject to forces/ changes that we cannot control – 
as with trees/ weather 
ii. Ebb and flow of emotions is one such natural phenomenon: 
there will always be storms but we can learn how to better 
weather these so we don’t make them worse or delay their 
subsiding 
c. Stress that emotions are neither good nor bad but they are 
pleasant and unpleasant – use this to help ensure they sense an 
understanding of their suffering 
d. Not a therapy for treating symptoms but for helping to change their 
relationship to their symptoms so that they spend less time 
labelling/fighting them  
e. Vicious cycle: exacerbating unpleasant feelings 
i. Inward vs outward focus 
ii. Desire for life: will emerge and manifest itself in small signs 
that they want to DO things 
iii. Mind’s capacity for restoration/ rejuvenation if given the 
right conditions (although this is not permanent healing – 
the scab will ‘heal’ but we may be left with a scar and will 
certainly be wounded again during our lives) 
f. Check in on the patient’s understanding of these principles 
5. Explain the four phases of treatment 
a. Note that this is a treatment where you will help them to 
understand the principles of Morita Therapy and change their 
relationship to emotions by experiencing certain things, rather 
than a treatment aimed at intellectual understanding of the 
principles 
b. Use inpatient model to help explain what each phase is supposed 




from inwards to outwards and moving to a more action-oriented 
way of living 
i. Explain that the treatment is like a training program where 
we create slightly artificial circumstances in order to 
achieve these purposes 
c. Phase one: stress that rest/ inaction, or at least the purpose of 
rest (experiencing the ebb and flow of emotions), is essential – we 
will need to find a way for them to experience this somehow, and 
we think rest is the best way to achieve this 
i. ‘During this phase, it is important to dedicate as much time 
as possible to ‘sitting with’ your thoughts and feelings – 
how can we maximise this amount of time for you?  Who do 
we need to involve/ talk to?’ 
d. Phase two provides an opportunity to look outwards in detail – 
concentrate on what things smell, feel, look etc. like, find small 
tasks which involve repetitive movements e.g. knitting/ drawing, 
and focus on things they enjoy doing 
e. Phase three involves more complicated and demanding activities 
e.g. things in the garden/ more strenuous exercise 
f. Phase four involves more social activities 
g. Stress that this is a gradual process of re-engagement in which 
there is a breadth of options for activities which will be driven by 
their desires and signs that they are ready to move on (i.e. nothing 
too intimidating/ forced) 
6. Explain techniques you’ll be using 
a. Fumon: Explain upfront that emotions will be used as cues for 
discussions of desire, action, attitude and acceptance but we will 
not disentangle and analyse emotions – prepare patients to allow 
for less empathy/ acknowledgement of he negative 
i. Acknowledge importance of emotions and that you 
understand how they feel, but be clear that this therapy will 
not focus on those emotions and will instead help draw 
their attention to when they are looking outwards  
ii. Explain that spending time focusing on emotions will not 
improve how they feel and will feed into the vicious cycle 
1. ‘It is not that I don’t think those feelings are important 
or understand how difficult they are but because I 
don’t want to reinforce that vicious cycle – I’ll be 
picking up on when you focus your attention 
outwards rather than inwards 
b. Diaries 
i. Explain that this is not a structured diary but rather they will 
be asked to write a page every day about their day 
ii. Stress that they should write about whatever they like but 
reiterate that we will not focus on their emotions 
iii. Explain that the diaries will be exchanged so that you may 
comment on their previous week and that you will have a 
quick chat at the start of each session in case there’s 
anything in your comments that they want to mention or 
don’t understand 
7. Consider with the patient whether they should bring a significant other to 




(3)(b) Providing diary guidance (and responses during therapy sessions) 
*ACTIVITY: trainees to take example diary entries away, provide comments and 
bring them to the next session for discussion* 
1. Reinforce actions (especially ‘in spite of the way you were feeling…’) 
2. Interpret negative emotions as desires for life 
3. Note when making a connection with the natural world 
4. Reinforce their acknowledge of/ insight into the vicious cycle (and if they 
break out of it) 
5. Note when they are experiencing the natural ebb and flow of emotions 
6. Note when they are looking outwards generally e.g. responding to the 
external environment 
 NB: adapt comments to reflect the phase they are in so that you reinforce 
appropriate (in)action for the phase e.g. ‘this sounds like a really suitable 
activity for this time’ 
 NB: avoid emotionally loaded language 
 NB: keep language personalised e.g. ‘you are…’ 
 NB: consider using metaphors to illustrate the nature of their experiences 
(3)(c) Session 2: Negotiating rest 
 Remember: 3 rationales for rest: 
o Experiencing the ebb and flow of emotions 
o Allowing recovery from fatigue 
o Removing patients from unhelpful expectations/ routines 
 Purpose one is fundamental and relevant to all patients.  
The other two purposes are more dependent on patient 
presentation. 
1. Cover purpose two/three: prescribe and permit rest (including sleep) 
a. As part of the natural world we cannot resist this need 
b. If we take a break from unhelpful situations/ patterns/ expectations 
and also from fighting how we think/ feel, we can conserve energy 
2. Cover purpose one: ‘you will find that your emotions naturally go up and 
down – sometimes you may sleep, sometimes you may feel peaceful and 
other times you will feel distress and emotional turmoil’ (make sure 
patients are aware that this is to be expected and will happen by itself) 
a. This will provide an opportunity for you to experience the ebb and 
flow of thoughts and feelings over time 
b. Don’t focus on making yourself feel better or trying to change your 
thoughts/feelings – just be with it and observe what happens 
c. Use the boat/stormy sea metaphor and scab metaphor (the itch 
will go away – we don’t normally give ourselves the opportunity for 
things to change naturally because we quickly jump to trying to 
force change) 
3. Facilitate rest 
a. How are we going to make this work for you, to ensure you get 
these experiences? 
b. Stress the importance of this phase: you have a serious condition 
and this is part of your treatment which requires an investment 
from you which will hopefully pay off in the long term (what you 




c. Be clear that this is radical – it is not what they would normally be 
doing 
d. Consider if it is possible to be signed off work for a week – what 
would they do if they were physically ill? 
4. What are the challenges/ barriers they envisage? 
a. Make sure they are aware that it will be challenging 
b. Explore how to create a resting space in which they feel safe 
c. Use the diary as a container for their experiences and 
observations 
5. Specify the conditions/ practicalities 
a. In silence with no distractions etc. 
b. Tend to basic needs 
6. Make an individualised aide-memoire with the patient outlining what they 
should be doing and the purpose of this – something which might mimic 
a reassuring therapist presence 
(3)(d) Session 3 
1. Return the diary with your comments on to the patient for the first time 
a. Ask them what sense they make of those comments/ what 
messages they take from them 
b. Ask them if they can see how the comments reflect some of the 
principles of Morita Therapy 
i. If they cannot, explain your comments in terms of the 
principles 
2. Ask how they have got on with establishing rest this week 
a. Explore how much/ how they set it up etc. (give sufficient attention 
to this to reflect the value of rest) 
3. Prescribe rest for a further week 
a. If it seems that patients require further concentrated rest, consider 
taking further time off work 
i. If patients have only experienced distress and no ups and 
downs, reassure them that we are expecting that this will 
be difficult, they are in the early stages and they are still 
taking the (in)action that they need to take 
b. If it seems that patients have experienced a reasonable amount of 
rest, are showing some indicators of progress and have learned 
appropriate lessons (i.e. how emotions ebb and flow), discuss 
moving onto smaller periods of rest, fitting around their work 
c. This provides you with an opportunity to review their diary data 
from the rest period before considering moving onto phase two 
(3)(e) Negotiating further phases 
 Always bear in mind the purpose of the phase and then consider how 
this can be achieved 
 Be prescriptive in terms of the conditions/ criteria that activities need to 
fulfil i.e. looking outwards 
a. If there are no such activities patients can think of in phase two, 





b. For phase two, avoid reactive/ automatic activities or ‘mind’ 
orientated activities e.g. Sudoku/ crosswords 
 Use active therapeutics 
a. Phase two: explore and observe outside/ pick up leaves etc. and 
study those – demonstrate to patients the level of observation and 
detailed attention paying we would like them to engage in 
b. Phase three: take patients to the community garden etc. – they 
should now be observing for useful tasks they could complete 
 Both observe and enquire about the indicators of progress to reassure 
you that it is time to move on 
a. Also consider the overall indicators of progress on p. 82 of the 
protocol – “do you look at your emotions any differently now?” 
(3)(f) Ending a session 
 Ask the patient what they are taking away from the session 
 Confirm with them which phase you are in and what (in)action they will 
be taking this week 
o Ensure they are planning to write in their diary, and to reflect on 
the comments you have made in their diary from the previous 
week 
(4) Arrange supervision slots 
(5) Additional reading 
 MORITA, S., KONDO, A. & LEVINE, P. (1998) Morita therapy and the 
true nature of anxiety-based disorders (Shinkeishitsu). New York, NY: 
State University of New York Press. 
 OGAWA, B. (2013) Desire For Life: The Practitioner’s Introduction to 







































































Appendix VIII: Feasibility study recruitment 
This appendix provides a copy of supporting documents used for feasibility 
study recruitment, specifically: 
 Study summary sheet 
 Permission to contact form 
 Participant Information Leaflet 
 Consent form 
 Clinical Information Form 

































Participant Information Leaflet 
 
 
Participant Information Leaflet 
  
The Morita Trial (Morita Therapy for Depression and Anxiety:  
A Feasibility and Pilot Study) 
 
Thank you for returning your permission to contact form for this research study.  Before 
you decide whether you want to take part or not it is important for you to understand 
why the research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part. 
 
What is the purpose of the study? 
 
Depression and anxiety cause misery to many people and are major health problems in 
the UK.  Although some current treatments are effective for some people, they do not 
work for everybody and it is important to develop new therapies so as to offer people a 
choice of treatments which may suit them.  One possible treatment for depression and 
anxiety is called Morita therapy.   Although this treatment is widely used in Japan, we 
do not know if it is effective for and acceptable to patients and clinicians in the UK.  By 
carrying out a large clinical trial to assess the outcomes of Morita therapy, we hope to 
find out whether it is an effective depression and anxiety treatment for people here.  
However, before we can do this, we need to test the treatment and our procedures in a 
small trial.  We also need to speak with patients and therapists to find out what they 
think about Morita therapy. 
 
Why have I been invited and will the study be suitable for me? 
 
Either your GP surgery or local Improving Access to Psychological Therapies (IAPT) 
service is taking part in this trial and sent you a letter asking you to consider taking part 




which we are treating in this study, or you have contacted us in response to one of our 
adverts for the study online or in your GP waiting room.  This information sheet is for 
you to keep, if you decide to take part one of our research team will go through the 
information sheet with you and answer any questions you have.  You will also be asked 
some questions by the researcher to see if you are eligible to be included in the study.  
You may take part whether you are taking medication or not, and whether you have 
tried therapy in the past or not.  However, if you are currently receiving another 
psychological therapy you will not be able to take part in this study. 
 
Do I have to take part? 
 
No. It is entirely up to you to decide whether or not to take part.  If you do decide to 
take part you will be asked to sign a consent form.  If you do decide to take part, you 
will still be still free to withdraw at any time and without giving a reason.  A decision to 
withdraw or not to take part will not affect the care you receive in any way. 
 
What is being tested? 
 
We are running a small clinical trial to compare Morita therapy for depression and 
anxiety with usual care.  We are intending to carry out a large trial to test Morita 
therapy but before we can do this, we need to find out how big such a trial needs to be 
and how many people we need to approach to take part.  We also need to know what 
patients and therapists think about Morita therapy.  A small trial will allow us to develop 
the treatment and our trial methods, and we will use qualitative interviews to find out if 
Morita therapy is acceptable to people. 
   
Morita therapy is based on the idea that symptoms of depression and anxiety are a 
natural part of peoples’ experience, but that responses to these feelings can make 
them worse.  In particular, focusing too much on trying to change unpleasant feelings 
can actually fuel them, like being caught in a vicious cycle.  The therapist helps you to 
understand these behaviours and how they can be unhelpful.  As opposed to current 
therapies such as Cognitive Behavioural therapy, the aim is therefore to focus on how 
to live constructively in spite of symptoms, rather than focusing on changing thoughts 
and feelings.  
 
Usual care means you will not receive any treatment through the study itself but there 




elsewhere.  You will be returned to the care of your GP and may discuss treatment 
options with them. 
 
What will happen if I take part? 
 
Thank you for speaking with us over the phone and arranging to meet with us to find 
out if you are eligible to take part in the study.  You can ask us about the study at any 
time.  If we confirm at our meeting that you are eligible and you agree to take part you 
will receive Morita therapy or usual care.  However, if after you have spoken with the 
researcher and answered some questions it is found that you are not eligible to take 
part, we are really sorry if it causes you disappointment and thank you for your interest 
and time that you have given.  If you are not eligible to take part we would refer you 
back to your GP to continue treatment in the normal way. 
 
If you are eligible to take part we need to explain that this study is a randomised 
controlled trial which means that once you have been interviewed by a researcher and 
have decided you would like to take part, the decision about whether you receive 
Morita therapy or usual care is made completely by chance.  In this trial half of our 
participants will receive Morita therapy and half will receive usual care.  We will allocate 
you to either Morita therapy or usual care by assigning you a personal identification 
number, known only to the research team, which will be entered into a secure 
computer system that picks the numbers at random and allocates them to one of the 
options at random.  We will let your GP know that you are participating in this study. 
 
If you are allocated to Morita therapy, you will receive between eight and twelve 
sessions of one hour duration with a trained therapist once a week, spread over eight 
to twelve weeks.  The therapist will see you face to face and help you to complete a 
daily diary between sessions which outlines your daily activities.  If you are allocated to 
usual care, we will let your GP know and you will be free to access any other 
treatments which you can discuss with your GP.  
 
Once you have been allocated to Morita therapy or usual care, you may be invited to a 
more in-depth interview about why you have chosen to take part in the trial.  We will 
also meet you again for a follow-up appointment with a researcher four months after 
our first meeting, to complete a number of questionnaires.  If you are allocated to 
Morita therapy, once you have attended all the treatment sessions we will also invite 




experiences of taking part in the trial.  Overall, your involvement in the study will be for 
a maximum of five months although the research study will last for two years.   
 
What information do you need from me? 
 
At our arranged meeting we will find out more about you.  We will need to ask about 
your current and past mental health as well as your life more generally.  We will ask 
you some questions about how you have been feeling recently and there will be a few 
questionnaires that we would like you to fill out.  You will also be able to ask any 
questions you may have about the study.  This meeting will take about two hours.  We 
expect that the follow-up appointment will take no more than around one hour and we 
will collect some more questionnaires from you at this appointment. 
 
We are interested in finding out about why people have volunteered to take part in the 
trial.  Therefore, we may ask you to attend a more in-depth interview of up to one hour 
after we have seen you for our first meeting.  We are also interested in finding out what 
people think of Morita therapy and their experiences of taking part in the trial.  
Therefore, we will ask people who are allocated to receive Morita therapy to attend a 
more in-depth interview of around one hour after they have completed treatment.  We 
would like to audio record these interviews if you are happy for us to.  The interviews 
would be conducted over the phone or face to face at your home.  Alternatively, if you 
cannot speak on the phone or meet a study researcher at your home, we will arrange 
to meet with you at the University of Exeter.  There is a separate part to the consent 
form to allow you to give your consent for these interviews, and you do not have to 
agree to it if you do not want to.   If you choose not to take part in the interviews, you 
can still take part in the trial and it will not affect the standard of care you receive.  If 
you agree, the recordings will be anonymously transcribed (typed up word for word, 
with any information which may identify you or your family or friends removed) before 
being destroyed. 
 
Will I have to do anything differently? 
 
No, there are no restrictions in your lifestyle from taking part in this research. You 








Will I be paid to take part? 
 
No.  We cannot pay people to attend appointments with their therapist and we will not 
reimburse travel expenses for these.  Occasionally, it may be necessary for people to 
attend additional interviews with a study researcher at the University of Exeter for 
which we will pay travel expenses. 
 
What happens when the research study stops? 
 
We will encourage you to continue to see your GP who will treat you as s/he feels is 
best for you and with your agreement.   
Are there any side effects, disadvantages and risks of taking part? 
 
We are not aware of any side effects, disadvantages or risks to you of taking part in 
this research.  If any relevant new information comes to light which may affect you or 
your decision to take part in the trial we will inform you of this. 
 
What are the possible benefits of taking part? 
 
Many people in Japan and other countries have found Morita therapy helpful and it has 
been shown to have a positive effect for some people with mental health problems 
such as depression and anxiety.  If you are allocated to receive Morita therapy, we 
hope that the treatment you are given will help you. However, we cannot guarantee 
that you will benefit from the treatment.  The information we get from this study may 
help us to treat future patients with depression and anxiety better. 
 
What will happen to the results of this study? 
 
We will send you a summary of the results of the study if you would like us to.  We 
intend to publish the results of this study.  Any presentations and publications will not 
identify you personally.  We hope to use the information from this study to design a 
large trial of Morita therapy and potentially help us to treat future patients better.   
 
What if something goes wrong or I have a complaint? 
 
We do not expect any harm coming to you from being in this study.  However, if you 
wished to complain, or had any concerns about any aspect of the way you have been 




Service complaints mechanisms are available to you through the Patient Advice and 
Liaison Service (PALS) on 0800 0730741.  Alternatively, if you are randomised to 
receive Morita therapy, you may prefer to raise the matter with the Mood Disorders 
Centre AccEPT Clinic.  Written complaints should be sent to the AccEPT clinic 
complaints manager at: Washington Singer Laboratories, School of Psychology, 
University of Exeter, Perry Road, Exeter, EX4 4QG.  If you are eligible, agree to take 
part, randomised to Morita therapy and are unhappy with the care or treatment you 
receive, you can also raise the matter (in writing or by speaking) with your clinic 
therapist. 
 
Will my taking part in this study be kept confidential? 
 
All information collected about you during the course of the research will be kept strictly 
confidential.  Any personal details, such as name and address, that we collect from you 
will be stored securely for five years and accessed only by the study team.  Any 
information about you that is collected from the questionnaires or interviews will be 
stored indefinitely on the University of Exeter’s open access repository (Open 
Research Exeter) in order to support other research in the future.  These will have all 
personal details removed so that you cannot be recognised from them.   
 
As your GP may be involved in your treatment, s/he will be informed of your progress 
as part of the research study.  Should your condition worsen to a point where it is felt 
by either a researcher or a clinician that you may be a danger to yourself or others, 
your GP will be informed of this; with or without your permission.  However, this is the 
only time we would ever break confidentially. 
 
In the unlikely event that you become unable to consent to taking part during the study, 
we will withdraw you from the study.  We will retain any data which you have already 
given us but will only use this confidentially and in line with the consent you have 
already given us. 
 
Who is organising and funding the research? 
 
The study researcher is funded by the University of Exeter Medical School who also 
sponsor this research.  This is not a commercially funded industry study.  This means 
that your GP surgery and the Exeter Depression and Anxiety Service who may have 
invited you to express your interest in the study, and the research team, will not receive 





Who has reviewed the study? 
 
All research involving NHS patients is looked at by an independent group of people 
called a Research Ethics Committee to protect your safety, rights well-being and 
dignity.  The study has been reviewed and given a favourable opinion by the South 
West - Frenchay Research Ethics Committee. 
 
Further Information – Next Steps 
 
Please look at the ‘Participant Flow Chart’ on the next page which sets out the 
assessment and treatment process in a way which we hope you find helpful.  During 
our arranged meeting you will have the chance to ask questions and we will ask you for 
more information to find out if you are eligible.  If you are eligible and want to take part, 
we will ask you to sign a form to say so and then get you to fill out some questionnaires 
about yourself.   
 
Contact for Further Information 
 
If you need further information or have any questions, please contact: 
 
Holly Sugg, Morita Trial Researcher   
University of Exeter Medical School   
Room 1.33, South Cloisters 
St Luke's Campus  
Heavitree Road 
Exeter EX1 2LU 
 
Email: h.v.s.sugg@exeter.ac.uk 
Office telephone: 01392 727412 
 
 




Morita Trial Participant Flow Chart 
 
 
At the assessment the study will be explained to you fully and you can ask any questions you 
may have.   You will be asked some questions to see if you are eligible 
You expressed your interest in taking part in a trial of a treatment called Morita therapy 
If you are enrolled into the trial your details will be entered onto a secure computer that 
picks at random whether you will receive Morita therapy or treatment as usual                 
You have spoken to the study researcher who has arranged an assessment meeting with 
you to find out if you are eligible to take part in the study 
If you are eligible and 
happy to proceed you 
will be asked to provide 
your consent to take 
part in the study 
If after the assessment you are found not to 
be eligible to enter into the study, we are 
very sorry and thank you very much for your 
interest in the Morita Trial. You will return 
to the usual care of your GP 
Morita therapy involves between 8 and 
12 one hour one-to-one sessions with a 
therapist on a weekly basis 
Treatment as usual means you will not 
receive treatment in the study but may 
access treatment elsewhere as normal 
There will be a follow-up appointment at 4 months 
You will be invited to an interview 
after you finish Morita therapy 
Thank you.  You have completed your involvement in the Morita Trial and we thank 
you for your participation. You will return to the usual care of your GP and will be sent 
a summary of the results of the Morita studies if you would like to 
  


















Date of baseline 
assessment 
 
SCID major depressive 
disorder (symptoms 
present most of the day 
nearly every day for at 
least two weeks within 
past month) 
 
Depressed or down -           
Loss of interest or pleasure -  
Change in appetite/ weight (gain or loss?) -  
Change in sleep (insomnia or hypersomnia?) -  
Psychomotor change (agitation or retardation?) -  
Fatigue/ loss of energy -  
Feelings of worthlessness/ guilt -  
Trouble concentrating/ indecisiveness -  
Recurrent thoughts of death -  
 
Number of episodes: 
 












Panic disorder (lifetime) -  
Panic disorder (current) -  
Panic disorder with agoraphobia (lifetime) -  
Panic disorder with agoraphobia (current) -  
Agoraphobia without panic disorder (lifetime) - 
Agoraphobia without panic disorder (current) - 
Social phobia (lifetime) -  
Social phobia (current) - 
Specific phobia (lifetime) - 
Specific phobia (current) - 
Define specific phobia: 
OCD (lifetime) - 
OCD (current) - 
PTSD (lifetime) - 
PTSD (current) - 
GAD (6 months preceding MDD) - 
 
Notes: 












Baseline GAD-7 score 
 
 
Baseline Work and 





Any other notes/ issues 
































Phone number  
 
Okay to leave message?  
 
Mobile number  
 
Okay to leave message?  
 
Email address  
 
GP name  
 




Preferred days/ times for therapy  
 
Preferred gender for therapist  
 
Consent to audio record therapy sessions?  
 










Appendix IX: Feasibility study management and data collection 
This appendix provides a copy of supporting documents used during the 
management of and data collection for the feasibility study, specifically: 
 Therapist fidelity checklist 
 Topic guide for participants 
 Topic guide for therapists 
 Risk protocol 
 Serious Adverse Events reporting form 
 Letters: 
o National Research Ethics Committee South West – Frenchay 
(ethics approval) 
















Therapist fidelity checklist 
Morita Therapy: Therapist Fidelity Record 
Session 1: Introducing Therapy 
Therapist name:___________________________ Patient Trial 
ID:______________________ 
Date of session:___________________________ Session number: 1 
 Tick if 
completed 
1. Acknowledgement that participant is part of a research project  
2. Introduction to the history of Morita Therapy  
3. Information gathering on why the patient is seeking treatment  
a. Elicit examples of possible desire for life  
b. Elicit examples of the vicious cycle  
4. Explanation of principles  
a. Use of patient’s own examples  
b. Nature  
c. Emotions as pleasant/unpleasant but neither good/bad  
d. Therapy for changing relationship to emotions, not emotions 
themselves 
 
e. Vicious cycle  
f. Inward vs outward focus  
g. Desire for life  
h. Mind’s capacity for rejuvenation in right circumstances  
i. Check in on patient’s understanding of principles  
5. Explanation of four phases  
a. Experiential treatment  
b. Rest as an opportunity to experience the ebb and flow of 
emotions 
 
c. Phase two as an opportunity to look outwards in detail  
d. Phase three involving more complicated/ demanding 
activities 
 
e. Phase four involving more social activities  
f. Gradual process of re-engagement with breadth of options  
6. Explanation of techniques  
a. Fumon: emotions will be used as cues for discussions but we 
will not disentangle and focus on emotions 
 
i. Acknowledgement of importance of emotions  
b. Diaries  
i. Maximum one page per day  
ii. Patient should ‘just write’  
iii. No right or wrong  
iv. Exchange process  
v. Patient given diary to complete over next week  
7. Consideration of whether the patient should bring a significant other 







Morita Therapy: Therapist Fidelity Record 
Session 2: Preparing for Rest 
Therapist name:___________________________ Patient Trial 
ID:______________________ 
Date of session:___________________________ Session number: 2 
 Tick if 
completed 
1. Explanation of rationale for rest  
a. Allow recovery from fatigue: as part of the natural world we 
cannot resist this need 
 
b. Remove patient from unhelpful expectations/ routines/ 
patterns including fighting how they feel 
 
c. Experience the ebb and flow of emotions  
i. Patient will find that their emotions go up and down 
and that they may experience distress which is 
natural 
 
ii. Patient should not focus on trying to change their 
thoughts/ feelings but be with them and observe 
how they flow over time 
 
iii. Metaphor use – stormy sea/ scab  
2. Facilitation of rest  
a. Ensuring that the patient has a way to get these experiences 
– the longer the rest, the better 
 
b. Stressing of the importance of this phase as an investment  
c. Clarity that this is radical – not their normal experience of 
rest 
 
d. For working patients, consideration of whether they may be 
signed off for one week 
 
3. Exploration of challenges/ barriers to rest  
a. Ensuring the patient is aware that rest will be challenging  
b. Exploration of how to create a safe space  
c. Advice given to patients to use the diary as a container for 
their experiences 
 
d. Addressing any guilt the patient expresses  
4. Specification of the conditions for rest  
a. In silence with no distractions etc.  
b. Tend to basic needs  










Morita Therapy: Therapist Fidelity Record 
Session 3 onwards 
Therapist name:___________________________ Patient Trial 
ID:______________________ 
Date of session:___________________________ Session 
number:_____________________ 
Phase (1: rest/2:  light activities/ 3: heavy activities/ 4: social reintegration): 
___________________ 
PRINCIPLES/ STANCE 
  Tick if 
completed 
ESSENTIAL 1. Fumon  
 2. Reference to the natural world  
 3. Interpretation of negative emotions as desires for 
life 
 
AS APPROPRIATE 4. Use of metaphor  
 5. Explanation of/ reinforcement of patient’s insight 
into the vicious cycle 
 
 6. Reference to accepting the natural ebb and flow of 
emotions 
 
 7. Reinforcement of emerging desire for life  
 8. Reinforcement of outward focus  
 9. Reinforcement of action  
 
OPERATIONALISATION  
  Tick if 
completed 
 1. Diary exchange  
 a. Patient asked to review comments and feedback  
 b. Patient asked if they can see how the comments 
reflect Morita Therapy principles 
 
 2. Review of how the patient got on with the phase over the 
previous week 
 
 3. Enquiry into indicators of progress for the current phase  
 4. Negotiation of the next phase (see overleaf) if appropriate  
 5. Check on what patient is taking away from the session  
 6. Confirmation with patient which phase they are in/ what 
(in)action they will take this week 
 
 a. Ensuring patient is planning to complete diary  
 




  Tick if 
completed 
PHASE 1 1. Exploration of how (much) rest was set up – sufficient 
attention given to reflect value of rest 
 
 2. Prescription of rest for additional week if appropriate 
(essential for session 3) 
 
 a. Where indicators of progress present in session 3, 
discussion of moving onto smaller periods of rest 
 
 3. For patients who have experienced a lot of distress, 
provision of reassurance that this is expected/ early stages 
 
PHASE 2 1. Explanation of the purpose when negotiating phase  
 a. Experience the ebb and flow of emotions if left 
alone 
 
 b. Increase focus outwards  
 c. Connect with nature  
 d. Channel and fuel desires  
 2. Facilitation of the patient’s identification of activities which 
meet the criteria 
 
 a. Engagement with nature  
 b. Observation and use of senses  
 c. Light and repetitive tasks using hands  
 d. Absorbing activities  
 e. Enjoyable activities  
 3. Use of active therapeutics if appropriate e.g. moving 
outside to observe/ explore 
 
PHASE 3 1. Explanation of the purpose when negotiating phase  
 a. Increase focus outwards  
 b. Connect with nature  
 c. Channel and fuel desires  
 d. Try to experience the self in the moment and as 
part of their body 
 
 2. Facilitation of the patient’s identification of activities which 
meet the criteria 
 
 a. Engagement with nature  
 b. Concrete and functional tasks in which the patient 
can succeed 
 
 c. Attending to what is significant in their 
environment – what requires their attention 
 
 d. Small steps  
 e. Tasks involving whole body movements  
 3. Use of active therapeutics if appropriate e.g. use of 
community garden 
 
PHASE 4 1. Explanation of the purpose when negotiating phase  
 a. Reintegrate the patient back into their real life in 
society 
 
 b. Anxious action-taking to develop an 
action/purpose-based rather than mood-oriented 
lifestyle 
 
 2. Facilitation of the patient’s identification of activities which 
meet the criteria 
 
 a. Small steps/ cumulative efforts  




Topic guide for participants 
 




Thank you very much for meeting with me today.  We really appreciate your time.  Once I’ve 
explained this part of the study to you and answered any questions you may have, the 
interview itself should last about one hour so we should be finished by….  Is that going to be ok 
for you? 
You may remember that we’d like to know what you think about the treatment you’ve 
received as part of this study.  We’d also like to hear your views of how we have set up and run 
the study so I’ll be asking you some questions about that, too. 
Compared with when I last met with you, this interview will be a bit different.  We’d like to 
know what you think about things.  This means that I will ask you questions for you to tell me 
your views and opinions – how things have been from your perspective.  Sometimes, I might 
follow up something you say with a few more questions to make sure that I fully understand it. 
IF CONSENTED TO AUDIO RECORDING: Before we begin, are you still happy for our interview 
to be audio-recorded?  I’ll let you know when I start recording. 
IF DID NOT CONSENT TO AUDIO RECORDING: Can I just check whether you’re happy for me to 
audio-record the interview?  When I transcribe the interview I will take out any information 
that might identify you personally.   (IF NO, TAKE NOTES INSTEAD/ IF YES, ASK THEM TO RE-
INITIAL THE RELEVANT PART OF THE CONSENT FORM AND PUT THE DATE NEXT TO THE 
CHANGE) 
I will take some notes as we talk instead, but please be assured that I am still listening.  
You may remember that everything you say is kept strictly confidential with one exception and 
that’s if you tell me anything which makes me think you may be at risk of harming yourself or 
someone else.  Is that OK? 
And for my write up if I include any direct quotes from you I can either label them as 
anonymous or replace your first name with a pseudonym if there’s a particular name you 
would like to choose? (ADD CHOSEN PSEUDONYM OR “ANONYMOUS” TO INTERVIEW NOTES 
AT THE END OF THE TOPIC GUIDE) 




As we go through the questions, if anything is unclear, please do ask me to explain. 
Ready to begin? 
I’m going to start recording now. 
Switch on recorder and introduce the recording by stating the date and time of the interview 
and the interviewee’s first name. 
Ask them to confirm that the study has been explained to them and they have given their 
consent to participate. 
1. Thoughts and feelings before treatment 
Can you tell me a bit about what led you to take part in this trial?   
Probe areas:  
 -Was there anything about Morita Therapy in particular 
 -Why are they involved in this trial in particular 
-What did they expect from treatment 
-Were there any problems with which they particularly wanted                                                                                                       
help?  What were they? 
 
2. Understanding/ Experiences of treatment 
Having now attended Morita Therapy, please can you describe to me your understanding 
of what Morita therapy is? 
Probe area:  
-Understanding of the goals of Morita Therapy 
Please tell me about your experiences of receiving treatment.  
Probe areas:  
-Length of therapy sessions, total length of treatment,                                                                   
way in which therapy was ended 
       -What it felt like receiving treatment 
 -Anything in particular that they liked or found helpful 
 -Anything they didn’t like or found less helpful 
 -How could the treatment have been improved 
 -How well the therapy helped them with the problems they wanted to work on 
-To what extent did therapy match their expectations – why (not)/ how (not)/ in what 
ways 












-What is their view of the different phases of Morita Therapy, especially the rest phase 
(including directions received/ preparing for rest with the therapist) 
-What are their thoughts/ feelings about the style of the therapist (including their 
explanation of how/why they would not be paying particular attention to emotions, 
and how this was experienced in practice) 
-What is their view of the concept of ‘desire for life’ – how this was explained/ the 
examples used and how relevant it was for them 
-What is their view of the vicious cycle and how this does or does not relate to them 
-How did they feel about the idea of accepting the natural ebb and flow of emotions 
and how this was put across to them 
-What is their view of the connection to natural world/ how this was put into practice 
for them in a literal sense 
-What is their view of the use of metaphors? Any that stick in their mind as particularly 
helpful or unhelpful 
-What is their view of the amount of explanation and rationale that was given for the 
therapy as a whole, and anything they were asked to do (diary/ each phase) 
 
3. Barriers to treatment  
We are interested in reasons why people might decide to attend some or all of their 
therapy sessions.  Please could you tell me about your reasons for deciding to continue 
with or stop therapy?  (If relevant: Why did you decline treatment/ stop early?) 
Probe areas: 
 -Personal contextual factors 
-Specific therapy factors 
-Therapeutic relationship factors (including therapist style) 
-Stages or exercises i.e. diary writing/ particular phases found difficult? 
-Anything (else) that could have been done to overcome these difficulties 
 
4. Active treatment components/ mechanisms 
We are interested in the ways in which treatment may have brought about changes for 
you, particularly in terms of anything you may have learned from the treatment.  Please 
can you tell me about any changes that happened for you during treatment? 
Probe areas:  
 -Anything they learned during treatment 
-‘What was it about treatment that changed that for you?’  












5.   Experiences of the trial 
Your views and opinions of the trial itself are also important to us. How did you feel about 
taking part in a research trial? 
Do you have any views or comments on how we have set up and run the trial? 
Probe areas: 
 -When did they decide to take part in the study 
-What did they think of the written information they received                                         (  
-How did they feel about how long it took for us to contact them                                                    
after they returned their form 
-How did they feel about the process of being randomised to either Morita therapy or 
TAU 
-What did they think of how long it took the clinic team to contact them after their 
baseline  
-How easy was it to schedule therapy appointments 
-How well were their questions or concerns during the study addressed 
-What could have been done to improve the running of the study 
  
6.   Experiences of the MASA questionnaire 
We are interested in your experiences completing one of the questionnaires in particular, 
the MASA (give example).  Do you have any comments on this?  
Probe areas:  
 -Anything they didn’t like 
 -Anything they didn’t understand 
-Relevance to them/ their experience of therapy/                                                                           
the impact therapy had on them 




Stop recording and tell the patient that the recorder has been switched off. 
Explain that the patient will receive a short summary of the results of the interviews once 













Topic guide for therapists 
 




Thank you very much for meeting with me today.  I really appreciate your time.  Once I’ve 
explained the study to you and answered any questions you may have, the interview itself 
should last about one hour so we should be finished by….  Is that going to be ok for you? 
As you know, I would like to find out what you think about the therapy you’ve delivered as part 
of this study.  I’d also like to hear your views of how we have set up and run the Morita Trial so 
I’ll be asking you some questions about that too.  I have broad questions that will help 
structure the interview but I will also be led by what you say.  Sometimes I might follow up 
something you tell me with more questions to help me understand it in full. 
Is that OK? 
Before we begin, I would like to acknowledge that it may sometimes be difficult for you to 
provide honest feedback.  However, it is important for me to understand what did and didn’t 
work well.  The information you provide will be used to help develop a large clinical trial on 
Morita therapy.  Everything you say is kept strictly confidential.   
And for my write up, if I include any direct quotes from you, I can either label them as 
anonymous or replace your first name with a pseudonym if there’s a particular name you 
would like to choose? (ADD CHOSEN PSEUDONYM OR “ANONYMOUS” TO INTERVIEW NOTES 
AT THE END OF THE TOPIC GUIDE) 
I will not, without your permission, include a quote that would directly identify you by 
something you said.  However, because a very small number of therapists have been involved 
in the Morita Trial, it may be possible for a reader who is familiar with the project to attribute 
quotes and/or views, to you or your colleagues. 
Do you have any concerns? 
IF CONSENTED TO AUDIO RECORDING: Before we begin, are you still happy for our interview 
to be audio-recorded?  I’ll let you know when I start recording. 
IF DID NOT CONSENT TO AUDIO RECORDING: Can I just check whether you’re happy for me to 
audio-record the interview?  When I transcribe the interview I will take out any information 




INITIAL THE RELEVANT PART OF THE CONSENT FORM AND PUT THE DATE NEXT TO THE 
CHANGE) 
I will take some notes as we talk instead, but please be assured that I am still listening.  
Is there anything that you would like to ask before we begin?   
As we go through the interview, if any of my questions are unclear, please do ask me to 
explain. 
Ready to begin? 
I’m going to start recording now. 
Switch on recorder and introduce the recording by stating the date and time of the interview 
and the interviewee’s first name. 
Ask them to confirm that the study has been explained to them and they have given their 
consent to participate. 
1. Understanding of Morita therapy 
To help me understand what you think of Morita therapy, I would like to know how you 





2. Experiences of Morita therapy 
I would now like to ask you about the therapy you have implemented as part of this study.  
First, please tell me what you thought of Morita therapy. 
Probe areas:  
-The frequency and length of each session/ total duration of treatment 
-What they thought about the diary writing 
-How they expected patients to benefit from Morita therapy 
-Any patients or circumstances where Morita therapy felt inappropriate and how they 
handled that 
-Patients for whom Morita therapy worked especially well or not and why 
-Reasons why patients declined Morita therapy or dropped out early and how they felt 
about this 












-How they felt about the criteria for ending treatment and implementing this in practice 
-What, if any, support they wanted to offer upon ending treatment 
-DIARIES (how often returned/ completed) 
-Phases especially REST 
-Use of FUMON and ACCEPTANCE of emotions 
-Connection to NATURE 
-DESIRE FOR LIFE/ Reinterpreting fears as desires 
-Vicious cycle 
 
3. Mechanisms of change 
We are interested in the ways in which Morita Therapy may have brought changes 
about for patients, especially in terms of things they may have learnt from 
treatment.  Please can you tell me what you think the changes were that Morita 
Therapy brought about for patients? 
Probe areas: 
-What impact do you think this has for patients? 
-What was it about Morita Therapy that you think may have                             
brought about these changes? 
 
4. Orientation towards Morita Therapy 
We are interested in your views of Morita Therapy and how this has impacted 
upon you.  Can you tell me about your views and experiences of delivering Morita 
Therapy? 
Probe areas: 
-Any impact on them personally      
-Any impact on views of mental health/ other approaches to                          
treatment 















5. The therapy protocol 
We are also interested in your experiences using the Morita therapy protocol.  Please 
could you tell me what you thought of the protocol? 
Probe areas: 
     -  How user friendly and understandable 
      - How helpful during treatment sessions 
       -Any impact they found from changes made to the protocol during the intervention  
optimisation study 
       -Ways in which the current version could be improved 
       -Views on using the protocol as part of training new therapists  
Please tell me about anything else that feels important to feedback on your experience of 
Morita therapy 
 
6. Feasibility and appropriateness of trial procedures 
Your views and opinions of how this study has been set up and run are also important to 
us.  Please can you tell me your thoughts on taking part in this study? 
Probe areas:  
-What they thought of the Morita therapy orientation meeting  
-How well details of new patients were passed on/ comments on the                               
patient information received from me from baseline assessment 
-Problems scheduling therapy sessions 
-Views and experiences of record keeping and file management including copying of diaries 
-How they felt about SAE and risk procedures 
-Views on DNA protocol and letters to people who withdrew from therapy 
-How they felt about clinical supervision 
-What might be done to improve how the study is run 
Please tell me about anything else that feels important to feedback on the set up and 
running of the Morita Trial 
FINISH 














  PROTOCOL FOR ASSESSING, REPORTING AND MONITORING RISK  
Amended from the COBRA Protocol for assessing, reporting and monitoring risk v.2.2 120313 
1. Policy Statement 
GPs are responsible for the ongoing clinical care of Morita trial participants. Therefore, all trial 
staff directly involved with research participants have a duty of care to ensure that 
participants’ GPs are aware of any risk to participants or from participants to others, including 
suicidal thoughts expressed by participants. 
Researchers must initiate the risk protocol each time a participant expresses suicidal thoughts, 
thoughts of self-harm or thoughts of harm to others. This may be as a result of responses to 
questionnaire items or the participant may disclose information during an interview that leads 
the researcher to believe that there are thoughts of suicide or harm to self or others. In both 
instances, the researcher should initiate the risk protocol and notify their first supervisor. 
2. Principles 
The following principles and procedures govern risk assessment, reporting and monitoring for 
the Morita Trial. 
The Morita trial excludes participants at baseline interview who demonstrate any risk to self or 
others that would require management by specialist mental health or other services. However, 
included participants might develop such risk during the trial and must be assisted accordingly. 
The first supervisor has overall responsibility for risk assessment and management for the 
Morita trial. The first supervisor must ensure that any research personnel involved with the 
Morita trial are adequately qualified and trained on risk assessment prior to any patient 
contact in which risk could be disclosed, and that these personnel receive support and 
supervision around risk issues during their involvement with the trial.  
All cases where significant risk is identified by researchers will be managed according to the 
Morita risk protocol and discussed with the first supervisor.  All assessment reports and 
correspondence relating to risk sent by research staff will be checked by the first supervisor 







3.  Procedures for research personnel 
 
All researchers will be made familiar with the protocol and new staff who will be involved in 
assessing/treating patients will be familiarised as part of their induction/training.  Risk 
assessment should therefore be conducted following appropriate training and with 
appropriate supervision.  
The first supervisor is responsible for ensuring that appropriate cover is arranged for any risk 
issues that might arise in their absence when away from research sites. This will entail a 
person being named as responsible for overseeing risk assessments in their absence and 
contact details being shared with Morita trial staff. 
Whenever any significant risk is identified (during an interview or through reviewing patient 
reported outcome measures) a risk assessment form (appendix A) should be completed and 
(counter-) signed by the first supervisor. If at all possible this should be done at the time of 
the assessment, or as soon afterwards as possible. Research staff should seek supervision the 
same working day that they receive any information regarding risk and ensure management of 
the information has been handed over to the first supervisor.   
All contact with patients/GPs and any other professionals around risk should be documented 
in writing in the participant’s file. Contact with the patient’s GP, duty GP or other emergency 
service should be instigated according to the level of risk identified having followed the Morita 
risk policy. As specified in the policy, contact may be by telephone, or if by fax a phone call to 
the GP Surgery made to ensure receipt of the fax. 
Many of the Morita questionnaires (e.g. PHQ-9) include questions about suicide risk.  Morita 
trial staff should always respond to any identified risk (as specified below) via these measures, 
and a risk assessment in line with this protocol should be completed.  
A score of 1 or more on the PHQ-9 item 9 requires further assessment.   
All personnel working on the Morita trial should also ensure they ascertain whether 
participants represent a risk to themselves or others through neglect or active harm and 
whether participants are themselves at risk of being harmed by others. The same process is to 
be followed in any instance of risk and supervision from the first supervisor should be 





4. Questions To Ask & Protocol If Risk Has Been Identified For Morita trial Patients 
 
THOUGHTS 
 “I see that you’ve said / you mentioned that……...  These are thoughts / feelings that people 
suffering from depression often have, but it’s important to make sure you are receiving the 
right kind of support.  So if it’s OK, I would now like to ask you some more questions that will 
explore these feelings in a little more depth.” 
 
 PLANS 
1 Do you know how you would kill yourself?   Yes / No 
 
If yes – details 
 
2 Have you made any actual plans to end your life?  Yes / No 
 




3 Have you made any actual preparations to kill yourself?  Yes / No 
 
If yes – details 
 
4 Have you ever attempted suicide in the past?   Yes / No 
 




5 Is there anything stopping you killing or harming yourself  
at the moment?       Yes / No 
 
If yes – details 
 
6 Do you feel that there is any immediate danger that you  
will harm or kill yourself?     Yes / No 
 
If yes - details: 
 
  
FOLLOW-UP FROM PREVIOUS CONTACT 
 
7 If Action B was enacted at previous assessment and level B risk is identified at 
current assessment: Last time we met I suggested that you spoke to your GP about these 
thoughts, and I also wrote to your GP about this. Have you been able to speak with your 







To be used following any indication of risk from questionnaire items, responses to interview 
questions or any other sources. Look at answers from the sheet to determine level of risk, A B 
or C: 
 
Actions by Morita trial Staff member 
 
Tell Participant 









I can see that things have been very difficult for you, but it seems to 
me these thoughts about death are not ones you would act on – 
would this be how you see things?  (if they say yes)  I would advise 
you to make an appointment to see your GP to talk about these 
feelings.   
 
‘Yes’ for any one of Qs 1-4;  plus ‘yes’ 








‘Yes’ for any one of Qs 1-4;  plus ‘yes’ 





Things seem to be very hard for you right now and I think it would 
help if you were to speak to your GP about these feelings.  I will be 
writing to your GP to tell them that you have been here today and 
have been having some troubling thoughts. I would also advise you 




I think it’s important that your GP knows how difficult things are for 
you right now. I will be telephoning your GP to speak with him/her 
and suggest that you meet with one another. I also advise that you 
make an appointment to see your GP to talk about these feelings.  
N.B: telephone call to GP to be followed up by letter. The letter 
should include the statement “the clinical management of this 
patient remains your responsibility, but it is part of our protocol to 
inform you of any risks disclosed to ourselves so that you can take 
account of them in your care plan.” 
 
Scoring ‘no’ to Q5 or ‘yes’ to Q6 
 
 









I am very concerned about your safety at this moment,  I am going to 
make some telephone calls to your GP/ Care Co-ordinator / 
Crisis Management team/the emergency services to let them know 




Action to take in the case of immediate risk: 
Participant needs immediate help – do not leave them alone, or if on telephone, do not hang up.  Follow your 
chain of supervisory contact in order to involve supervisory clinician right away. Then (with supervisor if 
possible) follow the chain of contact below: 
1. GP/out-of-hours GP; if not 
2. Crisis team; if not  
3. Clinician accompanies to A&E; if not (or interview is over telephone)  








Appendix A:  Morita Risk Assessment Form    
 
Date risk protocol enacted:                                                      Participant ID: 
Time Point: Telephone screen / Baseline / 4 month / other, please specify: 
 
Risk protocol has identified level of risk as:     A                B1                B2                C 
Suicide Risk Information: 
Report which questionnaire and the score that gave cause for concern and attach copy of 
risk assessment.  Include whether the participant has reported any of the following: 
 Current suicidal ideation 
 Suicide plans 
 Active preparations to commit suicide 
 
 Protective factors or lack of them 












Clinical supervisor contacted:  Y / N                                        Date: 




































POTENTIAL RISK TO PATIENT 
 
Re: Participant Name________________________ DOB_________________ 
 
As you know, PATIENT NAME, is taking part in the Morita trial comparing Morita 
therapy with primary care as usual for the treatment of Depression and Anxiety. As 
part of the trial, the Morita trial researcher interviews patients on a number of 
occasions to assess their health, during which we assess risk, including risk to self and 
others and suicide risk. 
 
During the interview we conducted on DATE PATIENT NAME reported 
…………………………………………………………………………….. (DETAILS OF PARTICIPANT’S 
THOUGHTS, PLANS ACTIONS). 
 
As a consequence of this we instigated the Morita risk policy. We  
……………………………………………………………………………… (DETAILS OF ACTIONS TAKEN).  
 
The Morita trial’s clinical and research procedures do not provide participants with 
services to manage significant risk to self or others, including suicidal intentions. 
Clinical management of all patients in the Morita trial remains the responsibility of 
their GP. Of course, as part of our study protocol we have a duty to inform you of 
these disclosures and our actions in response to them so that you can take account of 
them in your clinical management of this patient. We trust that the above information 














Action to take in the case of immediate risk: 
Participant needs immediate help – do not leave them alone, or if on telephone, do not hang up.   
 
1. Contact your supervisor AS SOON AS POSSIBLE: 
1. Prof Dave Richards  – 07930 393456 
2. Holly Sugg – 07803 706516 
 
When contacting staff by mobile if you are unable to reach them please text “URGENT please contact 
regarding Morita risk protocol” 
 
2. Then follow the chain of contact below: 
 
5. Participant’s GP 
 
Inform the receptionist that you need to speak to the GP and that it is urgent because it is about risk 
to their patient.  If the GP is unavailable at the moment, ask when they are likely to be available.  Ask 
the receptionist to ask the GP to call you back and make sure they pass on the message that this is 
urgent/ related to their patient being at risk. 
 
“Hello, my name is________, I’m one of the researchers working on the Morita Therapy trial at the 
University of Exeter’s Medical School.  I’m ringing because I’m with your patient ________ for an 
appointment at the moment and I’m very concerned about their safety.  I have run through our 
suicide risk protocol with them and they have told me that ________ (briefly detail thoughts/ plans 
and the fact that they have nothing stopping them from harming themselves and/ or they have said 
that they are in immediate danger of harming themselves).  Because I am a researcher and not a 
clinician, and to ensure their safety, I need to make sure they are seen by an appropriate clinician as 
soon as possible.  Is it possible for yourself or a colleague of yours to meet with them here (University 
premises or patient’s home)?  …. I will stay [on the phone] with them until you arrive.  (if not and you 
are with the participant in person: Is it possible for me to accompany them to your Practice so that I 
can stay with them until someone is able to meet with them for an appointment?)” 
 
 
6. If participant’s GP not available: Out-of-hours/ Duty GP 
 
If the receptionist tells you that the GP is not in that day, ask for whoever the duty GP is/ if it is out of 
hours, speak with the out of hours GP.  Use the same script as above. 
 
 
7. If no GP available: Crisis team: 
 
 Depending on where your appointment is being held (or the location of the participant if on 
the phone), contact the Mental Wellbeing and Access Team on: 
o Exeter: 01392 207799 
o Mid, Tiverton: 01884 235710/ Crediton: 01363 778600 
o East, Exmouth: 01395 280300/ Honiton: 01404 540100 
o Teignbridge (e.g. Dawlish): 01803 290782 
o North Devon (e.g. South Molton): Barnstaple: 01271 378781/ Bideford: 01237 472379 
 




the Crisis Resolution Team:  
o Wonford House (Exeter, East and Mid Devon): 01392 208540 or 07968845048 
o Teignbridge (e.g. Dawlish): 01392 388266 or 01626 357351 or 01626 357327  
o North Devon (e.g. South Molton): 01271 311835 or 0845 6000 388 
 
“Hello, my name is ________, I’m a researcher working at the University of Exeter.  I am currently in 
an appointment with a participant and I have become very concerned for their safety.  I have run 
through our suicide risk protocol with them and they have told me that ________ (briefly detail 
thoughts/ plans and the fact that they have nothing stopping them from harming themselves and/ or 
they have said that they are in immediate danger of harming themselves).  Because I am a researcher 
and not a clinician, and to ensure their safety, I need to make sure they are seen by an appropriate 
clinician as soon as possible but I’m not able to reach a GP at their Practice at the moment.  Is it 
possible for a clinician within your service to meet with them here (University premises or patient’s 
home)?  …. I will stay [on the phone] with them until you arrive” 
 
 
8. If GP/ Crisis team unavailable and you’re with the participant in person:  Accompany to A&E 
(if at all possible this should be done by Dave, not you)  
 
“Hello, I’m a researcher working at the University of Exeter.  I have come here with a participant 
because I am very concerned for their safety.  According to what they have told me they are in 
immediate danger of harming themselves. Please can you arrange for them to be seen by a clinician 
to ensure their safety?”   
 
Stay with participant until they are seen by a clinician. 
 
 
9. If GP/ Crisis team unavailable and you’re on the phone with the participant:  Call ambulance.       
 
“Hello, I’m a researcher working at the University of Exeter.  I am currently with a participant and 
have become very concerned for their safety.  According to what they have told me they are in 
immediate danger of harming themselves. …”   
 
Stay with participant [on the phone] until the ambulance arrives. 
 
   
 
 












Serious Adverse Events reporting form 
Date of incident:        Participant ID:                















Please indicate type (tick all that apply): 
 
Fatality:                                                       
 
Life-threatening:                                        
  
Hospitalisation or prolongation of           
hospitalisation:                  
 
 
Persistent or significant disability or incapacity:   
      
 
Congenital anomaly or birth defect:                        
 
 
Other:                                                                            
    
                         

















Name of Researcher / Chief 









1. Details of Primary Supervisor 
 
Name: Prof David A Richards 
Address: University of Exeter Medical School 
Haighton Building 
University of Exeter 




Telephone: 01392 724615 
Email: D.A.Richards@exeter.ac.uk  
 
 
2. Details of Study 
 
Full title of study: Morita Therapy for Depression and Anxiety: A feasibility 
and pilot study 
Name of main REC:  
REC reference:  
Research sponsor:  
Sponsor’s reference for this 




3. Type of Event 
 
Please categorise this event, ticking all appropriate options: 
Fatality: 
 
Life threatening:    
 
Hospitalisation or prolongation 
of hospitalisation:    
 
Persistent or significant 
disability or incapacity:   
 
Congenital anomaly or 
birth defect:    
 







4. Circumstances of the Event 
 
Date of event:  
Location of event:  
Describe the circumstances of 
the event (attach further 








What is your assessment of 
the implications, if any, for the 
safety of study participants 












Name of Chief Investigator: 
(BLOCK CAPITALS) 
 







6. Acknowledgement of Receipt by REC 
 















Signed original to be sent back to the Chief Investigator; copy to be kept for information by 



























































Appendix X: Feasibility study qualitative data analysis 
This appendix provides a copy of supporting documents used for the analysis of 
embedded qualitative interviews in the feasibility study, specifically: 
 Sample participant field note 
 Transcription template 
Finally, examples of the analytic process in the development of themes on the 




























Morita Trial Standard Operating Procedure: Transcription 
Interviews should be transcribed verbatim i.e. written down word for word (including “ums” 
etc.), using the template transcript below. 
Formatting: The template transcript (see below) has been formatted so that each exchange of 
conversation is labelled by the identifier for the person (participant, interviewer) who is 
speaking.  Insert what the person says on the line below their identifier.  Interviewer and 
participant identifiers have been formatted as ‘heading levels’; what people say must be 
formatted as ‘normal’ text.  Insert a line break after what someone says and the next 
identifier.  The start of the transcript is labelled by the participant’s identifier – this label is 
formatted as normal text.  The end of the transcript is demarcated by, “END OF TRANSCRIPT” – 
this has been written as normal text.  All formatting should be left as is. 
 
Identifiers:  The interviewer is Holly Sugg, identifier I-HS.  Participant identifiers contain two 
pieces of information and they are written in the form: MT-XX.  The digits of the participant’s 
trial ID number should replace the XX.  As an example, the identifier for the participant with 
trial ID number MT01 would be ‘MT-01’.  The participant’s trial ID number can be obtained 
from the name of the recording (which are in the format ID number _date of 
interview_interviewer’s initials _post treatment interview_recording] 
 
File labels: Please save transcripts in the form: ID number _date of interview_interviewer’s 
initials _post treatment interview_transcript  E.G. MT01_08.04.15_HS_post treatment 
interview_transcript.   
 
Identifiable participant information: No identifiable data should be recorded.  Where the 
participant reveals identifiable data during the interview (such as the name of the street they 
or a family member lives on), refer to the transcription conventions below.  If the participant 
states a name and you are unsure who they are referring to and thus what information to 
place within brackets, please enter the name into the transcript but highlight it in yellow and 
alert me to it. 
 
Transcription conventions: 
{ } Interviewer and participant talk at same time (place both sections of speech in their own 
brackets) 
[ ] non-verbal utterances e.g. laughter, and to indicate removal of identifiable information 
(e.g. [cough] or [participant’s home town]) 
Xxx unintelligible (please try to decipher speech if at all possible) 
(…) significant pause (2 or more seconds)  
- abrupt cut off or self-interruption 














Insert text here and continue on a new line as required. 
Insert a blank line between the end of this text and the patient’s identifier.  Ensure that the 




Replace XX with the digits of the participant’s trial ID number. 
Insert text here and continue on a new line as required. 
Insert a blank line between the end of this text and the interviewer’s identifier.  Ensure that 





































Examples of the analytic process in the development of themes on the 
acceptability of Morita Therapy to participants 
1. List of initial codes following first-cycle descriptive coding 
Expectations and hopes for treatment 
Seeking someone to talk to and understand 
Seeking something new 
Seeking tools and techniques 
Comparisons to other therapies 
Suits their previous approach 
Understanding purpose and rationale 
Misunderstandings 
Accepting, allowing and being with 
Learning everything passes 
Learning what you can't control 
Losing attachment to emotions 
Normalising emotions 
The ebb and flow of emotions 
Vicious cycle 
Authentic self 
Desires and values 
Nature - general 
Nature - enjoyment 
Conceptualising the self as part of nature 
Understanding through nature 
Understanding through metaphors 
Refocusing attention 
Taking action 
Applying the principles 
Not connecting to the principles 
Interpretation of meaning of phases 
Experiences of rest 
Rest – fear 
Rest - time difficulties 
Experiences of phase 2 
Experiences of phase 3 
Experiences of phase 4 
Diary as difficult 
Diary as helpful 
Fumon 
Holistic 
Aspects of therapy working together 
Instinctive/ experiential changes 
Structure 
Natural, gradual, gentle progression 
Small steps and goals 
Making you think 





Relationship with therapist 
Support system 
Dealing with difficult thoughts 
Impact of treatment 
Impact - confidence 
Impact - less criticism 
Thinking differently 
Coping with and managing emotions 
Longer term solution 
Ongoing process 
Ending treatment 
Session structure and number 
Risk protocol 
AccEPT Clinic/ building issues 
Trial management 
Randomisation  































“Buy into” premise 





















3. Codes categorised into initial thematic framework following second 
cycle pattern coding 
1. Preconceptions, motivations and previous treatment 
     A welcome change to CBT and counselling 
     Seeking something new 
     Compatible expectations 
     Incompatible expectations 
2. Principles: relevance and appeal 
     Accepting, allowing and being with 
     Normalising emotions 
     Nature 
     Taking action 
     Values, desires and authentic self 
     Vicious cycle 
     Exceptions: not connecting to principles 
     Applicability to difficult thoughts 
3. The process of Morita Therapy: Tools for learning vs learning tools 
     Seeking tools and techniques 
     Selecting ongoing resources 
     Mechanisms for accepting and learning 
     Mechanisms to enable action 
     Mechanisms to increase awareness of the vicious cycle 
     Mechanisms to re-focus attention 
     Making you think 
     Holistic approach 
     Natural, gradual, gentle progression 
     Small steps and goals 
     Instinctive/ experiential changes 
4. How challenges become barriers 
     Pressure and burden 
     Time difficulties 
     Personal circumstances 
     Guidance and rationale 
     Misunderstanding 
     Support and opinions of others 
     Reluctance to stop "doing" 
     Discomfort in facing oneself and one's emotions 
     Relationship with therapist 
5. Impact of treatment 
     Accepting, allowing and normalising  
     Acceptance of self and others 
     Breaking the vicious cycle 
     Empowerment 
     Action and purpose-oriented living 
     Continued practice and ongoing process 
     Symptoms and mood 
     Work, social and family life 




     AccEPT clinic/ building issues 
     Trial management 
     Randomisation 
     Impact of trial 











Process:                 











5. Modified thematic framework following review and refinement of coded 
data during continued second cycle pattern coding 
1. Managing incompatible expectations, motivations and understandings 
 Unmet expectations 
 Seeking techniques and cures 
 Misunderstanding and substitution of rationale 
 Applicability to difficult thoughts 
 Incompatibility with Fumon 
 Creating pressure 
2. The principles of Morita Therapy: receptivity and relevance 
 Readiness to accept 
 Identification with the vicious cycle 
 Connection to nature 
 Seeking an action-focus 
 Working with the authentic self 
 Exceptions: disconnect with principles 
3. Approaching Morita Therapy as a process 
 Holistic approach 
 Natural and gentle progression 
 Trusting the process 
 Experience over intellect 
 Making you think 
 Mechanisms for accepting and learning 
 Mechanisms to for transition and refocusing attention 
4. Facilitating the process: (overcoming) challenges and barriers 
 Fear and discomfort 
 Needing safety and support from others  
 Providing guidance and reassurance 
 Therapy as onerous 
5. The value and impact of Morita Therapy 
 A preferable alternative 
 The value of acceptance 
 Breaking the vicious cycle 
 Empowerment and liberation 
 Engagement with life and action 
 Discovering joy 
 Effect on mood and symptoms 
 Wider impact 
6. Trial and measures 
The AccEPT Clinic 
Trial management 
Randomisation 







6. Example framework matrix (theme two: the principles of Morita Therapy: receptivity and relevance) 
  
FINAL CONSTITUENT THEME: READINESS TO 
ACCEPT 
FINAL CONSTITUENT THEME: ATTRACTION TO 








Readiness to accept 
Identification with 














CBT focused on trying to 
change thoughts - the 
Morita focus on accepting 
feelings felt easier to 
understand and connect 
with 
 Attracted to the 
connection to 
nature - using 
nature to help/ 
relating how 
you're feeling to 
natural patterns 
 Looking at what 
he wants to 
achieve and 
building around 






Felt able to accept that 
he gets depressed/ has 
good and bad days - 
resonated to look at this 
within the ebb and flow of 
nature 
 Already enjoyed 
the outdoors so 
using the weather 
as a metaphor 
worked for him 




Appreciated that Morita 
Therapy is not a cure, it's 
about being with and 
allowing unpleasant 
emotions as natural - she 
likes that anxiety is 
natural/ part of who she is 
 Interested pre-





Liked that it’s 
about action, 
it’s very 
practical - she 
understands 
that she can't 
change 
thoughts 
Connected to the 
concept of the 
authentic self - 
thinking about 
how she could 
get back to 
aspects of herself 








Had read about allowing 
anxiety/giving up the 
struggle - this resonated 
with him.  Attracted to 
Morita Therapy because 
it's about treating anxiety 
like any other emotion - 
wanted reinforcement of 
the fact that you can't 
cure it.  CBT helps you 
understand but MT gives 
extra element of not 
treating anxiety as bad or 
wrong 
Already understood 
he had a need to fix 
himself and engaged 
in a vicious cycle of 
rumination/analysis 
(which CBT fed).  
Would not have taken 
part if it had been 
about challenging 
thoughts as he 
considered this 
another battle 
 Was already 
doing things 
despite anxiety 
- doesn't avoid 
things.  "So 
that’s why I 
actually - if I 
was designing 
a therapy, I 
would probably 




 Connection to nature did 
not resonate with him in 
terms of 
appreciating/enjoying 




Expectations here were 
not to be cured.  
Teaching you how to live 
with it is much more 
sensible than the 
impression the NHS gave 
which was that she would 
be cured - that made her 
feel worse 
The vicious cycle 
made sense - the 
concept made a big 
impact/ resonated 
She was "into" 




easy to get into 
this aspect 




Attracted to Morita 
Therapy as way of 
understanding symptoms 
as natural parts of human 
experience and not 
catastrophising them.  
Wanted to live with it, not 
manage it like CBT 
 Attracted to 
Morita Therapy 
as a way of 





 The concept of 
fears and desires 
is useful in 







 "Picking the scab" 
made a big impact 
because she knew 
she did that - the idea 
of 'shoulds' being 
unhelpful resonated 
  Looking at the flip 
side of difficulties 
resonated for her 








Morita Therapy appealed 
in comparison to other 
approaches as she was 
already aware some 
things cannot be changed 




   Happy about 
connection to the 
natural world 
because he 
enjoys being in 
nature already 
  Whilst understood 
principle of ebb and flow 
of emotions, could not 
"feel the flow" as he is "a 
logician, not emotional 
person" - focus of Morita 
Therapy seemed to be 
on emotions, not 
thoughts, thus not 




      Wanted to eliminate 
unpleasant thoughts and 
break the vicious cycle 
by force, thus doesn't 
really understand the 





  Liked idea of 
being part of 
nature 
  Didn't relate to seeing 
emotions like seasons/ 
the weather - they are 
more difficult to deal 






Drawn to the idea of 
accepting difficulties 
because in her past 
experience they have 
come and gone, as per 
the premise of Morita 
Therapy 
Could relate pre-
treatment to principles 
around not pushing 
things away because 
they tend to come 
back - that's what's 
happened throughout 
her life.  Had always 
kept herself busy/ 
distracted self and 
self-harmed - helpful 
to see it within the 
vicious cycle 
  Found the 






seen as "bad" - 
this provided a 
very different way 




Liked idea you cannot 
stop thoughts and 
feelings, in contrast to 
counselling 
Felt talking about 
problems with a 
counsellor just 
highlights them and 
worsens them - the 
Morita Therapy 
approach is more 
valuable 




her - connecting 
with nature/ 
thoughts and 
feelings as part of 
a circle - 
considered this a 
nice way of 
coming to terms 
with your 
feelings.  Already 
found being in 
nature helpful - 
often inspired her 
Part of what 
she sought was 
to get back into 
the world and 







Attracted to the 
idea of being 
nurtured slowly to 
get back to your 
values/ tap into 
the authentic self.  
Wanted to be 
true to her values 
- been looking for 
















Living with it and getting 
on with things appealed 
to her - she knew from 
experience that 
depression comes and 
goes. The  CBT approach 
of changing negative 
thoughts to positive 
thoughts created an 
internal battle - 
acceptance felt a better 
way for her to deal with it 
  Liked the focus 
on doing things 






       Wasn't sure that going 
through the process 
without fighting it was 
"him" - likes to find 
solutions/ not on board 
with the idea that if you 
go through the bad you 
will get to good.  Plus 
felt nature doesn't have 
a brain, it just happens - 






7. Final themes following within-case and cross-case analysis using 
framework matrices 
1. The impact of incompatible expectations and understandings 
 Seeking a solution for symptoms 
 Exploring and expressing the self 
 Failing at the wrong job: the substitution of rationale 
2. Identifying with the principles of Morita Therapy: receptivity and relevance 
 Readiness to accept 
 Attraction to the features of Morita Therapy 
3. Approaching and understanding Morita Therapy as a process 
 Allowing a natural progression 
 Mechanisms: transition and learning 
 Ownership of responsibility: making you think 
4. Facilitating the process: (overcoming) challenges and barriers 
 Fear and discomfort 
 Safety and support from others 
 Providing guidance and reassurance 
 Burden and commitment 
5. The value and impact of Morita Therapy 
 A preferable alternative 
 Relinquishing control: the value of acceptance 
 Transformation: from dwelling to doing 
 Empowerment and liberation 
 Effect on mood and symptoms 
6. Trial and measures 
The AccEPT Clinic 
Trial management 
Randomisation 











Appendix XI: Example page of therapeutic diary 
Date: 
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